{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "initial_id",
   "metadata": {
    "collapsed": true,
    "ExecuteTime": {
     "end_time": "2024-01-29T15:33:47.672034100Z",
     "start_time": "2024-01-29T15:33:17.068287200Z"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "WARNING:tensorflow:From C:\\Users\\omar.wafy\\AppData\\Local\\anaconda3\\Lib\\site-packages\\keras\\src\\losses.py:2976: The name tf.losses.sparse_softmax_cross_entropy is deprecated. Please use tf.compat.v1.losses.sparse_softmax_cross_entropy instead.\n"
     ]
    }
   ],
   "source": [
    "import numpy as np\n",
    "import pandas as pd\n",
    "from transformers import pipeline\n",
    "from AHBS_AIServices import similarity"
   ]
  },
  {
   "cell_type": "markdown",
   "source": [
    "# Read the dose sample data"
   ],
   "metadata": {
    "collapsed": false
   },
   "id": "c7b0ae67b2785da2"
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "outputs": [
    {
     "data": {
      "text/plain": "100"
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(pd.read_excel('data/Dose_sample_100.xlsx'))"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-29T15:37:26.816340400Z",
     "start_time": "2024-01-29T15:37:25.986027300Z"
    }
   },
   "id": "6fadb5ecfd8180ce"
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "outputs": [
    {
     "data": {
      "text/plain": "                 drug_name  Age Range           medical_condition_h3  \\\nUnnamed: 0                                                             \n367         dimenhydrinate      Adult  Prevention of Motion Sickness   \n367         dimenhydrinate      Adult  Prevention of Motion Sickness   \n367         dimenhydrinate      Adult  Prevention of Motion Sickness   \n368         dimenhydrinate      Adult  Meniere's Disease (Off-label)   \n369         dimenhydrinate      Adult  Meniere's Disease (Off-label)   \n...                    ...        ...                            ...   \n20220           vardenafil      Adult           Erectile Dysfunction   \n20221           vardenafil  Geriatric           Erectile Dysfunction   \n20222           vardenafil  Geriatric           Erectile Dysfunction   \n20223           vardenafil  Geriatric           Erectile Dysfunction   \n20224           vardenafil  Geriatric           Erectile Dysfunction   \n\n           medical_condition_h4 medical_condition_h5  \\\nUnnamed: 0                                             \n367                         NaN                  NaN   \n367                         NaN                  NaN   \n367                         NaN                  NaN   \n368                         NaN                  NaN   \n369                         NaN                  NaN   \n...                         ...                  ...   \n20220                       NaN                  NaN   \n20221                       NaN                  NaN   \n20222                       NaN                  NaN   \n20223                       NaN                  NaN   \n20224                       NaN                  NaN   \n\n                                    dose_title dose  dose_range_start  \\\nUnnamed: 0                                                              \n367                                        NaN  NaN              50.0   \n367                                        NaN  NaN              50.0   \n367                                        NaN  NaN              50.0   \n368                                        NaN  NaN              25.0   \n369                                        NaN   50               NaN   \n...                                        ...  ...               ...   \n20220                                      NaN   10               5.0   \n20221                       Film-coated tablet   10               5.0   \n20222       Orally disintegrating tablet (ODT)   10               NaN   \n20223                       Film-coated tablet  NaN               NaN   \n20224                                      NaN    5               NaN   \n\n            dose_range_end dose_unit_new  ... maximum_dose  maximum_dose_unit  \\\nUnnamed: 0                                ...                                   \n367                  100.0            mg  ...          400                NaN   \n367                  100.0            mg  ...          400                NaN   \n367                  100.0            mg  ...          400                NaN   \n368                   50.0            mg  ...          NaN                NaN   \n369                    NaN            mg  ...          NaN                NaN   \n...                    ...           ...  ...          ...                ...   \n20220                 20.0            mg  ...          NaN                NaN   \n20221                 20.0            mg  ...          NaN                NaN   \n20222                  NaN            mg  ...          NaN                NaN   \n20223                  NaN           NaN  ...          NaN                NaN   \n20224                  NaN            mg  ...          NaN                NaN   \n\n           age_range_start  age_range_end age_range_unit  \\\nUnnamed: 0                                                 \n367                    NaN            NaN            NaN   \n367                    NaN            NaN            NaN   \n367                    NaN            NaN            NaN   \n368                    NaN            NaN            NaN   \n369                    NaN            NaN            NaN   \n...                    ...            ...            ...   \n20220                  NaN            NaN            NaN   \n20221                  NaN             65          years   \n20222                  NaN             65          years   \n20223                   65            NaN            NaN   \n20224                   65            NaN            NaN   \n\n           body_weight_range_start body_weight_range_end  \\\nUnnamed: 0                                                 \n367                            NaN                   NaN   \n367                            NaN                   NaN   \n367                            NaN                   NaN   \n368                            NaN                   NaN   \n369                            NaN                   NaN   \n...                            ...                   ...   \n20220                          NaN                   NaN   \n20221                          NaN                   NaN   \n20222                          NaN                   NaN   \n20223                          NaN                   NaN   \n20224                          NaN                   NaN   \n\n           body_weight_range_unit  \\\nUnnamed: 0                          \n367                           NaN   \n367                           NaN   \n367                           NaN   \n368                           NaN   \n369                           NaN   \n...                           ...   \n20220                         NaN   \n20221                         NaN   \n20222                         NaN   \n20223                         NaN   \n20224                         NaN   \n\n                                                    reference  \\\nUnnamed: 0                                                      \n367         50-100 mg PO/IV/IM q4-6hr PRN, 30 minutes befo...   \n367         50-100 mg PO/IV/IM q4-6hr PRN, 30 minutes befo...   \n367         50-100 mg PO/IV/IM q4-6hr PRN, 30 minutes befo...   \n368         25-50 mg PO q8hr for maintenance\\n\\n50 mg IM f...   \n369         25-50 mg PO q8hr for maintenance\\n\\n50 mg IM f...   \n...                                                       ...   \n20220       10 mg PO ~1 hour before sexual activity; may b...   \n20221       <65 years\\n\\nFilm-coated tablet: 10 mg PO ~1 h...   \n20222       <65 years\\n\\nFilm-coated tablet: 10 mg PO ~1 h...   \n20223       <65 years\\n\\nFilm-coated tablet: 10 mg PO ~1 h...   \n20224       <65 years\\n\\nFilm-coated tablet: 10 mg PO ~1 h...   \n\n           administration_notes  \nUnnamed: 0                       \n367                         NaN  \n367                         NaN  \n367                         NaN  \n368                         NaN  \n369                         NaN  \n...                         ...  \n20220                       NaN  \n20221                       NaN  \n20222                       NaN  \n20223                       NaN  \n20224                       NaN  \n\n[4032 rows x 31 columns]",
      "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>drug_name</th>\n      <th>Age Range</th>\n      <th>medical_condition_h3</th>\n      <th>medical_condition_h4</th>\n      <th>medical_condition_h5</th>\n      <th>dose_title</th>\n      <th>dose</th>\n      <th>dose_range_start</th>\n      <th>dose_range_end</th>\n      <th>dose_unit_new</th>\n      <th>...</th>\n      <th>maximum_dose</th>\n      <th>maximum_dose_unit</th>\n      <th>age_range_start</th>\n      <th>age_range_end</th>\n      <th>age_range_unit</th>\n      <th>body_weight_range_start</th>\n      <th>body_weight_range_end</th>\n      <th>body_weight_range_unit</th>\n      <th>reference</th>\n      <th>administration_notes</th>\n    </tr>\n    <tr>\n      <th>Unnamed: 0</th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>367</th>\n      <td>dimenhydrinate</td>\n      <td>Adult</td>\n      <td>Prevention of Motion Sickness</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>50.0</td>\n      <td>100.0</td>\n      <td>mg</td>\n      <td>...</td>\n      <td>400</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>50-100 mg PO/IV/IM q4-6hr PRN, 30 minutes befo...</td>\n      <td>NaN</td>\n    </tr>\n    <tr>\n      <th>367</th>\n      <td>dimenhydrinate</td>\n      <td>Adult</td>\n      <td>Prevention of Motion Sickness</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>50.0</td>\n      <td>100.0</td>\n      <td>mg</td>\n      <td>...</td>\n      <td>400</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>50-100 mg PO/IV/IM q4-6hr PRN, 30 minutes befo...</td>\n      <td>NaN</td>\n    </tr>\n    <tr>\n      <th>367</th>\n      <td>dimenhydrinate</td>\n      <td>Adult</td>\n      <td>Prevention of Motion Sickness</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>50.0</td>\n      <td>100.0</td>\n      <td>mg</td>\n      <td>...</td>\n      <td>400</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>50-100 mg PO/IV/IM q4-6hr PRN, 30 minutes befo...</td>\n      <td>NaN</td>\n    </tr>\n    <tr>\n      <th>368</th>\n      <td>dimenhydrinate</td>\n      <td>Adult</td>\n      <td>Meniere's Disease (Off-label)</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>25.0</td>\n      <td>50.0</td>\n      <td>mg</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>25-50 mg PO q8hr for maintenance\\n\\n50 mg IM f...</td>\n      <td>NaN</td>\n    </tr>\n    <tr>\n      <th>369</th>\n      <td>dimenhydrinate</td>\n      <td>Adult</td>\n      <td>Meniere's Disease (Off-label)</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>50</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>mg</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>25-50 mg PO q8hr for maintenance\\n\\n50 mg IM f...</td>\n      <td>NaN</td>\n    </tr>\n    <tr>\n      <th>...</th>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n    </tr>\n    <tr>\n      <th>20220</th>\n      <td>vardenafil</td>\n      <td>Adult</td>\n      <td>Erectile Dysfunction</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>10</td>\n      <td>5.0</td>\n      <td>20.0</td>\n      <td>mg</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>10 mg PO ~1 hour before sexual activity; may b...</td>\n      <td>NaN</td>\n    </tr>\n    <tr>\n      <th>20221</th>\n      <td>vardenafil</td>\n      <td>Geriatric</td>\n      <td>Erectile Dysfunction</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Film-coated tablet</td>\n      <td>10</td>\n      <td>5.0</td>\n      <td>20.0</td>\n      <td>mg</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>65</td>\n      <td>years</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>&lt;65 years\\n\\nFilm-coated tablet: 10 mg PO ~1 h...</td>\n      <td>NaN</td>\n    </tr>\n    <tr>\n      <th>20222</th>\n      <td>vardenafil</td>\n      <td>Geriatric</td>\n      <td>Erectile Dysfunction</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Orally disintegrating tablet (ODT)</td>\n      <td>10</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>mg</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>65</td>\n      <td>years</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>&lt;65 years\\n\\nFilm-coated tablet: 10 mg PO ~1 h...</td>\n      <td>NaN</td>\n    </tr>\n    <tr>\n      <th>20223</th>\n      <td>vardenafil</td>\n      <td>Geriatric</td>\n      <td>Erectile Dysfunction</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Film-coated tablet</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>65</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>&lt;65 years\\n\\nFilm-coated tablet: 10 mg PO ~1 h...</td>\n      <td>NaN</td>\n    </tr>\n    <tr>\n      <th>20224</th>\n      <td>vardenafil</td>\n      <td>Geriatric</td>\n      <td>Erectile Dysfunction</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>5</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>mg</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>65</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>&lt;65 years\\n\\nFilm-coated tablet: 10 mg PO ~1 h...</td>\n      <td>NaN</td>\n    </tr>\n  </tbody>\n</table>\n<p>4032 rows × 31 columns</p>\n</div>"
     },
     "execution_count": 62,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drug_data=pd.read_excel('data/Final_Drug_dose.xlsx',index_col=0)\n",
    "drug_data"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T09:07:27.132474800Z",
     "start_time": "2024-01-30T09:07:26.352304300Z"
    }
   },
   "id": "b0c9487b93e75028"
  },
  {
   "cell_type": "markdown",
   "source": [
    "# classify the medical_condition_h3 col"
   ],
   "metadata": {
    "collapsed": false
   },
   "id": "60b1bbd65a0e6e4b"
  },
  {
   "cell_type": "code",
   "execution_count": 63,
   "outputs": [],
   "source": [
    "# Specify the model directory\n",
    "model_directory = './models/zero_shot_classifier'\n",
    "\n",
    "# Load the saved pipeline\n",
    "loaded_zero_shot_classifier_pipeline = pipeline(task='zero-shot-classification', model=model_directory)"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T09:07:40.502477100Z",
     "start_time": "2024-01-30T09:07:34.746203100Z"
    }
   },
   "id": "3f2ccbc569cce7b6"
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "outputs": [],
   "source": [
    "candidate_labels= ['medical diagnosis', 'medical procedures or interventions']\n",
    "drug_data['is_medical_diagnosis'] =drug_data['medical_condition_h3'].apply(lambda x:loaded_zero_shot_classifier_pipeline(x,candidate_labels)['labels'][0]=='medical diagnosis')"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T09:33:07.890483600Z",
     "start_time": "2024-01-30T09:07:57.077983100Z"
    }
   },
   "id": "39d300abbad7a3d8"
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "outputs": [
    {
     "data": {
      "text/plain": "                     medical_condition_h3  is_medical_diagnosis\nUnnamed: 0                                                     \n367         Prevention of Motion Sickness                  True\n367         Prevention of Motion Sickness                  True\n367         Prevention of Motion Sickness                  True\n368         Meniere's Disease (Off-label)                  True\n369         Meniere's Disease (Off-label)                  True\n...                                   ...                   ...\n20220                Erectile Dysfunction                  True\n20221                Erectile Dysfunction                  True\n20222                Erectile Dysfunction                  True\n20223                Erectile Dysfunction                  True\n20224                Erectile Dysfunction                  True\n\n[4032 rows x 2 columns]",
      "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>medical_condition_h3</th>\n      <th>is_medical_diagnosis</th>\n    </tr>\n    <tr>\n      <th>Unnamed: 0</th>\n      <th></th>\n      <th></th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>367</th>\n      <td>Prevention of Motion Sickness</td>\n      <td>True</td>\n    </tr>\n    <tr>\n      <th>367</th>\n      <td>Prevention of Motion Sickness</td>\n      <td>True</td>\n    </tr>\n    <tr>\n      <th>367</th>\n      <td>Prevention of Motion Sickness</td>\n      <td>True</td>\n    </tr>\n    <tr>\n      <th>368</th>\n      <td>Meniere's Disease (Off-label)</td>\n      <td>True</td>\n    </tr>\n    <tr>\n      <th>369</th>\n      <td>Meniere's Disease (Off-label)</td>\n      <td>True</td>\n    </tr>\n    <tr>\n      <th>...</th>\n      <td>...</td>\n      <td>...</td>\n    </tr>\n    <tr>\n      <th>20220</th>\n      <td>Erectile Dysfunction</td>\n      <td>True</td>\n    </tr>\n    <tr>\n      <th>20221</th>\n      <td>Erectile Dysfunction</td>\n      <td>True</td>\n    </tr>\n    <tr>\n      <th>20222</th>\n      <td>Erectile Dysfunction</td>\n      <td>True</td>\n    </tr>\n    <tr>\n      <th>20223</th>\n      <td>Erectile Dysfunction</td>\n      <td>True</td>\n    </tr>\n    <tr>\n      <th>20224</th>\n      <td>Erectile Dysfunction</td>\n      <td>True</td>\n    </tr>\n  </tbody>\n</table>\n<p>4032 rows × 2 columns</p>\n</div>"
     },
     "execution_count": 65,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "\n",
    "drug_data[['medical_condition_h3','is_medical_diagnosis']]"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T09:33:07.909182600Z",
     "start_time": "2024-01-30T09:33:07.891481400Z"
    }
   },
   "id": "80585e8c12c0efb9"
  },
  {
   "cell_type": "code",
   "execution_count": 72,
   "outputs": [
    {
     "data": {
      "text/plain": "True     3397\nFalse     635\nName: is_medical_diagnosis, dtype: int64"
     },
     "execution_count": 72,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drug_data['is_medical_diagnosis'].value_counts()"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T09:43:08.426415800Z",
     "start_time": "2024-01-30T09:43:08.329994Z"
    }
   },
   "id": "6b9e25479b7be185"
  },
  {
   "cell_type": "code",
   "execution_count": 70,
   "outputs": [
    {
     "data": {
      "text/plain": "4032"
     },
     "execution_count": 70,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(drug_data)"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T09:36:42.057624200Z",
     "start_time": "2024-01-30T09:36:42.015610800Z"
    }
   },
   "id": "45e2607edb0514aa"
  },
  {
   "cell_type": "markdown",
   "source": [
    "# Read the ICD10 Codes data"
   ],
   "metadata": {
    "collapsed": false
   },
   "id": "1e648719c4c4ec6"
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "outputs": [],
   "source": [],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-29T15:38:13.224081500Z",
     "start_time": "2024-01-29T15:38:13.216467500Z"
    }
   },
   "id": "759964fd6ea1d74d"
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "outputs": [
    {
     "data": {
      "text/plain": "      diseaseCode                                        description\n0           A00.0  certain infectious and parasitic diseases , in...\n1           A00.1  certain infectious and parasitic diseases , in...\n2           A00.9  certain infectious and parasitic diseases , in...\n3          A01.00  certain infectious and parasitic diseases , in...\n4          A01.01  certain infectious and parasitic diseases , in...\n...           ...                                                ...\n50123      Z99.12  factors influencing health status and contact ...\n50124       Z99.2  factors influencing health status and contact ...\n50125       Z99.3  factors influencing health status and contact ...\n50126      Z99.81  factors influencing health status and contact ...\n50127      Z99.89  factors influencing health status and contact ...\n\n[50128 rows x 2 columns]",
      "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>diseaseCode</th>\n      <th>description</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>A00.0</td>\n      <td>certain infectious and parasitic diseases , in...</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>A00.1</td>\n      <td>certain infectious and parasitic diseases , in...</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>A00.9</td>\n      <td>certain infectious and parasitic diseases , in...</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>A01.00</td>\n      <td>certain infectious and parasitic diseases , in...</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>A01.01</td>\n      <td>certain infectious and parasitic diseases , in...</td>\n    </tr>\n    <tr>\n      <th>...</th>\n      <td>...</td>\n      <td>...</td>\n    </tr>\n    <tr>\n      <th>50123</th>\n      <td>Z99.12</td>\n      <td>factors influencing health status and contact ...</td>\n    </tr>\n    <tr>\n      <th>50124</th>\n      <td>Z99.2</td>\n      <td>factors influencing health status and contact ...</td>\n    </tr>\n    <tr>\n      <th>50125</th>\n      <td>Z99.3</td>\n      <td>factors influencing health status and contact ...</td>\n    </tr>\n    <tr>\n      <th>50126</th>\n      <td>Z99.81</td>\n      <td>factors influencing health status and contact ...</td>\n    </tr>\n    <tr>\n      <th>50127</th>\n      <td>Z99.89</td>\n      <td>factors influencing health status and contact ...</td>\n    </tr>\n  </tbody>\n</table>\n<p>50128 rows × 2 columns</p>\n</div>"
     },
     "execution_count": 66,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_codes=pd.read_csv('data/idc10_top_to_leaf_data.csv')\n",
    "df_codes"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T09:33:08.130050600Z",
     "start_time": "2024-01-30T09:33:07.909182600Z"
    }
   },
   "id": "4ff0d8d23c837298"
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "outputs": [
    {
     "data": {
      "text/plain": "      diseaseCode                                        description\n41487         U49  codes for special purposes , provisional assig...\n41488         U50  codes for special purposes , provisional assig...\n41489         U85  codes for special purposes , provisional assig...",
      "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>diseaseCode</th>\n      <th>description</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>41487</th>\n      <td>U49</td>\n      <td>codes for special purposes , provisional assig...</td>\n    </tr>\n    <tr>\n      <th>41488</th>\n      <td>U50</td>\n      <td>codes for special purposes , provisional assig...</td>\n    </tr>\n    <tr>\n      <th>41489</th>\n      <td>U85</td>\n      <td>codes for special purposes , provisional assig...</td>\n    </tr>\n  </tbody>\n</table>\n</div>"
     },
     "execution_count": 67,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_codes[df_codes.duplicated(['description'])]"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T09:33:08.143852900Z",
     "start_time": "2024-01-30T09:33:08.107850600Z"
    }
   },
   "id": "e173e6f21b80c4b5"
  },
  {
   "cell_type": "code",
   "execution_count": 68,
   "outputs": [],
   "source": [
    "# disease_code_dict=dict(zip(df_codes['description'].tolist(),df_codes['diseaseCode'].tolist()))"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T09:33:08.145847200Z",
     "start_time": "2024-01-30T09:33:08.133877Z"
    }
   },
   "id": "f774e57915fc6099"
  },
  {
   "cell_type": "markdown",
   "source": [
    "# Compute the similarity between the two sources"
   ],
   "metadata": {
    "collapsed": false
   },
   "id": "5958c53bc63d716"
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "outputs": [],
   "source": [
    "# similarity_df=pd.DataFrame(similarity.get_sentences_similarity(sentence_list_1=drug_data['medical_condition_h3'],sentence_list_2=df_codes['description'].tolist(),get_score=True),columns=['medical_condition_h3','most_similar_description','similarity_score'])"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-29T15:38:17.547821200Z",
     "start_time": "2024-01-29T15:38:17.537369100Z"
    }
   },
   "id": "6fa6e0cfd64b4759"
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "outputs": [],
   "source": [],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-29T15:38:18.198053100Z",
     "start_time": "2024-01-29T15:38:18.188000800Z"
    }
   },
   "id": "3ae5aae286817056"
  },
  {
   "cell_type": "code",
   "execution_count": 73,
   "outputs": [],
   "source": [
    "similarities=similarity.get_sentences_similarity(sentence_list_1=drug_data['medical_condition_h3'].unique().tolist(),sentence_list_2=df_codes['description'].tolist(),get_score=True)"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T09:46:31.011358Z",
     "start_time": "2024-01-30T09:43:39.346749300Z"
    }
   },
   "id": "6d6e5e6720633cdb"
  },
  {
   "cell_type": "code",
   "execution_count": 73,
   "outputs": [],
   "source": [],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T09:48:23.622388500Z",
     "start_time": "2024-01-30T09:48:23.590930Z"
    }
   },
   "id": "bb9bd5b841e0a73f"
  },
  {
   "cell_type": "code",
   "execution_count": 74,
   "outputs": [
    {
     "data": {
      "text/plain": "810"
     },
     "execution_count": 74,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "similarity_df=pd.DataFrame(similarities,columns=['medical_condition_h3','most_similar_description','similarity_score'])\n",
    "len(similarity_df)"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T09:48:24.243950900Z",
     "start_time": "2024-01-30T09:48:24.210926700Z"
    }
   },
   "id": "96d3d79aa34c8e1e"
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "outputs": [
    {
     "data": {
      "text/plain": "{'Prevention of Motion Sickness': 'injury, poisoning and certain other consequences of external causes , other and unspecified effects of external causes , other and unspecified effects of other external causes , motion sickness , sequela',\n \"Meniere's Disease (Off-label)\": 'diseases of the ear and mastoid process , diseases of inner ear , disorders of vestibular function , ménières disease , bilateral',\n 'Allergic Rhinitis': 'diseases of the respiratory system , other diseases of upper respiratory tract , vasomotor and allergic rhinitis , allergic rhinitis, unspecified',\n 'Urticaria': 'diseases of the skin and subcutaneous tissue , urticaria and erythema , urticaria , idiopathic urticaria',\n 'Allergic Rhinitis & Urticaria': 'diseases of the skin and subcutaneous tissue , urticaria and erythema , urticaria , allergic urticaria',\n 'Chronic Idiopathic Urticaria': 'diseases of the skin and subcutaneous tissue , urticaria and erythema , urticaria , idiopathic urticaria',\n 'Perennial Allergic Rhinitis, Chronic Idiopathic Urticaria': 'diseases of the skin and subcutaneous tissue , urticaria and erythema , urticaria , allergic urticaria',\n 'Cough': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the circulatory and respiratory systems , cough , cough, unspecified',\n 'Anesthesia': 'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , unintended awareness under general anesthesia during procedure , sequela',\n 'MAC Sedation': 'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , failed moderate sedation during procedure , sequela',\n 'Postoperative Nausea/Vomiting': 'diseases of the digestive system , other diseases of the digestive system , intraoperative and postprocedural complications and disorders of digestive system, not elsewhere classified , vomiting following gastrointestinal surgery',\n 'ICU Patient': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , general symptoms and signs , symptoms and signs specifically associated with systemic inflammation and infection , systemic inflammatory response syndrome sirs of non-infectious origin , with acute organ dysfunction',\n 'Anesthesia Induction': 'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , unintended awareness under general anesthesia during procedure , sequela',\n 'Resistant Depression (Off-label)': 'mental, behavioral and neurodevelopmental disorders , mood affective disorders , depressive episode , depression, unspecified',\n 'Sedation/Analgesia (Off-label)': 'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , failed moderate sedation during procedure , sequela',\n 'Subarachnoid block': 'certain conditions originating in the perinatal period , birth trauma , intracranial laceration and hemorrhage due to birth injury , subarachnoid hemorrhage due to birth injury',\n 'Local Anesthesia': 'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , unintended awareness under general anesthesia during procedure , sequela',\n 'Regional Anesthesia': 'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , unintended awareness under general anesthesia during procedure , sequela',\n 'Postsurgical Analgesia for Arthroscopic Subacromial Decompression': 'diseases of the respiratory system , intraoperative and postprocedural complications and disorders of respiratory system, not elsewhere classified , intraoperative and postprocedural complications and disorders of respiratory system, not elsewhere classified , postprocedural subglottic stenosis',\n 'Regional Anesthesia ': 'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , unintended awareness under general anesthesia during procedure , sequela',\n 'Surgery Premedication': 'factors influencing health status and contact with health services , encounters for other specific health care , encounter for other postprocedural aftercare , encounter for other specified postprocedural aftercare , encounter for surgical aftercare following surgery on specified body systems , encounter for surgical aftercare following surgery on the skin and subcutaneous tissue',\n 'General Anesthesia': 'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , unintended awareness under general anesthesia during procedure , sequela',\n 'Analgesia (Off-label)': 'injury, poisoning and certain other consequences of external causes , poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of nonopioid analgesics, antipyretics and antirheumatics , poisoning by, adverse effect of and underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified , poisoning by, adverse effect of and underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified , poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, undetermined , sequela',\n 'Surgery Premedication (Off-label)': 'factors influencing health status and contact with health services , encounters for other specific health care , encounter for prophylactic surgery , encounter for prophylactic surgery for risk factors related to malignant neoplasms , encounter for prophylactic removal of other organ',\n 'Continuous Sedation/Analgesia': 'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , failed moderate sedation during procedure , sequela',\n 'Adjunct Anesthesia': 'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , unintended awareness under general anesthesia during procedure , sequela',\n 'Reversal of Conscious Sedation and General Anesthesia': 'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , failed moderate sedation during procedure , sequela',\n 'Benzodiazepine Overdose': 'injury, poisoning and certain other consequences of external causes , poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of antiepileptic, sedative- hypnotic and antiparkinsonism drugs , poisoning by, adverse effect of and underdosing of benzodiazepines , poisoning by, adverse effect of and underdosing of benzodiazepines , adverse effect of benzodiazepines , sequela',\n 'Reversal of Benzodiazepine Sedation': 'injury, poisoning and certain other consequences of external causes , poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of antiepileptic, sedative- hypnotic and antiparkinsonism drugs , poisoning by, adverse effect of and underdosing of benzodiazepines , poisoning by, adverse effect of and underdosing of benzodiazepines , adverse effect of benzodiazepines , subsequent encounter',\n 'Hypoglycemia': 'endocrine, nutritional and metabolic diseases , diabetes mellitus , type 2 diabetes mellitus , type 2 diabetes mellitus with other specified complications , type 2 diabetes mellitus with hypoglycemia , without coma',\n 'Diagnostic Aid': 'factors influencing health status and contact with health services , persons encountering health services for examinations , encounter for other special examination without complaint, suspected or reported diagnosis , encounter for other specified special examinations , encounter for antibody response examination',\n 'Beta-Blocker & Calcium Channel Blocker Toxicity (Off-label)': 'injury, poisoning and certain other consequences of external causes , poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system , poisoning by, adverse effect of and underdosing of calcium-channel blockers , poisoning by, adverse effect of and underdosing of calcium-channel blockers , poisoning by calcium-channel blockers, undetermined , sequela',\n 'Neurocysticercosis (Taenia Solium Tapeworm)': 'certain infectious and parasitic diseases , helminthiases , taeniasis , taenia solium taeniasis',\n 'Hydatid (Echinococcus Tapeworm)': 'certain infectious and parasitic diseases , helminthiases , echinococcosis , echinococcus multilocularis infection, unspecified',\n 'Ancylostoma, Ascariasis, Hookworm, Trichostrongylus': 'certain infectious and parasitic diseases , helminthiases , hookworm diseases , ancylostomiasis',\n 'Capillariasis': 'diseases of the circulatory system , diseases of arteries, arterioles and capillaries , diseases of capillaries , disease of capillaries, unspecified',\n 'Larva Migrans, Cutaneous & Trichuriasis': 'certain infectious and parasitic diseases , helminthiases , trichuriasis',\n 'Larva Migrans, Visceral': 'certain infectious and parasitic diseases , helminthiases , other helminthiases , visceral larva migrans',\n 'Enterobius (Pinworm)': 'certain infectious and parasitic diseases , intestinal infectious diseases , other bacterial intestinal infections , campylobacter enteritis',\n 'Fluke (Clonorchis Sinensis)': 'certain infectious and parasitic diseases , helminthiases , other fluke infections , clonorchiasis',\n 'Gnathostomiasis, Microsporidiosis': 'certain infectious and parasitic diseases , helminthiases , other helminthiases , gnathostomiasis',\n 'Ancylostoma, Ascariasis, Hookworm, Trichostrongylus ': 'certain infectious and parasitic diseases , helminthiases , hookworm diseases , ancylostomiasis',\n 'Schistosomiasis': 'certain infectious and parasitic diseases , helminthiases , schistosomiasis bilharziasis , schistosomiasis due to schistosoma mansoni intestinal schistosomiasis',\n 'Clonorchiasis, Opisthorchiasis': 'certain infectious and parasitic diseases , helminthiases , other fluke infections , clonorchiasis',\n 'Cysticercosis (Off-label)': 'certain infectious and parasitic diseases , helminthiases , cysticercosis , cysticercosis, unspecified',\n 'Tapeworms (Off-label)': 'certain infectious and parasitic diseases , helminthiases , hookworm diseases , hookworm disease, unspecified',\n 'Pinworm (Enterobius vermicularis)': 'certain infectious and parasitic diseases , intestinal infectious diseases , amebiasis , ameboma of intestine',\n 'Roundworm (Ascaris lumbricoides)': 'certain infectious and parasitic diseases , helminthiases , ascariasis , ascariasis, unspecified',\n 'Whipworm (Trichuris trichiura)': 'certain infectious and parasitic diseases , helminthiases , trichuriasis',\n 'Hookworm (Ancylostoma duodenale, Necator americanus)': 'certain infectious and parasitic diseases , helminthiases , hookworm diseases , ancylostomiasis',\n 'Giardia Duodenalis (Giardiasis; Off-label)': 'certain infectious and parasitic diseases , intestinal infectious diseases , other protozoal intestinal diseases , giardiasis lambliasis',\n 'Mansonella Perstans (Filariasis; Off-label))': 'certain infectious and parasitic diseases , helminthiases , filariasis , mansonelliasis',\n 'Visceral Larva Migrans (Toxocariasis; Off-label)': 'certain infectious and parasitic diseases , protozoal diseases , toxoplasmosis , toxoplasmosis, unspecified',\n 'Candidemia': 'certain infectious and parasitic diseases , mycoses , candidiasis , candidiasis, unspecified',\n 'Esophageal Candidiasis': 'certain infectious and parasitic diseases , mycoses , candidiasis , candidiasis of other sites , candidal esophagitis',\n 'Candida auris (Off-label)': 'certain infectious and parasitic diseases , mycoses , candidiasis , candidiasis of vulva and vagina , acute candidiasis of vulva and vagina',\n 'Candidemia ': 'certain infectious and parasitic diseases , mycoses , candidiasis , candidiasis, unspecified',\n 'Candida Infections': 'certain infectious and parasitic diseases , mycoses , candidiasis , candidiasis, unspecified',\n 'Invasive Aspergillosis': 'certain infectious and parasitic diseases , mycoses , aspergillosis , invasive pulmonary aspergillosis',\n 'Febrile Neutropenia': 'diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism , other disorders of blood and blood-forming organs , neutropenia , neutropenia due to infection',\n 'Treatment of candidemia, acute disseminated candidiasis, candida peritonitis and abscesses': 'certain infectious and parasitic diseases , mycoses , candidiasis , candidal sepsis',\n 'Treatment of Esophageal Candidiasis': 'certain infectious and parasitic diseases , mycoses , candidiasis , candidiasis of other sites , candidal esophagitis',\n 'Prophylaxis of Candida Infections in HSCT Recipients': 'certain infectious and parasitic diseases , mycoses , candidiasis , candidiasis of vulva and vagina , acute candidiasis of vulva and vagina',\n 'Invasive Mucormycosis': 'certain infectious and parasitic diseases , mycoses , zygomycosis , disseminated mucormycosis',\n 'Oropharyngeal Candidiasis': 'certain infectious and parasitic diseases , mycoses , candidiasis , candidiasis, unspecified',\n 'Cryptococcal Meningitis': 'certain infectious and parasitic diseases , mycoses , cryptococcosis , cutaneous cryptococcosis',\n 'Prophylaxis of Candidiasis with BMT': 'certain infectious and parasitic diseases , mycoses , candidiasis , candidiasis, unspecified',\n 'Vaginal Candidiasis': 'certain infectious and parasitic diseases , mycoses , candidiasis , candidiasis of vulva and vagina , chronic candidiasis of vulva and vagina',\n 'Candida UTI/Peritonitis': 'certain infectious and parasitic diseases , mycoses , candidiasis , candidiasis of skin and nail',\n 'Systemic Candida Infections': 'certain infectious and parasitic diseases , mycoses , candidiasis , candidal sepsis',\n 'Premature Neonates': 'certain conditions originating in the perinatal period , disorders of newborn related to length of gestation and fetal growth , disorders of newborn related to short gestation and low birth weight, not elsewhere classified , preterm premature newborn other , preterm newborn, gestational age 29 completed weeks',\n 'Life-threatening Infections': 'certain infectious and parasitic diseases , other bacterial diseases , bacterial infection of unspecified site , bacterial infection, unspecified',\n 'Blastomycosis': 'certain infectious and parasitic diseases , mycoses , blastomycosis , other forms of blastomycosis , other forms of blastomycosis',\n 'Aspergillosis': 'certain infectious and parasitic diseases , mycoses , aspergillosis , aspergillosis, unspecified',\n 'Histoplasmosis': 'certain infectious and parasitic diseases , mycoses , histoplasmosis , histoplasmosis, unspecified',\n 'Onychomycosis': 'certain infectious and parasitic diseases , mycoses , chromomycosis and pheomycotic abscess , cutaneous chromomycosis',\n 'Candidiasis': 'certain infectious and parasitic diseases , mycoses , candidiasis , candidiasis, unspecified',\n 'Serious Fungal Infections': 'certain infectious and parasitic diseases , mycoses , candidiasis , candidiasis, unspecified',\n 'Dosage Modification': 'injury, poisoning and certain other consequences of external causes , poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of diuretics and other and unspecified drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of antidotes and chelating agents , poisoning by, adverse effect of and underdosing of antidotes and chelating agents , adverse effect of antidotes and chelating agents , sequela',\n 'Susceptible Fungal Infections (Off-label, Aged 2-12 yr)': 'certain infectious and parasitic diseases , mycoses , candidiasis , candidiasis, unspecified',\n 'Acute Malaria Infections': 'certain infectious and parasitic diseases , protozoal diseases , unspecified malaria',\n 'Malaria Prevention': 'certain infectious and parasitic diseases , protozoal diseases , unspecified malaria',\n 'Amebiasis, Intestinal': 'certain infectious and parasitic diseases , intestinal infectious diseases , amebiasis , ameboma of intestine',\n 'Amebic Liver Abscess': 'certain infectious and parasitic diseases , intestinal infectious diseases , amebiasis , amebic liver abscess',\n 'Giardiasis or Trichomoniasis': 'certain infectious and parasitic diseases , intestinal infectious diseases , other protozoal intestinal diseases , giardiasis lambliasis',\n 'Bacterial Vaginosis (Nonpregnant)': 'diseases of the genitourinary system , noninflammatory disorders of female genital tract , menopausal and other perimenopausal disorders , postmenopausal atrophic vaginitis',\n 'Giardiasis': 'certain infectious and parasitic diseases , intestinal infectious diseases , other protozoal intestinal diseases , giardiasis lambliasis',\n 'Latent Tuberculosis Infection': 'certain infectious and parasitic diseases , tuberculosis , respiratory tuberculosis , respiratory tuberculosis unspecified',\n 'Active Tuberculosis Disease': 'certain infectious and parasitic diseases , tuberculosis , respiratory tuberculosis , respiratory tuberculosis unspecified',\n 'Tuberculosis Treatment For HIV Negative': 'certain infectious and parasitic diseases , tuberculosis , respiratory tuberculosis , primary respiratory tuberculosis',\n 'Tuberculosis Treatment For HIV Exposed/Infected': 'certain infectious and parasitic diseases , tuberculosis , respiratory tuberculosis , tuberculous pleurisy',\n 'Tuberculosis Treatment': 'certain infectious and parasitic diseases , tuberculosis , respiratory tuberculosis , respiratory tuberculosis unspecified',\n 'Cytomegalovirus Retinitis': 'certain infectious and parasitic diseases , other viral diseases , cytomegaloviral disease , cytomegaloviral pneumonitis',\n 'CMV Colitis or Esophagitis in HIV-Infected Patients (Off-label)': 'diseases of the digestive system , noninfective enteritis and colitis , ulcerative colitis , other ulcerative colitis , without complications',\n 'CMV Prevention in Solid Organ Transplant ': 'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , complications of transplanted organs and tissue , complication of unspecified transplanted organ and tissue , unspecified transplanted organ and tissue infection',\n 'CMV Prevention in Kidney & Heart Transplant ': 'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , complications of transplanted organs and tissue , complications of heart transplant , heart transplant infection',\n 'Influenza A and B Prophylaxis': 'diseases of the respiratory system , influenza and pneumonia , pneumonia, unspecified organism , hypostatic pneumonia, unspecified organism',\n 'Influenza A and B Treatment': 'diseases of the respiratory system , influenza and pneumonia , bacterial pneumonia, not elsewhere classified , pneumonia due to streptococcus, group b',\n 'H1N1 Influenza A (Swine Flu) Prophylaxis (Off-label)': 'diseases of the respiratory system , influenza and pneumonia , influenza due to certain identified influenza viruses , influenza due to identified novel influenza a virus , with gastrointestinal manifestations',\n 'H1N1 Influenza A (Swine Flu) Treatment (Off-label)': 'diseases of the respiratory system , influenza and pneumonia , influenza due to certain identified influenza viruses , influenza due to identified novel influenza a virus , with gastrointestinal manifestations',\n 'Influenza A and B Prophylaxis ': 'diseases of the respiratory system , influenza and pneumonia , pneumonia, unspecified organism , hypostatic pneumonia, unspecified organism',\n 'H1N1 Influenza A (Swine Flu) Prophylaxis (Off-label) ': 'diseases of the respiratory system , influenza and pneumonia , influenza due to certain identified influenza viruses , influenza due to identified novel influenza a virus , with gastrointestinal manifestations',\n 'Acute Herpes Zoster (Shingles)': 'certain infectious and parasitic diseases , viral infections characterized by skin and mucous membrane lesions , zoster herpes zoster , disseminated zoster',\n 'Genital Herpes': 'certain infectious and parasitic diseases , infections with a predominantly sexual mode of transmission , anogenital herpesviral herpes simplex infections , herpesviral infection of genitalia and urogenital tract , herpesviral cervicitis',\n 'Herpes (HIV-Infected Adults)': 'certain infectious and parasitic diseases , other human herpesviruses , other human herpesviruses , other human herpesvirus infection , human herpesvirus 6 infection',\n 'Dosing Modifications': 'injury, poisoning and certain other consequences of external causes , poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of hormones and their synthetic substitutes and antagonists, not elsewhere classified , poisoning by, adverse effect of and underdosing of other and unspecified hormones and synthetic substitutes , poisoning by, adverse effect of and underdosing of unspecified hormones and synthetic substitutes , underdosing of unspecified hormones and synthetic substitutes , sequela',\n 'Genital Herpes (Off-label)': 'certain infectious and parasitic diseases , infections with a predominantly sexual mode of transmission , anogenital herpesviral herpes simplex infections , herpesviral infection of genitalia and urogenital tract , herpesviral cervicitis',\n 'Complicated Skin/Skin Structure Infections': 'certain infectious and parasitic diseases , viral infections characterized by skin and mucous membrane lesions , herpesviral herpes simplex infections , herpesviral vesicular dermatitis',\n 'Complicated Intra-abdominal Infections': 'certain infectious and parasitic diseases , intestinal infectious diseases , other bacterial intestinal infections , bacterial intestinal infection, unspecified',\n 'Community-Acquired Pneumonia (Off-label)': 'diseases of the respiratory system , influenza and pneumonia , viral pneumonia, not elsewhere classified , viral pneumonia, unspecified',\n 'Febrile Neutropenia (Off-label)': 'diseases of the skin and subcutaneous tissue , other disorders of the skin and subcutaneous tissue , other disorders of skin and subcutaneous tissue, not elsewhere classified , febrile neutrophilic dermatosis sweet',\n 'Bacterial Meningitis': 'certain infectious and parasitic diseases , other bacterial diseases , meningococcal infection , meningococcal meningitis',\n 'Moderate-to-Severe Infections': 'certain infectious and parasitic diseases , intestinal infectious diseases , other salmonella infections , salmonella infection, unspecified',\n 'Mild Infections With Gram-Positive Cocci': 'certain infectious and parasitic diseases , mycoses , coccidioidomycosis , other forms of coccidioidomycosis , other forms of coccidioidomycosis',\n 'Mild-to-Moderate Cholecystitis': 'diseases of the eye and adnexa , disorders of choroid and retina , chorioretinal inflammation , posterior cyclitis , bilateral',\n 'Uncomplicated Urinary Tract Infection': 'certain conditions originating in the perinatal period , infections specific to the perinatal period , other infections specific to the perinatal period , neonatal urinary tract infection',\n 'Preparation for Surgery': 'factors influencing health status and contact with health services , encounters for other specific health care , encounter for prophylactic surgery , encounter for prophylactic surgery for risk factors related to malignant neoplasms , encounter for prophylactic removal of other organ',\n 'Bacterial Keratitis (Off-label) ': 'diseases of the skin and subcutaneous tissue , other disorders of the skin and subcutaneous tissue , keratoderma in diseases classified elsewhere',\n 'Infections With Gram-Positive Cocci': 'certain infectious and parasitic diseases , mycoses , coccidioidomycosis , other forms of coccidioidomycosis , other forms of coccidioidomycosis',\n 'Endocarditis': 'diseases of the circulatory system , other forms of heart disease , acute and subacute endocarditis , acute and subacute infective endocarditis',\n 'Community-Acquired Pneumonia': 'diseases of the respiratory system , influenza and pneumonia , viral pneumonia, not elsewhere classified , viral pneumonia, unspecified',\n 'Pharyngitis': 'diseases of the respiratory system , acute upper respiratory infections , acute pharyngitis , acute pharyngitis, unspecified',\n 'Skin & Skin Structure Infections': 'certain infectious and parasitic diseases , viral infections characterized by skin and mucous membrane lesions , herpesviral herpes simplex infections , herpesviral vesicular dermatitis',\n 'Tonsillitis': 'diseases of the respiratory system , acute upper respiratory infections , acute tonsillitis , acute tonsillitis, unspecified , acute recurrent tonsillitis, unspecified',\n 'Urinary Tract Infections': 'certain conditions originating in the perinatal period , infections specific to the perinatal period , other infections specific to the perinatal period , neonatal urinary tract infection',\n 'Susceptible Infections': 'certain infectious and parasitic diseases , other bacterial diseases , bacterial infection of unspecified site , bacterial infection, unspecified',\n 'Streptococcal Pharyngitis': 'diseases of the respiratory system , acute upper respiratory infections , acute pharyngitis , streptococcal pharyngitis',\n 'Lower Respiratory Tract Infections': 'diseases of the respiratory system , other acute lower respiratory infections , unspecified acute lower respiratory infection',\n 'Otitis Media ': 'diseases of the ear and mastoid process , diseases of middle ear and mastoid , suppurative and unspecified otitis media , otitis media, unspecified , unspecified ear',\n 'Uncomplicated Skin and Skin Structure Infections': 'certain infectious and parasitic diseases , viral infections characterized by skin and mucous membrane lesions , unspecified viral infection characterized by skin and mucous membrane lesions',\n 'Bronchitis': 'diseases of the respiratory system , chronic lower respiratory diseases , unspecified chronic bronchitis',\n 'Pharyngitis and Tonsillitis': 'diseases of the respiratory system , acute upper respiratory infections , acute pharyngitis , acute pharyngitis, unspecified',\n 'Otitis Media': 'diseases of the ear and mastoid process , diseases of middle ear and mastoid , suppurative and unspecified otitis media , otitis media, unspecified , unspecified ear',\n 'Pharyngitis & Tonsillitis': 'diseases of the respiratory system , acute upper respiratory infections , acute pharyngitis , acute pharyngitis, unspecified',\n 'Respiratory Tract Infections': 'diseases of the respiratory system , other acute lower respiratory infections , unspecified acute lower respiratory infection',\n 'Skin Infections': 'certain infectious and parasitic diseases , viral infections characterized by skin and mucous membrane lesions , herpesviral herpes simplex infections , herpesviral vesicular dermatitis',\n 'Acute Otitis Media': 'diseases of the ear and mastoid process , diseases of middle ear and mastoid , nonsuppurative otitis media , acute serous otitis media , left ear',\n 'Acute Sinusitis': 'diseases of the respiratory system , acute upper respiratory infections , acute sinusitis , acute ethmoidal sinusitis , unspecified',\n 'Acute Maxillary Sinusitis': 'diseases of the respiratory system , acute upper respiratory infections , acute sinusitis , acute maxillary sinusitis , acute recurrent maxillary sinusitis',\n 'Skin/Skin Structure Infections': 'certain infectious and parasitic diseases , viral infections characterized by skin and mucous membrane lesions , herpesviral herpes simplex infections , herpesviral vesicular dermatitis',\n 'Acute Bacterial Otitis Media ': 'diseases of the ear and mastoid process , diseases of middle ear and mastoid , nonsuppurative otitis media , acute serous otitis media , left ear',\n 'Pharyngitis/Tonsillitis': 'diseases of the respiratory system , acute upper respiratory infections , acute pharyngitis , acute pharyngitis, unspecified',\n 'Acute Exacerbations of Chronic Bronchitis': 'diseases of the respiratory system , chronic lower respiratory diseases , bronchiectasis , bronchiectasis with acute exacerbation',\n 'Uncomplicated Gonorrhea': 'certain infectious and parasitic diseases , infections with a predominantly sexual mode of transmission , gonococcal infection , other gonococcal infections , gonococcal pneumonia',\n 'Uncomplicated Urinary Tract Infections': 'certain conditions originating in the perinatal period , infections specific to the perinatal period , other infections specific to the perinatal period , neonatal urinary tract infection',\n 'Typhoid Fever (Off-label)': 'certain infectious and parasitic diseases , intestinal infectious diseases , typhoid and paratyphoid fevers , typhoid fever , unspecified',\n 'Acute Bronchitis & Acute Exacerbations of Chronic Bronchitis': 'diseases of the respiratory system , other acute lower respiratory infections , acute bronchitis , acute bronchitis, unspecified',\n 'Gonococcal Urethritis/Cervicitis': 'certain infectious and parasitic diseases , infections with a predominantly sexual mode of transmission , gonococcal infection , gonococcal pelviperitonitis and other gonococcal genitourinary infection , gonococcal infection of kidney and ureter',\n 'Gonorrhea, Rectal': 'certain infectious and parasitic diseases , infections with a predominantly sexual mode of transmission , gonococcal infection , gonococcal infection of anus and rectum',\n 'Infections Caused by Susceptible Organisms': 'certain infectious and parasitic diseases , other bacterial diseases , bacterial infection of unspecified site , bacterial infection, unspecified',\n 'Epiglottitis': 'diseases of the respiratory system , acute upper respiratory infections , acute obstructive laryngitis croup and epiglottitis , acute epiglottitis , with obstruction',\n 'Meningitis': 'certain infectious and parasitic diseases , other bacterial diseases , meningococcal infection , meningococcal meningitis',\n 'Pneumonia': 'diseases of the respiratory system , influenza and pneumonia , pneumonia, unspecified organism , pneumonia, unspecified organism',\n 'Sepsis': 'certain infectious and parasitic diseases , other bacterial diseases , streptococcal sepsis , sepsis due to streptococcus, group a',\n 'Typhoid Fever': 'certain infectious and parasitic diseases , intestinal infectious diseases , typhoid and paratyphoid fevers , typhoid fever , unspecified',\n 'Acute Community-Acquired Pneumonia': 'diseases of the respiratory system , influenza and pneumonia , viral pneumonia, not elsewhere classified , viral pneumonia, unspecified',\n 'Gonorrhea': 'certain infectious and parasitic diseases , infections with a predominantly sexual mode of transmission , gonococcal infection , other gonococcal infections , gonococcal pneumonia',\n 'General Dosage Range': 'external causes of morbidity , misadventures to patients during surgical and medical care , failure in dosage during surgical and medical care , failure in dosage during unspecified surgical and medical care',\n 'Chronic Bronchitis, Bacterial Exacerbation': 'diseases of the respiratory system , chronic lower respiratory diseases , unspecified chronic bronchitis',\n 'Cystitis, Acute Uncomplicated': 'diseases of the genitourinary system , other diseases of the urinary system , cystitis , acute cystitis , without hematuria',\n 'Bone & Joint Infections': 'diseases of the musculoskeletal system and connective tissue , infectious arthropathies , direct infections of joint in infectious and parasitic diseases classified elsewhere , direct infection of joint in infectious and parasitic diseases classified elsewhere , direct infection of vertebrae in infectious and parasitic diseases classified elsewhere',\n 'Gynecologic & Intra-abdominal Infections': 'diseases of the genitourinary system , noninflammatory disorders of female genital tract , other abnormal uterine and vaginal bleeding , pre-pubertal vaginal bleeding',\n 'Pulmonary Infections': 'diseases of the respiratory system , other acute lower respiratory infections , unspecified acute lower respiratory infection',\n 'Mild Skin/Skin Structure Infections': 'certain infectious and parasitic diseases , viral infections characterized by skin and mucous membrane lesions , herpesviral herpes simplex infections , herpesviral vesicular dermatitis',\n 'Life-Threatening Infections': 'certain infectious and parasitic diseases , other bacterial diseases , bacterial infection of unspecified site , bacterial infection, unspecified',\n 'Intra-abdominal Infections': 'certain infectious and parasitic diseases , intestinal infectious diseases , other bacterial intestinal infections , bacterial intestinal infection, unspecified',\n 'Acute Bacterial Otitis Media': 'diseases of the ear and mastoid process , diseases of middle ear and mastoid , nonsuppurative otitis media , acute serous otitis media , left ear',\n 'Pelvic Inflammatory Disease': 'diseases of the genitourinary system , inflammatory diseases of female pelvic organs , female pelvic inflammatory disorders in diseases classified elsewhere',\n 'Prosthetic Joint Infection': 'diseases of the musculoskeletal system and connective tissue , infectious arthropathies , direct infections of joint in infectious and parasitic diseases classified elsewhere , direct infection of joint in infectious and parasitic diseases classified elsewhere , direct infection of knee in infectious and parasitic diseases classified elsewhere , direct infection of unspecified knee in infectious and parasitic diseases classified elsewhere',\n 'Acute Uncomplicated Pyelonephritis': 'diseases of the genitourinary system , renal tubulo-interstitial diseases , acute pyelonephritis',\n 'Surgical Prophylaxis': 'factors influencing health status and contact with health services , encounters for other specific health care , encounter for prophylactic surgery , encounter for prophylactic surgery, unspecified',\n 'Uncomplicated Gonococcal Infections': 'certain infectious and parasitic diseases , infections with a predominantly sexual mode of transmission , gonococcal infection , other gonococcal infections , gonococcal pneumonia',\n 'Septic/toxic Shock (Off-label)': 'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , complications of procedures, not elsewhere classified , postprocedural shock , postprocedural septic shock , sequela',\n 'Acute Epididymitis (Off-label)': 'diseases of the genitourinary system , diseases of male genital organs , orchitis and epididymitis , epididymitis',\n 'Skin and Soft Necrotizing Infection (Off-label)': 'certain infectious and parasitic diseases , viral infections characterized by skin and mucous membrane lesions , unspecified viral infection characterized by skin and mucous membrane lesions',\n 'Severe Acute Bacterial Rhinosinusitis (Off-label)': 'diseases of the respiratory system , acute upper respiratory infections , acute sinusitis , acute frontal sinusitis , unspecified',\n 'Other Gonococcal Infections (Off-label)': 'certain infectious and parasitic diseases , infections with a predominantly sexual mode of transmission , gonococcal infection , other gonococcal infections , gonococcal pneumonia',\n 'Epiglottis (Off-label)': 'diseases of the respiratory system , acute upper respiratory infections , acute obstructive laryngitis croup and epiglottitis , acute epiglottitis , with obstruction',\n 'Serious Infections Other Than Meningitis': 'certain infectious and parasitic diseases , other bacterial diseases , meningococcal infection , meningococcal meningitis',\n 'Gonococcal Infections': 'certain infectious and parasitic diseases , infections with a predominantly sexual mode of transmission , gonococcal infection , gonococcal pharyngitis',\n 'Chronic Bacterial Prostatitis': 'diseases of the genitourinary system , diseases of male genital organs , inflammatory diseases of prostate , chronic prostatitis',\n 'Infectious Diarrhea': 'certain infectious and parasitic diseases , intestinal infectious diseases , infectious gastroenteritis and colitis, unspecified',\n 'Empirical Therapy in Febrile Neutropenic Patients': 'diseases of the skin and subcutaneous tissue , other disorders of the skin and subcutaneous tissue , other disorders of skin and subcutaneous tissue, not elsewhere classified , febrile neutrophilic dermatosis sweet',\n 'Nosocomial Pneumonia': 'certain conditions originating in the perinatal period , respiratory and cardiovascular disorders specific to the perinatal period , congenital pneumonia , congenital pneumonia due to other bacterial agents',\n 'Urethral & Cervical Gonococcal Infections': 'certain infectious and parasitic diseases , infections with a predominantly sexual mode of transmission , gonococcal infection , gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess , gonococcal cystitis and urethritis, unspecified',\n 'Anthrax Infection': 'certain infectious and parasitic diseases , certain zoonotic bacterial diseases , anthrax , cutaneous anthrax',\n 'Plague': 'certain infectious and parasitic diseases , certain zoonotic bacterial diseases , plague , plague, unspecified',\n 'Complicated Urinary Tract Infections or Pyelonephritis': 'diseases of the genitourinary system , renal tubulo-interstitial diseases , acute pyelonephritis',\n 'Cholera': 'certain infectious and parasitic diseases , intestinal infectious diseases , cholera , cholera, unspecified',\n 'Inhalational Anthrax (Off-label)': 'certain infectious and parasitic diseases , certain zoonotic bacterial diseases , anthrax , pulmonary anthrax',\n 'Cystic Fibrosis (Off-label)': 'endocrine, nutritional and metabolic diseases , metabolic disorders , cystic fibrosis , cystic fibrosis with other manifestations',\n 'Staphylococcal Enterocolitis': 'certain infectious and parasitic diseases , bacterial and viral infectious agents , streptococcus, staphylococcus, and enterococcus as the cause of diseases classified elsewhere , enterococcus as the cause of diseases classified elsewhere',\n 'Clostridium difficile-associated Diarrhea': 'certain infectious and parasitic diseases , intestinal infectious diseases , other bacterial intestinal infections , enterocolitis due to clostridium difficile , recurrent',\n 'Skin and Skin Structure Infections': 'certain infectious and parasitic diseases , viral infections characterized by skin and mucous membrane lesions , herpesviral herpes simplex infections , herpesviral vesicular dermatitis',\n 'Bone Infections': 'diseases of the musculoskeletal system and connective tissue , other osteopathies , osteomyelitis , acute hematogenous osteomyelitis , other sites',\n 'Preoperative Antimicrobial Prophylaxis (Off-label)': 'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , complications of procedures, not elsewhere classified , infection following a procedure , infection following a procedure, deep incisional surgical site , subsequent encounter',\n 'Surgical Prophylaxis (Off-label)': 'factors influencing health status and contact with health services , encounters for other specific health care , encounter for prophylactic surgery , encounter for prophylactic surgery for risk factors related to malignant neoplasms , encounter for prophylactic removal of other organ',\n 'Infective Endocarditis': 'diseases of the circulatory system , other forms of heart disease , acute and subacute endocarditis , acute and subacute infective endocarditis',\n 'Septicemia': 'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , complications of procedures, not elsewhere classified , postprocedural shock , postprocedural septic shock , sequela',\n 'Other Infections': 'certain infectious and parasitic diseases , other bacterial diseases , meningococcal infection , other meningococcal infections , other meningococcal infections',\n 'Complicated Skin Infections': 'certain infectious and parasitic diseases , viral infections characterized by skin and mucous membrane lesions , herpesviral herpes simplex infections , herpesviral vesicular dermatitis',\n 'HIV Infection': 'certain infectious and parasitic diseases , human immunodeficiency virus hiv disease , human immunodeficiency virus hiv disease',\n 'Chronic Hepatitis B': 'certain infectious and parasitic diseases , viral hepatitis , chronic viral hepatitis , chronic viral hepatitis b without delta-agent',\n 'Renal Impairment': 'diseases of the genitourinary system , other disorders of kidney and ureter , disorders resulting from impaired renal tubular function , disorder resulting from impaired renal tubular function, unspecified',\n 'Staphylococcus Aureus Bacteremia': 'certain conditions originating in the perinatal period , infections specific to the perinatal period , bacterial sepsis of newborn , sepsis of newborn due to staphylococcus aureus',\n 'Complicated Skin and Skin Structure Infections': 'certain infectious and parasitic diseases , viral infections characterized by skin and mucous membrane lesions , unspecified viral infection characterized by skin and mucous membrane lesions',\n 'Complicated Skin & Skin Structure Infections': 'certain infectious and parasitic diseases , viral infections characterized by skin and mucous membrane lesions , unspecified viral infection characterized by skin and mucous membrane lesions',\n 'Acute Exacerbation of Chronic Bronchitis': 'diseases of the respiratory system , chronic lower respiratory diseases , bronchiectasis , bronchiectasis with acute exacerbation',\n 'Mycobacterial Infection': 'certain infectious and parasitic diseases , other bacterial diseases , infection due to other mycobacteria , mycobacterial infection, unspecified',\n 'Peptic Ulcer Disease': 'diseases of the digestive system , diseases of esophagus, stomach and duodenum , peptic ulcer, site unspecified , acute peptic ulcer, site unspecified, with both hemorrhage and perforation',\n 'Pharyngitis, Tonsillitis': 'diseases of the respiratory system , acute upper respiratory infections , acute pharyngitis , acute pharyngitis, unspecified',\n 'Skin/Skin Structure Infection': 'certain infectious and parasitic diseases , viral infections characterized by skin and mucous membrane lesions , herpesviral herpes simplex infections , herpesviral vesicular dermatitis',\n 'Pertussis (Off-label)': 'certain infectious and parasitic diseases , other bacterial diseases , whooping cough , whooping cough due to bordetella pertussis , without pneumonia',\n 'Endocarditis (Off-label)': 'diseases of the circulatory system , other forms of heart disease , acute and subacute endocarditis , acute and subacute infective endocarditis',\n 'Sinusitis': 'diseases of the respiratory system , acute upper respiratory infections , acute sinusitis , acute frontal sinusitis , unspecified',\n 'Bacterial Vaginosis': 'diseases of the genitourinary system , inflammatory diseases of female pelvic organs , other inflammation of vagina and vulva , acute vaginitis',\n 'Trichomoniasis ': 'certain infectious and parasitic diseases , infections with a predominantly sexual mode of transmission , trichomoniasis , trichomoniasis, unspecified',\n 'Trichomoniasis': 'certain infectious and parasitic diseases , infections with a predominantly sexual mode of transmission , trichomoniasis , trichomoniasis, unspecified',\n 'Vancomycin-Resistant Enterococcal Infections': 'factors influencing health status and contact with health services , resistance to antimicrobial drugs , resistance to antimicrobial drugs , resistance to other antibiotics , resistance to vancomycin',\n 'Complicated Skin & Skin Structure Infections ': 'certain infectious and parasitic diseases , viral infections characterized by skin and mucous membrane lesions , unspecified viral infection characterized by skin and mucous membrane lesions',\n 'Community-Acquired Pneumonia (Including Concurrent Bacteremia)': 'certain infectious and parasitic diseases , other bacterial diseases , streptococcal sepsis , sepsis due to streptococcus pneumoniae',\n 'Methicillin-Resistant Staphylococcal Infections ': 'certain infectious and parasitic diseases , other bacterial diseases , other sepsis , sepsis due to staphylococcus aureus , sepsis due to methicillin susceptible staphylococcus aureus',\n 'Methicillin-Susceptible Staphylococcus Aureus': 'certain infectious and parasitic diseases , other bacterial diseases , other sepsis , sepsis due to staphylococcus aureus , sepsis due to methicillin susceptible staphylococcus aureus',\n 'Uncomplicated Skin & Skin Structure Infections': 'certain infectious and parasitic diseases , viral infections characterized by skin and mucous membrane lesions , unspecified viral infection characterized by skin and mucous membrane lesions',\n 'Ear, Nose, & Throat Infections': 'diseases of the ear and mastoid process , diseases of external ear , otitis externa , unspecified otitis externa , right ear',\n 'Genitourinary Tract Infections': 'diseases of the genitourinary system , other diseases of the urinary system , other disorders of urinary system , urinary tract infection, site not specified',\n 'Helicobacter Pylori': 'certain infectious and parasitic diseases , bacterial and viral infectious agents , other bacterial agents as the cause of diseases classified elsewhere , other specified bacterial agents as the cause of diseases classified elsewhere , helicobacter pylori h pylori as the cause of diseases classified elsewhere',\n 'Anthrax': 'certain infectious and parasitic diseases , certain zoonotic bacterial diseases , anthrax , other forms of anthrax',\n 'Lyme Disease (Off-label)': 'certain infectious and parasitic diseases , other spirochetal diseases , other spirochetal infections , lyme disease , unspecified',\n 'Chlamydial Infection in Pregnant Women (Off-label)': 'pregnancy, childbirth and the puerperium , other maternal disorders predominantly related to pregnancy , infections of genitourinary tract in pregnancy , infections of the genital tract in pregnancy , infection of other part of genital tract in pregnancy , unspecified trimester',\n 'Anthrax (Off-label)': 'certain infectious and parasitic diseases , certain zoonotic bacterial diseases , anthrax , other forms of anthrax',\n 'Infective Endocarditis (Off-label)': 'diseases of the circulatory system , other forms of heart disease , acute and subacute endocarditis , acute and subacute infective endocarditis',\n 'General Dosing Guidelines': 'external causes of morbidity , misadventures to patients during surgical and medical care , failure in dosage during surgical and medical care , failure in dosage during unspecified surgical and medical care',\n 'Endocarditis Prophylaxis (Off-label)': 'diseases of the circulatory system , other forms of heart disease , acute and subacute endocarditis , acute and subacute infective endocarditis',\n 'Genitourinary Tract Infections (Excluding Gonorrhea)': 'certain infectious and parasitic diseases , infections with a predominantly sexual mode of transmission , gonococcal infection , gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess , other gonococcal infection of lower genitourinary tract',\n 'Gastrointestinal Tract Infections': 'certain infectious and parasitic diseases , intestinal infectious diseases , infectious gastroenteritis and colitis, unspecified',\n 'Urinary Tract Infection (ampicillin-susceptible Enterococcus; Off-label)': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , abnormal findings on examination of urine, without diagnosis , other and unspecified abnormal findings in urine , abnormal findings on microbiological examination of urine , bacteriuria',\n 'Bacterial Meningitis/Septicemia': 'certain infectious and parasitic diseases , other bacterial diseases , meningococcal infection , acute meningococcemia',\n 'Group B Streptococcus (Off-label)': 'certain infectious and parasitic diseases , other bacterial diseases , streptococcal sepsis , sepsis due to streptococcus, group b',\n 'Listeria Infection (Off-label)': 'certain infectious and parasitic diseases , other bacterial diseases , listeriosis , listerial sepsis',\n 'Neonates (<28 Days)': 'certain conditions originating in the perinatal period , disorders of newborn related to length of gestation and fetal growth , disorders of newborn related to short gestation and low birth weight, not elsewhere classified , preterm premature newborn other , preterm newborn, gestational age 29 completed weeks',\n 'Endocarditis Treatment': 'diseases of the circulatory system , other forms of heart disease , acute and subacute endocarditis , acute and subacute infective endocarditis',\n 'Soft Tissue Infections': 'certain infectious and parasitic diseases , viral infections characterized by skin and mucous membrane lesions , unspecified viral infection characterized by skin and mucous membrane lesions',\n 'Community Acquired Pneumonia': 'diseases of the respiratory system , influenza and pneumonia , bacterial pneumonia, not elsewhere classified , unspecified bacterial pneumonia',\n 'RSV Prophylaxis': 'factors influencing health status and contact with health services , persons with potential health hazards related to communicable diseases , encounter for other prophylactic measures , encounter for prophylactic immunotherapy , for respiratory syncytial virus rsv',\n 'Rickettsial Infections': 'certain infectious and parasitic diseases , rickettsioses , typhus fever , epidemic louse-borne typhus fever due to rickettsia prowazekii',\n 'Sexually Transmitted Infections': 'certain infectious and parasitic diseases , infections with a predominantly sexual mode of transmission , unspecified sexually transmitted disease',\n 'Specific Bacterial Infections': 'certain infectious and parasitic diseases , other bacterial diseases , bacterial infection of unspecified site , bacterial infection, unspecified',\n 'Ophthalmic infections': 'certain infectious and parasitic diseases , viral infections characterized by skin and mucous membrane lesions , herpesviral herpes simplex infections , herpesviral ocular disease , other herpesviral disease of eye',\n 'Acute Intestinal Amebiasis ': 'certain infectious and parasitic diseases , intestinal infectious diseases , amebiasis , ameboma of intestine',\n 'Acne Vulgaris ': 'diseases of the skin and subcutaneous tissue , disorders of skin appendages , acne , acne vulgaris',\n 'Rosacea ': 'diseases of the skin and subcutaneous tissue , disorders of skin appendages , rosacea , other rosacea',\n 'Malaria': 'certain infectious and parasitic diseases , protozoal diseases , unspecified malaria',\n 'Periodontal Disease': 'diseases of the digestive system , diseases of oral cavity and salivary glands , gingivitis and periodontal diseases , periodontosis',\n 'Hypertension': 'diseases of the circulatory system , hypertensive diseases , essential primary hypertension',\n 'Migraine': 'diseases of the nervous system , episodic and paroxysmal disorders , migraine , cyclical vomiting , in migraine, intractable',\n 'Angina': 'diseases of the circulatory system , ischemic heart diseases , angina pectoris , unstable angina',\n 'Pheochromocytoma': 'congenital malformations, deformations and chromosomal abnormalities , other congenital malformations , phakomatoses, not elsewhere classified , phakomatosis, unspecified',\n 'Hypertrophic Subaortic Stenosis': 'diseases of the musculoskeletal system and connective tissue , biomechanical lesions, not elsewhere classified , biomechanical lesions, not elsewhere classified , subluxation stenosis of neural canal , of sacral region',\n 'Myocardial Infarction': 'diseases of the circulatory system , ischemic heart diseases , acute myocardial infarction , non-st elevation nstemi myocardial infarction',\n 'Supraventricular Arrhythmia': 'diseases of the circulatory system , other forms of heart disease , other cardiac arrhythmias , atrial premature depolarization',\n 'Essential Tremor': 'diseases of the nervous system , extrapyramidal and movement disorders , other extrapyramidal and movement disorders , essential tremor',\n 'Portal Hypertension (Off-label)': 'diseases of the digestive system , diseases of liver , other diseases of liver , portal hypertension',\n 'Antipsychotic-Induced Akathisia (Off-label)': 'diseases of the nervous system , extrapyramidal and movement disorders , other extrapyramidal and movement disorders , other and unspecified drug induced movement disorders , drug induced akathisia',\n 'Esophageal Bleeding (Off-label)': 'diseases of the digestive system , diseases of esophagus, stomach and duodenum , esophagitis , other esophagitis , with bleeding',\n 'Panic Disorder (Off-label)': 'mental, behavioral and neurodevelopmental disorders , anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders , other anxiety disorders , panic disorder episodic paroxysmal anxiety',\n 'Aggressive Behavior (Off-label)': 'neoplasms , neoplasms of unspecified behavior , neoplasms of unspecified behavior , neoplasm of unspecified behavior of unspecified site',\n 'Infantile Hemangiomas': 'neoplasms , benign neoplasms, except benign neuroendocrine tumors , hemangioma and lymphangioma, any site , hemangioma , of intra-abdominal structures',\n 'Hypertension (Off-label)': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the circulatory and respiratory systems , abnormal blood-pressure reading, without diagnosis , elevated blood-pressure reading, without diagnosis of hypertension',\n 'Arrhythmias (Off-label)': 'diseases of the circulatory system , other forms of heart disease , paroxysmal tachycardia , re-entry ventricular arrhythmia',\n 'Hypercyanotic Spells (Off-label)': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the skin and subcutaneous tissue , other skin changes , cyanosis',\n 'Thyrotoxicosis (Off-label)': 'endocrine, nutritional and metabolic diseases , disorders of thyroid gland , thyrotoxicosis hyperthyroidism , thyrotoxicosis, unspecified , with thyrotoxic crisis or storm',\n 'Angina Pectoris': 'diseases of the circulatory system , ischemic heart diseases , angina pectoris , other forms of angina pectoris',\n 'Heart Failure (Post-Myocardial Infarction)': 'diseases of the circulatory system , other forms of heart disease , heart failure , left ventricular failure, unspecified',\n 'Myocardial Infarction/Stroke Prevention': 'diseases of the circulatory system , ischemic heart diseases , acute myocardial infarction , non-st elevation nstemi myocardial infarction',\n 'Diabetic Nephropathy (Off-label)': 'endocrine, nutritional and metabolic diseases , diabetes mellitus , diabetes mellitus due to underlying condition , diabetes mellitus due to underlying condition with kidney complications , diabetes mellitus due to underlying condition with diabetic nephropathy',\n 'Acute Hypertension': 'diseases of the circulatory system , hypertensive diseases , hypertensive crisis , hypertensive emergency',\n 'Hypertension (Alone or with Thiazide)': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the circulatory and respiratory systems , abnormal blood-pressure reading, without diagnosis , elevated blood-pressure reading, without diagnosis of hypertension',\n 'Congestive Heart Failure (With Diuretics and Digitalis)': 'diseases of the circulatory system , other forms of heart disease , heart failure , heart failure, unspecified',\n 'Left Ventricular Dysfunction After Myocardial Infarction': 'diseases of the circulatory system , ischemic heart diseases , acute myocardial infarction , st elevation stemi myocardial infarction of anterior wall , st elevation stemi myocardial infarction involving left main coronary artery',\n 'Diabetic Nephropathy': 'endocrine, nutritional and metabolic diseases , diabetes mellitus , diabetes mellitus due to underlying condition , diabetes mellitus due to underlying condition with kidney complications , diabetes mellitus due to underlying condition with diabetic nephropathy',\n 'Acute hypertension': 'diseases of the circulatory system , hypertensive diseases , hypertensive crisis , hypertensive emergency',\n 'Hypertension (alone or with thiazide)': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the circulatory and respiratory systems , abnormal blood-pressure reading, without diagnosis , elevated blood-pressure reading, without diagnosis of hypertension',\n 'Congestive heart failure (with diuretics and digitalis)': 'diseases of the circulatory system , other forms of heart disease , heart failure , heart failure, unspecified',\n 'Left ventricular dysfunction after myocardial infarction': 'diseases of the circulatory system , ischemic heart diseases , acute myocardial infarction , st elevation stemi myocardial infarction of anterior wall , st elevation stemi myocardial infarction involving left main coronary artery',\n 'Diabetic nephropathy': 'endocrine, nutritional and metabolic diseases , diabetes mellitus , diabetes mellitus due to underlying condition , diabetes mellitus due to underlying condition with kidney complications , diabetes mellitus due to underlying condition with diabetic nephropathy',\n 'Acute Myocardial Infarction': 'diseases of the circulatory system , ischemic heart diseases , acute myocardial infarction , acute myocardial infarction, unspecified',\n 'Heart Failure': 'diseases of the circulatory system , other forms of heart disease , heart failure , heart failure, unspecified',\n 'Primary Hypertension (Orphan)': 'diseases of the circulatory system , hypertensive diseases , essential primary hypertension',\n 'Nephropathy in Type 2 Diabetes': 'endocrine, nutritional and metabolic diseases , diabetes mellitus , type 2 diabetes mellitus , type 2 diabetes mellitus with kidney complications , type 2 diabetes mellitus with diabetic nephropathy',\n 'Post-Myocardial Infarction': 'diseases of the circulatory system , ischemic heart diseases , certain current complications following st elevation stemi and non-st elevation nstemi myocardial infarction within the 28 day period , postinfarction angina',\n 'Cardiovascular risk reduction': 'diseases of the circulatory system , ischemic heart diseases , certain current complications following st elevation stemi and non-st elevation nstemi myocardial infarction within the 28 day period , postinfarction angina',\n 'Primary Hyperaldosteronism': 'endocrine, nutritional and metabolic diseases , disorders of other endocrine glands , hyperaldosteronism , primary hyperaldosteronism , other primary hyperaldosteronism',\n 'Edematous Conditions': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , general symptoms and signs , edema, not elsewhere classified , edema, unspecified',\n 'Essential Hypertension': 'diseases of the circulatory system , hypertensive diseases , essential primary hypertension',\n 'Congestive Heart Failure': 'diseases of the circulatory system , other forms of heart disease , heart failure , systolic congestive heart failure , acute on chronic systolic congestive heart failure',\n 'Hypokalemia': 'endocrine, nutritional and metabolic diseases , metabolic disorders , other disorders of fluid, electrolyte and acid-base balance , hypokalemia',\n 'Hirsutism (Off-label)': 'diseases of the skin and subcutaneous tissue , disorders of skin appendages , hypertrichosis , hirsutism',\n 'Acne (Off-label)': 'diseases of the skin and subcutaneous tissue , disorders of skin appendages , acne , acne vulgaris',\n 'Edema (Off-label)': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , general symptoms and signs , edema, not elsewhere classified , edema, unspecified',\n 'Stroke Prophylaxis with Atrial Fibrillation': 'diseases of the circulatory system , other forms of heart disease , atrial fibrillation and flutter , chronic atrial fibrillation , permanent atrial fibrillation',\n 'Postoperative Prophylaxis of DVT/PE': 'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , complications of procedures, not elsewhere classified , infection following a procedure , infection following a procedure, unspecified , sequela',\n 'DVT or PE Treatment': 'diseases of the genitourinary system , noninflammatory disorders of female genital tract , pain and other conditions associated with female genital organs and menstrual cycle , dyspareunia , superficial introital dyspareunia',\n 'Stroke Prophylaxis With Atrial Fibrillation ': 'diseases of the circulatory system , other forms of heart disease , atrial fibrillation and flutter , chronic atrial fibrillation , permanent atrial fibrillation',\n 'Deep Vein Thrombosis Prophylaxis for Hip or Knee Replacement Surgery': 'diseases of the circulatory system , diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified , other venous embolism and thrombosis , acute embolism and thrombosis of deep veins of lower extremity , acute embolism and thrombosis of femoral vein , acute embolism and thrombosis of unspecified femoral vein',\n 'Venous Thromboembolism Prophylaxis for Restricted Mobility': 'diseases of the circulatory system , diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified , other venous embolism and thrombosis , chronic embolism and thrombosis of veins of upper extremity , chronic embolism and thrombosis of unspecified veins of upper extremity , bilateral',\n 'DVT and/or PE Treatment': 'diseases of the genitourinary system , noninflammatory disorders of female genital tract , pain and other conditions associated with female genital organs and menstrual cycle , dyspareunia , superficial introital dyspareunia',\n 'Reduction in Risk of Recurrence of DVT or PE': 'factors influencing health status and contact with health services , persons with potential health hazards related to family and personal history and certain conditions influencing health status , personal history of other diseases and conditions , personal history of diseases of genitourinary system , personal history of dysplasia of the female genital tract , personal history of vulvar dysplasia',\n 'Risk Reduction of Major Cardiovascular Events': 'diseases of the circulatory system , ischemic heart diseases , certain current complications following st elevation stemi and non-st elevation nstemi myocardial infarction within the 28 day period , postinfarction angina',\n 'Risk Reduction of Major Thrombotic Vascular Events': 'diseases of the circulatory system , diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified , other disorders of veins , postthrombotic syndrome , postthrombotic syndrome with other complications , of right lower extremity',\n 'VTE Treatment or Prevention': 'codes for special purposes , provisional assignment of new diseases of uncertain etiology or emergency use , emergency use of , vaping-related disorder',\n 'Thromboprophylaxis for Fontan Procedure': 'diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism , coagulation defects, purpura and other hemorrhagic conditions , purpura and other hemorrhagic conditions , other primary thrombocytopenia , other primary thrombocytopenia',\n 'Intraoperative Tachycardia/Hypertension': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the circulatory and respiratory systems , abnormalities of heart beat , tachycardia, unspecified',\n 'Supraventricular Tachycardia': 'diseases of the circulatory system , other forms of heart disease , paroxysmal tachycardia , supraventricular tachycardia',\n 'Hypertensive Emergency ': 'diseases of the circulatory system , hypertensive diseases , hypertensive crisis , hypertensive emergency',\n 'Supraventricular Tachycardia (Off-label)': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the circulatory and respiratory systems , abnormalities of heart beat , tachycardia, unspecified',\n 'Postoperative Hypertension (Off-label)': 'diseases of the circulatory system , other and unspecified disorders of the circulatory system , intraoperative and postprocedural complications and disorders of circulatory system, not elsewhere classified , postprocedural hypertension',\n 'Supraventricular tachycardia': 'diseases of the circulatory system , other forms of heart disease , paroxysmal tachycardia , supraventricular tachycardia',\n 'Hypertensive emergency ': 'diseases of the circulatory system , hypertensive diseases , hypertensive crisis , hypertensive emergency',\n 'Intraoperative tachycardia/hypertension': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the circulatory and respiratory systems , abnormalities of heart beat , tachycardia, unspecified',\n 'Stable Monomorphic or Polymorphic Ventricular Tachycardia (Off-label)': 'diseases of the circulatory system , other forms of heart disease , paroxysmal tachycardia , re-entry ventricular arrhythmia',\n 'ACLS, Pulseless Ventricular Fibrillation/Ventricular Tachycardia (Off-label)': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the circulatory and respiratory systems , abnormalities of heart beat , tachycardia, unspecified',\n 'Ventricular Arrhythmias': 'diseases of the circulatory system , other forms of heart disease , paroxysmal tachycardia , re-entry ventricular arrhythmia',\n 'Conversion to oral amiodarone after IV administration': 'injury, poisoning and certain other consequences of external causes , poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of hormones and their synthetic substitutes and antagonists, not elsewhere classified , poisoning by, adverse effect of and underdosing of other and unspecified hormones and synthetic substitutes , poisoning by, adverse effect of and underdosing of unspecified hormones and synthetic substitutes , adverse effect of unspecified hormones and synthetic substitutes , sequela',\n 'Drug Resistant Refractory Cardiac Arrhythmias (Off-label)': 'diseases of the circulatory system , other forms of heart disease , other cardiac arrhythmias , atrial premature depolarization',\n 'Pulseless Ventricular Tachycardia or Ventricular Fibrillation (PALS dosing) (Off-label)': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the circulatory and respiratory systems , abnormalities of heart beat , tachycardia, unspecified',\n 'Paroxysmal Supraventricular Tachycardia': 'diseases of the circulatory system , other forms of heart disease , paroxysmal tachycardia , supraventricular tachycardia',\n 'Stress Testing (Diagnostic)': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving cognition, perception, emotional state and behavior , symptoms and signs involving appearance and behavior , undue concern and preoccupation with stressful events',\n 'Paroxysmal Superventricular Tachycardia (per ACLS)': 'diseases of the circulatory system , other forms of heart disease , paroxysmal tachycardia , supraventricular tachycardia',\n 'PSVT (Adenocard)': 'certain infectious and parasitic diseases , other viral diseases , viral infection of unspecified site , adenovirus infection, unspecified',\n 'Adenoscan (Diagnostic)': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , abnormal tumor markers , abnormal tumor markers , other abnormal tumor markers',\n 'Atrial Fibrillation': 'diseases of the circulatory system , other forms of heart disease , atrial fibrillation and flutter , persistent atrial fibrillation , longstanding persistent atrial fibrillation',\n 'Heart Failure/Atrial Fibrillation': 'diseases of the circulatory system , other forms of heart disease , atrial fibrillation and flutter , paroxysmal atrial fibrillation',\n 'Hypomagnesemia': 'endocrine, nutritional and metabolic diseases , metabolic disorders , disorders of mineral metabolism , disorders of magnesium metabolism , hypomagnesemia',\n 'Toxemia of Pregnancy': 'certain conditions originating in the perinatal period , hemorrhagic and hematological disorders of newborn , other perinatal hematological disorders , congenital anemia from fetal blood loss',\n 'Torsades de Pointes': 'diseases of the circulatory system , other forms of heart disease , paroxysmal tachycardia , ventricular tachycardia , torsades de pointes',\n 'Preterm Labor (Off-label)': 'pregnancy, childbirth and the puerperium , complications of labor and delivery , preterm labor , preterm labor with preterm delivery , preterm labor with preterm delivery, unspecified trimester , not applicable or unspecified',\n 'Acute Nephritis': 'diseases of the genitourinary system , glomerular diseases , acute nephritic syndrome , acute nephritic syndrome with other morphologic changes',\n 'Bronchospasm (Off-label)': 'diseases of the respiratory system , other diseases of the respiratory system , other respiratory disorders , diseases of bronchus, not elsewhere classified , acute bronchospasm',\n 'Acute Coronary Syndrome or History of MI': 'diseases of the circulatory system , ischemic heart diseases , acute myocardial infarction , acute myocardial infarction, unspecified',\n 'Coronary Artery Disease': 'diseases of the circulatory system , ischemic heart diseases , chronic ischemic heart disease , atherosclerotic heart disease of native coronary artery , without angina pectoris',\n 'Acute Ischemic Stroke or TIA': 'diseases of the nervous system , episodic and paroxysmal disorders , transient cerebral ischemic attacks and related syndromes , multiple and bilateral precerebral artery syndromes',\n 'Acute Coronary Syndrome': 'diseases of the circulatory system , ischemic heart diseases , other acute ischemic heart diseases , acute coronary thrombosis not resulting in myocardial infarction',\n 'Recent MI, Stroke, or Established Peripheral Arterial Disease': 'diseases of the circulatory system , diseases of arteries, arterioles and capillaries , other peripheral vascular diseases , peripheral vascular disease, unspecified',\n 'Cardioembolic Stroke': 'diseases of the circulatory system , cerebrovascular diseases , cerebral infarction , cerebral infarction due to embolism of precerebral arteries , cerebral infarction due to embolism of basilar artery',\n 'Carotid Artery Stenting (Off-label)': 'diseases of the circulatory system , cerebrovascular diseases , occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction , occlusion and stenosis of carotid artery , occlusion and stenosis of bilateral carotid arteries',\n 'Left Ventricular Dysfunction Following Myocardial Infarction': 'diseases of the circulatory system , ischemic heart diseases , acute myocardial infarction , st elevation stemi myocardial infarction of anterior wall , st elevation stemi myocardial infarction involving left main coronary artery',\n 'Angina pectoris': 'diseases of the circulatory system , ischemic heart diseases , angina pectoris , other forms of angina pectoris',\n 'Conversion to Extended Release Form': 'mental, behavioral and neurodevelopmental disorders , anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders , dissociative and conversion disorders , conversion disorder with mixed symptom presentation',\n 'Post Myocardial Infarction': 'diseases of the circulatory system , ischemic heart diseases , certain current complications following st elevation stemi and non-st elevation nstemi myocardial infarction within the 28 day period , postinfarction angina',\n 'Alcohol Withdrawal Syndrome (Off-label)': 'mental, behavioral and neurodevelopmental disorders , mental and behavioral disorders due to psychoactive substance use , alcohol related disorders , alcohol dependence , alcohol dependence with withdrawal , uncomplicated',\n 'Supraventricular Arrhythmias (Off-label)': 'diseases of the circulatory system , other forms of heart disease , other cardiac arrhythmias , atrial premature depolarization',\n 'Migraine Prophylaxis (Off-label)': 'diseases of the nervous system , episodic and paroxysmal disorders , migraine , migraine, unspecified , migraine, unspecified, intractable , with status migrainosus',\n 'Pulmonary Hypertension': 'diseases of the circulatory system , pulmonary heart disease and diseases of pulmonary circulation , other pulmonary heart diseases , other secondary pulmonary hypertension , chronic thromboembolic pulmonary hypertension',\n 'Raynaud Phenomenon (Off-label)': 'diseases of the circulatory system , diseases of arteries, arterioles and capillaries , other peripheral vascular diseases , raynauds syndrome , without gangrene',\n 'Anal Fissures (Off-label)': 'diseases of the digestive system , other diseases of intestines , fissure and fistula of anal and rectal regions , chronic anal fissure',\n 'Subarachnoid Hemorrhage': 'diseases of the circulatory system , cerebrovascular diseases , nontraumatic subarachnoid hemorrhage , other nontraumatic subarachnoid hemorrhage',\n 'Edema': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , general symptoms and signs , edema, not elsewhere classified , edema, unspecified',\n 'Hypertension, Resistant': 'diseases of the circulatory system , hypertensive diseases , secondary hypertension , renovascular hypertension',\n 'Acute Pulmonary Edema/Hypertensive Crisis/Increased Intracranial Pressure': 'diseases of the nervous system , other disorders of the nervous system , intraoperative and postprocedural complications and disorders of nervous system, not elsewhere classified , intracranial hypotension following ventricular shunting',\n 'Hyperkalemia in Advanced Cardiac Life Support (ACLS)': 'endocrine, nutritional and metabolic diseases , metabolic disorders , other disorders of fluid, electrolyte and acid-base balance , hyperkalemia',\n 'Hypermagnesemia in ACLS': 'endocrine, nutritional and metabolic diseases , metabolic disorders , disorders of mineral metabolism , disorders of magnesium metabolism , hypermagnesemia',\n 'Resistant Hypertension': 'diseases of the circulatory system , hypertensive diseases , secondary hypertension , secondary hypertension, unspecified',\n 'Hypertension in Heart Failure (Off-label)': 'diseases of the circulatory system , hypertensive diseases , hypertensive heart disease , hypertensive heart disease with heart failure',\n 'Mild Fluid Retention in Heart Failure (Off-label)': 'external causes of morbidity , misadventures to patients during surgical and medical care , failure in dosage during surgical and medical care , incorrect dilution of fluid used during infusion',\n 'Diuresis': 'diseases of the genitourinary system , other diseases of the urinary system , other disorders of urinary system , other specified urinary incontinence , post-void dribbling',\n 'Hypertriglyceridemia, Hypercholesterolemia': 'endocrine, nutritional and metabolic diseases , metabolic disorders , disorders of lipoprotein metabolism and other lipidemias , pure hypercholesterolemia , familial hypercholesterolemia',\n 'Hypercholesterolemia': 'endocrine, nutritional and metabolic diseases , metabolic disorders , disorders of lipoprotein metabolism and other lipidemias , pure hypercholesterolemia , familial hypercholesterolemia',\n 'Homozygous Familial Hypercholesterolemia': 'endocrine, nutritional and metabolic diseases , metabolic disorders , disorders of lipoprotein metabolism and other lipidemias , pure hypercholesterolemia , familial hypercholesterolemia',\n 'Slowing Progression of Atherosclerosis': 'diseases of the circulatory system , diseases of arteries, arterioles and capillaries , atherosclerosis , other and unspecified atherosclerosis , generalized atherosclerosis',\n 'Primary Prevention ': 'injury, poisoning and certain other consequences of external causes , other and unspecified effects of external causes , effects of other deprivation , other effects of deprivation , sequela',\n 'Familial Hypercholesterolemia': 'endocrine, nutritional and metabolic diseases , metabolic disorders , disorders of lipoprotein metabolism and other lipidemias , pure hypercholesterolemia , familial hypercholesterolemia',\n 'Prevention of Coronary Events': 'factors influencing health status and contact with health services , persons with potential health hazards related to family and personal history and certain conditions influencing health status , presence of cardiac and vascular implants and grafts , presence of coronary angioplasty implant and graft',\n 'Primary and secondary prevention of atheroschlerotic cardiovascular disease (ASCVD)': 'diseases of the circulatory system , ischemic heart diseases , chronic ischemic heart disease , atherosclerotic heart disease of native coronary artery , without angina pectoris',\n 'Hypercholesterolemia & Mixed Dyslipidemia': 'endocrine, nutritional and metabolic diseases , metabolic disorders , disorders of lipoprotein metabolism and other lipidemias , mixed hyperlipidemia',\n 'Patients Requiring <25% Decrease in LDL-C': 'factors influencing health status and contact with health services , persons with potential health hazards related to family and personal history and certain conditions influencing health status , long term current drug therapy , long term current use of anticoagulants and antithrombotics/antiplatelets , long term current use of antithrombotics/antiplatelets',\n 'Heterozygous Familial Hypercholesterolemia': 'endocrine, nutritional and metabolic diseases , metabolic disorders , disorders of lipoprotein metabolism and other lipidemias , pure hypercholesterolemia , familial hypercholesterolemia',\n 'Primary Hyperlipidemia and Mixed Dyslipidemia Adjunct to Diet': 'endocrine, nutritional and metabolic diseases , metabolic disorders , disorders of lipoprotein metabolism and other lipidemias , mixed hyperlipidemia',\n 'Homozygous Sitosterolemia': 'congenital malformations, deformations and chromosomal abnormalities , congenital malformations of genital organs , hypospadias , hypospadias, unspecified',\n 'Primary Hyperlipidemia': 'endocrine, nutritional and metabolic diseases , metabolic disorders , disorders of lipoprotein metabolism and other lipidemias , other hyperlipidemia , other hyperlipidemia',\n 'Prevention of Cardiovascular Events': 'external causes of morbidity , medical devices associated with adverse incidents in diagnostic and therapeutic use , cardiovascular devices associated with adverse incidents , diagnostic and monitoring cardiovascular devices associated with adverse incidents',\n 'Pain/Fever/Dysmenorrhea': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the genitourinary system , pain associated with micturition , painful micturition, unspecified',\n 'Inflammatory Disease': 'diseases of the nervous system , inflammatory diseases of the central nervous system , sequelae of inflammatory diseases of central nervous system',\n 'Osteoarthritis': 'diseases of the musculoskeletal system and connective tissue , osteoarthritis , osteoarthritis of knee , bilateral post-traumatic osteoarthritis of knee',\n 'Rheumatoid Arthritis': 'diseases of the musculoskeletal system and connective tissue , inflammatory polyarthropathies , other rheumatoid arthritis , rheumatoid nodule , unspecified site',\n 'Fever': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , general symptoms and signs , fever of other and unknown origin , fever, unspecified',\n 'Pain': 'diseases of the nervous system , other disorders of the nervous system , pain, not elsewhere classified , chronic pain, not elsewhere classified , chronic post-thoracotomy pain',\n 'Juvenile Idiopathic Arthritis': 'diseases of the musculoskeletal system and connective tissue , inflammatory polyarthropathies , juvenile arthritis , other juvenile arthritis , unspecified site',\n 'Patent Ductus Arteriosus': 'congenital malformations, deformations and chromosomal abnormalities , congenital malformations of the circulatory system , congenital malformations of great arteries , patent ductus arteriosus',\n 'Low Cardiac Output, Septic Shock': 'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , complications of procedures, not elsewhere classified , postprocedural shock , postprocedural septic shock , sequela',\n 'Actinic Keratosis': 'diseases of the skin and subcutaneous tissue , other disorders of the skin and subcutaneous tissue , seborrheic keratosis , inflamed seborrheic keratosis',\n 'Superficial Basal Cell Carcinoma': 'neoplasms , melanoma and other malignant neoplasms of skin , other and unspecified malignant neoplasm of skin , other and unspecified malignant neoplasm of overlapping sites of skin , basal cell carcinoma of overlapping sites of skin',\n 'External Genital Warts': 'certain infectious and parasitic diseases , infections with a predominantly sexual mode of transmission , other predominantly sexually transmitted diseases, not elsewhere classified , anogenital venereal warts',\n 'Acne Vulgaris': 'diseases of the skin and subcutaneous tissue , disorders of skin appendages , acne , acne vulgaris',\n 'Rosacea': 'diseases of the skin and subcutaneous tissue , disorders of skin appendages , rosacea , other rosacea',\n 'Tinea Cruris': 'certain infectious and parasitic diseases , mycoses , dermatophytosis , tinea cruris',\n 'Tinea Pedis': 'certain infectious and parasitic diseases , mycoses , dermatophytosis , tinea pedis',\n 'Tinea Corporis': 'certain infectious and parasitic diseases , mycoses , dermatophytosis , tinea corporis',\n 'Dermatophytoses': 'certain infectious and parasitic diseases , mycoses , dermatophytosis , other dermatophytoses',\n 'Tinea Corporis ': 'certain infectious and parasitic diseases , mycoses , dermatophytosis , tinea corporis',\n 'Psoriatic Arthritis': 'diseases of the skin and subcutaneous tissue , papulosquamous disorders , psoriasis , arthropathic psoriasis , psoriatic arthritis mutilans',\n 'Ankylosing Spondylitis': 'diseases of the musculoskeletal system and connective tissue , spondylopathies , ankylosing spondylitis , ankylosing spondylitis of thoracic region',\n 'Plaque Psoriasis': 'diseases of the skin and subcutaneous tissue , papulosquamous disorders , psoriasis , other psoriasis',\n 'Crohn Disease': 'diseases of the digestive system , noninfective enteritis and colitis , crohns disease regional enteritis , crohns disease, unspecified , without complications',\n 'Ulcerative Colitis': 'diseases of the digestive system , noninfective enteritis and colitis , ulcerative colitis , ulcerative colitis, unspecified , without complications',\n 'Hidradenitis Suppurativa': 'diseases of the skin and subcutaneous tissue , disorders of skin appendages , other follicular disorders , hidradenitis suppurativa',\n 'Uveitis': 'diseases of the skin and subcutaneous tissue , radiation-related disorders of the skin and subcutaneous tissue , other acute skin changes due to ultraviolet radiation , acute skin change due to ultraviolet radiation, unspecified',\n 'Pediatric Crohn Disease': 'diseases of the digestive system , noninfective enteritis and colitis , crohns disease regional enteritis , crohns disease of both small and large intestine , crohns disease of both small and large intestine with complications , crohns disease of both small and large intestine with rectal bleeding',\n 'Uveitis ': 'diseases of the skin and subcutaneous tissue , radiation-related disorders of the skin and subcutaneous tissue , other acute skin changes due to ultraviolet radiation , acute skin change due to ultraviolet radiation, unspecified',\n 'Juvenile Rheumatoid Arthritis': 'diseases of the musculoskeletal system and connective tissue , inflammatory polyarthropathies , juvenile arthritis , juvenile rheumatoid arthritis with systemic onset , unspecified site',\n 'Psoriasis': 'diseases of the skin and subcutaneous tissue , papulosquamous disorders , psoriasis , psoriasis, unspecified',\n 'Melanin Hyperpigmentation': 'diseases of the skin and subcutaneous tissue , other disorders of the skin and subcutaneous tissue , other disorders of pigmentation , other melanin hyperpigmentation',\n 'Severe Asthma': 'diseases of the respiratory system , chronic lower respiratory diseases , asthma , severe persistent asthma , with acute exacerbation',\n 'Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome)': 'diseases of the skin and subcutaneous tissue , other disorders of the skin and subcutaneous tissue , granulomatous disorders of skin and subcutaneous tissue , granuloma faciale eosinophilic granuloma of skin',\n 'Hypereosinophilic Syndrome': 'diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism , other disorders of blood and blood-forming organs , other disorders of white blood cells , eosinophilia , hypereosinophilic syndrome hes , idiopathic hypereosinophilic syndrome ihes',\n 'Chronic Rhinosinusitis with Nasal Polyps': 'diseases of the respiratory system , other diseases of upper respiratory tract , nasal polyp , polyp of nasal cavity',\n 'Antiseptic Wound Cauterization': 'pregnancy, childbirth and the puerperium , complications predominantly related to the puerperium , other puerperal infections , infection of obstetric surgical wound , superficial incisional site',\n 'Primary Immunoglobulin A Nephropathy': 'diseases of the genitourinary system , glomerular diseases , hereditary nephropathy, not elsewhere classified , hereditary nephropathy, not elsewhere classified with diffuse mesangial proliferative glomerulonephritis',\n 'Ulcerative Colitis (Orphan)': 'diseases of the digestive system , noninfective enteritis and colitis , ulcerative colitis , ulcerative colitis, unspecified , without complications',\n 'Constipation': 'diseases of the digestive system , other diseases of intestines , other functional intestinal disorders , constipation , slow transit constipation',\n 'Portal Systemic Encephalopathy': 'diseases of the digestive system , diseases of liver , other diseases of liver , portal hypertension',\n 'Antacid': 'mental, behavioral and neurodevelopmental disorders , behavioral syndromes associated with physiological disturbances and physical factors , abuse of non-psychoactive substances , abuse of antacids',\n 'Calcium Supplementation': 'endocrine, nutritional and metabolic diseases , other nutritional deficiencies , dietary calcium deficiency',\n 'Calcium dietary supplementation': 'endocrine, nutritional and metabolic diseases , other nutritional deficiencies , dietary calcium deficiency',\n 'Acute Diarrhea': 'diseases of the digestive system , other diseases of intestines , irritable bowel syndrome , irritable bowel syndrome with diarrhea',\n 'Chronic Diarrhea': 'diseases of the digestive system , other diseases of intestines , other functional intestinal disorders , functional diarrhea',\n \"Traveler's Diarrhea\": 'diseases of the digestive system , other diseases of intestines , irritable bowel syndrome , irritable bowel syndrome with diarrhea',\n 'Hepatic Encephalopathy ': 'diseases of the digestive system , diseases of liver , other diseases of liver , other specified diseases of liver , hepatic encephalopathy',\n 'Irritable Bowel Syndrome': 'diseases of the digestive system , other diseases of intestines , irritable bowel syndrome , mixed irritable bowel syndrome',\n 'Chemotherapy-Induced Nausea & Vomiting': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the digestive system and abdomen , nausea and vomiting , nausea with vomiting, unspecified',\n 'Postoperative Nausea & Vomiting': 'diseases of the digestive system , other diseases of the digestive system , intraoperative and postprocedural complications and disorders of digestive system, not elsewhere classified , vomiting following gastrointestinal surgery',\n 'Radiation-Induced Nausea & Vomiting': 'injury, poisoning and certain other consequences of external causes , other and unspecified effects of external causes , radiation sickness, unspecified , radiation sickness, unspecified, subsequent encounter',\n 'Cholestatic Pruritus (Off-label)': 'diseases of the skin and subcutaneous tissue , dermatitis and eczema , pruritus , pruritus, unspecified',\n 'Uremic Pruritus (Off-label)': 'diseases of the skin and subcutaneous tissue , dermatitis and eczema , pruritus , anogenital pruritus, unspecified',\n 'Spinal Opioid-Induced Pruritus (Off-label)': 'diseases of the nervous system , other disorders of the nervous system , intraoperative and postprocedural complications and disorders of nervous system, not elsewhere classified , other reaction to spinal and lumbar puncture',\n 'Rosacea (Off-label)': 'diseases of the skin and subcutaneous tissue , disorders of skin appendages , rosacea , rosacea, unspecified',\n 'Hyperemesis Gravidarum': 'pregnancy, childbirth and the puerperium , other maternal disorders predominantly related to pregnancy , excessive vomiting in pregnancy , mild hyperemesis gravidarum',\n 'Acute Gastroenteritis (Off-Label)': 'certain infectious and parasitic diseases , intestinal infectious diseases , infectious gastroenteritis and colitis, unspecified',\n 'Chemotherapy-Induced Nausea & Vomiting (Orphan)': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the digestive system and abdomen , nausea and vomiting , nausea with vomiting, unspecified',\n 'Vasodilatory Shock': 'injury, poisoning and certain other consequences of external causes , other and unspecified effects of external causes , other and unspecified effects of other external causes , effects of vibration , traumatic vasospastic syndrome , sequela',\n 'Abdominal Distention (Off-label)': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the digestive system and abdomen , other symptoms and signs involving the digestive system and abdomen , abdominal rigidity , epigastric abdominal rigidity',\n 'Diabetes Insipidus (Off-label)': 'endocrine, nutritional and metabolic diseases , disorders of other endocrine glands , hypofunction and other disorders of the pituitary gland , diabetes insipidus',\n 'Abdominal Roentgenography (Off-label)': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , abnormal findings on diagnostic imaging and in function studies, without diagnosis , abnormal findings on diagnostic imaging of other body structures , abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum',\n 'Gastrointestinal Hemorrhage (Off-label)': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , general symptoms and signs , hemorrhage, not elsewhere classified',\n 'Obesity Management': 'endocrine, nutritional and metabolic diseases , overweight, obesity and other hyperalimentation , overweight and obesity , obesity due to excess calories , morbid severe obesity due to excess calories',\n 'Duodenal Ulcer': 'diseases of the digestive system , diseases of esophagus, stomach and duodenum , duodenal ulcer , acute duodenal ulcer with both hemorrhage and perforation',\n 'Stress Ulcer (Off-label)': 'diseases of the skin and subcutaneous tissue , other disorders of the skin and subcutaneous tissue , pressure ulcer , pressure ulcer of unspecified site , unstageable',\n 'Active Duodenal Ulcer (Off-label)': 'diseases of the digestive system , diseases of esophagus, stomach and duodenum , duodenal ulcer , acute duodenal ulcer with perforation',\n 'Stomatitis (Off-label)': 'diseases of the digestive system , diseases of oral cavity and salivary glands , stomatitis and related lesions , other forms of stomatitis',\n 'Gastric Ulcer (Off-label)': 'diseases of the digestive system , diseases of esophagus, stomach and duodenum , gastric ulcer , acute gastric ulcer with perforation',\n 'Gas Retention in Gastrointestinal Tract': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the digestive system and abdomen , flatulence and related conditions , abdominal distension gaseous',\n 'Doage Forms & Strengths': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , general symptoms and signs , lack of expected normal physiological development in childhood and adults , adult failure to thrive',\n 'Active Duodenal Ulcer': 'diseases of the digestive system , diseases of esophagus, stomach and duodenum , duodenal ulcer , acute duodenal ulcer with both hemorrhage and perforation',\n 'Duodenal Ulcer Maintenance': 'diseases of the digestive system , diseases of esophagus, stomach and duodenum , duodenal ulcer , acute duodenal ulcer with perforation',\n 'Benign Gastric Ulcer': 'diseases of the digestive system , diseases of esophagus, stomach and duodenum , gastric ulcer , chronic gastric ulcer without hemorrhage or perforation',\n 'GERD': 'diseases of the digestive system , diseases of esophagus, stomach and duodenum , gastro-esophageal reflux disease , gastro-esophageal reflux disease without esophagitis',\n 'Active duodenal ulcer': 'diseases of the digestive system , diseases of esophagus, stomach and duodenum , duodenal ulcer , acute duodenal ulcer with both hemorrhage and perforation',\n 'Duodenal ulcer maintenance': 'diseases of the digestive system , diseases of esophagus, stomach and duodenum , duodenal ulcer , acute duodenal ulcer with perforation',\n 'Benign gastric ulcer': 'diseases of the digestive system , diseases of esophagus, stomach and duodenum , gastric ulcer , chronic gastric ulcer without hemorrhage or perforation',\n 'Constipation ': 'diseases of the digestive system , other diseases of intestines , other functional intestinal disorders , constipation , slow transit constipation',\n 'Acid Indigestion': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the digestive system and abdomen , heartburn',\n 'Nutritional Supplementation': 'endocrine, nutritional and metabolic diseases , other nutritional deficiencies , sequelae of malnutrition and other nutritional deficiencies , sequelae of vitamin a deficiency',\n 'Constipation/Laxative': 'diseases of the digestive system , other diseases of intestines , other functional intestinal disorders , constipation , drug induced constipation',\n 'Erosive Esophagitis': 'diseases of the digestive system , diseases of esophagus, stomach and duodenum , esophagitis , eosinophilic esophagitis',\n 'Gastroesophageal Reflux Disease': 'diseases of the digestive system , diseases of esophagus, stomach and duodenum , gastro-esophageal reflux disease , gastro-esophageal reflux disease without esophagitis',\n 'GERD Without Erosive Esophagitis': 'diseases of the digestive system , diseases of esophagus, stomach and duodenum , gastro-esophageal reflux disease , gastro-esophageal reflux disease without esophagitis',\n 'GERD With Erosive Esophagitis': 'diseases of the digestive system , diseases of esophagus, stomach and duodenum , esophagitis , eosinophilic esophagitis',\n 'Helicobacter Pylori Eradication': 'certain infectious and parasitic diseases , bacterial and viral infectious agents , other bacterial agents as the cause of diseases classified elsewhere , other specified bacterial agents as the cause of diseases classified elsewhere , helicobacter pylori h pylori as the cause of diseases classified elsewhere',\n 'Risk Reduction of NSAID-Associated Gastric Ulcer': 'diseases of the digestive system , diseases of esophagus, stomach and duodenum , gastric ulcer , acute gastric ulcer with perforation',\n 'NSAID-Induced Gastric Ulcer': 'diseases of the digestive system , diseases of esophagus, stomach and duodenum , gastric ulcer , chronic or unspecified gastric ulcer with perforation',\n 'Gastric or Duodenal Ulcers Following Therapeutic Endoscopy ': 'diseases of the digestive system , diseases of esophagus, stomach and duodenum , gastric ulcer , acute gastric ulcer with both hemorrhage and perforation',\n 'Frequent Heartburn': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the digestive system and abdomen , heartburn',\n 'Hepatic Impairment': 'diseases of the digestive system , diseases of liver , hepatic failure, not elsewhere classified , hepatic failure, unspecified , without coma',\n 'Short-term Treatment of GERD': 'diseases of the digestive system , diseases of esophagus, stomach and duodenum , gastro-esophageal reflux disease , gastro-esophageal reflux disease without esophagitis',\n 'GERD With Erosive Esophagitis (Healing)': 'diseases of the digestive system , diseases of esophagus, stomach and duodenum , esophagitis , eosinophilic esophagitis',\n 'Gastric Ulcer': 'diseases of the digestive system , diseases of esophagus, stomach and duodenum , gastric ulcer , acute gastric ulcer with perforation',\n 'NSAID-associated GU': 'mental, behavioral and neurodevelopmental disorders , mental and behavioral disorders due to psychoactive substance use , sedative, hypnotic, or anxiolytic related disorders , sedative, hypnotic or anxiolytic-related use, unspecified , sedative, hypnotic or anxiolytic use, unspecified with withdrawal , delirium',\n 'Hypersecretory Condition (eg, Zollinger-Ellison Syndrome)': 'diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism , certain disorders involving the immune mechanism , immunodeficiency associated with other major defects , di georges syndrome',\n 'Helicobacter Pylori Infection': 'certain infectious and parasitic diseases , bacterial and viral infectious agents , other bacterial agents as the cause of diseases classified elsewhere , other specified bacterial agents as the cause of diseases classified elsewhere , helicobacter pylori h pylori as the cause of diseases classified elsewhere',\n 'Heartburn': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the digestive system and abdomen , heartburn',\n 'GERD, Erosive Esophagitis': 'diseases of the digestive system , diseases of esophagus, stomach and duodenum , esophagitis , eosinophilic esophagitis',\n 'Nonerosive GERD': 'diseases of the digestive system , diseases of esophagus, stomach and duodenum , gastro-esophageal reflux disease , gastro-esophageal reflux disease without esophagitis',\n 'Hypersecretory Conditions (eg, Zollinger-Ellison Syndrome)': 'diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism , certain disorders involving the immune mechanism , immunodeficiency associated with other major defects , di georges syndrome',\n 'Neonates (Off-label)': 'certain conditions originating in the perinatal period , transitory endocrine and metabolic disorders specific to newborn , other transitory neonatal electrolyte and metabolic disturbances , disturbances of sodium balance of newborn , hypernatremia of newborn',\n 'Erosive Esophagitis Associated With GERD': 'diseases of the digestive system , diseases of esophagus, stomach and duodenum , esophagitis , eosinophilic esophagitis',\n 'Zollinger-Ellison Syndrome': 'congenital malformations, deformations and chromosomal abnormalities , other congenital malformations , phakomatoses, not elsewhere classified , other phakomatoses, not elsewhere classified , von hippel-lindau syndrome',\n 'Peptic Ulcer Disease (Off-label)': 'diseases of the digestive system , diseases of esophagus, stomach and duodenum , peptic ulcer, site unspecified , acute peptic ulcer, site unspecified, with perforation',\n 'Kidney Transplantation': 'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , complications of transplanted organs and tissue , complications of kidney transplant , unspecified complication of kidney transplant',\n 'Lupus Nephritis (Off-label)': 'diseases of the musculoskeletal system and connective tissue , systemic connective tissue disorders , systemic lupus erythematosus sle , systemic lupus erythematosus with organ or system involvement , tubulo-interstitial nephropathy in systemic lupus erythematosus',\n 'Crohn Disease (Off-label)': 'diseases of the digestive system , noninfective enteritis and colitis , crohns disease regional enteritis , crohns disease, unspecified , without complications',\n 'Ulcerative Colitis (Off-label)': 'diseases of the digestive system , noninfective enteritis and colitis , ulcerative colitis , ulcerative colitis, unspecified , without complications',\n 'Chronic Refractory Thrombocytopenic Purpura (Off-label)': 'diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism , coagulation defects, purpura and other hemorrhagic conditions , purpura and other hemorrhagic conditions , other primary thrombocytopenia , other primary thrombocytopenia',\n 'Transplantation (Off-label)': 'neoplasms , malignant neoplasms of ill-defined, other secondary and unspecified sites , malignant neoplasm without specification of site , malignant neoplasm associated with transplanted organ',\n 'Acute Lymphoblastic Leukemia': 'neoplasms , malignant neoplasms of lymphoid, hematopoietic and related tissue , lymphoid leukemia , acute lymphoblastic leukemia all , acute lymphoblastic leukemia, in remission',\n 'Non-Hodgkin Lymphoma': 'neoplasms , malignant neoplasms of lymphoid, hematopoietic and related tissue , other specified and unspecified types of non-hodgkin lymphoma , other specified types of non-hodgkin lymphoma , intrapelvic lymph nodes',\n 'Osteosarcoma': 'diseases of the musculoskeletal system and connective tissue , other osteopathies , osteopathies in diseases classified elsewhere , osteitis deformans in neoplastic diseases , unspecified site',\n 'Breast Cancer': 'neoplasms , malignant neoplasms of breast , malignant neoplasm of breast , malignant neoplasm of breast of unspecified site , malignant neoplasm of breast of unspecified site, female , malignant neoplasm of unspecified site of unspecified female breast',\n 'Squamous Cell Carcinoma of the Head and Neck': 'neoplasms , malignant neoplasms of ill-defined, other secondary and unspecified sites , malignant neoplasm of other and ill-defined sites , malignant neoplasm of head, face and neck',\n 'Gestational Trophoblastic Neoplasia': 'pregnancy, childbirth and the puerperium , pregnancy with abortive outcome , hydatidiform mole , hydatidiform mole, unspecified',\n 'Ectopic Pregnancy (Off-label)': 'pregnancy, childbirth and the puerperium , pregnancy with abortive outcome , ectopic pregnancy , ectopic pregnancy, unspecified , unspecified ectopic pregnancy without intrauterine pregnancy',\n 'Meningeal Leukemia': 'neoplasms , neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes , neoplasm of uncertain behavior of meninges , neoplasm of uncertain behavior of meninges, unspecified',\n 'Giant Cell Arteritis': 'diseases of the musculoskeletal system and connective tissue , systemic connective tissue disorders , other necrotizing vasculopathies , other giant cell arteritis',\n 'Systemic Sclerosis-Associated Interstitial Lung Disease': 'diseases of the musculoskeletal system and connective tissue , systemic connective tissue disorders , systemic sclerosis scleroderma , other forms of systemic sclerosis , systemic sclerosis with lung involvement',\n 'Cytokine Release Syndrome': 'diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism , certain disorders involving the immune mechanism , other disorders involving the immune mechanism, not elsewhere classified , other specified disorders involving the immune mechanism, not elsewhere classified , cytokine release syndrome , grade 1',\n 'COVID-19': 'codes for special purposes , provisional assignment of new diseases of uncertain etiology or emergency use , emergency use of , covid-19',\n 'Systemic Juvenile Idiopathic Arthritis': 'diseases of the musculoskeletal system and connective tissue , inflammatory polyarthropathies , juvenile arthritis , juvenile rheumatoid arthritis with systemic onset , unspecified site',\n 'Polyarticular Juvenile Idiopathic Arthritis': 'diseases of the musculoskeletal system and connective tissue , inflammatory polyarthropathies , juvenile arthritis , other juvenile arthritis , multiple sites',\n 'Cytokine Release Syndrome (CRS)': 'diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism , certain disorders involving the immune mechanism , other disorders involving the immune mechanism, not elsewhere classified , other specified disorders involving the immune mechanism, not elsewhere classified , cytokine release syndrome , grade 1',\n 'COVID-19 (EUA)': 'codes for special purposes , provisional assignment of new diseases of uncertain etiology or emergency use , emergency use of , covid-19',\n 'Multiple Sclerosis': 'diseases of the nervous system , demyelinating diseases of the central nervous system , multiple sclerosis',\n 'Type 2 Diabetes Mellitus': 'endocrine, nutritional and metabolic diseases , diabetes mellitus , type 2 diabetes mellitus , type 2 diabetes mellitus with unspecified complications',\n 'Maximum Dose': 'injury, poisoning and certain other consequences of external causes , poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of diuretics and other and unspecified drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of antidotes and chelating agents , poisoning by, adverse effect of and underdosing of antidotes and chelating agents , poisoning by antidotes and chelating agents, assault , sequela',\n 'Diabetes Mellitus Type 2': 'endocrine, nutritional and metabolic diseases , diabetes mellitus , type 2 diabetes mellitus , type 2 diabetes mellitus with unspecified complications',\n 'Obesity': 'endocrine, nutritional and metabolic diseases , overweight, obesity and other hyperalimentation , overweight and obesity , other obesity',\n 'Weight Management': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , general symptoms and signs , symptoms and signs concerning food and fluid intake , underweight',\n 'Type 1 or 2 Diabetes Mellitus': 'endocrine, nutritional and metabolic diseases , diabetes mellitus , type 1 diabetes mellitus , type 1 diabetes mellitus with unspecified complications',\n 'Type 1 Diabetes Mellitus': 'endocrine, nutritional and metabolic diseases , diabetes mellitus , type 1 diabetes mellitus , type 1 diabetes mellitus with unspecified complications',\n 'Diabetes Mellitus Type I or II ': 'endocrine, nutritional and metabolic diseases , diabetes mellitus , type 2 diabetes mellitus , type 2 diabetes mellitus with other specified complications , type 2 diabetes mellitus with other specified complication',\n 'Type 1 Diabetes Mellitus ': 'endocrine, nutritional and metabolic diseases , diabetes mellitus , type 1 diabetes mellitus , type 1 diabetes mellitus with unspecified complications',\n 'Type I or II Diabetes Mellitus': 'endocrine, nutritional and metabolic diseases , diabetes mellitus , type 2 diabetes mellitus , type 2 diabetes mellitus with unspecified complications',\n 'Chronic Kidney Disease': 'diseases of the genitourinary system , acute kidney failure and chronic kidney disease , chronic kidney disease ckd , chronic kidney disease, stage 1',\n 'Primary Hyperparathyroidism (HPT)': 'endocrine, nutritional and metabolic diseases , disorders of other endocrine glands , hyperparathyroidism and other disorders of parathyroid gland , primary hyperparathyroidism',\n 'Secondary Hyperparathyroidism': 'endocrine, nutritional and metabolic diseases , disorders of other endocrine glands , hyperparathyroidism and other disorders of parathyroid gland , secondary hyperparathyroidism, not elsewhere classified',\n 'Parathyroid Carcinoma': 'neoplasms , malignant neoplasms of thyroid and other endocrine glands , malignant neoplasm of other endocrine glands and related structures , malignant neoplasm of parathyroid gland',\n 'Allergic Conditions': 'diseases of the skin and subcutaneous tissue , dermatitis and eczema , allergic contact dermatitis , allergic contact dermatitis due to other chemical products',\n 'Acute Exacerbations of Multiple Sclerosis': 'diseases of the nervous system , demyelinating diseases of the central nervous system , multiple sclerosis',\n 'COVID-19 (Off-label)': 'codes for special purposes , provisional assignment of new diseases of uncertain etiology or emergency use , emergency use of , covid-19',\n 'Pneumocystis (carinii) jiroveci Pneumonia in AIDS Patients (Off-label)': 'certain infectious and parasitic diseases , protozoal diseases , pneumocystosis',\n 'Acute Spinal Cord Injury (Off-label)': 'injury, poisoning and certain other consequences of external causes , injuries to the neck , injury of nerves and spinal cord at neck level , concussion and edema of cervical spinal cord , sequela',\n 'Severe Lupus Nephritis (Off-label)': 'diseases of the musculoskeletal system and connective tissue , systemic connective tissue disorders , systemic lupus erythematosus sle , systemic lupus erythematosus with organ or system involvement , tubulo-interstitial nephropathy in systemic lupus erythematosus',\n 'Inflammation': 'diseases of the genitourinary system , inflammatory diseases of female pelvic organs , other inflammation of vagina and vulva , other specified inflammation of vagina and vulva , other specified inflammation of vagina and vulva',\n 'Status Asthmaticus': 'diseases of the respiratory system , chronic lower respiratory diseases , asthma , other and unspecified asthma , unspecified asthma , with status asthmaticus',\n 'Hyperprolactinemia': 'endocrine, nutritional and metabolic diseases , disorders of other endocrine glands , hyperfunction of pituitary gland , hyperprolactinemia',\n 'Postpartum Hemorrhage': 'pregnancy, childbirth and the puerperium , complications of labor and delivery , postpartum hemorrhage , other immediate postpartum hemorrhage',\n 'Labor Induction': 'pregnancy, childbirth and the puerperium , complications of labor and delivery , failed induction of labor , failed instrumental induction of labor',\n 'Incomplete or Inevitable Abortion': 'pregnancy, childbirth and the puerperium , pregnancy with abortive outcome , spontaneous abortion , complete or unspecified spontaneous abortion without complication',\n 'Serum Phosphorus Regulation': 'endocrine, nutritional and metabolic diseases , metabolic disorders , disorders of mineral metabolism , disorders of phosphorus metabolism and phosphatases , other disorders of phosphorus metabolism',\n 'Osteoporosis': 'diseases of the musculoskeletal system and connective tissue , disorders of bone density and structure , osteoporosis without current pathological fracture , age-related osteoporosis without current pathological fracture',\n 'Cervical Ripening': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , abnormal findings on examination of other body fluids, substances and tissues, without diagnosis , abnormal findings in specimens from female genital organs , abnormal cytological findings in specimens from female genital organs , abnormal cytological findings in specimens from cervix uteri , satisfactory cervical smear but lacking transformation zone',\n 'Pregnancy Termination': 'pregnancy, childbirth and the puerperium , pregnancy with abortive outcome , failed attempted termination of pregnancy , failed attempted termination of pregnancy with other and unspecified complications , cardiac arrest following failed attempted termination of pregnancy',\n 'Myasthenia Gravis': 'diseases of the nervous system , diseases of myoneural junction and muscle , myasthenia gravis and other myoneural disorders , myasthenia gravis , with acute exacerbation',\n 'Reversal of Nondepolarizing Muscle Relaxants': 'injury, poisoning and certain other consequences of external causes , poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of agents primarily acting on smooth and skeletal muscles and the respiratory system , poisoning by, adverse effect of and underdosing of skeletal muscle relaxants neuromuscular blocking agents , poisoning by, adverse effect of and underdosing of skeletal muscle relaxants neuromuscular blocking agents , poisoning by skeletal muscle relaxants neuromuscular blocking agents, undetermined , sequela',\n 'Pretreatment for Soman Nerve Gas Exposure': 'injury, poisoning and certain other consequences of external causes , poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of anesthetics and therapeutic gases , poisoning by, adverse effect of and underdosing of therapeutic gases , poisoning by, adverse effect of and underdosing of therapeutic gases , poisoning by therapeutic gases, intentional self-harm , initial encounter',\n 'Alzheimer Dementia': 'diseases of the nervous system , other degenerative diseases of the nervous system , alzheimers disease , alzheimers disease with late onset',\n 'Parkinson Dementia': 'diseases of the nervous system , extrapyramidal and movement disorders , parkinsons disease',\n 'Muscle Spasticity ': 'diseases of the musculoskeletal system and connective tissue , disorders of muscles , other disorders of muscle , other specified disorders of muscle , muscle spasm , other muscle spasm',\n 'Panic Disorder': 'mental, behavioral and neurodevelopmental disorders , anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders , phobic anxiety disorders , agoraphobia , with panic disorder',\n 'Seizure Disorders': 'diseases of the nervous system , episodic and paroxysmal disorders , epilepsy and recurrent seizures , other epilepsy and recurrent seizures , lennox-gastaut syndrome , intractable, without status epilepticus',\n 'Essential Tremor (Off-label)': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the nervous and musculoskeletal systems , abnormal involuntary movements , tremor, unspecified',\n 'REM Sleep Behavior Disorder (Off-label)': 'diseases of the nervous system , episodic and paroxysmal disorders , sleep disorders , parasomnia , rem sleep behavior disorder',\n 'Burning Mouth Syndrome (Off-label)': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , general symptoms and signs , other general symptoms and signs , dry mouth, unspecified',\n 'Recurrent, Acute, Repetitive Seizures (Orphan)': 'diseases of the nervous system , episodic and paroxysmal disorders , epilepsy and recurrent seizures , juvenile myoclonic epilepsy impulsive petit mal , juvenile myoclonic epilepsy, intractable , without status epilepticus',\n 'Anxiety': 'mental, behavioral and neurodevelopmental disorders , anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders , phobic anxiety disorders , social phobias , social phobia, unspecified',\n 'Alcohol Withdrawal': 'mental, behavioral and neurodevelopmental disorders , mental and behavioral disorders due to psychoactive substance use , alcohol related disorders , alcohol dependence , alcohol dependence with withdrawal , uncomplicated',\n 'Endoscopic Precedures': 'external causes of morbidity , misadventures to patients during surgical and medical care , failure of sterile precautions during surgical and medical care , failure of sterile precautions during endoscopic examination',\n 'Preoperative Sedation': 'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , failed moderate sedation during procedure , subsequent encounter',\n 'Sedation in the ICU': 'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , failed moderate sedation during procedure , sequela',\n 'Muscle Spasm': 'diseases of the musculoskeletal system and connective tissue , disorders of muscles , other disorders of muscle , other specified disorders of muscle , muscle spasm , other muscle spasm',\n 'Seizure Disorder': 'diseases of the nervous system , episodic and paroxysmal disorders , epilepsy and recurrent seizures , other epilepsy and recurrent seizures , lennox-gastaut syndrome , intractable, without status epilepticus',\n 'Status Epilepticus': 'diseases of the nervous system , episodic and paroxysmal disorders , epilepsy and recurrent seizures , absence epileptic syndrome , absence epileptic syndrome, intractable , with status epilepticus',\n 'Cardioversion': 'external causes of morbidity , supplementary factors related to causes of morbidity classified elsewhere , activity codes , activities involving other cardiorespiratory exercise , activity, circuit training',\n 'Sedative/Muscle Relaxant': 'mental, behavioral and neurodevelopmental disorders , mental and behavioral disorders due to psychoactive substance use , sedative, hypnotic, or anxiolytic related disorders , sedative, hypnotic or anxiolytic-related use, unspecified , sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced mood disorder',\n 'Preoperative Sedation/Anxiolysis With Anterograde Amnesia': 'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , failed moderate sedation during procedure , sequela',\n 'Sedation of Intubated/Ventilated Patients': 'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , failed moderate sedation during procedure , sequela',\n 'Sedation': 'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , failed moderate sedation during procedure , sequela',\n 'Anesthesia (Non-neonatal)': 'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , unintended awareness under general anesthesia during procedure , sequela',\n 'Anesthesia (Neonatal)': 'pregnancy, childbirth and the puerperium , other maternal disorders predominantly related to pregnancy , complications of anesthesia during pregnancy , unspecified complication of anesthesia during pregnancy , first trimester',\n 'Preoperative Sedation/Anxiolysis with Anterograde Amnesia': 'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , failed moderate sedation during procedure , sequela',\n 'Glaucoma': 'diseases of the eye and adnexa , glaucoma , glaucoma , other glaucoma , other specified glaucoma',\n 'Acute Altitude Sickness': 'injury, poisoning and certain other consequences of external causes , other and unspecified effects of external causes , effects of air pressure and water pressure , other and unspecified effects of high altitude , other effects of high altitude , subsequent encounter',\n 'Seizure': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , general symptoms and signs , convulsions, not elsewhere classified , post traumatic seizures',\n 'Drug-induced Edema': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , general symptoms and signs , edema, not elsewhere classified , edema, unspecified',\n 'Epilepsy': 'diseases of the nervous system , episodic and paroxysmal disorders , epilepsy and recurrent seizures , epilepsy, unspecified , epilepsy, unspecified, not intractable , with status epilepticus',\n 'Trigeminal Neuralgia': 'diseases of the nervous system , nerve, nerve root and plexus disorders , disorders of trigeminal nerve , trigeminal neuralgia',\n 'Bipolar Mania': 'mental, behavioral and neurodevelopmental disorders , mood affective disorders , bipolar disorder , bipolar disorder, current episode manic without psychotic features , severe',\n 'Restless Legs Syndrome (Off-label)': 'diseases of the nervous system , extrapyramidal and movement disorders , other extrapyramidal and movement disorders , other specified extrapyramidal and movement disorders , restless legs syndrome',\n 'Schizophrenia (Off-label)': 'mental, behavioral and neurodevelopmental disorders , schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders , unspecified psychosis not due to a substance or known physiological condition',\n 'Postherpatic Neuralgia': 'diseases of the nervous system , other disorders of the nervous system , pain, not elsewhere classified , acute pain, not elsewhere classified , acute post-thoracotomy pain',\n 'Partial-Onset or Primary Generalized Tonic-Clonic Seizures': 'diseases of the nervous system , episodic and paroxysmal disorders , epilepsy and recurrent seizures , localization-related focal partial symptomatic epilepsy and epileptic syndromes with simple partial seizures , localization-related focal partial symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable , without status epilepticus',\n 'Lennox-Gastaut Syndrome': 'diseases of the nervous system , episodic and paroxysmal disorders , epilepsy and recurrent seizures , other epilepsy and recurrent seizures , lennox-gastaut syndrome , intractable, with status epilepticus',\n 'Migraine Headache': 'diseases of the nervous system , episodic and paroxysmal disorders , migraine , migraine, unspecified , migraine, unspecified, intractable , with status migrainosus',\n 'Cluster Headache (Off-label)': 'diseases of the nervous system , episodic and paroxysmal disorders , other headache syndromes , cluster headaches and other trigeminal autonomic cephalgias tac , chronic cluster headache , intractable',\n 'Alcoholism (Off-label)': 'mental, behavioral and neurodevelopmental disorders , mental and behavioral disorders due to psychoactive substance use , alcohol related disorders , alcohol use, unspecified , alcohol use, unspecified with withdrawal , uncomplicated',\n 'Partial Onset Seizures': 'diseases of the nervous system , episodic and paroxysmal disorders , epilepsy and recurrent seizures , localization-related focal partial symptomatic epilepsy and epileptic syndromes with simple partial seizures , localization-related focal partial symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable , without status epilepticus',\n 'Primary Generalized Tonic-Clonic Seizures ': 'diseases of the nervous system , episodic and paroxysmal disorders , epilepsy and recurrent seizures , other generalized epilepsy and epileptic syndromes , other generalized epilepsy and epileptic syndromes, intractable , with status epilepticus',\n 'Partial-Onset Seizures (Conversion to Monotherapy)': 'diseases of the nervous system , episodic and paroxysmal disorders , epilepsy and recurrent seizures , localization-related focal partial symptomatic epilepsy and epileptic syndromes with simple partial seizures , localization-related focal partial symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable , with status epilepticus',\n 'Bipolar Disorder': 'mental, behavioral and neurodevelopmental disorders , mood affective disorders , bipolar disorder , bipolar disorder, unspecified',\n 'Diabetic Peripheral Neuropathic Pain': 'endocrine, nutritional and metabolic diseases , diabetes mellitus , diabetes mellitus due to underlying condition , diabetes mellitus due to underlying condition with neurological complications , diabetes mellitus due to underlying condition with diabetic autonomic polyneuropathy',\n 'Postherpetic Neuralgia': 'diseases of the nervous system , other disorders of the nervous system , pain, not elsewhere classified , acute pain, not elsewhere classified , acute post-thoracotomy pain',\n 'Fibromyalgia': 'diseases of the musculoskeletal system and connective tissue , other soft tissue disorders , other and unspecified soft tissue disorders, not elsewhere classified , fibromyalgia',\n 'Neuropathic Pain With Spinal Cord Injury': 'diseases of the nervous system , other disorders of the nervous system , pain, not elsewhere classified , acute pain, not elsewhere classified , acute pain due to trauma',\n 'Partial Seizures': 'diseases of the nervous system , episodic and paroxysmal disorders , epilepsy and recurrent seizures , localization-related focal partial symptomatic epilepsy and epileptic syndromes with simple partial seizures , localization-related focal partial symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable , without status epilepticus',\n 'Bipolar Disorder (Off-label)': 'mental, behavioral and neurodevelopmental disorders , mood affective disorders , bipolar disorder , bipolar disorder, currently in remission , most recent episode unspecified',\n 'Diabetic Neuropathy (Off-label)': 'endocrine, nutritional and metabolic diseases , diabetes mellitus , drug or chemical induced diabetes mellitus , drug or chemical induced diabetes mellitus with neurological complications , with diabetic neuropathy, unspecified',\n 'Neuralgia/Neuropathy (Off-label)': 'diseases of the nervous system , other disorders of the nervous system , pain, not elsewhere classified , acute pain, not elsewhere classified , other acute postprocedural pain',\n 'Partial Seizures (Adjunctive Treatment)': 'diseases of the nervous system , episodic and paroxysmal disorders , epilepsy and recurrent seizures , localization-related focal partial symptomatic epilepsy and epileptic syndromes with simple partial seizures , localization-related focal partial symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable , with status epilepticus',\n 'Partial Seizures (Monotherapy)': 'diseases of the nervous system , episodic and paroxysmal disorders , epilepsy and recurrent seizures , localization-related focal partial symptomatic epilepsy and epileptic syndromes with simple partial seizures , localization-related focal partial symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable , without status epilepticus',\n 'Cluster Headache': 'diseases of the nervous system , episodic and paroxysmal disorders , other headache syndromes , cluster headaches and other trigeminal autonomic cephalgias tac , chronic cluster headache , intractable',\n 'Parkinson Disease': 'diseases of the nervous system , extrapyramidal and movement disorders , parkinsons disease',\n 'Restless Legs Syndrome': 'diseases of the nervous system , extrapyramidal and movement disorders , other extrapyramidal and movement disorders , other specified extrapyramidal and movement disorders , restless legs syndrome',\n 'Restless legs syndrome (Off-label)': 'diseases of the nervous system , extrapyramidal and movement disorders , other extrapyramidal and movement disorders , other specified extrapyramidal and movement disorders , restless legs syndrome',\n 'Cocaine withdrawal (Off-label)': 'mental, behavioral and neurodevelopmental disorders , mental and behavioral disorders due to psychoactive substance use , cocaine related disorders , cocaine dependence , with withdrawal',\n 'Insomnia (Off-label)': 'diseases of the nervous system , episodic and paroxysmal disorders , sleep disorders , insomnia , other insomnia',\n 'Tremors in multiple sclerosis (Off-label)': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the nervous and musculoskeletal systems , abnormal involuntary movements , tremor, unspecified',\n 'Hot flashes-cancer related (Off-label)': 'external causes of morbidity , contact with heat and hot substances , contact with hot drinks, food, fats and cooking oils , contact with hot drinks , sequela',\n 'Amyotrophic Lateral Sclerosis (Orphan)': 'diseases of the nervous system , systemic atrophies primarily affecting the central nervous system , spinal muscular atrophy and related syndromes , motor neuron disease , amyotrophic lateral sclerosis',\n 'Insomnia (Sleep Onset & Maintenance)': 'diseases of the nervous system , episodic and paroxysmal disorders , sleep disorders , insomnia , other insomnia',\n 'Insomnia (Middle of Night Awakening)': 'diseases of the nervous system , episodic and paroxysmal disorders , sleep disorders , insomnia , other insomnia',\n 'Insomnia (Sleep Onset & Sleep Maintenance)': 'diseases of the nervous system , episodic and paroxysmal disorders , sleep disorders , insomnia , other insomnia',\n 'Myoclonic Seizures': 'diseases of the nervous system , episodic and paroxysmal disorders , epilepsy and recurrent seizures , juvenile myoclonic epilepsy impulsive petit mal , juvenile myoclonic epilepsy, intractable , with status epilepticus',\n 'Partial Onset Seizure': 'diseases of the nervous system , episodic and paroxysmal disorders , epilepsy and recurrent seizures , localization-related focal partial symptomatic epilepsy and epileptic syndromes with simple partial seizures , localization-related focal partial symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable , without status epilepticus',\n 'Primary Generalized Tonic-Clonic Seizures': 'diseases of the nervous system , episodic and paroxysmal disorders , epilepsy and recurrent seizures , other generalized epilepsy and epileptic syndromes , other generalized epilepsy and epileptic syndromes, intractable , with status epilepticus',\n 'Rheumatoid Arthritis, Osteoarthritis, Ankylosing Spondylitis': 'diseases of the musculoskeletal system and connective tissue , spondylopathies , ankylosing spondylitis , ankylosing spondylitis of thoracic region',\n 'Dysmenorrhea': 'diseases of the genitourinary system , noninflammatory disorders of female genital tract , pain and other conditions associated with female genital organs and menstrual cycle , primary dysmenorrhea',\n 'Gout, Acute': 'diseases of the musculoskeletal system and connective tissue , inflammatory polyarthropathies , gout , gout, unspecified',\n 'Migraine (Off-label)': 'diseases of the nervous system , episodic and paroxysmal disorders , migraine , migraine with aura , migraine with aura, intractable , without status migrainosus',\n 'Moderate-to-Severe Pain': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the genitourinary system , pain associated with micturition , painful micturition, unspecified',\n 'Acute Pain or Primary Dysmenorrhea': 'diseases of the genitourinary system , noninflammatory disorders of female genital tract , pain and other conditions associated with female genital organs and menstrual cycle , primary dysmenorrhea',\n 'Familial Adenomatous Polyposis (Off-label)': 'neoplasms , neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes , neoplasm of uncertain behavior of endocrine glands , neoplasm of uncertain behavior of aortic body and other paraganglia',\n 'Pain Management': 'diseases of the nervous system , other disorders of the nervous system , pain, not elsewhere classified , chronic pain, not elsewhere classified , chronic post-thoracotomy pain',\n 'Rheumatoid Arthritis or Osteoarthritis': 'diseases of the musculoskeletal system and connective tissue , inflammatory polyarthropathies , other rheumatoid arthritis , rheumatoid arthritis, unspecified',\n 'Acute Pain': 'diseases of the nervous system , other disorders of the nervous system , pain, not elsewhere classified , acute pain, not elsewhere classified , acute pain due to trauma',\n 'Primary Dysmenorrhea': 'diseases of the genitourinary system , noninflammatory disorders of female genital tract , pain and other conditions associated with female genital organs and menstrual cycle , primary dysmenorrhea',\n 'Acute pain': 'diseases of the nervous system , other disorders of the nervous system , pain, not elsewhere classified , acute pain, not elsewhere classified , acute pain due to trauma',\n 'Spasticity': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the nervous and musculoskeletal systems , abnormal involuntary movements , cramp and spasm',\n 'Orphan Indications': 'diseases of the genitourinary system , intraoperative and postprocedural complications and disorders of genitourinary system, not elsewhere classified , intraoperative and postprocedural complications and disorders of genitourinary system, not elsewhere classified , accidental puncture and laceration of a genitourinary system organ or structure during a procedure , accidental puncture and laceration of a genitourinary system organ or structure during a genitourinary system procedure',\n 'Attention Deficit Hyperactivity Disorder': 'mental, behavioral and neurodevelopmental disorders , behavioral and emotional disorders with onset usually occurring in childhood and adolescence , attention-deficit hyperactivity disorders , attention-deficit hyperactivity disorder, predominantly hyperactive type',\n 'Narcolepsy': 'diseases of the nervous system , episodic and paroxysmal disorders , sleep disorders , narcolepsy and cataplexy , narcolepsy , with cataplexy',\n 'Anxiety Associated With Depression': 'mental, behavioral and neurodevelopmental disorders , mental disorders due to known physiological conditions , dementia in other diseases classified elsewhere , dementia in other diseases classified elsewhere, severe , with anxiety',\n 'Premenstrual Syndrome (Off-label)': 'diseases of the genitourinary system , noninflammatory disorders of female genital tract , pain and other conditions associated with female genital organs and menstrual cycle , premenstrual tension syndrome',\n 'Depression': 'mental, behavioral and neurodevelopmental disorders , mood affective disorders , depressive episode , depression, unspecified',\n 'Post-traumatic Stress Disorder (Off-label)': 'mental, behavioral and neurodevelopmental disorders , anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders , reaction to severe stress, and adjustment disorders , post-traumatic stress disorder ptsd , post-traumatic stress disorder, unspecified',\n 'Hot Flashes (Off-label)': 'external causes of morbidity , contact with heat and hot substances , contact with hot drinks, food, fats and cooking oils , contact with hot drinks , subsequent encounter',\n 'Major Depressive Disorder': 'mental, behavioral and neurodevelopmental disorders , mood affective disorders , major depressive disorder, recurrent , major depressive disorder, recurrent, unspecified',\n 'Generalized Anxiety Disorder': 'mental, behavioral and neurodevelopmental disorders , anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders , other anxiety disorders , generalized anxiety disorder',\n 'Chronic Musculoskeletal Pain': 'diseases of the musculoskeletal system and connective tissue , other joint disorders , other joint disorder, not elsewhere classified , pain in joint , pain in unspecified joint',\n 'Obsessive-Compulsive Disorder': 'mental, behavioral and neurodevelopmental disorders , anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders , obsessive-compulsive disorder , mixed obsessional thoughts and acts',\n 'Social Phobia': 'mental, behavioral and neurodevelopmental disorders , anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders , phobic anxiety disorders , social phobias , social phobia, generalized',\n 'Posttraumatic Stress Disorder': 'mental, behavioral and neurodevelopmental disorders , anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders , reaction to severe stress, and adjustment disorders , post-traumatic stress disorder ptsd , post-traumatic stress disorder, unspecified',\n 'Premenstrual Dysphoric Disorder': 'mental, behavioral and neurodevelopmental disorders , mood affective disorders , depressive episode , other depressive episodes , premenstrual dysphoric disorder',\n 'Menopausal Vasomotor Symptoms': 'diseases of the genitourinary system , noninflammatory disorders of female genital tract , menopausal and other perimenopausal disorders , postmenopausal atrophic vaginitis',\n 'Stuttering (Off-label)': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving speech and voice , speech disturbances, not elsewhere classified , other speech disturbances , fluency disorder in conditions classified elsewhere',\n 'Vasovagal Syncope (Off-label)': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , general symptoms and signs , syncope and collapse',\n 'Binge-eating Disorder (Off-label)': 'mental, behavioral and neurodevelopmental disorders , behavioral syndromes associated with physiological disturbances and physical factors , eating disorders , other eating disorders , binge eating disorder',\n 'Generalized Anxiety Disorder (Off-label)': 'mental, behavioral and neurodevelopmental disorders , anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders , other anxiety disorders , panic disorder episodic paroxysmal anxiety',\n 'Obsessive-Compulsive Disorder (Off-label)': 'mental, behavioral and neurodevelopmental disorders , anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders , obsessive-compulsive disorder , mixed obsessional thoughts and acts',\n 'Premenstrual Dysphoric Disorder (Off-label)': 'mental, behavioral and neurodevelopmental disorders , mood affective disorders , depressive episode , other depressive episodes , premenstrual dysphoric disorder',\n 'Depression (Off-label)': 'mental, behavioral and neurodevelopmental disorders , mood affective disorders , depressive episode , depression, unspecified',\n 'Impulsive Aggresive Behavior (Off-label)': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving cognition, perception, emotional state and behavior , symptoms and signs involving emotional state , other symptoms and signs involving emotional state , impulsiveness',\n 'Depression Associated with Bipolar I Disorder ': 'mental, behavioral and neurodevelopmental disorders , mood affective disorders , bipolar disorder , bipolar disorder, currently in remission , bipolar disorder, in full remission, most recent episode depressed',\n 'Bulimia Nervosa': 'mental, behavioral and neurodevelopmental disorders , behavioral syndromes associated with physiological disturbances and physical factors , eating disorders , bulimia nervosa',\n 'Depression Associated with Bipolar I Disorder': 'mental, behavioral and neurodevelopmental disorders , mood affective disorders , bipolar disorder , bipolar disorder, currently in remission , bipolar disorder, in full remission, most recent episode depressed',\n 'Dosage Forms Strengths': 'external causes of morbidity , misadventures to patients during surgical and medical care , failure in dosage during surgical and medical care , failure in dosage during unspecified surgical and medical care',\n 'Major depressive disorder': 'mental, behavioral and neurodevelopmental disorders , mood affective disorders , major depressive disorder, recurrent , major depressive disorder, recurrent, unspecified',\n 'Social Anxiety Disorder': 'mental, behavioral and neurodevelopmental disorders , anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders , phobic anxiety disorders , social phobias , social phobia, unspecified',\n 'Schizophrenia': 'mental, behavioral and neurodevelopmental disorders , schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders , unspecified psychosis not due to a substance or known physiological condition',\n 'Dosage Modifications (Oral)': 'injury, poisoning and certain other consequences of external causes , poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinorlaryngological and dental drugs , poisoning by, adverse effect of and underdosing of dental drugs, topically applied , poisoning by, adverse effect of and underdosing of dental drugs, topically applied , adverse effect of dental drugs, topically applied , sequela',\n 'Dosage Modifications (Abilify Maintena)': 'injury, poisoning and certain other consequences of external causes , poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of hormones and their synthetic substitutes and antagonists, not elsewhere classified , poisoning by, adverse effect of and underdosing of other and unspecified hormones and synthetic substitutes , poisoning by, adverse effect of and underdosing of unspecified hormones and synthetic substitutes , adverse effect of unspecified hormones and synthetic substitutes , sequela',\n 'Dosage Modifications (Aristada)': 'injury, poisoning and certain other consequences of external causes , poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of agents primarily affecting the gastrointestinal system , poisoning by, adverse effect of and underdosing of other antacids and anti-gastric-secretion drugs , poisoning by, adverse effect of and underdosing of other antacids and anti-gastric-secretion drugs , poisoning by other antacids and anti-gastric-secretion drugs, undetermined , sequela',\n 'Dosage Modifications (Abilify Asimtufii)': 'injury, poisoning and certain other consequences of external causes , poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of nonopioid analgesics, antipyretics and antirheumatics , poisoning by, adverse effect of and underdosing of salicylates , poisoning by, adverse effect of and underdosing of aspirin , adverse effect of aspirin , sequela',\n 'Autism': 'mental, behavioral and neurodevelopmental disorders , pervasive and specific developmental disorders , pervasive developmental disorders , autistic disorder',\n 'Tourette Disorder': 'mental, behavioral and neurodevelopmental disorders , behavioral and emotional disorders with onset usually occurring in childhood and adolescence , tic disorder , tourettes disorder',\n 'Bipolar Depression': 'mental, behavioral and neurodevelopmental disorders , mood affective disorders , bipolar disorder , bipolar disorder, currently in remission , bipolar disorder, in full remission, most recent episode depressed',\n 'Chemotherapy Associated Nausea or Vomiting (Off-label)': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the digestive system and abdomen , nausea and vomiting , vomiting , without nausea',\n 'Bipolar I Disorder (Manic or Mixed Episodes) ': 'mental, behavioral and neurodevelopmental disorders , mood affective disorders , bipolar disorder , bipolar disorder, current episode mixed , severe, without psychotic features',\n 'Schizophrenia or Bipolar-Related Agitation': 'mental, behavioral and neurodevelopmental disorders , mood affective disorders , manic episode , manic episode, severe with psychotic symptoms',\n 'Tourette Syndrome (Off-label)': 'mental, behavioral and neurodevelopmental disorders , behavioral and emotional disorders with onset usually occurring in childhood and adolescence , tic disorder , tourettes disorder',\n 'Posttraumatic Stress Disorder (Off-label)': 'mental, behavioral and neurodevelopmental disorders , anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders , reaction to severe stress, and adjustment disorders , post-traumatic stress disorder ptsd , post-traumatic stress disorder, unspecified',\n 'Schizophrenia, Bipolar Mania': 'mental, behavioral and neurodevelopmental disorders , mood affective disorders , bipolar disorder , bipolar disorder, current episode manic severe with psychotic features',\n 'Psychosis, Agitation Related to Alzheimer Dementia (Off-label) ': 'mental, behavioral and neurodevelopmental disorders , mental disorders due to known physiological conditions , unspecified dementia , unspecified dementia, moderate , unspecified dementia, moderate, with behavioral disturbance , unspecified dementia, moderate, with agitation',\n 'Bipolar I Disorder, Mania': 'mental, behavioral and neurodevelopmental disorders , mood affective disorders , bipolar disorder , bipolar disorder, current episode manic severe with psychotic features',\n 'Bipolar Disorder, Depressive Episodes': 'mental, behavioral and neurodevelopmental disorders , mood affective disorders , bipolar disorder , bipolar disorder, current episode depressed, severe, without psychotic features',\n 'Bipolar I Disorder, Maintenance': 'mental, behavioral and neurodevelopmental disorders , mood affective disorders , bipolar disorder , bipolar disorder, currently in remission , most recent episode unspecified',\n 'Alcohol Dependence (Off-label)': 'mental, behavioral and neurodevelopmental disorders , mental and behavioral disorders due to psychoactive substance use , alcohol related disorders , alcohol dependence , alcohol dependence with withdrawal , with perceptual disturbance',\n 'Schizophrenia, Bipolar Disorder': 'mental, behavioral and neurodevelopmental disorders , schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders , schizoaffective disorders , schizoaffective disorder, bipolar type',\n 'Psychosis, Agitation Related to Alzheimer Dementia (Off-label)': 'mental, behavioral and neurodevelopmental disorders , mental disorders due to known physiological conditions , unspecified dementia , unspecified dementia, moderate , unspecified dementia, moderate, with behavioral disturbance , unspecified dementia, moderate, with agitation',\n 'Schizophrenia, Psychosis': 'mental, behavioral and neurodevelopmental disorders , schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders , unspecified psychosis not due to a substance or known physiological condition',\n 'Schizophrenia, Psychosis/Sedation': 'mental, behavioral and neurodevelopmental disorders , schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders , unspecified psychosis not due to a substance or known physiological condition',\n 'Behavioral Disorders': 'mental, behavioral and neurodevelopmental disorders , behavioral syndromes associated with physiological disturbances and physical factors , psychological and behavioral factors associated with disorders or diseases classified elsewhere',\n 'Acute Agitation': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving cognition, perception, emotional state and behavior , symptoms and signs involving emotional state , restlessness and agitation',\n 'Non Psychotic Anxiety': 'mental, behavioral and neurodevelopmental disorders , schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders , unspecified psychosis not due to a substance or known physiological condition',\n 'Schizophrenia/Psychosis ': 'mental, behavioral and neurodevelopmental disorders , schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders , unspecified psychosis not due to a substance or known physiological condition',\n 'Schizoaffective Disorder': 'mental, behavioral and neurodevelopmental disorders , schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders , schizoaffective disorders , schizoaffective disorder, unspecified',\n 'Respiratory Distress Syndrome': 'diseases of the respiratory system , other respiratory diseases principally affecting the interstitium , acute respiratory distress syndrome',\n 'Erectile Dysfunction': 'diseases of the genitourinary system , diseases of male genital organs , male erectile dysfunction , drug-induced erectile dysfunction',\n 'Benign Prostatic Hyperplasia': 'diseases of the genitourinary system , diseases of male genital organs , benign prostatic hyperplasia , benign prostatic hyperplasia with lower urinary tract symptoms',\n 'Pulmonary Arterial Hypertension': 'diseases of the circulatory system , pulmonary heart disease and diseases of pulmonary circulation , other pulmonary heart diseases , other secondary pulmonary hypertension , chronic thromboembolic pulmonary hypertension',\n 'Acute Bronchospasm': 'diseases of the respiratory system , other diseases of the respiratory system , other respiratory disorders , diseases of bronchus, not elsewhere classified , acute bronchospasm',\n 'Bronchospasm': 'diseases of the respiratory system , other diseases of the respiratory system , other respiratory disorders , diseases of bronchus, not elsewhere classified , acute bronchospasm',\n 'Neonatal Apnea': 'certain conditions originating in the perinatal period , respiratory and cardiovascular disorders specific to the perinatal period , other respiratory conditions originating in the perinatal period , other apnea of newborn , mixed neonatal apnea of newborn',\n 'Pulmonary Disease': 'diseases of the circulatory system , pulmonary heart disease and diseases of pulmonary circulation , other pulmonary heart diseases , pulmonary heart disease, unspecified',\n 'Diagnostic Bronchography': 'diseases of the respiratory system , chronic lower respiratory diseases , unspecified chronic bronchitis',\n 'Contrast Agent-Associated Nephrotoxicity (Off-label)': 'diseases of the genitourinary system , renal tubulo-interstitial diseases , drug- and heavy-metal-induced tubulo-interstitial and tubular conditions , nephropathy induced by other drugs, medicaments and biological substances , contrast-induced nephropathy',\n 'Keratoconjunctivitis Sicca (Off-label)': 'diseases of the eye and adnexa , disorders of sclera, cornea, iris and ciliary body , keratitis , keratoconjunctivitis , keratoconjunctivitis sicca, not specified as sjögrens , bilateral',\n 'Idiopathic Pulmonary Fibrosis': 'diseases of the respiratory system , other respiratory diseases principally affecting the interstitium , other interstitial pulmonary diseases , other interstitial pulmonary diseases with fibrosis , other interstitial pulmonary diseases with fibrosis in diseases classified elsewhere , interstitial lung disease with progressive fibrotic phenotype in diseases classified elsewhere',\n 'Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype': 'diseases of the respiratory system , other respiratory diseases principally affecting the interstitium , other interstitial pulmonary diseases , other interstitial pulmonary diseases with fibrosis , other interstitial pulmonary diseases with fibrosis in diseases classified elsewhere , interstitial lung disease with progressive fibrotic phenotype in diseases classified elsewhere',\n 'Systemic Sclerosis-associated Interstitial Lung Disease': 'diseases of the musculoskeletal system and connective tissue , systemic connective tissue disorders , systemic sclerosis scleroderma , other forms of systemic sclerosis , systemic sclerosis with lung involvement',\n 'Gout': 'diseases of the musculoskeletal system and connective tissue , inflammatory polyarthropathies , gout , other secondary gout , unspecified site',\n 'Antineoplastic-Induced Hyperuricemia': 'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , malignant hyperthermia due to anesthesia , sequela',\n 'Hyperuricemia': 'endocrine, nutritional and metabolic diseases , metabolic disorders , other disorders of fluid, electrolyte and acid-base balance , hyperosmolality and hypernatremia',\n 'Oral Ulcers associated with Behςet Disease': 'diseases of the digestive system , diseases of oral cavity and salivary glands , stomatitis and related lesions , oral mucositis ulcerative , unspecified',\n 'Cardiac Arrest': 'diseases of the circulatory system , other forms of heart disease , cardiac arrest , cardiac arrest due to underlying cardiac condition',\n 'Hyperkalemia': 'endocrine, nutritional and metabolic diseases , metabolic disorders , other disorders of fluid, electrolyte and acid-base balance , hyperkalemia',\n 'Metabolic Acidosis (Non-Life-Threatening)': 'endocrine, nutritional and metabolic diseases , metabolic disorders , other disorders of fluid, electrolyte and acid-base balance , acidosis , acute metabolic acidosis',\n 'Hypokalemia Prophylaxis': 'endocrine, nutritional and metabolic diseases , metabolic disorders , other disorders of fluid, electrolyte and acid-base balance , hypokalemia',\n 'IV intermittent infusions': 'external causes of morbidity , misadventures to patients during surgical and medical care , failure in dosage during surgical and medical care , excessive amount of blood or other fluid given during transfusion or infusion',\n 'Hypokalemia prophylaxis ': 'endocrine, nutritional and metabolic diseases , metabolic disorders , other disorders of fluid, electrolyte and acid-base balance , hypokalemia',\n 'Cardiac Decompensation': 'diseases of the circulatory system , other forms of heart disease , other cardiac arrhythmias , other and unspecified premature depolarization , other premature depolarization',\n 'Low Cardiac Output (Off-label)': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the circulatory and respiratory systems , abnormalities of heart beat , tachycardia, unspecified',\n 'Severe Essential Hypertension': 'diseases of the circulatory system , hypertensive diseases , essential primary hypertension',\n 'Hypertension (Chronic)': 'diseases of the circulatory system , hypertensive diseases , secondary hypertension , renovascular hypertension',\n 'Hypertensive Crisis': 'diseases of the circulatory system , hypertensive diseases , hypertensive crisis , hypertensive crisis, unspecified',\n 'Heart Failure, Afterload Reduction': 'diseases of the circulatory system , other and unspecified disorders of the circulatory system , intraoperative and postprocedural complications and disorders of circulatory system, not elsewhere classified , other postprocedural cardiac functional disturbances , postprocedural heart failure , following other surgery',\n 'Chronic Kidney Disease-Associated Anemia': 'diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism , aplastic and other anemias and other bone marrow failure syndromes , anemia in chronic diseases classified elsewhere , anemia in chronic kidney disease',\n 'Chemotherapy-Related Anemia with Nonmyeloid Malignancies': 'diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism , aplastic and other anemias and other bone marrow failure syndromes , other anemias , other specified anemias , anemia due to antineoplastic chemotherapy',\n 'Myelosuppressive Chemotherapy Treatment': 'factors influencing health status and contact with health services , persons with potential health hazards related to family and personal history and certain conditions influencing health status , long term current drug therapy , long term current use of immunomodulators and immunosuppressants , long term current use of myelosuppressive agent',\n 'Induction or Consolidation Chemotherapy': 'factors influencing health status and contact with health services , encounters for other specific health care , encounter for other aftercare and medical care , encounter for antineoplastic chemotherapy and immunotherapy , encounter for antineoplastic chemotherapy',\n 'Bone Marrow Transplantation': 'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , complications of transplanted organs and tissue , complications of bone marrow transplant , unspecified complication of bone marrow transplant',\n 'Peripheral Blood Progenitor Cell Collection': 'diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism , aplastic and other anemias and other bone marrow failure syndromes , anemia in chronic diseases classified elsewhere , anemia in neoplastic disease',\n 'Acute Radiation Syndrome': 'injury, poisoning and certain other consequences of external causes , other and unspecified effects of external causes , radiation sickness, unspecified , radiation sickness, unspecified, initial encounter',\n 'Autologous Peripheral Blood Progenitor Cell Collection and Therapy': 'neoplasms , malignant neoplasms of lymphoid, hematopoietic and related tissue , multiple myeloma and malignant plasma cell neoplasms , solitary plasmacytoma , not having achieved remission',\n 'Patients with Cancer Undergoing Bone Marrow Transplantation': 'factors influencing health status and contact with health services , encounters for other specific health care , donors of organs and tissues , bone marrow donor',\n 'Neutropenia': 'diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism , other disorders of blood and blood-forming organs , neutropenia , neutropenia, unspecified',\n 'Intermittent Claudication': 'diseases of the circulatory system , diseases of arteries, arterioles and capillaries , atherosclerosis , atherosclerosis of native arteries of the extremities , atherosclerosis of native arteries of extremities with intermittent claudication , bilateral legs',\n 'Recommended Daily Allowance (Elemental Iron)': 'endocrine, nutritional and metabolic diseases , other nutritional deficiencies , deficiency of other nutrient elements , iron deficiency',\n 'Iron Deficiency Anemia': 'diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism , nutritional anemias , iron deficiency anemia , other iron deficiency anemias',\n 'Visipaque 320 ': 'diseases of the eye and adnexa , visual disturbances and blindness , visual disturbances , subjective visual disturbances , visual discomfort , unspecified',\n 'Visipaque 270': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the nervous and musculoskeletal systems , other symptoms and signs involving the nervous and musculoskeletal systems , national institutes of health stroke scale nihss score , nihss score 30-39 , nihss score 30',\n 'Intra-arterial administration': 'external causes of morbidity , legal intervention, operations of war, military operations, and terrorism , legal intervention , legal intervention, means unspecified , legal intervention, means unspecified, unspecified person injured , sequela',\n 'Intra-arterial administration (IA-DSA)': 'factors influencing health status and contact with health services , persons encountering health services for examinations , encounter for administrative examination , encounter for other administrative examinations , encounter for adoption services',\n 'IV administration': 'external causes of morbidity , legal intervention, operations of war, military operations, and terrorism , legal intervention , legal intervention, means unspecified , legal intervention, means unspecified, law enforcement official injured , sequela',\n 'Intrathecal': 'diseases of the musculoskeletal system and connective tissue , other joint disorders , internal derangement of knee , unspecified internal derangement of knee , unspecified internal derangement of unspecified knee',\n 'Intravascular': 'diseases of the circulatory system , cerebrovascular diseases , other and unspecified nontraumatic intracranial hemorrhage , nontraumatic intracranial hemorrhage, unspecified',\n 'CT Scanning of the Body': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , abnormal findings on diagnostic imaging and in function studies, without diagnosis , abnormal findings on diagnostic imaging of other body structures , abnormal findings on diagnostic imaging of other specified body structures , abnormal findings on diagnostic imaging of other specified body structures',\n 'Digital Subtraction': 'neoplasms , malignant neoplasms of breast , malignant neoplasm of breast , malignant neoplasm of lower-outer quadrant of breast , malignant neoplasm of lower-outer quadrant of breast, female , malignant neoplasm of lower-outer quadrant of unspecified female breast',\n 'Excretory Urography': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the genitourinary system , retention of urine , retention of urine, unspecified',\n 'Oral': 'diseases of the digestive system , diseases of oral cavity and salivary glands , other disorders of teeth and supporting structures , unsatisfactory restoration of tooth , unrepairable overhanging of dental restorative materials',\n 'Intracavity': 'injury, poisoning and certain other consequences of external causes , other and unspecified effects of external causes , other and unspecified effects of other external causes , other specified effects of external causes , effects of abnormal gravitation g forces , sequela',\n 'Body Imaging': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , abnormal findings on diagnostic imaging and in function studies, without diagnosis , abnormal findings on diagnostic imaging of other body structures , diagnostic imaging inconclusive due to excess body fat of patient',\n 'Hypocalcemia, Emergency Treatment': 'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , hypothermia following anesthesia , sequela',\n 'Arrhythmias, Emergent': 'diseases of the circulatory system , other forms of heart disease , paroxysmal tachycardia , re-entry ventricular arrhythmia',\n 'Hypermagnesemia': 'endocrine, nutritional and metabolic diseases , metabolic disorders , disorders of mineral metabolism , disorders of magnesium metabolism , hypermagnesemia',\n 'Calcium Channel Blocker Overdose': 'injury, poisoning and certain other consequences of external causes , poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system , poisoning by, adverse effect of and underdosing of calcium-channel blockers , poisoning by, adverse effect of and underdosing of calcium-channel blockers , poisoning by calcium-channel blockers, undetermined , initial encounter',\n 'Beta-blocker Overdose, Refractory to Glucagon & High Dose Vasopressor': 'injury, poisoning and certain other consequences of external causes , poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of drugs primarily affecting the autonomic nervous system , poisoning by, adverse effect of and underdosing of beta-adrenoreceptor antagonists , poisoning by, adverse effect of and underdosing of beta-adrenoreceptor antagonists , adverse effect of beta-adrenoreceptor antagonists , sequela',\n 'Hypocalcemic Tetany': 'endocrine, nutritional and metabolic diseases , metabolic disorders , other disorders of fluid, electrolyte and acid-base balance , hypo-osmolality and hyponatremia',\n 'Hypocalcemia': 'endocrine, nutritional and metabolic diseases , metabolic disorders , other disorders of fluid, electrolyte and acid-base balance , hypo-osmolality and hyponatremia',\n 'Cardiac Arrest (Off-label)': 'diseases of the circulatory system , other forms of heart disease , cardiac arrest , cardiac arrest, cause unspecified',\n 'Hydrofluoric Acid Burn (Off-label)': 'injury, poisoning and certain other consequences of external causes , toxic effects of substances chiefly nonmedicinal as to source , toxic effect of other gases, fumes and vapors , toxic effect of fluorine gas and hydrogen fluoride , toxic effect of fluorine gas and hydrogen fluoride , toxic effect of fluorine gas and hydrogen fluoride, accidental unintentional , subsequent encounter',\n 'Calcium Channel Blocker Overdose (Off-label)': 'injury, poisoning and certain other consequences of external causes , poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system , poisoning by, adverse effect of and underdosing of calcium-channel blockers , poisoning by, adverse effect of and underdosing of calcium-channel blockers , poisoning by calcium-channel blockers, undetermined , initial encounter',\n 'Hyperkalemia (Off-label)': 'endocrine, nutritional and metabolic diseases , metabolic disorders , other disorders of fluid, electrolyte and acid-base balance , hyperkalemia',\n 'Hypermagnesemia (Off-label)': 'endocrine, nutritional and metabolic diseases , metabolic disorders , disorders of mineral metabolism , disorders of magnesium metabolism , hypermagnesemia',\n 'RDA': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , abnormal tumor markers , abnormal tumor markers , elevated prostate specific antigen psa , rising psa following treatment for malignant neoplasm of prostate',\n 'Urinary Acidification': 'endocrine, nutritional and metabolic diseases , metabolic disorders , other disorders of amino-acid metabolism , disorders of urea cycle metabolism , arginosuccinic aciduria',\n 'Ascorbic Acid Deficiency (Scurvy)': 'endocrine, nutritional and metabolic diseases , other nutritional deficiencies , ascorbic acid deficiency',\n 'Macular Degeneration (Off-label)': 'diseases of the eye and adnexa , disorders of choroid and retina , other retinal disorders , degeneration of macula and posterior pole , nonexudative age-related macular degeneration , nonexudative age-related macular degeneration, bilateral , advanced atrophic without subfoveal involvement',\n 'Neural Tube Defects Prophylaxis': 'external causes of morbidity , misadventures to patients during surgical and medical care , other misadventures during surgical and medical care , endotracheal tube wrongly placed during anesthetic procedure',\n 'Folic Acid Deficiency': 'diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism , nutritional anemias , folate deficiency anemia , dietary folate deficiency anemia',\n 'Methanol Toxicity': 'injury, poisoning and certain other consequences of external causes , toxic effects of substances chiefly nonmedicinal as to source , toxic effect of alcohol , toxic effect of methanol , toxic effect of methanol , toxic effect of methanol, undetermined , sequela',\n 'Methotrexate Toxicity Prophylaxis (Off-label)': 'injury, poisoning and certain other consequences of external causes , poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of narcotics and psychodysleptics hallucinogens , poisoning by, adverse effect of and underdosing of methadone , poisoning by, adverse effect of and underdosing of methadone , adverse effect of methadone , sequela',\n 'Advanced Ovarian Carcinoma': 'neoplasms , malignant neoplasms of female genital organs , malignant neoplasm of ovary , malignant neoplasm of bilateral ovaries',\n 'Metastatic Testicular Tumors': 'neoplasms , malignant neoplasms of male genital organs , malignant neoplasm of testis , malignant neoplasm of undescended testis , malignant neoplasm of undescended left testis',\n 'Advanced Bladder Cancer': 'neoplasms , malignant neoplasms of urinary tract , malignant neoplasm of bladder , malignant neoplasm of anterior wall of bladder',\n 'Metastatic Ovarian Carcinoma': 'neoplasms , malignant neoplasms of female genital organs , malignant neoplasm of ovary , malignant neoplasm of bilateral ovaries',\n 'Cancers (Off-label)': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , abnormal tumor markers , abnormal tumor markers , other abnormal tumor markers',\n 'Osteogenic Sarcoma/Neuroblastoma (Off-label)': 'neoplasms , secondary neuroendocrine tumors , secondary neuroendocrine tumors , secondary carcinoid tumors , of bone',\n 'Brain Tumors, Recurrent (Off-label)': 'neoplasms , malignant neoplasms of ill-defined, other secondary and unspecified sites , secondary malignant neoplasm of other and unspecified sites , secondary malignant neoplasm of brain and cerebral meninges , secondary malignant neoplasm of brain',\n 'Malignant Diseases': 'neoplasms , malignant neoplasms of ill-defined, other secondary and unspecified sites , malignant neoplasm without specification of site , disseminated malignant neoplasm, unspecified',\n 'Nephrotic Syndrome': 'diseases of the genitourinary system , glomerular diseases , nephrotic syndrome , nephrotic syndrome with other morphologic changes',\n 'Non-Hodgkin Lymphoma ': 'neoplasms , malignant neoplasms of lymphoid, hematopoietic and related tissue , other specified and unspecified types of non-hodgkin lymphoma , other specified types of non-hodgkin lymphoma , intrapelvic lymph nodes',\n 'Juvenile Idiopathic Arthritis/Vasculitis (Off-label)': 'diseases of the musculoskeletal system and connective tissue , inflammatory polyarthropathies , juvenile arthritis , juvenile rheumatoid arthritis with systemic onset , unspecified site',\n 'Lupus Nephritis (Off-Label)': 'diseases of the musculoskeletal system and connective tissue , systemic connective tissue disorders , systemic lupus erythematosus sle , systemic lupus erythematosus with organ or system involvement , tubulo-interstitial nephropathy in systemic lupus erythematosus',\n 'Juvenile Idiopathic Arthritis/Vasculitis': 'diseases of the musculoskeletal system and connective tissue , inflammatory polyarthropathies , juvenile arthritis , juvenile rheumatoid arthritis with systemic onset , unspecified site',\n 'Systemic Lupus Erythematosus': 'diseases of the musculoskeletal system and connective tissue , systemic connective tissue disorders , systemic lupus erythematosus sle , other forms of systemic lupus erythematosus',\n 'Breast Cancer Prevention (Off-label)': 'factors influencing health status and contact with health services , genetic carrier and genetic susceptibility to disease , genetic susceptibility to disease , genetic susceptibility to malignant neoplasm , of breast',\n 'Ovarian Epithelial Cancer (Off-label)': 'neoplasms , malignant neoplasms of ill-defined, other secondary and unspecified sites , secondary malignant neoplasm of other and unspecified sites , secondary malignant neoplasm of ovary , secondary malignant neoplasm of bilateral ovaries',\n 'Ductal Carcinoma in Situ': 'neoplasms , in situ neoplasms , carcinoma in situ of breast , unspecified type of carcinoma in situ of breast , unspecified type of carcinoma in situ of unspecified breast',\n 'Breast Cancer Prevention': 'factors influencing health status and contact with health services , genetic carrier and genetic susceptibility to disease , genetic susceptibility to disease , genetic susceptibility to malignant neoplasm , of breast',\n 'Ovulation Induction (Off-label)': 'pregnancy, childbirth and the puerperium , pregnancy with abortive outcome , other abnormal products of conception , other specified abnormal products of conception , inappropriate change in quantitative human chorionic gonadotropin hcg in early pregnancy',\n 'Mastalgia (Off-label)': 'diseases of the musculoskeletal system and connective tissue , other soft tissue disorders , other and unspecified soft tissue disorders, not elsewhere classified , myalgia , of mastication muscle',\n 'Advanced Prostate Cancer': 'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , abnormal tumor markers , abnormal tumor markers , elevated prostate specific antigen psa , elevated prostate specific antigen psa',\n 'Central Precocious Puberty': 'endocrine, nutritional and metabolic diseases , disorders of other endocrine glands , disorders of puberty, not elsewhere classified , precocious puberty',\n 'Metastatic Colorectal Cancer': 'neoplasms , malignant neoplasms of digestive organs , malignant neoplasm of colon , malignant neoplasm of descending colon',\n 'Non-Small Cell Lung Cancer': 'neoplasms , malignant neoplasms of ill-defined, other secondary and unspecified sites , secondary malignant neoplasm of respiratory and digestive organs , secondary malignant neoplasm of lung , secondary malignant neoplasm of unspecified lung',\n 'Renal Cell Carcinoma': 'neoplasms , malignant neuroendocrine tumors , malignant neuroendocrine tumors , malignant carcinoid tumors , malignant carcinoid tumors of other sites , malignant carcinoid tumor of the kidney',\n 'Ovarian, Fallopian Tube, or Peritoneal Cancer': 'diseases of the genitourinary system , noninflammatory disorders of female genital tract , noninflammatory disorders of ovary, fallopian tube and broad ligament , prolapse and hernia of ovary and fallopian tube , prolapse and hernia of right ovary and fallopian tube',\n 'Glioblastoma': 'neoplasms , malignant neoplasms of eye, brain and other parts of central nervous system , malignant neoplasm of brain , malignant neoplasm of occipital lobe',\n 'Exudative ARMD (Off-label)': 'factors influencing health status and contact with health services , encounters for other specific health care , encounter for fitting and adjustment of external prosthetic device , encounter for fitting and adjustment of artificial arm , encounter for fitting and adjustment of partial artificial arm , unspecified arm',\n 'Hepatocellular Carcinoma': 'neoplasms , malignant neoplasms of digestive organs , malignant neoplasm of liver and intrahepatic bile ducts , hepatoblastoma',\n 'Orphan Designations': 'congenital malformations, deformations and chromosomal abnormalities , other congenital malformations , other congenital malformations, not elsewhere classified , congenital malformation, unspecified',\n 'Myelodysplastic/Myeloproliferative Diseases': 'neoplasms , neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes , other neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue , chronic myeloproliferative disease',\n 'Hypereosinophilic Syndrome and/or Chronic Eosinophilic Leukemia': 'diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism , other disorders of blood and blood-forming organs , other disorders of white blood cells , eosinophilia , hypereosinophilic syndrome hes , idiopathic hypereosinophilic syndrome ihes',\n 'Chronic Myeloid Leukemia Philadelphia-Chromosome-positive': 'neoplasms , malignant neoplasms of lymphoid, hematopoietic and related tissue , myeloid leukemia , chronic myeloid leukemia, bcr/abl-positive , in relapse',\n 'Dermatofibrosarcoma Protuberans': 'diseases of the skin and subcutaneous tissue , dermatitis and eczema , seborrheic dermatitis , seborrheic infantile dermatitis',\n 'Mastocytosis': 'congenital malformations, deformations and chromosomal abnormalities , other congenital malformations , other congenital malformations of skin , congenital cutaneous mastocytosis',\n 'Gastrointestinal Stromal Tumors': 'neoplasms , malignant neoplasms of mesothelial and soft tissue , malignant neoplasm of other connective and soft tissue , gastrointestinal stromal tumor , of other sites',\n 'Chronic Myeloid Leukemia': 'neoplasms , malignant neoplasms of lymphoid, hematopoietic and related tissue , myeloid leukemia , atypical chronic myeloid leukemia, bcr/abl-negative , in relapse',\n 'Mydriasis/Cycloplegia Diaganosis': 'certain infectious and parasitic diseases , mycoses , coccidioidomycosis , cutaneous coccidioidomycosis',\n 'Mydriasis/Cycloplegia': 'certain infectious and parasitic diseases , other viral diseases , other viral diseases, not elsewhere classified , epidemic myalgia',\n 'Ocular Hypertension or Open-Angle Glaucoma': 'diseases of the eye and adnexa , glaucoma , glaucoma , open-angle glaucoma , low-tension glaucoma , low-tension glaucoma, unspecified eye , moderate stage',\n 'Elevated Intraocular Pressure': 'diseases of the eye and adnexa , glaucoma , glaucoma , glaucoma suspect , ocular hypertension , bilateral',\n 'Hypotrichosis of the Eyelashes': 'diseases of the eye and adnexa , disorders of vitreous body and globe , disorders of globe , hypotony of eye , unspecified hypotony of eye',\n 'Ocular Inflammation': 'diseases of the eye and adnexa , disorders of choroid and retina , chorioretinal inflammation , focal chorioretinal inflammation , focal chorioretinal inflammation of posterior pole , unspecified eye',\n 'Ocular Inflammation ': 'diseases of the eye and adnexa , disorders of choroid and retina , chorioretinal inflammation , focal chorioretinal inflammation , focal chorioretinal inflammation of posterior pole , unspecified eye',\n 'Refraction (Mydriasis)': 'diseases of the eye and adnexa , disorders of ocular muscles, binocular movement, accommodation and refraction , disorders of refraction and accommodation , myopia , bilateral',\n 'Funduscopic Exam (Cycloplegia)': 'diseases of the eye and adnexa , disorders of ocular muscles, binocular movement, accommodation and refraction , other strabismus , other and unspecified heterotropia , cyclotropia , left eye',\n 'Benign Prostatic Hyperplasia ': 'diseases of the genitourinary system , diseases of male genital organs , benign prostatic hyperplasia , benign prostatic hyperplasia with lower urinary tract symptoms',\n 'Androgenic Alopecia (Men Only)': 'diseases of the skin and subcutaneous tissue , disorders of skin appendages , androgenic alopecia , other androgenic alopecia',\n 'Female Hirsutism (Off-label)': 'diseases of the genitourinary system , inflammatory diseases of female pelvic organs , salpingitis and oophoritis , salpingitis and oophoritis, unspecified , salpingitis, unspecified',\n 'Benign Prostatic Hyperplasia (BPH)': 'diseases of the genitourinary system , diseases of male genital organs , benign prostatic hyperplasia , benign prostatic hyperplasia with lower urinary tract symptoms',\n 'Hypertension ': 'diseases of the circulatory system , hypertensive diseases , essential primary hypertension'}"
     },
     "execution_count": 75,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sim_dict=dict(zip(similarity_df['medical_condition_h3'].tolist(),similarity_df['most_similar_description'].tolist()))\n",
    "sim_dict"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T09:48:43.700295300Z",
     "start_time": "2024-01-30T09:48:43.515615100Z"
    }
   },
   "id": "90cf54c14d123568"
  },
  {
   "cell_type": "code",
   "execution_count": 76,
   "outputs": [
    {
     "data": {
      "text/plain": "{'Prevention of Motion Sickness': 0.7142633487102691,\n \"Meniere's Disease (Off-label)\": 0.7455485167840152,\n 'Allergic Rhinitis': 0.7060830123913676,\n 'Urticaria': 0.7652609552238315,\n 'Allergic Rhinitis & Urticaria': 0.7625888645037733,\n 'Chronic Idiopathic Urticaria': 0.7850641636257886,\n 'Perennial Allergic Rhinitis, Chronic Idiopathic Urticaria': 0.64111050893206,\n 'Cough': 0.44279053245680144,\n 'Anesthesia': 0.6338745664687833,\n 'MAC Sedation': 0.5396731050115812,\n 'Postoperative Nausea/Vomiting': 0.5605190528150404,\n 'ICU Patient': 0.3538045626142002,\n 'Anesthesia Induction': 0.5814224736110204,\n 'Resistant Depression (Off-label)': 0.3728966928394403,\n 'Sedation/Analgesia (Off-label)': 0.46808081568982757,\n 'Subarachnoid block': 0.337813788306733,\n 'Local Anesthesia': 0.5951740119031848,\n 'Regional Anesthesia': 0.5492820669819045,\n 'Postsurgical Analgesia for Arthroscopic Subacromial Decompression': 0.4190066668184466,\n 'Regional Anesthesia ': 0.5492820669819045,\n 'Surgery Premedication': 0.45550132923106157,\n 'General Anesthesia': 0.6619216074125882,\n 'Analgesia (Off-label)': 0.40049905829581156,\n 'Surgery Premedication (Off-label)': 0.45489221175572064,\n 'Continuous Sedation/Analgesia': 0.5737810330640828,\n 'Adjunct Anesthesia': 0.5386052419829004,\n 'Reversal of Conscious Sedation and General Anesthesia': 0.6470422473677299,\n 'Benzodiazepine Overdose': 0.6812920913082106,\n 'Reversal of Benzodiazepine Sedation': 0.6205162028195096,\n 'Hypoglycemia': 0.6550141080500669,\n 'Diagnostic Aid': 0.46350678332018747,\n 'Beta-Blocker & Calcium Channel Blocker Toxicity (Off-label)': 0.5642510013071338,\n 'Neurocysticercosis (Taenia Solium Tapeworm)': 0.6955313031245007,\n 'Hydatid (Echinococcus Tapeworm)': 0.6092097654075612,\n 'Ancylostoma, Ascariasis, Hookworm, Trichostrongylus': 0.7474160811068862,\n 'Capillariasis': 0.6202474156703507,\n 'Larva Migrans, Cutaneous & Trichuriasis': 0.7078853540708465,\n 'Larva Migrans, Visceral': 0.6433758341897107,\n 'Enterobius (Pinworm)': 0.561749481549013,\n 'Fluke (Clonorchis Sinensis)': 0.6893352529904739,\n 'Gnathostomiasis, Microsporidiosis': 0.4517960658755589,\n 'Ancylostoma, Ascariasis, Hookworm, Trichostrongylus ': 0.7474160811068862,\n 'Schistosomiasis': 0.7796103075297066,\n 'Clonorchiasis, Opisthorchiasis': 0.5217955231605897,\n 'Cysticercosis (Off-label)': 0.699975238383805,\n 'Tapeworms (Off-label)': 0.4346877969941843,\n 'Pinworm (Enterobius vermicularis)': 0.5410318577064693,\n 'Roundworm (Ascaris lumbricoides)': 0.5790978177303558,\n 'Whipworm (Trichuris trichiura)': 0.6458609744844613,\n 'Hookworm (Ancylostoma duodenale, Necator americanus)': 0.6360701128864232,\n 'Giardia Duodenalis (Giardiasis; Off-label)': 0.6214036047674425,\n 'Mansonella Perstans (Filariasis; Off-label))': 0.7291046463171368,\n 'Visceral Larva Migrans (Toxocariasis; Off-label)': 0.5678913378218726,\n 'Candidemia': 0.6563656529939781,\n 'Esophageal Candidiasis': 0.7843598159787482,\n 'Candida auris (Off-label)': 0.46237315067644996,\n 'Candidemia ': 0.6563656529939781,\n 'Candida Infections': 0.7195201109748646,\n 'Invasive Aspergillosis': 0.7797803071284456,\n 'Febrile Neutropenia': 0.5683953007656148,\n 'Treatment of candidemia, acute disseminated candidiasis, candida peritonitis and abscesses': 0.6751947651368699,\n 'Treatment of Esophageal Candidiasis': 0.7010332124202632,\n 'Prophylaxis of Candida Infections in HSCT Recipients': 0.5175316241324676,\n 'Invasive Mucormycosis': 0.784758170561848,\n 'Oropharyngeal Candidiasis': 0.598524005309118,\n 'Cryptococcal Meningitis': 0.6813984236298266,\n 'Prophylaxis of Candidiasis with BMT': 0.6258632596605235,\n 'Vaginal Candidiasis': 0.794110400229262,\n 'Candida UTI/Peritonitis': 0.6647587114524495,\n 'Systemic Candida Infections': 0.704189386542805,\n 'Premature Neonates': 0.6799141878451359,\n 'Life-threatening Infections': 0.5168576851192401,\n 'Blastomycosis': 0.8483174324477776,\n 'Aspergillosis': 0.8037444353549779,\n 'Histoplasmosis': 0.7929507768842989,\n 'Onychomycosis': 0.586594197830252,\n 'Candidiasis': 0.7643481120341938,\n 'Serious Fungal Infections': 0.6663699640024937,\n 'Dosage Modification': 0.46621577648198753,\n 'Susceptible Fungal Infections (Off-label, Aged 2-12 yr)': 0.5799310196963819,\n 'Acute Malaria Infections': 0.7041755337219638,\n 'Malaria Prevention': 0.5664332743037204,\n 'Amebiasis, Intestinal': 0.8953882024386612,\n 'Amebic Liver Abscess': 0.8268069998196785,\n 'Giardiasis or Trichomoniasis': 0.6620863833946123,\n 'Bacterial Vaginosis (Nonpregnant)': 0.5669149458977004,\n 'Giardiasis': 0.5884176537704534,\n 'Latent Tuberculosis Infection': 0.6757373498652008,\n 'Active Tuberculosis Disease': 0.7258169133028038,\n 'Tuberculosis Treatment For HIV Negative': 0.5081485964105318,\n 'Tuberculosis Treatment For HIV Exposed/Infected': 0.5065333657259583,\n 'Tuberculosis Treatment': 0.5979250818909236,\n 'Cytomegalovirus Retinitis': 0.6135657611909794,\n 'CMV Colitis or Esophagitis in HIV-Infected Patients (Off-label)': 0.47600246962982024,\n 'CMV Prevention in Solid Organ Transplant ': 0.43038205452562794,\n 'CMV Prevention in Kidney & Heart Transplant ': 0.44028521653507524,\n 'Influenza A and B Prophylaxis': 0.573608830388303,\n 'Influenza A and B Treatment': 0.5556817102365345,\n 'H1N1 Influenza A (Swine Flu) Prophylaxis (Off-label)': 0.47267754153844077,\n 'H1N1 Influenza A (Swine Flu) Treatment (Off-label)': 0.4620764164267417,\n 'Influenza A and B Prophylaxis ': 0.573608830388303,\n 'H1N1 Influenza A (Swine Flu) Prophylaxis (Off-label) ': 0.47267754153844077,\n 'Acute Herpes Zoster (Shingles)': 0.7389429095206296,\n 'Genital Herpes': 0.6128640131535391,\n 'Herpes (HIV-Infected Adults)': 0.5980561404993168,\n 'Dosing Modifications': 0.38710591601886024,\n 'Genital Herpes (Off-label)': 0.5422067278060041,\n 'Complicated Skin/Skin Structure Infections': 0.6108612792976127,\n 'Complicated Intra-abdominal Infections': 0.553950901927362,\n 'Community-Acquired Pneumonia (Off-label)': 0.5022271587235135,\n 'Febrile Neutropenia (Off-label)': 0.5017901829793194,\n 'Bacterial Meningitis': 0.7776037280504756,\n 'Moderate-to-Severe Infections': 0.5085673073618434,\n 'Mild Infections With Gram-Positive Cocci': 0.5896036914976777,\n 'Mild-to-Moderate Cholecystitis': 0.5340816887949837,\n 'Uncomplicated Urinary Tract Infection': 0.5925283393259472,\n 'Preparation for Surgery': 0.46096033426772454,\n 'Bacterial Keratitis (Off-label) ': 0.5625384748387655,\n 'Infections With Gram-Positive Cocci': 0.6066225791335909,\n 'Endocarditis': 0.7062988600437069,\n 'Community-Acquired Pneumonia': 0.560762288611912,\n 'Pharyngitis': 0.7535266660860129,\n 'Skin & Skin Structure Infections': 0.6629546871639828,\n 'Tonsillitis': 0.7270692810920553,\n 'Urinary Tract Infections': 0.70260433846657,\n 'Susceptible Infections': 0.591894910838897,\n 'Streptococcal Pharyngitis': 0.7718042786523684,\n 'Lower Respiratory Tract Infections': 0.7862349745528293,\n 'Otitis Media ': 0.7000420070367521,\n 'Uncomplicated Skin and Skin Structure Infections': 0.6454247291187339,\n 'Bronchitis': 0.7237363433590609,\n 'Pharyngitis and Tonsillitis': 0.7019939206563988,\n 'Otitis Media': 0.7000420070367521,\n 'Pharyngitis & Tonsillitis': 0.7053005754972909,\n 'Respiratory Tract Infections': 0.7746205238376007,\n 'Skin Infections': 0.6887223299372154,\n 'Acute Otitis Media': 0.7162529695616106,\n 'Acute Sinusitis': 0.8025655187683491,\n 'Acute Maxillary Sinusitis': 0.8065097259523542,\n 'Skin/Skin Structure Infections': 0.5901648814105854,\n 'Acute Bacterial Otitis Media ': 0.6643173677545448,\n 'Pharyngitis/Tonsillitis': 0.6533709949451407,\n 'Acute Exacerbations of Chronic Bronchitis': 0.7207235738277229,\n 'Uncomplicated Gonorrhea': 0.567366402067745,\n 'Uncomplicated Urinary Tract Infections': 0.6363570254307613,\n 'Typhoid Fever (Off-label)': 0.6889307070286801,\n 'Acute Bronchitis & Acute Exacerbations of Chronic Bronchitis': 0.7269697261261795,\n 'Gonococcal Urethritis/Cervicitis': 0.7179584409399231,\n 'Gonorrhea, Rectal': 0.512730503213638,\n 'Infections Caused by Susceptible Organisms': 0.6542418988289114,\n 'Epiglottitis': 0.6131789641019356,\n 'Meningitis': 0.7568044437179403,\n 'Pneumonia': 0.6847946765343379,\n 'Sepsis': 0.7013085899964798,\n 'Typhoid Fever': 0.750419092058494,\n 'Acute Community-Acquired Pneumonia': 0.5286963575157126,\n 'Gonorrhea': 0.5537080189696637,\n 'General Dosage Range': 0.3950315598421273,\n 'Chronic Bronchitis, Bacterial Exacerbation': 0.6890628358524503,\n 'Cystitis, Acute Uncomplicated': 0.6655397568555954,\n 'Bone & Joint Infections': 0.6585778201110517,\n 'Gynecologic & Intra-abdominal Infections': 0.5454316311751003,\n 'Pulmonary Infections': 0.6915953544985427,\n 'Mild Skin/Skin Structure Infections': 0.6243861654782753,\n 'Life-Threatening Infections': 0.5168576658260774,\n 'Intra-abdominal Infections': 0.5486706175305649,\n 'Acute Bacterial Otitis Media': 0.6643173677545448,\n 'Pelvic Inflammatory Disease': 0.8042541394007907,\n 'Prosthetic Joint Infection': 0.5671331040192138,\n 'Acute Uncomplicated Pyelonephritis': 0.7282794184062354,\n 'Surgical Prophylaxis': 0.5212524765093115,\n 'Uncomplicated Gonococcal Infections': 0.7743048531635676,\n 'Septic/toxic Shock (Off-label)': 0.651080574641321,\n 'Acute Epididymitis (Off-label)': 0.5654976261566851,\n 'Skin and Soft Necrotizing Infection (Off-label)': 0.5939704064246512,\n 'Severe Acute Bacterial Rhinosinusitis (Off-label)': 0.5762732731941836,\n 'Other Gonococcal Infections (Off-label)': 0.7733214933895065,\n 'Epiglottis (Off-label)': 0.46317706257635954,\n 'Serious Infections Other Than Meningitis': 0.7532680444994625,\n 'Gonococcal Infections': 0.8267148528326945,\n 'Chronic Bacterial Prostatitis': 0.6335715073033136,\n 'Infectious Diarrhea': 0.6487791221919429,\n 'Empirical Therapy in Febrile Neutropenic Patients': 0.45091489779920096,\n 'Nosocomial Pneumonia': 0.6093541689705391,\n 'Urethral & Cervical Gonococcal Infections': 0.7452269585262608,\n 'Anthrax Infection': 0.8289565177610885,\n 'Plague': 0.6976535185417746,\n 'Complicated Urinary Tract Infections or Pyelonephritis': 0.7112796824828982,\n 'Cholera': 0.7603817573022232,\n 'Inhalational Anthrax (Off-label)': 0.6071152375033473,\n 'Cystic Fibrosis (Off-label)': 0.6211421246338857,\n 'Staphylococcal Enterocolitis': 0.6716477019313433,\n 'Clostridium difficile-associated Diarrhea': 0.7483236990846678,\n 'Skin and Skin Structure Infections': 0.670599619018995,\n 'Bone Infections': 0.6079631645923509,\n 'Preoperative Antimicrobial Prophylaxis (Off-label)': 0.4014308128557824,\n 'Surgical Prophylaxis (Off-label)': 0.4737265903886998,\n 'Infective Endocarditis': 0.7840435013187731,\n 'Septicemia': 0.5302070590599348,\n 'Other Infections': 0.7084196902687305,\n 'Complicated Skin Infections': 0.7027869657140577,\n 'HIV Infection': 0.7032401565806282,\n 'Chronic Hepatitis B': 0.7417817864975367,\n 'Renal Impairment': 0.6364689427525908,\n 'Staphylococcus Aureus Bacteremia': 0.636636894710219,\n 'Complicated Skin and Skin Structure Infections': 0.6883789854131491,\n 'Complicated Skin & Skin Structure Infections': 0.6826387812268573,\n 'Acute Exacerbation of Chronic Bronchitis': 0.7293895431346078,\n 'Mycobacterial Infection': 0.7866007181838546,\n 'Peptic Ulcer Disease': 0.7234786089328119,\n 'Pharyngitis, Tonsillitis': 0.7053005754972909,\n 'Skin/Skin Structure Infection': 0.5665482955934583,\n 'Pertussis (Off-label)': 0.528989664674074,\n 'Endocarditis (Off-label)': 0.5619927522513577,\n 'Sinusitis': 0.7375993398184438,\n 'Bacterial Vaginosis': 0.5515004956576879,\n 'Trichomoniasis ': 0.7693116566908619,\n 'Trichomoniasis': 0.7693116566908619,\n 'Vancomycin-Resistant Enterococcal Infections': 0.5222462301162683,\n 'Complicated Skin & Skin Structure Infections ': 0.6826387812268573,\n 'Community-Acquired Pneumonia (Including Concurrent Bacteremia)': 0.5293423835982207,\n 'Methicillin-Resistant Staphylococcal Infections ': 0.6938187429599327,\n 'Methicillin-Susceptible Staphylococcus Aureus': 0.6621823116998468,\n 'Uncomplicated Skin & Skin Structure Infections': 0.6543819620259546,\n 'Ear, Nose, & Throat Infections': 0.6181740182946938,\n 'Genitourinary Tract Infections': 0.6772250757056345,\n 'Helicobacter Pylori': 0.5816843922246987,\n 'Anthrax': 0.6868229308460311,\n 'Lyme Disease (Off-label)': 0.6578441223556768,\n 'Chlamydial Infection in Pregnant Women (Off-label)': 0.6661892419850668,\n 'Anthrax (Off-label)': 0.554156182573365,\n 'Infective Endocarditis (Off-label)': 0.6677659378421721,\n 'General Dosing Guidelines': 0.46325238564298277,\n 'Endocarditis Prophylaxis (Off-label)': 0.5130027065580929,\n 'Genitourinary Tract Infections (Excluding Gonorrhea)': 0.7129661922435812,\n 'Gastrointestinal Tract Infections': 0.7293359432868898,\n 'Urinary Tract Infection (ampicillin-susceptible Enterococcus; Off-label)': 0.5324758169208202,\n 'Bacterial Meningitis/Septicemia': 0.7457418825005926,\n 'Group B Streptococcus (Off-label)': 0.6086516621267526,\n 'Listeria Infection (Off-label)': 0.5741025949250147,\n 'Neonates (<28 Days)': 0.4747517574063445,\n 'Endocarditis Treatment': 0.6035048854531263,\n 'Soft Tissue Infections': 0.5845992372233987,\n 'Community Acquired Pneumonia': 0.5852098486264972,\n 'RSV Prophylaxis': 0.562380638151807,\n 'Rickettsial Infections': 0.8100120106532425,\n 'Sexually Transmitted Infections': 0.7536262667846733,\n 'Specific Bacterial Infections': 0.7607488169818925,\n 'Ophthalmic infections': 0.677203763127907,\n 'Acute Intestinal Amebiasis ': 0.86171212859779,\n 'Acne Vulgaris ': 0.7677694489351926,\n 'Rosacea ': 0.7502143617378646,\n 'Malaria': 0.7096606450650548,\n 'Periodontal Disease': 0.7551825672020884,\n 'Hypertension': 0.5760609641624918,\n 'Migraine': 0.6744685776486454,\n 'Angina': 0.512428762956057,\n 'Pheochromocytoma': 0.4301933953687016,\n 'Hypertrophic Subaortic Stenosis': 0.5340037850866853,\n 'Myocardial Infarction': 0.6637562501090267,\n 'Supraventricular Arrhythmia': 0.5306025999186836,\n 'Essential Tremor': 0.7041068719260642,\n 'Portal Hypertension (Off-label)': 0.5297129202900255,\n 'Antipsychotic-Induced Akathisia (Off-label)': 0.562941314907203,\n 'Esophageal Bleeding (Off-label)': 0.5711136681829854,\n 'Panic Disorder (Off-label)': 0.5345639284117261,\n 'Aggressive Behavior (Off-label)': 0.45643803609050326,\n 'Infantile Hemangiomas': 0.649885347914565,\n 'Hypertension (Off-label)': 0.44305081530485846,\n 'Arrhythmias (Off-label)': 0.41109371738165235,\n 'Hypercyanotic Spells (Off-label)': 0.31112362768872925,\n 'Thyrotoxicosis (Off-label)': 0.5747334379527488,\n 'Angina Pectoris': 0.7081592560537818,\n 'Heart Failure (Post-Myocardial Infarction)': 0.5694547513474061,\n 'Myocardial Infarction/Stroke Prevention': 0.5402225873219845,\n 'Diabetic Nephropathy (Off-label)': 0.7063624790561127,\n 'Acute Hypertension': 0.5479717085012873,\n 'Hypertension (Alone or with Thiazide)': 0.4468345341376675,\n 'Congestive Heart Failure (With Diuretics and Digitalis)': 0.5729024966645236,\n 'Left Ventricular Dysfunction After Myocardial Infarction': 0.5515647983197606,\n 'Diabetic Nephropathy': 0.8244687614011105,\n 'Acute hypertension': 0.5479717085012873,\n 'Hypertension (alone or with thiazide)': 0.4468345341376675,\n 'Congestive heart failure (with diuretics and digitalis)': 0.5729024966645236,\n 'Left ventricular dysfunction after myocardial infarction': 0.5515647983197606,\n 'Diabetic nephropathy': 0.8244687614011105,\n 'Acute Myocardial Infarction': 0.6662113937398321,\n 'Heart Failure': 0.6849195924051905,\n 'Primary Hypertension (Orphan)': 0.6288036079256748,\n 'Nephropathy in Type 2 Diabetes': 0.7873500095074174,\n 'Post-Myocardial Infarction': 0.6048962389846974,\n 'Cardiovascular risk reduction': 0.4215755239803475,\n 'Primary Hyperaldosteronism': 0.7729386973760294,\n 'Edematous Conditions': 0.6164021646204884,\n 'Essential Hypertension': 0.631991266492158,\n 'Congestive Heart Failure': 0.6969915661696152,\n 'Hypokalemia': 0.6742767245032076,\n 'Hirsutism (Off-label)': 0.2968143834607347,\n 'Acne (Off-label)': 0.5401182840599628,\n 'Edema (Off-label)': 0.5411466496819968,\n 'Stroke Prophylaxis with Atrial Fibrillation': 0.5729691282416193,\n 'Postoperative Prophylaxis of DVT/PE': 0.4089787339212816,\n 'DVT or PE Treatment': 0.3569986704665525,\n 'Stroke Prophylaxis With Atrial Fibrillation ': 0.5729691282416193,\n 'Deep Vein Thrombosis Prophylaxis for Hip or Knee Replacement Surgery': 0.4660420167680183,\n 'Venous Thromboembolism Prophylaxis for Restricted Mobility': 0.4535423636580979,\n 'DVT and/or PE Treatment': 0.35920694433082934,\n 'Reduction in Risk of Recurrence of DVT or PE': 0.3268505449494983,\n 'Risk Reduction of Major Cardiovascular Events': 0.4353376892055291,\n 'Risk Reduction of Major Thrombotic Vascular Events': 0.4714594636522733,\n 'VTE Treatment or Prevention': 0.3775124589297333,\n 'Thromboprophylaxis for Fontan Procedure': 0.4652929606138324,\n 'Intraoperative Tachycardia/Hypertension': 0.5450142701431512,\n 'Supraventricular Tachycardia': 0.6582358524389232,\n 'Hypertensive Emergency ': 0.6740478220117071,\n 'Supraventricular Tachycardia (Off-label)': 0.5294042440254239,\n 'Postoperative Hypertension (Off-label)': 0.483794808316669,\n 'Supraventricular tachycardia': 0.6582358524389232,\n 'Hypertensive emergency ': 0.6740478220117071,\n 'Intraoperative tachycardia/hypertension': 0.5450142701431512,\n 'Stable Monomorphic or Polymorphic Ventricular Tachycardia (Off-label)': 0.5188443613001233,\n 'ACLS, Pulseless Ventricular Fibrillation/Ventricular Tachycardia (Off-label)': 0.4798985581272605,\n 'Ventricular Arrhythmias': 0.665473243805401,\n 'Conversion to oral amiodarone after IV administration': 0.3438361797791924,\n 'Drug Resistant Refractory Cardiac Arrhythmias (Off-label)': 0.41288941202546214,\n 'Pulseless Ventricular Tachycardia or Ventricular Fibrillation (PALS dosing) (Off-label)': 0.4994547437561272,\n 'Paroxysmal Supraventricular Tachycardia': 0.7395556852941264,\n 'Stress Testing (Diagnostic)': 0.597401712012193,\n 'Paroxysmal Superventricular Tachycardia (per ACLS)': 0.623455094156824,\n 'PSVT (Adenocard)': 0.37291101659339104,\n 'Adenoscan (Diagnostic)': 0.5117591546204439,\n 'Atrial Fibrillation': 0.6890514020301138,\n 'Heart Failure/Atrial Fibrillation': 0.633119014219651,\n 'Hypomagnesemia': 0.6776336795632325,\n 'Toxemia of Pregnancy': 0.5410209209421144,\n 'Torsades de Pointes': 0.5252028482563782,\n 'Preterm Labor (Off-label)': 0.5254708920482827,\n 'Acute Nephritis': 0.7037789812901009,\n 'Bronchospasm (Off-label)': 0.5264845394819927,\n 'Acute Coronary Syndrome or History of MI': 0.5000488310628872,\n 'Coronary Artery Disease': 0.6826627633339539,\n 'Acute Ischemic Stroke or TIA': 0.5446964514485146,\n 'Acute Coronary Syndrome': 0.6293843833433482,\n 'Recent MI, Stroke, or Established Peripheral Arterial Disease': 0.5528326378824887,\n 'Cardioembolic Stroke': 0.49422348723776593,\n 'Carotid Artery Stenting (Off-label)': 0.4888256610390868,\n 'Left Ventricular Dysfunction Following Myocardial Infarction': 0.5815636242707429,\n 'Angina pectoris': 0.7081592560537818,\n 'Conversion to Extended Release Form': 0.263467137797208,\n 'Post Myocardial Infarction': 0.5597367185759117,\n 'Alcohol Withdrawal Syndrome (Off-label)': 0.653505490410427,\n 'Supraventricular Arrhythmias (Off-label)': 0.440434875409504,\n 'Migraine Prophylaxis (Off-label)': 0.47655409926933723,\n 'Pulmonary Hypertension': 0.6902283466930402,\n 'Raynaud Phenomenon (Off-label)': 0.5797095393896705,\n 'Anal Fissures (Off-label)': 0.5082317575520796,\n 'Subarachnoid Hemorrhage': 0.6518603960870679,\n 'Edema': 0.7015356563708657,\n 'Hypertension, Resistant': 0.5049004482658835,\n 'Acute Pulmonary Edema/Hypertensive Crisis/Increased Intracranial Pressure': 0.46614345496262044,\n 'Hyperkalemia in Advanced Cardiac Life Support (ACLS)': 0.49338223388521557,\n 'Hypermagnesemia in ACLS': 0.4082310830567485,\n 'Resistant Hypertension': 0.5095184309441523,\n 'Hypertension in Heart Failure (Off-label)': 0.5629816494618223,\n 'Mild Fluid Retention in Heart Failure (Off-label)': 0.49475918513964756,\n 'Diuresis': 0.47255315778532087,\n 'Hypertriglyceridemia, Hypercholesterolemia': 0.7246626995449985,\n 'Hypercholesterolemia': 0.7326845202385055,\n 'Homozygous Familial Hypercholesterolemia': 0.7346106659088322,\n 'Slowing Progression of Atherosclerosis': 0.5553460150426853,\n 'Primary Prevention ': 0.3758679410556635,\n 'Familial Hypercholesterolemia': 0.7188027834399232,\n 'Prevention of Coronary Events': 0.4748950631882989,\n 'Primary and secondary prevention of atheroschlerotic cardiovascular disease (ASCVD)': 0.5076637816412503,\n 'Hypercholesterolemia & Mixed Dyslipidemia': 0.7396645117646401,\n 'Patients Requiring <25% Decrease in LDL-C': 0.392189364828964,\n 'Heterozygous Familial Hypercholesterolemia': 0.714174764235477,\n 'Primary Hyperlipidemia and Mixed Dyslipidemia Adjunct to Diet': 0.7325206037299671,\n 'Homozygous Sitosterolemia': 0.47664177261137486,\n 'Primary Hyperlipidemia': 0.5925724012447725,\n 'Prevention of Cardiovascular Events': 0.4957002990684618,\n 'Pain/Fever/Dysmenorrhea': 0.5603000399274292,\n 'Inflammatory Disease': 0.630635654797412,\n 'Osteoarthritis': 0.6739888163992217,\n 'Rheumatoid Arthritis': 0.6904569660835188,\n 'Fever': 0.6883101820274699,\n 'Pain': 0.4608896419873703,\n 'Juvenile Idiopathic Arthritis': 0.7845218664744094,\n 'Patent Ductus Arteriosus': 0.5440732350097807,\n 'Low Cardiac Output, Septic Shock': 0.5961293972337199,\n 'Actinic Keratosis': 0.6683262250919745,\n 'Superficial Basal Cell Carcinoma': 0.6631373838521224,\n 'External Genital Warts': 0.7235407507660703,\n 'Acne Vulgaris': 0.7677694489351926,\n 'Rosacea': 0.7502143617378646,\n 'Tinea Cruris': 0.5094805518386019,\n 'Tinea Pedis': 0.5213094987437671,\n 'Tinea Corporis': 0.5001697169646268,\n 'Dermatophytoses': 0.6999944575288486,\n 'Tinea Corporis ': 0.5001697169646268,\n 'Psoriatic Arthritis': 0.7042304971309314,\n 'Ankylosing Spondylitis': 0.8321084719833766,\n 'Plaque Psoriasis': 0.6832336531652201,\n 'Crohn Disease': 0.6986621517089013,\n 'Ulcerative Colitis': 0.7039657967563091,\n 'Hidradenitis Suppurativa': 0.7789688813386942,\n 'Uveitis': 0.5830686039245518,\n 'Pediatric Crohn Disease': 0.6588104640304077,\n 'Uveitis ': 0.5830686039245518,\n 'Juvenile Rheumatoid Arthritis': 0.7955099742324583,\n 'Psoriasis': 0.7611438242561889,\n 'Melanin Hyperpigmentation': 0.7019212533268172,\n 'Severe Asthma': 0.7323384613589187,\n 'Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome)': 0.679636998712376,\n 'Hypereosinophilic Syndrome': 0.7063047793681672,\n 'Chronic Rhinosinusitis with Nasal Polyps': 0.7902390889242004,\n 'Antiseptic Wound Cauterization': 0.4035474590566758,\n 'Primary Immunoglobulin A Nephropathy': 0.595121704317486,\n 'Ulcerative Colitis (Orphan)': 0.6006389820321819,\n 'Constipation': 0.6737684916753414,\n 'Portal Systemic Encephalopathy': 0.5655063038370934,\n 'Antacid': 0.43362209871372653,\n 'Calcium Supplementation': 0.6032239626453161,\n 'Calcium dietary supplementation': 0.6331508835833052,\n 'Acute Diarrhea': 0.5659767000768764,\n 'Chronic Diarrhea': 0.6587214850427127,\n \"Traveler's Diarrhea\": 0.4615295990231133,\n 'Hepatic Encephalopathy ': 0.7387374952226271,\n 'Irritable Bowel Syndrome': 0.8345931791196517,\n 'Chemotherapy-Induced Nausea & Vomiting': 0.5652594841506906,\n 'Postoperative Nausea & Vomiting': 0.6326924723094027,\n 'Radiation-Induced Nausea & Vomiting': 0.6969916490535774,\n 'Cholestatic Pruritus (Off-label)': 0.5718948569304008,\n 'Uremic Pruritus (Off-label)': 0.5537197086093848,\n 'Spinal Opioid-Induced Pruritus (Off-label)': 0.4857506538811689,\n 'Rosacea (Off-label)': 0.6507617664937128,\n 'Hyperemesis Gravidarum': 0.5311710469605498,\n 'Acute Gastroenteritis (Off-Label)': 0.5115664231132933,\n 'Chemotherapy-Induced Nausea & Vomiting (Orphan)': 0.5311399826234509,\n 'Vasodilatory Shock': 0.5582670001884732,\n 'Abdominal Distention (Off-label)': 0.4955342956193332,\n 'Diabetes Insipidus (Off-label)': 0.4918042071558453,\n 'Abdominal Roentgenography (Off-label)': 0.5748533219179429,\n 'Gastrointestinal Hemorrhage (Off-label)': 0.5622302860319462,\n 'Obesity Management': 0.5371029398238757,\n 'Duodenal Ulcer': 0.7528728290012029,\n 'Stress Ulcer (Off-label)': 0.5358100232075949,\n 'Active Duodenal Ulcer (Off-label)': 0.64341166187167,\n 'Stomatitis (Off-label)': 0.5655412894330719,\n 'Gastric Ulcer (Off-label)': 0.6188301271219239,\n 'Gas Retention in Gastrointestinal Tract': 0.6000201365582246,\n 'Doage Forms & Strengths': 0.23124620985157604,\n 'Active Duodenal Ulcer': 0.7377517090800007,\n 'Duodenal Ulcer Maintenance': 0.6850666369161791,\n 'Benign Gastric Ulcer': 0.6732857039197936,\n 'GERD': 0.38780233209622683,\n 'Active duodenal ulcer': 0.7377517090800007,\n 'Duodenal ulcer maintenance': 0.6850666369161791,\n 'Benign gastric ulcer': 0.6732857039197936,\n 'Constipation ': 0.6737684916753414,\n 'Acid Indigestion': 0.5451584072023907,\n 'Nutritional Supplementation': 0.5646661132113987,\n 'Constipation/Laxative': 0.6209470640274537,\n 'Erosive Esophagitis': 0.6664786236650371,\n 'Gastroesophageal Reflux Disease': 0.7844964489096242,\n 'GERD Without Erosive Esophagitis': 0.6122774688650896,\n 'GERD With Erosive Esophagitis': 0.6477740509873299,\n 'Helicobacter Pylori Eradication': 0.5131228659721226,\n 'Risk Reduction of NSAID-Associated Gastric Ulcer': 0.5546654758849533,\n 'NSAID-Induced Gastric Ulcer': 0.5646669287714519,\n 'Gastric or Duodenal Ulcers Following Therapeutic Endoscopy ': 0.6658919151328064,\n 'Frequent Heartburn': 0.6650809823488704,\n 'Hepatic Impairment': 0.709158727745867,\n 'Short-term Treatment of GERD': 0.3449603357433594,\n 'GERD With Erosive Esophagitis (Healing)': 0.5328415075153695,\n 'Gastric Ulcer': 0.7276211587312575,\n 'NSAID-associated GU': 0.284946256740859,\n 'Hypersecretory Condition (eg, Zollinger-Ellison Syndrome)': 0.5232377160913331,\n 'Helicobacter Pylori Infection': 0.6397889912835479,\n 'Heartburn': 0.6128808410597572,\n 'GERD, Erosive Esophagitis': 0.6694593480611655,\n 'Nonerosive GERD': 0.377879862172471,\n 'Hypersecretory Conditions (eg, Zollinger-Ellison Syndrome)': 0.5365651746078799,\n 'Neonates (Off-label)': 0.3195542426418722,\n 'Erosive Esophagitis Associated With GERD': 0.6643882793138268,\n 'Zollinger-Ellison Syndrome': 0.48138463113346386,\n 'Peptic Ulcer Disease (Off-label)': 0.6763253025165873,\n 'Kidney Transplantation': 0.5601403810490941,\n 'Lupus Nephritis (Off-label)': 0.602578764122947,\n 'Crohn Disease (Off-label)': 0.608498661566003,\n 'Ulcerative Colitis (Off-label)': 0.5712476320521636,\n 'Chronic Refractory Thrombocytopenic Purpura (Off-label)': 0.5679215301017487,\n 'Transplantation (Off-label)': 0.3548700582388277,\n 'Acute Lymphoblastic Leukemia': 0.7158015508072656,\n 'Non-Hodgkin Lymphoma': 0.6211998404105483,\n 'Osteosarcoma': 0.561490249214686,\n 'Breast Cancer': 0.5995671412612964,\n 'Squamous Cell Carcinoma of the Head and Neck': 0.6538319655087644,\n 'Gestational Trophoblastic Neoplasia': 0.5034564622310429,\n 'Ectopic Pregnancy (Off-label)': 0.6682587999745756,\n 'Meningeal Leukemia': 0.534048171327083,\n 'Giant Cell Arteritis': 0.6970072319649073,\n 'Systemic Sclerosis-Associated Interstitial Lung Disease': 0.7148781448428063,\n 'Cytokine Release Syndrome': 0.5767737848238084,\n 'COVID-19': 0.5016322819456102,\n 'Systemic Juvenile Idiopathic Arthritis': 0.7760212058227521,\n 'Polyarticular Juvenile Idiopathic Arthritis': 0.8023430424380388,\n 'Cytokine Release Syndrome (CRS)': 0.47384056138272007,\n 'COVID-19 (EUA)': 0.46851022784216656,\n 'Multiple Sclerosis': 0.7493384093627987,\n 'Type 2 Diabetes Mellitus': 0.702638506854811,\n 'Maximum Dose': 0.4049013727784221,\n 'Diabetes Mellitus Type 2': 0.6911361987795583,\n 'Obesity': 0.6271759833126686,\n 'Weight Management': 0.4302465070927247,\n 'Type 1 or 2 Diabetes Mellitus': 0.6610745332861868,\n 'Type 1 Diabetes Mellitus': 0.6913454117177733,\n 'Diabetes Mellitus Type I or II ': 0.6282494083444626,\n 'Type 1 Diabetes Mellitus ': 0.6913454117177733,\n 'Type I or II Diabetes Mellitus': 0.6349834718957182,\n 'Chronic Kidney Disease': 0.7467431670218847,\n 'Primary Hyperparathyroidism (HPT)': 0.584808110782902,\n 'Secondary Hyperparathyroidism': 0.7328534084918272,\n 'Parathyroid Carcinoma': 0.6957821380139593,\n 'Allergic Conditions': 0.6182882524166842,\n 'Acute Exacerbations of Multiple Sclerosis': 0.6385424910902325,\n 'COVID-19 (Off-label)': 0.4553796558044756,\n 'Pneumocystis (carinii) jiroveci Pneumonia in AIDS Patients (Off-label)': 0.6013195116150962,\n 'Acute Spinal Cord Injury (Off-label)': 0.5495907741625531,\n 'Severe Lupus Nephritis (Off-label)': 0.5705851324315222,\n 'Inflammation': 0.5553314345770901,\n 'Status Asthmaticus': 0.7431995933198292,\n 'Hyperprolactinemia': 0.5590789926910431,\n 'Postpartum Hemorrhage': 0.7724548331522798,\n 'Labor Induction': 0.6254644744714879,\n 'Incomplete or Inevitable Abortion': 0.6749642262907308,\n 'Serum Phosphorus Regulation': 0.6920035960295465,\n 'Osteoporosis': 0.684113401113404,\n 'Cervical Ripening': 0.47402194467726627,\n 'Pregnancy Termination': 0.7222194895764574,\n 'Myasthenia Gravis': 0.6240334292372801,\n 'Reversal of Nondepolarizing Muscle Relaxants': 0.45463736242914154,\n 'Pretreatment for Soman Nerve Gas Exposure': 0.48410182325765966,\n 'Alzheimer Dementia': 0.6178095815100902,\n 'Parkinson Dementia': 0.6050305312256584,\n 'Muscle Spasticity ': 0.7013343653935012,\n 'Panic Disorder': 0.618473880127383,\n 'Seizure Disorders': 0.6880930875681822,\n 'Essential Tremor (Off-label)': 0.6174554300469673,\n 'REM Sleep Behavior Disorder (Off-label)': 0.6322040783628179,\n 'Burning Mouth Syndrome (Off-label)': 0.47844484381766883,\n 'Recurrent, Acute, Repetitive Seizures (Orphan)': 0.6354240736522031,\n 'Anxiety': 0.5987565786005519,\n 'Alcohol Withdrawal': 0.7005114541074744,\n 'Endoscopic Precedures': 0.4874679435881577,\n 'Preoperative Sedation': 0.6701472733303535,\n 'Sedation in the ICU': 0.6105923325901542,\n 'Muscle Spasm': 0.6977825662900164,\n 'Seizure Disorder': 0.6536481584486475,\n 'Status Epilepticus': 0.6974264608227598,\n 'Cardioversion': 0.38601445066343837,\n 'Sedative/Muscle Relaxant': 0.4459195500450254,\n 'Preoperative Sedation/Anxiolysis With Anterograde Amnesia': 0.578772753310776,\n 'Sedation of Intubated/Ventilated Patients': 0.6422758704297096,\n 'Sedation': 0.6264159547915191,\n 'Anesthesia (Non-neonatal)': 0.603069140985851,\n 'Anesthesia (Neonatal)': 0.6294129167835063,\n 'Preoperative Sedation/Anxiolysis with Anterograde Amnesia': 0.578772753310776,\n 'Glaucoma': 0.6528334574871053,\n 'Acute Altitude Sickness': 0.6508288037730534,\n 'Seizure': 0.5836796080405172,\n 'Drug-induced Edema': 0.6589251896839309,\n 'Epilepsy': 0.713341430656229,\n 'Trigeminal Neuralgia': 0.7641485699186855,\n 'Bipolar Mania': 0.7000081420984756,\n 'Restless Legs Syndrome (Off-label)': 0.6041023312425793,\n 'Schizophrenia (Off-label)': 0.5242506012837038,\n 'Postherpatic Neuralgia': 0.559744391792498,\n 'Partial-Onset or Primary Generalized Tonic-Clonic Seizures': 0.673429658189103,\n 'Lennox-Gastaut Syndrome': 0.5431959787501262,\n 'Migraine Headache': 0.6514398534163539,\n 'Cluster Headache (Off-label)': 0.49226310698868325,\n 'Alcoholism (Off-label)': 0.5295073770855275,\n 'Partial Onset Seizures': 0.6644114427526169,\n 'Primary Generalized Tonic-Clonic Seizures ': 0.6168897127592169,\n 'Partial-Onset Seizures (Conversion to Monotherapy)': 0.5195852221237651,\n 'Bipolar Disorder': 0.6922456181293313,\n 'Diabetic Peripheral Neuropathic Pain': 0.6284465558646599,\n 'Postherpetic Neuralgia': 0.5993357141710594,\n 'Fibromyalgia': 0.7254734369843544,\n 'Neuropathic Pain With Spinal Cord Injury': 0.6178243908117534,\n 'Partial Seizures': 0.6643703968213162,\n 'Bipolar Disorder (Off-label)': 0.6014804268066126,\n 'Diabetic Neuropathy (Off-label)': 0.671928766437383,\n 'Neuralgia/Neuropathy (Off-label)': 0.5565088379865302,\n 'Partial Seizures (Adjunctive Treatment)': 0.5452385619192573,\n 'Partial Seizures (Monotherapy)': 0.514301719807022,\n 'Cluster Headache': 0.6052018501080019,\n 'Parkinson Disease': 0.696968131051117,\n 'Restless Legs Syndrome': 0.6966921757866193,\n 'Restless legs syndrome (Off-label)': 0.6041023312425793,\n 'Cocaine withdrawal (Off-label)': 0.623712800774415,\n 'Insomnia (Off-label)': 0.4717616706829935,\n 'Tremors in multiple sclerosis (Off-label)': 0.6588413122327005,\n 'Hot flashes-cancer related (Off-label)': 0.34556675626992245,\n 'Amyotrophic Lateral Sclerosis (Orphan)': 0.5734764990596052,\n 'Insomnia (Sleep Onset & Maintenance)': 0.5830948596811565,\n 'Insomnia (Middle of Night Awakening)': 0.5422848036429396,\n 'Insomnia (Sleep Onset & Sleep Maintenance)': 0.5912440039095178,\n 'Myoclonic Seizures': 0.6720556832468367,\n 'Partial Onset Seizure': 0.6265816463487563,\n 'Primary Generalized Tonic-Clonic Seizures': 0.6168897127592169,\n 'Rheumatoid Arthritis, Osteoarthritis, Ankylosing Spondylitis': 0.767644974197646,\n 'Dysmenorrhea': 0.622006140160788,\n 'Gout, Acute': 0.6436459588412432,\n 'Migraine (Off-label)': 0.5225847025623236,\n 'Moderate-to-Severe Pain': 0.5013567659690313,\n 'Acute Pain or Primary Dysmenorrhea': 0.6319843506275867,\n 'Familial Adenomatous Polyposis (Off-label)': 0.4509006932028433,\n 'Pain Management': 0.5495463747320158,\n 'Rheumatoid Arthritis or Osteoarthritis': 0.7164409797623332,\n 'Acute Pain': 0.6251560837933741,\n 'Primary Dysmenorrhea': 0.6683638525861695,\n 'Acute pain': 0.6251560837933741,\n 'Spasticity': 0.4942620845690029,\n 'Orphan Indications': 0.45977296846666993,\n 'Attention Deficit Hyperactivity Disorder': 0.7333720630453493,\n 'Narcolepsy': 0.6218050267947173,\n 'Anxiety Associated With Depression': 0.5563014931606136,\n 'Premenstrual Syndrome (Off-label)': 0.4847436838188749,\n 'Depression': 0.5479845351356714,\n 'Post-traumatic Stress Disorder (Off-label)': 0.6286279332840853,\n 'Hot Flashes (Off-label)': 0.34866320498348563,\n 'Major Depressive Disorder': 0.6694929879975056,\n 'Generalized Anxiety Disorder': 0.6681982472035856,\n 'Chronic Musculoskeletal Pain': 0.6609322924952639,\n 'Obsessive-Compulsive Disorder': 0.6761303827681255,\n 'Social Phobia': 0.7083949912037699,\n 'Posttraumatic Stress Disorder': 0.6832184915619786,\n 'Premenstrual Dysphoric Disorder': 0.6687770711498284,\n 'Menopausal Vasomotor Symptoms': 0.5203941208142565,\n 'Stuttering (Off-label)': 0.28282095984433653,\n 'Vasovagal Syncope (Off-label)': 0.3811496354845654,\n 'Binge-eating Disorder (Off-label)': 0.4708910396912677,\n 'Generalized Anxiety Disorder (Off-label)': 0.5994594358525038,\n 'Obsessive-Compulsive Disorder (Off-label)': 0.6143763193373591,\n 'Premenstrual Dysphoric Disorder (Off-label)': 0.6530460998423622,\n 'Depression (Off-label)': 0.4818919703971566,\n 'Impulsive Aggresive Behavior (Off-label)': 0.36496240246877276,\n 'Depression Associated with Bipolar I Disorder ': 0.638400949241672,\n 'Bulimia Nervosa': 0.6666128576376543,\n 'Depression Associated with Bipolar I Disorder': 0.638400949241672,\n 'Dosage Forms Strengths': 0.42029068900310146,\n 'Major depressive disorder': 0.6694929879975056,\n 'Social Anxiety Disorder': 0.6867464546757036,\n 'Schizophrenia': 0.6525001124370385,\n 'Dosage Modifications (Oral)': 0.4440568755137045,\n 'Dosage Modifications (Abilify Maintena)': 0.366381463408274,\n 'Dosage Modifications (Aristada)': 0.43875676660845514,\n 'Dosage Modifications (Abilify Asimtufii)': 0.4519695580323973,\n 'Autism': 0.6153416509249702,\n 'Tourette Disorder': 0.7071535787131572,\n 'Bipolar Depression': 0.6840402334553976,\n 'Chemotherapy Associated Nausea or Vomiting (Off-label)': 0.5600552933626436,\n 'Bipolar I Disorder (Manic or Mixed Episodes) ': 0.7445765986951068,\n 'Schizophrenia or Bipolar-Related Agitation': 0.6166552796655268,\n 'Tourette Syndrome (Off-label)': 0.6216553834021923,\n 'Posttraumatic Stress Disorder (Off-label)': 0.6286279332840853,\n 'Schizophrenia, Bipolar Mania': 0.7093026834403987,\n 'Psychosis, Agitation Related to Alzheimer Dementia (Off-label) ': 0.6459341620623416,\n 'Bipolar I Disorder, Mania': 0.6931230411455208,\n 'Bipolar Disorder, Depressive Episodes': 0.7621696007053727,\n 'Bipolar I Disorder, Maintenance': 0.6439788800923446,\n 'Alcohol Dependence (Off-label)': 0.575123109627885,\n 'Schizophrenia, Bipolar Disorder': 0.695236807155102,\n 'Psychosis, Agitation Related to Alzheimer Dementia (Off-label)': 0.6459341620623416,\n 'Schizophrenia, Psychosis': 0.6951292543298905,\n 'Schizophrenia, Psychosis/Sedation': 0.6557397423116603,\n 'Behavioral Disorders': 0.7243571084973248,\n 'Acute Agitation': 0.5322732952860377,\n 'Non Psychotic Anxiety': 0.5968549248730982,\n 'Schizophrenia/Psychosis ': 0.7033191169005963,\n 'Schizoaffective Disorder': 0.7133494627634815,\n 'Respiratory Distress Syndrome': 0.694740403330364,\n 'Erectile Dysfunction': 0.6907445939065252,\n 'Benign Prostatic Hyperplasia': 0.7480303729061745,\n 'Pulmonary Arterial Hypertension': 0.6697142473821439,\n 'Acute Bronchospasm': 0.7063471445057428,\n 'Bronchospasm': 0.6506355685616334,\n 'Neonatal Apnea': 0.7268648429704037,\n 'Pulmonary Disease': 0.7034021046870558,\n 'Diagnostic Bronchography': 0.6386093169394901,\n 'Contrast Agent-Associated Nephrotoxicity (Off-label)': 0.4648329208559992,\n 'Keratoconjunctivitis Sicca (Off-label)': 0.6150694633061693,\n 'Idiopathic Pulmonary Fibrosis': 0.6423326729280686,\n 'Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype': 0.7569085406475992,\n 'Systemic Sclerosis-associated Interstitial Lung Disease': 0.7148781448428063,\n 'Gout': 0.6042833298713683,\n 'Antineoplastic-Induced Hyperuricemia': 0.4900519911006394,\n 'Hyperuricemia': 0.5254624332053015,\n 'Oral Ulcers associated with Behςet Disease': 0.6091201150423505,\n 'Cardiac Arrest': 0.7065530117732068,\n 'Hyperkalemia': 0.6572610833098618,\n 'Metabolic Acidosis (Non-Life-Threatening)': 0.7433569247661758,\n 'Hypokalemia Prophylaxis': 0.584759793823786,\n 'IV intermittent infusions': 0.48527610185308906,\n 'Hypokalemia prophylaxis ': 0.584759793823786,\n 'Cardiac Decompensation': 0.5324273340675196,\n 'Low Cardiac Output (Off-label)': 0.35096466086594147,\n 'Severe Essential Hypertension': 0.6303752701091893,\n 'Hypertension (Chronic)': 0.6145634467462824,\n 'Hypertensive Crisis': 0.6772948698339131,\n 'Heart Failure, Afterload Reduction': 0.5232866229992478,\n 'Chronic Kidney Disease-Associated Anemia': 0.7987100486077929,\n 'Chemotherapy-Related Anemia with Nonmyeloid Malignancies': 0.7109793683991166,\n 'Myelosuppressive Chemotherapy Treatment': 0.5000574270550261,\n 'Induction or Consolidation Chemotherapy': 0.38625064495974554,\n 'Bone Marrow Transplantation': 0.5778567543346528,\n 'Peripheral Blood Progenitor Cell Collection': 0.3675954631756319,\n 'Acute Radiation Syndrome': 0.6517141864970821,\n 'Autologous Peripheral Blood Progenitor Cell Collection and Therapy': 0.37875003403729957,\n 'Patients with Cancer Undergoing Bone Marrow Transplantation': 0.5352154989085004,\n 'Neutropenia': 0.7178616189410192,\n 'Intermittent Claudication': 0.5122364202511738,\n 'Recommended Daily Allowance (Elemental Iron)': 0.3737262413585384,\n 'Iron Deficiency Anemia': 0.7706013978597829,\n 'Visipaque 320 ': 0.23997414464094793,\n 'Visipaque 270': 0.22740431916507528,\n 'Intra-arterial administration': 0.36249240644827424,\n 'Intra-arterial administration (IA-DSA)': 0.3647582704106994,\n 'IV administration': 0.32460575588761414,\n 'Intrathecal': 0.35066492004378713,\n 'Intravascular': 0.5025149570274756,\n 'CT Scanning of the Body': 0.47568057096213945,\n 'Digital Subtraction': 0.17142734499772924,\n 'Excretory Urography': 0.543917128875089,\n 'Oral': 0.44817243436750803,\n 'Intracavity': 0.3162721627933037,\n 'Body Imaging': 0.5165599416195341,\n 'Hypocalcemia, Emergency Treatment': 0.5103988351687937,\n 'Arrhythmias, Emergent': 0.5665191040786018,\n 'Hypermagnesemia': 0.5930110727235487,\n 'Calcium Channel Blocker Overdose': 0.7166754623292605,\n 'Beta-blocker Overdose, Refractory to Glucagon & High Dose Vasopressor': 0.4735871198901394,\n 'Hypocalcemic Tetany': 0.4415889795104692,\n 'Hypocalcemia': 0.5853640455464768,\n 'Cardiac Arrest (Off-label)': 0.5612026622467434,\n 'Hydrofluoric Acid Burn (Off-label)': 0.2897122229658777,\n 'Calcium Channel Blocker Overdose (Off-label)': 0.640458619315117,\n 'Hyperkalemia (Off-label)': 0.5619917158718347,\n 'Hypermagnesemia (Off-label)': 0.5483104027434755,\n 'RDA': 0.23478997809217134,\n 'Urinary Acidification': 0.48213589353262565,\n 'Ascorbic Acid Deficiency (Scurvy)': 0.6485286816768794,\n 'Macular Degeneration (Off-label)': 0.5886182325650162,\n 'Neural Tube Defects Prophylaxis': 0.5057553573437964,\n 'Folic Acid Deficiency': 0.6910450564556077,\n 'Methanol Toxicity': 0.7943522362805838,\n 'Methotrexate Toxicity Prophylaxis (Off-label)': 0.42627430814462197,\n 'Advanced Ovarian Carcinoma': 0.6458383231137834,\n 'Metastatic Testicular Tumors': 0.6562473300426735,\n 'Advanced Bladder Cancer': 0.6698103463482161,\n 'Metastatic Ovarian Carcinoma': 0.6536093886214558,\n 'Cancers (Off-label)': 0.498835710270362,\n 'Osteogenic Sarcoma/Neuroblastoma (Off-label)': 0.43383999691416486,\n 'Brain Tumors, Recurrent (Off-label)': 0.5611564067515105,\n 'Malignant Diseases': 0.5556523355738056,\n 'Nephrotic Syndrome': 0.7813387381257315,\n 'Non-Hodgkin Lymphoma ': 0.6211998404105483,\n 'Juvenile Idiopathic Arthritis/Vasculitis (Off-label)': 0.6972722280809247,\n 'Lupus Nephritis (Off-Label)': 0.602578764122947,\n 'Juvenile Idiopathic Arthritis/Vasculitis': 0.7239502538685436,\n 'Systemic Lupus Erythematosus': 0.7541405024135127,\n 'Breast Cancer Prevention (Off-label)': 0.5137977582601945,\n 'Ovarian Epithelial Cancer (Off-label)': 0.6498449536028468,\n 'Ductal Carcinoma in Situ': 0.6596427592548613,\n 'Breast Cancer Prevention': 0.5362699149237633,\n 'Ovulation Induction (Off-label)': 0.42458812120268546,\n 'Mastalgia (Off-label)': 0.5193840758316258,\n 'Advanced Prostate Cancer': 0.6196499879571782,\n 'Central Precocious Puberty': 0.5909570752573874,\n 'Metastatic Colorectal Cancer': 0.565896391733592,\n 'Non-Small Cell Lung Cancer': 0.5151814349772889,\n 'Renal Cell Carcinoma': 0.6968122920662378,\n 'Ovarian, Fallopian Tube, or Peritoneal Cancer': 0.5942835029798959,\n 'Glioblastoma': 0.430641619211111,\n 'Exudative ARMD (Off-label)': 0.30584931849762215,\n 'Hepatocellular Carcinoma': 0.6174727710738023,\n 'Orphan Designations': 0.41143290585126185,\n 'Myelodysplastic/Myeloproliferative Diseases': 0.6573744193829861,\n 'Hypereosinophilic Syndrome and/or Chronic Eosinophilic Leukemia': 0.689196814784804,\n 'Chronic Myeloid Leukemia Philadelphia-Chromosome-positive': 0.5266864214751059,\n 'Dermatofibrosarcoma Protuberans': 0.552073256141716,\n 'Mastocytosis': 0.6490237274752277,\n 'Gastrointestinal Stromal Tumors': 0.7283954797718981,\n 'Chronic Myeloid Leukemia': 0.6843957581114509,\n 'Mydriasis/Cycloplegia Diaganosis': 0.5993079354754315,\n 'Mydriasis/Cycloplegia': 0.537550459747091,\n 'Ocular Hypertension or Open-Angle Glaucoma': 0.7605035980172175,\n 'Elevated Intraocular Pressure': 0.5099929150618064,\n 'Hypotrichosis of the Eyelashes': 0.45421602707421355,\n 'Ocular Inflammation': 0.6763454492752929,\n 'Ocular Inflammation ': 0.6763454492752929,\n 'Refraction (Mydriasis)': 0.5859127309506084,\n 'Funduscopic Exam (Cycloplegia)': 0.4561503615646212,\n 'Benign Prostatic Hyperplasia ': 0.7480303729061745,\n 'Androgenic Alopecia (Men Only)': 0.6905264308000986,\n 'Female Hirsutism (Off-label)': 0.41619573102292734,\n 'Benign Prostatic Hyperplasia (BPH)': 0.6419908135600085,\n 'Hypertension ': 0.5760609641624918}"
     },
     "execution_count": 76,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sim_score_dict=dict(zip(similarity_df['medical_condition_h3'].tolist(),similarity_df['similarity_score'].tolist()))\n",
    "sim_score_dict"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T09:48:46.237115500Z",
     "start_time": "2024-01-30T09:48:46.193530600Z"
    }
   },
   "id": "ea2c29d6105c2157"
  },
  {
   "cell_type": "code",
   "execution_count": 77,
   "outputs": [
    {
     "data": {
      "text/plain": "[['Prevention of Motion Sickness',\n  'injury, poisoning and certain other consequences of external causes , other and unspecified effects of external causes , other and unspecified effects of other external causes , motion sickness , sequela',\n  0.7142633487102691],\n [\"Meniere's Disease (Off-label)\",\n  'diseases of the ear and mastoid process , diseases of inner ear , disorders of vestibular function , ménières disease , bilateral',\n  0.7455485167840152],\n ['Allergic Rhinitis',\n  'diseases of the respiratory system , other diseases of upper respiratory tract , vasomotor and allergic rhinitis , allergic rhinitis, unspecified',\n  0.7060830123913676],\n ['Urticaria',\n  'diseases of the skin and subcutaneous tissue , urticaria and erythema , urticaria , idiopathic urticaria',\n  0.7652609552238315],\n ['Allergic Rhinitis & Urticaria',\n  'diseases of the skin and subcutaneous tissue , urticaria and erythema , urticaria , allergic urticaria',\n  0.7625888645037733],\n ['Chronic Idiopathic Urticaria',\n  'diseases of the skin and subcutaneous tissue , urticaria and erythema , urticaria , idiopathic urticaria',\n  0.7850641636257886],\n ['Perennial Allergic Rhinitis, Chronic Idiopathic Urticaria',\n  'diseases of the skin and subcutaneous tissue , urticaria and erythema , urticaria , allergic urticaria',\n  0.64111050893206],\n ['Cough',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the circulatory and respiratory systems , cough , cough, unspecified',\n  0.44279053245680144],\n ['Anesthesia',\n  'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , unintended awareness under general anesthesia during procedure , sequela',\n  0.6338745664687833],\n ['MAC Sedation',\n  'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , failed moderate sedation during procedure , sequela',\n  0.5396731050115812],\n ['Postoperative Nausea/Vomiting',\n  'diseases of the digestive system , other diseases of the digestive system , intraoperative and postprocedural complications and disorders of digestive system, not elsewhere classified , vomiting following gastrointestinal surgery',\n  0.5605190528150404],\n ['ICU Patient',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , general symptoms and signs , symptoms and signs specifically associated with systemic inflammation and infection , systemic inflammatory response syndrome sirs of non-infectious origin , with acute organ dysfunction',\n  0.3538045626142002],\n ['Anesthesia Induction',\n  'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , unintended awareness under general anesthesia during procedure , sequela',\n  0.5814224736110204],\n ['Resistant Depression (Off-label)',\n  'mental, behavioral and neurodevelopmental disorders , mood affective disorders , depressive episode , depression, unspecified',\n  0.3728966928394403],\n ['Sedation/Analgesia (Off-label)',\n  'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , failed moderate sedation during procedure , sequela',\n  0.46808081568982757],\n ['Subarachnoid block',\n  'certain conditions originating in the perinatal period , birth trauma , intracranial laceration and hemorrhage due to birth injury , subarachnoid hemorrhage due to birth injury',\n  0.337813788306733],\n ['Local Anesthesia',\n  'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , unintended awareness under general anesthesia during procedure , sequela',\n  0.5951740119031848],\n ['Regional Anesthesia',\n  'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , unintended awareness under general anesthesia during procedure , sequela',\n  0.5492820669819045],\n ['Postsurgical Analgesia for Arthroscopic Subacromial Decompression',\n  'diseases of the respiratory system , intraoperative and postprocedural complications and disorders of respiratory system, not elsewhere classified , intraoperative and postprocedural complications and disorders of respiratory system, not elsewhere classified , postprocedural subglottic stenosis',\n  0.4190066668184466],\n ['Regional Anesthesia ',\n  'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , unintended awareness under general anesthesia during procedure , sequela',\n  0.5492820669819045],\n ['Surgery Premedication',\n  'factors influencing health status and contact with health services , encounters for other specific health care , encounter for other postprocedural aftercare , encounter for other specified postprocedural aftercare , encounter for surgical aftercare following surgery on specified body systems , encounter for surgical aftercare following surgery on the skin and subcutaneous tissue',\n  0.45550132923106157],\n ['General Anesthesia',\n  'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , unintended awareness under general anesthesia during procedure , sequela',\n  0.6619216074125882],\n ['Analgesia (Off-label)',\n  'injury, poisoning and certain other consequences of external causes , poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of nonopioid analgesics, antipyretics and antirheumatics , poisoning by, adverse effect of and underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified , poisoning by, adverse effect of and underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified , poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, undetermined , sequela',\n  0.40049905829581156],\n ['Surgery Premedication (Off-label)',\n  'factors influencing health status and contact with health services , encounters for other specific health care , encounter for prophylactic surgery , encounter for prophylactic surgery for risk factors related to malignant neoplasms , encounter for prophylactic removal of other organ',\n  0.45489221175572064],\n ['Continuous Sedation/Analgesia',\n  'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , failed moderate sedation during procedure , sequela',\n  0.5737810330640828],\n ['Adjunct Anesthesia',\n  'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , unintended awareness under general anesthesia during procedure , sequela',\n  0.5386052419829004],\n ['Reversal of Conscious Sedation and General Anesthesia',\n  'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , failed moderate sedation during procedure , sequela',\n  0.6470422473677299],\n ['Benzodiazepine Overdose',\n  'injury, poisoning and certain other consequences of external causes , poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of antiepileptic, sedative- hypnotic and antiparkinsonism drugs , poisoning by, adverse effect of and underdosing of benzodiazepines , poisoning by, adverse effect of and underdosing of benzodiazepines , adverse effect of benzodiazepines , sequela',\n  0.6812920913082106],\n ['Reversal of Benzodiazepine Sedation',\n  'injury, poisoning and certain other consequences of external causes , poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of antiepileptic, sedative- hypnotic and antiparkinsonism drugs , poisoning by, adverse effect of and underdosing of benzodiazepines , poisoning by, adverse effect of and underdosing of benzodiazepines , adverse effect of benzodiazepines , subsequent encounter',\n  0.6205162028195096],\n ['Hypoglycemia',\n  'endocrine, nutritional and metabolic diseases , diabetes mellitus , type 2 diabetes mellitus , type 2 diabetes mellitus with other specified complications , type 2 diabetes mellitus with hypoglycemia , without coma',\n  0.6550141080500669],\n ['Diagnostic Aid',\n  'factors influencing health status and contact with health services , persons encountering health services for examinations , encounter for other special examination without complaint, suspected or reported diagnosis , encounter for other specified special examinations , encounter for antibody response examination',\n  0.46350678332018747],\n ['Beta-Blocker & Calcium Channel Blocker Toxicity (Off-label)',\n  'injury, poisoning and certain other consequences of external causes , poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system , poisoning by, adverse effect of and underdosing of calcium-channel blockers , poisoning by, adverse effect of and underdosing of calcium-channel blockers , poisoning by calcium-channel blockers, undetermined , sequela',\n  0.5642510013071338],\n ['Neurocysticercosis (Taenia Solium Tapeworm)',\n  'certain infectious and parasitic diseases , helminthiases , taeniasis , taenia solium taeniasis',\n  0.6955313031245007],\n ['Hydatid (Echinococcus Tapeworm)',\n  'certain infectious and parasitic diseases , helminthiases , echinococcosis , echinococcus multilocularis infection, unspecified',\n  0.6092097654075612],\n ['Ancylostoma, Ascariasis, Hookworm, Trichostrongylus',\n  'certain infectious and parasitic diseases , helminthiases , hookworm diseases , ancylostomiasis',\n  0.7474160811068862],\n ['Capillariasis',\n  'diseases of the circulatory system , diseases of arteries, arterioles and capillaries , diseases of capillaries , disease of capillaries, unspecified',\n  0.6202474156703507],\n ['Larva Migrans, Cutaneous & Trichuriasis',\n  'certain infectious and parasitic diseases , helminthiases , trichuriasis',\n  0.7078853540708465],\n ['Larva Migrans, Visceral',\n  'certain infectious and parasitic diseases , helminthiases , other helminthiases , visceral larva migrans',\n  0.6433758341897107],\n ['Enterobius (Pinworm)',\n  'certain infectious and parasitic diseases , intestinal infectious diseases , other bacterial intestinal infections , campylobacter enteritis',\n  0.561749481549013],\n ['Fluke (Clonorchis Sinensis)',\n  'certain infectious and parasitic diseases , helminthiases , other fluke infections , clonorchiasis',\n  0.6893352529904739],\n ['Gnathostomiasis, Microsporidiosis',\n  'certain infectious and parasitic diseases , helminthiases , other helminthiases , gnathostomiasis',\n  0.4517960658755589],\n ['Ancylostoma, Ascariasis, Hookworm, Trichostrongylus ',\n  'certain infectious and parasitic diseases , helminthiases , hookworm diseases , ancylostomiasis',\n  0.7474160811068862],\n ['Schistosomiasis',\n  'certain infectious and parasitic diseases , helminthiases , schistosomiasis bilharziasis , schistosomiasis due to schistosoma mansoni intestinal schistosomiasis',\n  0.7796103075297066],\n ['Clonorchiasis, Opisthorchiasis',\n  'certain infectious and parasitic diseases , helminthiases , other fluke infections , clonorchiasis',\n  0.5217955231605897],\n ['Cysticercosis (Off-label)',\n  'certain infectious and parasitic diseases , helminthiases , cysticercosis , cysticercosis, unspecified',\n  0.699975238383805],\n ['Tapeworms (Off-label)',\n  'certain infectious and parasitic diseases , helminthiases , hookworm diseases , hookworm disease, unspecified',\n  0.4346877969941843],\n ['Pinworm (Enterobius vermicularis)',\n  'certain infectious and parasitic diseases , intestinal infectious diseases , amebiasis , ameboma of intestine',\n  0.5410318577064693],\n ['Roundworm (Ascaris lumbricoides)',\n  'certain infectious and parasitic diseases , helminthiases , ascariasis , ascariasis, unspecified',\n  0.5790978177303558],\n ['Whipworm (Trichuris trichiura)',\n  'certain infectious and parasitic diseases , helminthiases , trichuriasis',\n  0.6458609744844613],\n ['Hookworm (Ancylostoma duodenale, Necator americanus)',\n  'certain infectious and parasitic diseases , helminthiases , hookworm diseases , ancylostomiasis',\n  0.6360701128864232],\n ['Giardia Duodenalis (Giardiasis; Off-label)',\n  'certain infectious and parasitic diseases , intestinal infectious diseases , other protozoal intestinal diseases , giardiasis lambliasis',\n  0.6214036047674425],\n ['Mansonella Perstans (Filariasis; Off-label))',\n  'certain infectious and parasitic diseases , helminthiases , filariasis , mansonelliasis',\n  0.7291046463171368],\n ['Visceral Larva Migrans (Toxocariasis; Off-label)',\n  'certain infectious and parasitic diseases , protozoal diseases , toxoplasmosis , toxoplasmosis, unspecified',\n  0.5678913378218726],\n ['Candidemia',\n  'certain infectious and parasitic diseases , mycoses , candidiasis , candidiasis, unspecified',\n  0.6563656529939781],\n ['Esophageal Candidiasis',\n  'certain infectious and parasitic diseases , mycoses , candidiasis , candidiasis of other sites , candidal esophagitis',\n  0.7843598159787482],\n ['Candida auris (Off-label)',\n  'certain infectious and parasitic diseases , mycoses , candidiasis , candidiasis of vulva and vagina , acute candidiasis of vulva and vagina',\n  0.46237315067644996],\n ['Candidemia ',\n  'certain infectious and parasitic diseases , mycoses , candidiasis , candidiasis, unspecified',\n  0.6563656529939781],\n ['Candida Infections',\n  'certain infectious and parasitic diseases , mycoses , candidiasis , candidiasis, unspecified',\n  0.7195201109748646],\n ['Invasive Aspergillosis',\n  'certain infectious and parasitic diseases , mycoses , aspergillosis , invasive pulmonary aspergillosis',\n  0.7797803071284456],\n ['Febrile Neutropenia',\n  'diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism , other disorders of blood and blood-forming organs , neutropenia , neutropenia due to infection',\n  0.5683953007656148],\n ['Treatment of candidemia, acute disseminated candidiasis, candida peritonitis and abscesses',\n  'certain infectious and parasitic diseases , mycoses , candidiasis , candidal sepsis',\n  0.6751947651368699],\n ['Treatment of Esophageal Candidiasis',\n  'certain infectious and parasitic diseases , mycoses , candidiasis , candidiasis of other sites , candidal esophagitis',\n  0.7010332124202632],\n ['Prophylaxis of Candida Infections in HSCT Recipients',\n  'certain infectious and parasitic diseases , mycoses , candidiasis , candidiasis of vulva and vagina , acute candidiasis of vulva and vagina',\n  0.5175316241324676],\n ['Invasive Mucormycosis',\n  'certain infectious and parasitic diseases , mycoses , zygomycosis , disseminated mucormycosis',\n  0.784758170561848],\n ['Oropharyngeal Candidiasis',\n  'certain infectious and parasitic diseases , mycoses , candidiasis , candidiasis, unspecified',\n  0.598524005309118],\n ['Cryptococcal Meningitis',\n  'certain infectious and parasitic diseases , mycoses , cryptococcosis , cutaneous cryptococcosis',\n  0.6813984236298266],\n ['Prophylaxis of Candidiasis with BMT',\n  'certain infectious and parasitic diseases , mycoses , candidiasis , candidiasis, unspecified',\n  0.6258632596605235],\n ['Vaginal Candidiasis',\n  'certain infectious and parasitic diseases , mycoses , candidiasis , candidiasis of vulva and vagina , chronic candidiasis of vulva and vagina',\n  0.794110400229262],\n ['Candida UTI/Peritonitis',\n  'certain infectious and parasitic diseases , mycoses , candidiasis , candidiasis of skin and nail',\n  0.6647587114524495],\n ['Systemic Candida Infections',\n  'certain infectious and parasitic diseases , mycoses , candidiasis , candidal sepsis',\n  0.704189386542805],\n ['Premature Neonates',\n  'certain conditions originating in the perinatal period , disorders of newborn related to length of gestation and fetal growth , disorders of newborn related to short gestation and low birth weight, not elsewhere classified , preterm premature newborn other , preterm newborn, gestational age 29 completed weeks',\n  0.6799141878451359],\n ['Life-threatening Infections',\n  'certain infectious and parasitic diseases , other bacterial diseases , bacterial infection of unspecified site , bacterial infection, unspecified',\n  0.5168576851192401],\n ['Blastomycosis',\n  'certain infectious and parasitic diseases , mycoses , blastomycosis , other forms of blastomycosis , other forms of blastomycosis',\n  0.8483174324477776],\n ['Aspergillosis',\n  'certain infectious and parasitic diseases , mycoses , aspergillosis , aspergillosis, unspecified',\n  0.8037444353549779],\n ['Histoplasmosis',\n  'certain infectious and parasitic diseases , mycoses , histoplasmosis , histoplasmosis, unspecified',\n  0.7929507768842989],\n ['Onychomycosis',\n  'certain infectious and parasitic diseases , mycoses , chromomycosis and pheomycotic abscess , cutaneous chromomycosis',\n  0.586594197830252],\n ['Candidiasis',\n  'certain infectious and parasitic diseases , mycoses , candidiasis , candidiasis, unspecified',\n  0.7643481120341938],\n ['Serious Fungal Infections',\n  'certain infectious and parasitic diseases , mycoses , candidiasis , candidiasis, unspecified',\n  0.6663699640024937],\n ['Dosage Modification',\n  'injury, poisoning and certain other consequences of external causes , poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of diuretics and other and unspecified drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of antidotes and chelating agents , poisoning by, adverse effect of and underdosing of antidotes and chelating agents , adverse effect of antidotes and chelating agents , sequela',\n  0.46621577648198753],\n ['Susceptible Fungal Infections (Off-label, Aged 2-12 yr)',\n  'certain infectious and parasitic diseases , mycoses , candidiasis , candidiasis, unspecified',\n  0.5799310196963819],\n ['Acute Malaria Infections',\n  'certain infectious and parasitic diseases , protozoal diseases , unspecified malaria',\n  0.7041755337219638],\n ['Malaria Prevention',\n  'certain infectious and parasitic diseases , protozoal diseases , unspecified malaria',\n  0.5664332743037204],\n ['Amebiasis, Intestinal',\n  'certain infectious and parasitic diseases , intestinal infectious diseases , amebiasis , ameboma of intestine',\n  0.8953882024386612],\n ['Amebic Liver Abscess',\n  'certain infectious and parasitic diseases , intestinal infectious diseases , amebiasis , amebic liver abscess',\n  0.8268069998196785],\n ['Giardiasis or Trichomoniasis',\n  'certain infectious and parasitic diseases , intestinal infectious diseases , other protozoal intestinal diseases , giardiasis lambliasis',\n  0.6620863833946123],\n ['Bacterial Vaginosis (Nonpregnant)',\n  'diseases of the genitourinary system , noninflammatory disorders of female genital tract , menopausal and other perimenopausal disorders , postmenopausal atrophic vaginitis',\n  0.5669149458977004],\n ['Giardiasis',\n  'certain infectious and parasitic diseases , intestinal infectious diseases , other protozoal intestinal diseases , giardiasis lambliasis',\n  0.5884176537704534],\n ['Latent Tuberculosis Infection',\n  'certain infectious and parasitic diseases , tuberculosis , respiratory tuberculosis , respiratory tuberculosis unspecified',\n  0.6757373498652008],\n ['Active Tuberculosis Disease',\n  'certain infectious and parasitic diseases , tuberculosis , respiratory tuberculosis , respiratory tuberculosis unspecified',\n  0.7258169133028038],\n ['Tuberculosis Treatment For HIV Negative',\n  'certain infectious and parasitic diseases , tuberculosis , respiratory tuberculosis , primary respiratory tuberculosis',\n  0.5081485964105318],\n ['Tuberculosis Treatment For HIV Exposed/Infected',\n  'certain infectious and parasitic diseases , tuberculosis , respiratory tuberculosis , tuberculous pleurisy',\n  0.5065333657259583],\n ['Tuberculosis Treatment',\n  'certain infectious and parasitic diseases , tuberculosis , respiratory tuberculosis , respiratory tuberculosis unspecified',\n  0.5979250818909236],\n ['Cytomegalovirus Retinitis',\n  'certain infectious and parasitic diseases , other viral diseases , cytomegaloviral disease , cytomegaloviral pneumonitis',\n  0.6135657611909794],\n ['CMV Colitis or Esophagitis in HIV-Infected Patients (Off-label)',\n  'diseases of the digestive system , noninfective enteritis and colitis , ulcerative colitis , other ulcerative colitis , without complications',\n  0.47600246962982024],\n ['CMV Prevention in Solid Organ Transplant ',\n  'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , complications of transplanted organs and tissue , complication of unspecified transplanted organ and tissue , unspecified transplanted organ and tissue infection',\n  0.43038205452562794],\n ['CMV Prevention in Kidney & Heart Transplant ',\n  'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , complications of transplanted organs and tissue , complications of heart transplant , heart transplant infection',\n  0.44028521653507524],\n ['Influenza A and B Prophylaxis',\n  'diseases of the respiratory system , influenza and pneumonia , pneumonia, unspecified organism , hypostatic pneumonia, unspecified organism',\n  0.573608830388303],\n ['Influenza A and B Treatment',\n  'diseases of the respiratory system , influenza and pneumonia , bacterial pneumonia, not elsewhere classified , pneumonia due to streptococcus, group b',\n  0.5556817102365345],\n ['H1N1 Influenza A (Swine Flu) Prophylaxis (Off-label)',\n  'diseases of the respiratory system , influenza and pneumonia , influenza due to certain identified influenza viruses , influenza due to identified novel influenza a virus , with gastrointestinal manifestations',\n  0.47267754153844077],\n ['H1N1 Influenza A (Swine Flu) Treatment (Off-label)',\n  'diseases of the respiratory system , influenza and pneumonia , influenza due to certain identified influenza viruses , influenza due to identified novel influenza a virus , with gastrointestinal manifestations',\n  0.4620764164267417],\n ['Influenza A and B Prophylaxis ',\n  'diseases of the respiratory system , influenza and pneumonia , pneumonia, unspecified organism , hypostatic pneumonia, unspecified organism',\n  0.573608830388303],\n ['H1N1 Influenza A (Swine Flu) Prophylaxis (Off-label) ',\n  'diseases of the respiratory system , influenza and pneumonia , influenza due to certain identified influenza viruses , influenza due to identified novel influenza a virus , with gastrointestinal manifestations',\n  0.47267754153844077],\n ['Acute Herpes Zoster (Shingles)',\n  'certain infectious and parasitic diseases , viral infections characterized by skin and mucous membrane lesions , zoster herpes zoster , disseminated zoster',\n  0.7389429095206296],\n ['Genital Herpes',\n  'certain infectious and parasitic diseases , infections with a predominantly sexual mode of transmission , anogenital herpesviral herpes simplex infections , herpesviral infection of genitalia and urogenital tract , herpesviral cervicitis',\n  0.6128640131535391],\n ['Herpes (HIV-Infected Adults)',\n  'certain infectious and parasitic diseases , other human herpesviruses , other human herpesviruses , other human herpesvirus infection , human herpesvirus 6 infection',\n  0.5980561404993168],\n ['Dosing Modifications',\n  'injury, poisoning and certain other consequences of external causes , poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of hormones and their synthetic substitutes and antagonists, not elsewhere classified , poisoning by, adverse effect of and underdosing of other and unspecified hormones and synthetic substitutes , poisoning by, adverse effect of and underdosing of unspecified hormones and synthetic substitutes , underdosing of unspecified hormones and synthetic substitutes , sequela',\n  0.38710591601886024],\n ['Genital Herpes (Off-label)',\n  'certain infectious and parasitic diseases , infections with a predominantly sexual mode of transmission , anogenital herpesviral herpes simplex infections , herpesviral infection of genitalia and urogenital tract , herpesviral cervicitis',\n  0.5422067278060041],\n ['Complicated Skin/Skin Structure Infections',\n  'certain infectious and parasitic diseases , viral infections characterized by skin and mucous membrane lesions , herpesviral herpes simplex infections , herpesviral vesicular dermatitis',\n  0.6108612792976127],\n ['Complicated Intra-abdominal Infections',\n  'certain infectious and parasitic diseases , intestinal infectious diseases , other bacterial intestinal infections , bacterial intestinal infection, unspecified',\n  0.553950901927362],\n ['Community-Acquired Pneumonia (Off-label)',\n  'diseases of the respiratory system , influenza and pneumonia , viral pneumonia, not elsewhere classified , viral pneumonia, unspecified',\n  0.5022271587235135],\n ['Febrile Neutropenia (Off-label)',\n  'diseases of the skin and subcutaneous tissue , other disorders of the skin and subcutaneous tissue , other disorders of skin and subcutaneous tissue, not elsewhere classified , febrile neutrophilic dermatosis sweet',\n  0.5017901829793194],\n ['Bacterial Meningitis',\n  'certain infectious and parasitic diseases , other bacterial diseases , meningococcal infection , meningococcal meningitis',\n  0.7776037280504756],\n ['Moderate-to-Severe Infections',\n  'certain infectious and parasitic diseases , intestinal infectious diseases , other salmonella infections , salmonella infection, unspecified',\n  0.5085673073618434],\n ['Mild Infections With Gram-Positive Cocci',\n  'certain infectious and parasitic diseases , mycoses , coccidioidomycosis , other forms of coccidioidomycosis , other forms of coccidioidomycosis',\n  0.5896036914976777],\n ['Mild-to-Moderate Cholecystitis',\n  'diseases of the eye and adnexa , disorders of choroid and retina , chorioretinal inflammation , posterior cyclitis , bilateral',\n  0.5340816887949837],\n ['Uncomplicated Urinary Tract Infection',\n  'certain conditions originating in the perinatal period , infections specific to the perinatal period , other infections specific to the perinatal period , neonatal urinary tract infection',\n  0.5925283393259472],\n ['Preparation for Surgery',\n  'factors influencing health status and contact with health services , encounters for other specific health care , encounter for prophylactic surgery , encounter for prophylactic surgery for risk factors related to malignant neoplasms , encounter for prophylactic removal of other organ',\n  0.46096033426772454],\n ['Bacterial Keratitis (Off-label) ',\n  'diseases of the skin and subcutaneous tissue , other disorders of the skin and subcutaneous tissue , keratoderma in diseases classified elsewhere',\n  0.5625384748387655],\n ['Infections With Gram-Positive Cocci',\n  'certain infectious and parasitic diseases , mycoses , coccidioidomycosis , other forms of coccidioidomycosis , other forms of coccidioidomycosis',\n  0.6066225791335909],\n ['Endocarditis',\n  'diseases of the circulatory system , other forms of heart disease , acute and subacute endocarditis , acute and subacute infective endocarditis',\n  0.7062988600437069],\n ['Community-Acquired Pneumonia',\n  'diseases of the respiratory system , influenza and pneumonia , viral pneumonia, not elsewhere classified , viral pneumonia, unspecified',\n  0.560762288611912],\n ['Pharyngitis',\n  'diseases of the respiratory system , acute upper respiratory infections , acute pharyngitis , acute pharyngitis, unspecified',\n  0.7535266660860129],\n ['Skin & Skin Structure Infections',\n  'certain infectious and parasitic diseases , viral infections characterized by skin and mucous membrane lesions , herpesviral herpes simplex infections , herpesviral vesicular dermatitis',\n  0.6629546871639828],\n ['Tonsillitis',\n  'diseases of the respiratory system , acute upper respiratory infections , acute tonsillitis , acute tonsillitis, unspecified , acute recurrent tonsillitis, unspecified',\n  0.7270692810920553],\n ['Urinary Tract Infections',\n  'certain conditions originating in the perinatal period , infections specific to the perinatal period , other infections specific to the perinatal period , neonatal urinary tract infection',\n  0.70260433846657],\n ['Susceptible Infections',\n  'certain infectious and parasitic diseases , other bacterial diseases , bacterial infection of unspecified site , bacterial infection, unspecified',\n  0.591894910838897],\n ['Streptococcal Pharyngitis',\n  'diseases of the respiratory system , acute upper respiratory infections , acute pharyngitis , streptococcal pharyngitis',\n  0.7718042786523684],\n ['Lower Respiratory Tract Infections',\n  'diseases of the respiratory system , other acute lower respiratory infections , unspecified acute lower respiratory infection',\n  0.7862349745528293],\n ['Otitis Media ',\n  'diseases of the ear and mastoid process , diseases of middle ear and mastoid , suppurative and unspecified otitis media , otitis media, unspecified , unspecified ear',\n  0.7000420070367521],\n ['Uncomplicated Skin and Skin Structure Infections',\n  'certain infectious and parasitic diseases , viral infections characterized by skin and mucous membrane lesions , unspecified viral infection characterized by skin and mucous membrane lesions',\n  0.6454247291187339],\n ['Bronchitis',\n  'diseases of the respiratory system , chronic lower respiratory diseases , unspecified chronic bronchitis',\n  0.7237363433590609],\n ['Pharyngitis and Tonsillitis',\n  'diseases of the respiratory system , acute upper respiratory infections , acute pharyngitis , acute pharyngitis, unspecified',\n  0.7019939206563988],\n ['Otitis Media',\n  'diseases of the ear and mastoid process , diseases of middle ear and mastoid , suppurative and unspecified otitis media , otitis media, unspecified , unspecified ear',\n  0.7000420070367521],\n ['Pharyngitis & Tonsillitis',\n  'diseases of the respiratory system , acute upper respiratory infections , acute pharyngitis , acute pharyngitis, unspecified',\n  0.7053005754972909],\n ['Respiratory Tract Infections',\n  'diseases of the respiratory system , other acute lower respiratory infections , unspecified acute lower respiratory infection',\n  0.7746205238376007],\n ['Skin Infections',\n  'certain infectious and parasitic diseases , viral infections characterized by skin and mucous membrane lesions , herpesviral herpes simplex infections , herpesviral vesicular dermatitis',\n  0.6887223299372154],\n ['Acute Otitis Media',\n  'diseases of the ear and mastoid process , diseases of middle ear and mastoid , nonsuppurative otitis media , acute serous otitis media , left ear',\n  0.7162529695616106],\n ['Acute Sinusitis',\n  'diseases of the respiratory system , acute upper respiratory infections , acute sinusitis , acute ethmoidal sinusitis , unspecified',\n  0.8025655187683491],\n ['Acute Maxillary Sinusitis',\n  'diseases of the respiratory system , acute upper respiratory infections , acute sinusitis , acute maxillary sinusitis , acute recurrent maxillary sinusitis',\n  0.8065097259523542],\n ['Skin/Skin Structure Infections',\n  'certain infectious and parasitic diseases , viral infections characterized by skin and mucous membrane lesions , herpesviral herpes simplex infections , herpesviral vesicular dermatitis',\n  0.5901648814105854],\n ['Acute Bacterial Otitis Media ',\n  'diseases of the ear and mastoid process , diseases of middle ear and mastoid , nonsuppurative otitis media , acute serous otitis media , left ear',\n  0.6643173677545448],\n ['Pharyngitis/Tonsillitis',\n  'diseases of the respiratory system , acute upper respiratory infections , acute pharyngitis , acute pharyngitis, unspecified',\n  0.6533709949451407],\n ['Acute Exacerbations of Chronic Bronchitis',\n  'diseases of the respiratory system , chronic lower respiratory diseases , bronchiectasis , bronchiectasis with acute exacerbation',\n  0.7207235738277229],\n ['Uncomplicated Gonorrhea',\n  'certain infectious and parasitic diseases , infections with a predominantly sexual mode of transmission , gonococcal infection , other gonococcal infections , gonococcal pneumonia',\n  0.567366402067745],\n ['Uncomplicated Urinary Tract Infections',\n  'certain conditions originating in the perinatal period , infections specific to the perinatal period , other infections specific to the perinatal period , neonatal urinary tract infection',\n  0.6363570254307613],\n ['Typhoid Fever (Off-label)',\n  'certain infectious and parasitic diseases , intestinal infectious diseases , typhoid and paratyphoid fevers , typhoid fever , unspecified',\n  0.6889307070286801],\n ['Acute Bronchitis & Acute Exacerbations of Chronic Bronchitis',\n  'diseases of the respiratory system , other acute lower respiratory infections , acute bronchitis , acute bronchitis, unspecified',\n  0.7269697261261795],\n ['Gonococcal Urethritis/Cervicitis',\n  'certain infectious and parasitic diseases , infections with a predominantly sexual mode of transmission , gonococcal infection , gonococcal pelviperitonitis and other gonococcal genitourinary infection , gonococcal infection of kidney and ureter',\n  0.7179584409399231],\n ['Gonorrhea, Rectal',\n  'certain infectious and parasitic diseases , infections with a predominantly sexual mode of transmission , gonococcal infection , gonococcal infection of anus and rectum',\n  0.512730503213638],\n ['Infections Caused by Susceptible Organisms',\n  'certain infectious and parasitic diseases , other bacterial diseases , bacterial infection of unspecified site , bacterial infection, unspecified',\n  0.6542418988289114],\n ['Epiglottitis',\n  'diseases of the respiratory system , acute upper respiratory infections , acute obstructive laryngitis croup and epiglottitis , acute epiglottitis , with obstruction',\n  0.6131789641019356],\n ['Meningitis',\n  'certain infectious and parasitic diseases , other bacterial diseases , meningococcal infection , meningococcal meningitis',\n  0.7568044437179403],\n ['Pneumonia',\n  'diseases of the respiratory system , influenza and pneumonia , pneumonia, unspecified organism , pneumonia, unspecified organism',\n  0.6847946765343379],\n ['Sepsis',\n  'certain infectious and parasitic diseases , other bacterial diseases , streptococcal sepsis , sepsis due to streptococcus, group a',\n  0.7013085899964798],\n ['Typhoid Fever',\n  'certain infectious and parasitic diseases , intestinal infectious diseases , typhoid and paratyphoid fevers , typhoid fever , unspecified',\n  0.750419092058494],\n ['Acute Community-Acquired Pneumonia',\n  'diseases of the respiratory system , influenza and pneumonia , viral pneumonia, not elsewhere classified , viral pneumonia, unspecified',\n  0.5286963575157126],\n ['Gonorrhea',\n  'certain infectious and parasitic diseases , infections with a predominantly sexual mode of transmission , gonococcal infection , other gonococcal infections , gonococcal pneumonia',\n  0.5537080189696637],\n ['General Dosage Range',\n  'external causes of morbidity , misadventures to patients during surgical and medical care , failure in dosage during surgical and medical care , failure in dosage during unspecified surgical and medical care',\n  0.3950315598421273],\n ['Chronic Bronchitis, Bacterial Exacerbation',\n  'diseases of the respiratory system , chronic lower respiratory diseases , unspecified chronic bronchitis',\n  0.6890628358524503],\n ['Cystitis, Acute Uncomplicated',\n  'diseases of the genitourinary system , other diseases of the urinary system , cystitis , acute cystitis , without hematuria',\n  0.6655397568555954],\n ['Bone & Joint Infections',\n  'diseases of the musculoskeletal system and connective tissue , infectious arthropathies , direct infections of joint in infectious and parasitic diseases classified elsewhere , direct infection of joint in infectious and parasitic diseases classified elsewhere , direct infection of vertebrae in infectious and parasitic diseases classified elsewhere',\n  0.6585778201110517],\n ['Gynecologic & Intra-abdominal Infections',\n  'diseases of the genitourinary system , noninflammatory disorders of female genital tract , other abnormal uterine and vaginal bleeding , pre-pubertal vaginal bleeding',\n  0.5454316311751003],\n ['Pulmonary Infections',\n  'diseases of the respiratory system , other acute lower respiratory infections , unspecified acute lower respiratory infection',\n  0.6915953544985427],\n ['Mild Skin/Skin Structure Infections',\n  'certain infectious and parasitic diseases , viral infections characterized by skin and mucous membrane lesions , herpesviral herpes simplex infections , herpesviral vesicular dermatitis',\n  0.6243861654782753],\n ['Life-Threatening Infections',\n  'certain infectious and parasitic diseases , other bacterial diseases , bacterial infection of unspecified site , bacterial infection, unspecified',\n  0.5168576658260774],\n ['Intra-abdominal Infections',\n  'certain infectious and parasitic diseases , intestinal infectious diseases , other bacterial intestinal infections , bacterial intestinal infection, unspecified',\n  0.5486706175305649],\n ['Acute Bacterial Otitis Media',\n  'diseases of the ear and mastoid process , diseases of middle ear and mastoid , nonsuppurative otitis media , acute serous otitis media , left ear',\n  0.6643173677545448],\n ['Pelvic Inflammatory Disease',\n  'diseases of the genitourinary system , inflammatory diseases of female pelvic organs , female pelvic inflammatory disorders in diseases classified elsewhere',\n  0.8042541394007907],\n ['Prosthetic Joint Infection',\n  'diseases of the musculoskeletal system and connective tissue , infectious arthropathies , direct infections of joint in infectious and parasitic diseases classified elsewhere , direct infection of joint in infectious and parasitic diseases classified elsewhere , direct infection of knee in infectious and parasitic diseases classified elsewhere , direct infection of unspecified knee in infectious and parasitic diseases classified elsewhere',\n  0.5671331040192138],\n ['Acute Uncomplicated Pyelonephritis',\n  'diseases of the genitourinary system , renal tubulo-interstitial diseases , acute pyelonephritis',\n  0.7282794184062354],\n ['Surgical Prophylaxis',\n  'factors influencing health status and contact with health services , encounters for other specific health care , encounter for prophylactic surgery , encounter for prophylactic surgery, unspecified',\n  0.5212524765093115],\n ['Uncomplicated Gonococcal Infections',\n  'certain infectious and parasitic diseases , infections with a predominantly sexual mode of transmission , gonococcal infection , other gonococcal infections , gonococcal pneumonia',\n  0.7743048531635676],\n ['Septic/toxic Shock (Off-label)',\n  'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , complications of procedures, not elsewhere classified , postprocedural shock , postprocedural septic shock , sequela',\n  0.651080574641321],\n ['Acute Epididymitis (Off-label)',\n  'diseases of the genitourinary system , diseases of male genital organs , orchitis and epididymitis , epididymitis',\n  0.5654976261566851],\n ['Skin and Soft Necrotizing Infection (Off-label)',\n  'certain infectious and parasitic diseases , viral infections characterized by skin and mucous membrane lesions , unspecified viral infection characterized by skin and mucous membrane lesions',\n  0.5939704064246512],\n ['Severe Acute Bacterial Rhinosinusitis (Off-label)',\n  'diseases of the respiratory system , acute upper respiratory infections , acute sinusitis , acute frontal sinusitis , unspecified',\n  0.5762732731941836],\n ['Other Gonococcal Infections (Off-label)',\n  'certain infectious and parasitic diseases , infections with a predominantly sexual mode of transmission , gonococcal infection , other gonococcal infections , gonococcal pneumonia',\n  0.7733214933895065],\n ['Epiglottis (Off-label)',\n  'diseases of the respiratory system , acute upper respiratory infections , acute obstructive laryngitis croup and epiglottitis , acute epiglottitis , with obstruction',\n  0.46317706257635954],\n ['Serious Infections Other Than Meningitis',\n  'certain infectious and parasitic diseases , other bacterial diseases , meningococcal infection , meningococcal meningitis',\n  0.7532680444994625],\n ['Gonococcal Infections',\n  'certain infectious and parasitic diseases , infections with a predominantly sexual mode of transmission , gonococcal infection , gonococcal pharyngitis',\n  0.8267148528326945],\n ['Chronic Bacterial Prostatitis',\n  'diseases of the genitourinary system , diseases of male genital organs , inflammatory diseases of prostate , chronic prostatitis',\n  0.6335715073033136],\n ['Infectious Diarrhea',\n  'certain infectious and parasitic diseases , intestinal infectious diseases , infectious gastroenteritis and colitis, unspecified',\n  0.6487791221919429],\n ['Empirical Therapy in Febrile Neutropenic Patients',\n  'diseases of the skin and subcutaneous tissue , other disorders of the skin and subcutaneous tissue , other disorders of skin and subcutaneous tissue, not elsewhere classified , febrile neutrophilic dermatosis sweet',\n  0.45091489779920096],\n ['Nosocomial Pneumonia',\n  'certain conditions originating in the perinatal period , respiratory and cardiovascular disorders specific to the perinatal period , congenital pneumonia , congenital pneumonia due to other bacterial agents',\n  0.6093541689705391],\n ['Urethral & Cervical Gonococcal Infections',\n  'certain infectious and parasitic diseases , infections with a predominantly sexual mode of transmission , gonococcal infection , gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess , gonococcal cystitis and urethritis, unspecified',\n  0.7452269585262608],\n ['Anthrax Infection',\n  'certain infectious and parasitic diseases , certain zoonotic bacterial diseases , anthrax , cutaneous anthrax',\n  0.8289565177610885],\n ['Plague',\n  'certain infectious and parasitic diseases , certain zoonotic bacterial diseases , plague , plague, unspecified',\n  0.6976535185417746],\n ['Complicated Urinary Tract Infections or Pyelonephritis',\n  'diseases of the genitourinary system , renal tubulo-interstitial diseases , acute pyelonephritis',\n  0.7112796824828982],\n ['Cholera',\n  'certain infectious and parasitic diseases , intestinal infectious diseases , cholera , cholera, unspecified',\n  0.7603817573022232],\n ['Inhalational Anthrax (Off-label)',\n  'certain infectious and parasitic diseases , certain zoonotic bacterial diseases , anthrax , pulmonary anthrax',\n  0.6071152375033473],\n ['Cystic Fibrosis (Off-label)',\n  'endocrine, nutritional and metabolic diseases , metabolic disorders , cystic fibrosis , cystic fibrosis with other manifestations',\n  0.6211421246338857],\n ['Staphylococcal Enterocolitis',\n  'certain infectious and parasitic diseases , bacterial and viral infectious agents , streptococcus, staphylococcus, and enterococcus as the cause of diseases classified elsewhere , enterococcus as the cause of diseases classified elsewhere',\n  0.6716477019313433],\n ['Clostridium difficile-associated Diarrhea',\n  'certain infectious and parasitic diseases , intestinal infectious diseases , other bacterial intestinal infections , enterocolitis due to clostridium difficile , recurrent',\n  0.7483236990846678],\n ['Skin and Skin Structure Infections',\n  'certain infectious and parasitic diseases , viral infections characterized by skin and mucous membrane lesions , herpesviral herpes simplex infections , herpesviral vesicular dermatitis',\n  0.670599619018995],\n ['Bone Infections',\n  'diseases of the musculoskeletal system and connective tissue , other osteopathies , osteomyelitis , acute hematogenous osteomyelitis , other sites',\n  0.6079631645923509],\n ['Preoperative Antimicrobial Prophylaxis (Off-label)',\n  'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , complications of procedures, not elsewhere classified , infection following a procedure , infection following a procedure, deep incisional surgical site , subsequent encounter',\n  0.4014308128557824],\n ['Surgical Prophylaxis (Off-label)',\n  'factors influencing health status and contact with health services , encounters for other specific health care , encounter for prophylactic surgery , encounter for prophylactic surgery for risk factors related to malignant neoplasms , encounter for prophylactic removal of other organ',\n  0.4737265903886998],\n ['Infective Endocarditis',\n  'diseases of the circulatory system , other forms of heart disease , acute and subacute endocarditis , acute and subacute infective endocarditis',\n  0.7840435013187731],\n ['Septicemia',\n  'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , complications of procedures, not elsewhere classified , postprocedural shock , postprocedural septic shock , sequela',\n  0.5302070590599348],\n ['Other Infections',\n  'certain infectious and parasitic diseases , other bacterial diseases , meningococcal infection , other meningococcal infections , other meningococcal infections',\n  0.7084196902687305],\n ['Complicated Skin Infections',\n  'certain infectious and parasitic diseases , viral infections characterized by skin and mucous membrane lesions , herpesviral herpes simplex infections , herpesviral vesicular dermatitis',\n  0.7027869657140577],\n ['HIV Infection',\n  'certain infectious and parasitic diseases , human immunodeficiency virus hiv disease , human immunodeficiency virus hiv disease',\n  0.7032401565806282],\n ['Chronic Hepatitis B',\n  'certain infectious and parasitic diseases , viral hepatitis , chronic viral hepatitis , chronic viral hepatitis b without delta-agent',\n  0.7417817864975367],\n ['Renal Impairment',\n  'diseases of the genitourinary system , other disorders of kidney and ureter , disorders resulting from impaired renal tubular function , disorder resulting from impaired renal tubular function, unspecified',\n  0.6364689427525908],\n ['Staphylococcus Aureus Bacteremia',\n  'certain conditions originating in the perinatal period , infections specific to the perinatal period , bacterial sepsis of newborn , sepsis of newborn due to staphylococcus aureus',\n  0.636636894710219],\n ['Complicated Skin and Skin Structure Infections',\n  'certain infectious and parasitic diseases , viral infections characterized by skin and mucous membrane lesions , unspecified viral infection characterized by skin and mucous membrane lesions',\n  0.6883789854131491],\n ['Complicated Skin & Skin Structure Infections',\n  'certain infectious and parasitic diseases , viral infections characterized by skin and mucous membrane lesions , unspecified viral infection characterized by skin and mucous membrane lesions',\n  0.6826387812268573],\n ['Acute Exacerbation of Chronic Bronchitis',\n  'diseases of the respiratory system , chronic lower respiratory diseases , bronchiectasis , bronchiectasis with acute exacerbation',\n  0.7293895431346078],\n ['Mycobacterial Infection',\n  'certain infectious and parasitic diseases , other bacterial diseases , infection due to other mycobacteria , mycobacterial infection, unspecified',\n  0.7866007181838546],\n ['Peptic Ulcer Disease',\n  'diseases of the digestive system , diseases of esophagus, stomach and duodenum , peptic ulcer, site unspecified , acute peptic ulcer, site unspecified, with both hemorrhage and perforation',\n  0.7234786089328119],\n ['Pharyngitis, Tonsillitis',\n  'diseases of the respiratory system , acute upper respiratory infections , acute pharyngitis , acute pharyngitis, unspecified',\n  0.7053005754972909],\n ['Skin/Skin Structure Infection',\n  'certain infectious and parasitic diseases , viral infections characterized by skin and mucous membrane lesions , herpesviral herpes simplex infections , herpesviral vesicular dermatitis',\n  0.5665482955934583],\n ['Pertussis (Off-label)',\n  'certain infectious and parasitic diseases , other bacterial diseases , whooping cough , whooping cough due to bordetella pertussis , without pneumonia',\n  0.528989664674074],\n ['Endocarditis (Off-label)',\n  'diseases of the circulatory system , other forms of heart disease , acute and subacute endocarditis , acute and subacute infective endocarditis',\n  0.5619927522513577],\n ['Sinusitis',\n  'diseases of the respiratory system , acute upper respiratory infections , acute sinusitis , acute frontal sinusitis , unspecified',\n  0.7375993398184438],\n ['Bacterial Vaginosis',\n  'diseases of the genitourinary system , inflammatory diseases of female pelvic organs , other inflammation of vagina and vulva , acute vaginitis',\n  0.5515004956576879],\n ['Trichomoniasis ',\n  'certain infectious and parasitic diseases , infections with a predominantly sexual mode of transmission , trichomoniasis , trichomoniasis, unspecified',\n  0.7693116566908619],\n ['Trichomoniasis',\n  'certain infectious and parasitic diseases , infections with a predominantly sexual mode of transmission , trichomoniasis , trichomoniasis, unspecified',\n  0.7693116566908619],\n ['Vancomycin-Resistant Enterococcal Infections',\n  'factors influencing health status and contact with health services , resistance to antimicrobial drugs , resistance to antimicrobial drugs , resistance to other antibiotics , resistance to vancomycin',\n  0.5222462301162683],\n ['Complicated Skin & Skin Structure Infections ',\n  'certain infectious and parasitic diseases , viral infections characterized by skin and mucous membrane lesions , unspecified viral infection characterized by skin and mucous membrane lesions',\n  0.6826387812268573],\n ['Community-Acquired Pneumonia (Including Concurrent Bacteremia)',\n  'certain infectious and parasitic diseases , other bacterial diseases , streptococcal sepsis , sepsis due to streptococcus pneumoniae',\n  0.5293423835982207],\n ['Methicillin-Resistant Staphylococcal Infections ',\n  'certain infectious and parasitic diseases , other bacterial diseases , other sepsis , sepsis due to staphylococcus aureus , sepsis due to methicillin susceptible staphylococcus aureus',\n  0.6938187429599327],\n ['Methicillin-Susceptible Staphylococcus Aureus',\n  'certain infectious and parasitic diseases , other bacterial diseases , other sepsis , sepsis due to staphylococcus aureus , sepsis due to methicillin susceptible staphylococcus aureus',\n  0.6621823116998468],\n ['Uncomplicated Skin & Skin Structure Infections',\n  'certain infectious and parasitic diseases , viral infections characterized by skin and mucous membrane lesions , unspecified viral infection characterized by skin and mucous membrane lesions',\n  0.6543819620259546],\n ['Ear, Nose, & Throat Infections',\n  'diseases of the ear and mastoid process , diseases of external ear , otitis externa , unspecified otitis externa , right ear',\n  0.6181740182946938],\n ['Genitourinary Tract Infections',\n  'diseases of the genitourinary system , other diseases of the urinary system , other disorders of urinary system , urinary tract infection, site not specified',\n  0.6772250757056345],\n ['Helicobacter Pylori',\n  'certain infectious and parasitic diseases , bacterial and viral infectious agents , other bacterial agents as the cause of diseases classified elsewhere , other specified bacterial agents as the cause of diseases classified elsewhere , helicobacter pylori h pylori as the cause of diseases classified elsewhere',\n  0.5816843922246987],\n ['Anthrax',\n  'certain infectious and parasitic diseases , certain zoonotic bacterial diseases , anthrax , other forms of anthrax',\n  0.6868229308460311],\n ['Lyme Disease (Off-label)',\n  'certain infectious and parasitic diseases , other spirochetal diseases , other spirochetal infections , lyme disease , unspecified',\n  0.6578441223556768],\n ['Chlamydial Infection in Pregnant Women (Off-label)',\n  'pregnancy, childbirth and the puerperium , other maternal disorders predominantly related to pregnancy , infections of genitourinary tract in pregnancy , infections of the genital tract in pregnancy , infection of other part of genital tract in pregnancy , unspecified trimester',\n  0.6661892419850668],\n ['Anthrax (Off-label)',\n  'certain infectious and parasitic diseases , certain zoonotic bacterial diseases , anthrax , other forms of anthrax',\n  0.554156182573365],\n ['Infective Endocarditis (Off-label)',\n  'diseases of the circulatory system , other forms of heart disease , acute and subacute endocarditis , acute and subacute infective endocarditis',\n  0.6677659378421721],\n ['General Dosing Guidelines',\n  'external causes of morbidity , misadventures to patients during surgical and medical care , failure in dosage during surgical and medical care , failure in dosage during unspecified surgical and medical care',\n  0.46325238564298277],\n ['Endocarditis Prophylaxis (Off-label)',\n  'diseases of the circulatory system , other forms of heart disease , acute and subacute endocarditis , acute and subacute infective endocarditis',\n  0.5130027065580929],\n ['Genitourinary Tract Infections (Excluding Gonorrhea)',\n  'certain infectious and parasitic diseases , infections with a predominantly sexual mode of transmission , gonococcal infection , gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess , other gonococcal infection of lower genitourinary tract',\n  0.7129661922435812],\n ['Gastrointestinal Tract Infections',\n  'certain infectious and parasitic diseases , intestinal infectious diseases , infectious gastroenteritis and colitis, unspecified',\n  0.7293359432868898],\n ['Urinary Tract Infection (ampicillin-susceptible Enterococcus; Off-label)',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , abnormal findings on examination of urine, without diagnosis , other and unspecified abnormal findings in urine , abnormal findings on microbiological examination of urine , bacteriuria',\n  0.5324758169208202],\n ['Bacterial Meningitis/Septicemia',\n  'certain infectious and parasitic diseases , other bacterial diseases , meningococcal infection , acute meningococcemia',\n  0.7457418825005926],\n ['Group B Streptococcus (Off-label)',\n  'certain infectious and parasitic diseases , other bacterial diseases , streptococcal sepsis , sepsis due to streptococcus, group b',\n  0.6086516621267526],\n ['Listeria Infection (Off-label)',\n  'certain infectious and parasitic diseases , other bacterial diseases , listeriosis , listerial sepsis',\n  0.5741025949250147],\n ['Neonates (<28 Days)',\n  'certain conditions originating in the perinatal period , disorders of newborn related to length of gestation and fetal growth , disorders of newborn related to short gestation and low birth weight, not elsewhere classified , preterm premature newborn other , preterm newborn, gestational age 29 completed weeks',\n  0.4747517574063445],\n ['Endocarditis Treatment',\n  'diseases of the circulatory system , other forms of heart disease , acute and subacute endocarditis , acute and subacute infective endocarditis',\n  0.6035048854531263],\n ['Soft Tissue Infections',\n  'certain infectious and parasitic diseases , viral infections characterized by skin and mucous membrane lesions , unspecified viral infection characterized by skin and mucous membrane lesions',\n  0.5845992372233987],\n ['Community Acquired Pneumonia',\n  'diseases of the respiratory system , influenza and pneumonia , bacterial pneumonia, not elsewhere classified , unspecified bacterial pneumonia',\n  0.5852098486264972],\n ['RSV Prophylaxis',\n  'factors influencing health status and contact with health services , persons with potential health hazards related to communicable diseases , encounter for other prophylactic measures , encounter for prophylactic immunotherapy , for respiratory syncytial virus rsv',\n  0.562380638151807],\n ['Rickettsial Infections',\n  'certain infectious and parasitic diseases , rickettsioses , typhus fever , epidemic louse-borne typhus fever due to rickettsia prowazekii',\n  0.8100120106532425],\n ['Sexually Transmitted Infections',\n  'certain infectious and parasitic diseases , infections with a predominantly sexual mode of transmission , unspecified sexually transmitted disease',\n  0.7536262667846733],\n ['Specific Bacterial Infections',\n  'certain infectious and parasitic diseases , other bacterial diseases , bacterial infection of unspecified site , bacterial infection, unspecified',\n  0.7607488169818925],\n ['Ophthalmic infections',\n  'certain infectious and parasitic diseases , viral infections characterized by skin and mucous membrane lesions , herpesviral herpes simplex infections , herpesviral ocular disease , other herpesviral disease of eye',\n  0.677203763127907],\n ['Acute Intestinal Amebiasis ',\n  'certain infectious and parasitic diseases , intestinal infectious diseases , amebiasis , ameboma of intestine',\n  0.86171212859779],\n ['Acne Vulgaris ',\n  'diseases of the skin and subcutaneous tissue , disorders of skin appendages , acne , acne vulgaris',\n  0.7677694489351926],\n ['Rosacea ',\n  'diseases of the skin and subcutaneous tissue , disorders of skin appendages , rosacea , other rosacea',\n  0.7502143617378646],\n ['Malaria',\n  'certain infectious and parasitic diseases , protozoal diseases , unspecified malaria',\n  0.7096606450650548],\n ['Periodontal Disease',\n  'diseases of the digestive system , diseases of oral cavity and salivary glands , gingivitis and periodontal diseases , periodontosis',\n  0.7551825672020884],\n ['Hypertension',\n  'diseases of the circulatory system , hypertensive diseases , essential primary hypertension',\n  0.5760609641624918],\n ['Migraine',\n  'diseases of the nervous system , episodic and paroxysmal disorders , migraine , cyclical vomiting , in migraine, intractable',\n  0.6744685776486454],\n ['Angina',\n  'diseases of the circulatory system , ischemic heart diseases , angina pectoris , unstable angina',\n  0.512428762956057],\n ['Pheochromocytoma',\n  'congenital malformations, deformations and chromosomal abnormalities , other congenital malformations , phakomatoses, not elsewhere classified , phakomatosis, unspecified',\n  0.4301933953687016],\n ['Hypertrophic Subaortic Stenosis',\n  'diseases of the musculoskeletal system and connective tissue , biomechanical lesions, not elsewhere classified , biomechanical lesions, not elsewhere classified , subluxation stenosis of neural canal , of sacral region',\n  0.5340037850866853],\n ['Myocardial Infarction',\n  'diseases of the circulatory system , ischemic heart diseases , acute myocardial infarction , non-st elevation nstemi myocardial infarction',\n  0.6637562501090267],\n ['Supraventricular Arrhythmia',\n  'diseases of the circulatory system , other forms of heart disease , other cardiac arrhythmias , atrial premature depolarization',\n  0.5306025999186836],\n ['Essential Tremor',\n  'diseases of the nervous system , extrapyramidal and movement disorders , other extrapyramidal and movement disorders , essential tremor',\n  0.7041068719260642],\n ['Portal Hypertension (Off-label)',\n  'diseases of the digestive system , diseases of liver , other diseases of liver , portal hypertension',\n  0.5297129202900255],\n ['Antipsychotic-Induced Akathisia (Off-label)',\n  'diseases of the nervous system , extrapyramidal and movement disorders , other extrapyramidal and movement disorders , other and unspecified drug induced movement disorders , drug induced akathisia',\n  0.562941314907203],\n ['Esophageal Bleeding (Off-label)',\n  'diseases of the digestive system , diseases of esophagus, stomach and duodenum , esophagitis , other esophagitis , with bleeding',\n  0.5711136681829854],\n ['Panic Disorder (Off-label)',\n  'mental, behavioral and neurodevelopmental disorders , anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders , other anxiety disorders , panic disorder episodic paroxysmal anxiety',\n  0.5345639284117261],\n ['Aggressive Behavior (Off-label)',\n  'neoplasms , neoplasms of unspecified behavior , neoplasms of unspecified behavior , neoplasm of unspecified behavior of unspecified site',\n  0.45643803609050326],\n ['Infantile Hemangiomas',\n  'neoplasms , benign neoplasms, except benign neuroendocrine tumors , hemangioma and lymphangioma, any site , hemangioma , of intra-abdominal structures',\n  0.649885347914565],\n ['Hypertension (Off-label)',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the circulatory and respiratory systems , abnormal blood-pressure reading, without diagnosis , elevated blood-pressure reading, without diagnosis of hypertension',\n  0.44305081530485846],\n ['Arrhythmias (Off-label)',\n  'diseases of the circulatory system , other forms of heart disease , paroxysmal tachycardia , re-entry ventricular arrhythmia',\n  0.41109371738165235],\n ['Hypercyanotic Spells (Off-label)',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the skin and subcutaneous tissue , other skin changes , cyanosis',\n  0.31112362768872925],\n ['Thyrotoxicosis (Off-label)',\n  'endocrine, nutritional and metabolic diseases , disorders of thyroid gland , thyrotoxicosis hyperthyroidism , thyrotoxicosis, unspecified , with thyrotoxic crisis or storm',\n  0.5747334379527488],\n ['Angina Pectoris',\n  'diseases of the circulatory system , ischemic heart diseases , angina pectoris , other forms of angina pectoris',\n  0.7081592560537818],\n ['Heart Failure (Post-Myocardial Infarction)',\n  'diseases of the circulatory system , other forms of heart disease , heart failure , left ventricular failure, unspecified',\n  0.5694547513474061],\n ['Myocardial Infarction/Stroke Prevention',\n  'diseases of the circulatory system , ischemic heart diseases , acute myocardial infarction , non-st elevation nstemi myocardial infarction',\n  0.5402225873219845],\n ['Diabetic Nephropathy (Off-label)',\n  'endocrine, nutritional and metabolic diseases , diabetes mellitus , diabetes mellitus due to underlying condition , diabetes mellitus due to underlying condition with kidney complications , diabetes mellitus due to underlying condition with diabetic nephropathy',\n  0.7063624790561127],\n ['Acute Hypertension',\n  'diseases of the circulatory system , hypertensive diseases , hypertensive crisis , hypertensive emergency',\n  0.5479717085012873],\n ['Hypertension (Alone or with Thiazide)',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the circulatory and respiratory systems , abnormal blood-pressure reading, without diagnosis , elevated blood-pressure reading, without diagnosis of hypertension',\n  0.4468345341376675],\n ['Congestive Heart Failure (With Diuretics and Digitalis)',\n  'diseases of the circulatory system , other forms of heart disease , heart failure , heart failure, unspecified',\n  0.5729024966645236],\n ['Left Ventricular Dysfunction After Myocardial Infarction',\n  'diseases of the circulatory system , ischemic heart diseases , acute myocardial infarction , st elevation stemi myocardial infarction of anterior wall , st elevation stemi myocardial infarction involving left main coronary artery',\n  0.5515647983197606],\n ['Diabetic Nephropathy',\n  'endocrine, nutritional and metabolic diseases , diabetes mellitus , diabetes mellitus due to underlying condition , diabetes mellitus due to underlying condition with kidney complications , diabetes mellitus due to underlying condition with diabetic nephropathy',\n  0.8244687614011105],\n ['Acute hypertension',\n  'diseases of the circulatory system , hypertensive diseases , hypertensive crisis , hypertensive emergency',\n  0.5479717085012873],\n ['Hypertension (alone or with thiazide)',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the circulatory and respiratory systems , abnormal blood-pressure reading, without diagnosis , elevated blood-pressure reading, without diagnosis of hypertension',\n  0.4468345341376675],\n ['Congestive heart failure (with diuretics and digitalis)',\n  'diseases of the circulatory system , other forms of heart disease , heart failure , heart failure, unspecified',\n  0.5729024966645236],\n ['Left ventricular dysfunction after myocardial infarction',\n  'diseases of the circulatory system , ischemic heart diseases , acute myocardial infarction , st elevation stemi myocardial infarction of anterior wall , st elevation stemi myocardial infarction involving left main coronary artery',\n  0.5515647983197606],\n ['Diabetic nephropathy',\n  'endocrine, nutritional and metabolic diseases , diabetes mellitus , diabetes mellitus due to underlying condition , diabetes mellitus due to underlying condition with kidney complications , diabetes mellitus due to underlying condition with diabetic nephropathy',\n  0.8244687614011105],\n ['Acute Myocardial Infarction',\n  'diseases of the circulatory system , ischemic heart diseases , acute myocardial infarction , acute myocardial infarction, unspecified',\n  0.6662113937398321],\n ['Heart Failure',\n  'diseases of the circulatory system , other forms of heart disease , heart failure , heart failure, unspecified',\n  0.6849195924051905],\n ['Primary Hypertension (Orphan)',\n  'diseases of the circulatory system , hypertensive diseases , essential primary hypertension',\n  0.6288036079256748],\n ['Nephropathy in Type 2 Diabetes',\n  'endocrine, nutritional and metabolic diseases , diabetes mellitus , type 2 diabetes mellitus , type 2 diabetes mellitus with kidney complications , type 2 diabetes mellitus with diabetic nephropathy',\n  0.7873500095074174],\n ['Post-Myocardial Infarction',\n  'diseases of the circulatory system , ischemic heart diseases , certain current complications following st elevation stemi and non-st elevation nstemi myocardial infarction within the 28 day period , postinfarction angina',\n  0.6048962389846974],\n ['Cardiovascular risk reduction',\n  'diseases of the circulatory system , ischemic heart diseases , certain current complications following st elevation stemi and non-st elevation nstemi myocardial infarction within the 28 day period , postinfarction angina',\n  0.4215755239803475],\n ['Primary Hyperaldosteronism',\n  'endocrine, nutritional and metabolic diseases , disorders of other endocrine glands , hyperaldosteronism , primary hyperaldosteronism , other primary hyperaldosteronism',\n  0.7729386973760294],\n ['Edematous Conditions',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , general symptoms and signs , edema, not elsewhere classified , edema, unspecified',\n  0.6164021646204884],\n ['Essential Hypertension',\n  'diseases of the circulatory system , hypertensive diseases , essential primary hypertension',\n  0.631991266492158],\n ['Congestive Heart Failure',\n  'diseases of the circulatory system , other forms of heart disease , heart failure , systolic congestive heart failure , acute on chronic systolic congestive heart failure',\n  0.6969915661696152],\n ['Hypokalemia',\n  'endocrine, nutritional and metabolic diseases , metabolic disorders , other disorders of fluid, electrolyte and acid-base balance , hypokalemia',\n  0.6742767245032076],\n ['Hirsutism (Off-label)',\n  'diseases of the skin and subcutaneous tissue , disorders of skin appendages , hypertrichosis , hirsutism',\n  0.2968143834607347],\n ['Acne (Off-label)',\n  'diseases of the skin and subcutaneous tissue , disorders of skin appendages , acne , acne vulgaris',\n  0.5401182840599628],\n ['Edema (Off-label)',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , general symptoms and signs , edema, not elsewhere classified , edema, unspecified',\n  0.5411466496819968],\n ['Stroke Prophylaxis with Atrial Fibrillation',\n  'diseases of the circulatory system , other forms of heart disease , atrial fibrillation and flutter , chronic atrial fibrillation , permanent atrial fibrillation',\n  0.5729691282416193],\n ['Postoperative Prophylaxis of DVT/PE',\n  'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , complications of procedures, not elsewhere classified , infection following a procedure , infection following a procedure, unspecified , sequela',\n  0.4089787339212816],\n ['DVT or PE Treatment',\n  'diseases of the genitourinary system , noninflammatory disorders of female genital tract , pain and other conditions associated with female genital organs and menstrual cycle , dyspareunia , superficial introital dyspareunia',\n  0.3569986704665525],\n ['Stroke Prophylaxis With Atrial Fibrillation ',\n  'diseases of the circulatory system , other forms of heart disease , atrial fibrillation and flutter , chronic atrial fibrillation , permanent atrial fibrillation',\n  0.5729691282416193],\n ['Deep Vein Thrombosis Prophylaxis for Hip or Knee Replacement Surgery',\n  'diseases of the circulatory system , diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified , other venous embolism and thrombosis , acute embolism and thrombosis of deep veins of lower extremity , acute embolism and thrombosis of femoral vein , acute embolism and thrombosis of unspecified femoral vein',\n  0.4660420167680183],\n ['Venous Thromboembolism Prophylaxis for Restricted Mobility',\n  'diseases of the circulatory system , diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified , other venous embolism and thrombosis , chronic embolism and thrombosis of veins of upper extremity , chronic embolism and thrombosis of unspecified veins of upper extremity , bilateral',\n  0.4535423636580979],\n ['DVT and/or PE Treatment',\n  'diseases of the genitourinary system , noninflammatory disorders of female genital tract , pain and other conditions associated with female genital organs and menstrual cycle , dyspareunia , superficial introital dyspareunia',\n  0.35920694433082934],\n ['Reduction in Risk of Recurrence of DVT or PE',\n  'factors influencing health status and contact with health services , persons with potential health hazards related to family and personal history and certain conditions influencing health status , personal history of other diseases and conditions , personal history of diseases of genitourinary system , personal history of dysplasia of the female genital tract , personal history of vulvar dysplasia',\n  0.3268505449494983],\n ['Risk Reduction of Major Cardiovascular Events',\n  'diseases of the circulatory system , ischemic heart diseases , certain current complications following st elevation stemi and non-st elevation nstemi myocardial infarction within the 28 day period , postinfarction angina',\n  0.4353376892055291],\n ['Risk Reduction of Major Thrombotic Vascular Events',\n  'diseases of the circulatory system , diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified , other disorders of veins , postthrombotic syndrome , postthrombotic syndrome with other complications , of right lower extremity',\n  0.4714594636522733],\n ['VTE Treatment or Prevention',\n  'codes for special purposes , provisional assignment of new diseases of uncertain etiology or emergency use , emergency use of , vaping-related disorder',\n  0.3775124589297333],\n ['Thromboprophylaxis for Fontan Procedure',\n  'diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism , coagulation defects, purpura and other hemorrhagic conditions , purpura and other hemorrhagic conditions , other primary thrombocytopenia , other primary thrombocytopenia',\n  0.4652929606138324],\n ['Intraoperative Tachycardia/Hypertension',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the circulatory and respiratory systems , abnormalities of heart beat , tachycardia, unspecified',\n  0.5450142701431512],\n ['Supraventricular Tachycardia',\n  'diseases of the circulatory system , other forms of heart disease , paroxysmal tachycardia , supraventricular tachycardia',\n  0.6582358524389232],\n ['Hypertensive Emergency ',\n  'diseases of the circulatory system , hypertensive diseases , hypertensive crisis , hypertensive emergency',\n  0.6740478220117071],\n ['Supraventricular Tachycardia (Off-label)',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the circulatory and respiratory systems , abnormalities of heart beat , tachycardia, unspecified',\n  0.5294042440254239],\n ['Postoperative Hypertension (Off-label)',\n  'diseases of the circulatory system , other and unspecified disorders of the circulatory system , intraoperative and postprocedural complications and disorders of circulatory system, not elsewhere classified , postprocedural hypertension',\n  0.483794808316669],\n ['Supraventricular tachycardia',\n  'diseases of the circulatory system , other forms of heart disease , paroxysmal tachycardia , supraventricular tachycardia',\n  0.6582358524389232],\n ['Hypertensive emergency ',\n  'diseases of the circulatory system , hypertensive diseases , hypertensive crisis , hypertensive emergency',\n  0.6740478220117071],\n ['Intraoperative tachycardia/hypertension',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the circulatory and respiratory systems , abnormalities of heart beat , tachycardia, unspecified',\n  0.5450142701431512],\n ['Stable Monomorphic or Polymorphic Ventricular Tachycardia (Off-label)',\n  'diseases of the circulatory system , other forms of heart disease , paroxysmal tachycardia , re-entry ventricular arrhythmia',\n  0.5188443613001233],\n ['ACLS, Pulseless Ventricular Fibrillation/Ventricular Tachycardia (Off-label)',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the circulatory and respiratory systems , abnormalities of heart beat , tachycardia, unspecified',\n  0.4798985581272605],\n ['Ventricular Arrhythmias',\n  'diseases of the circulatory system , other forms of heart disease , paroxysmal tachycardia , re-entry ventricular arrhythmia',\n  0.665473243805401],\n ['Conversion to oral amiodarone after IV administration',\n  'injury, poisoning and certain other consequences of external causes , poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of hormones and their synthetic substitutes and antagonists, not elsewhere classified , poisoning by, adverse effect of and underdosing of other and unspecified hormones and synthetic substitutes , poisoning by, adverse effect of and underdosing of unspecified hormones and synthetic substitutes , adverse effect of unspecified hormones and synthetic substitutes , sequela',\n  0.3438361797791924],\n ['Drug Resistant Refractory Cardiac Arrhythmias (Off-label)',\n  'diseases of the circulatory system , other forms of heart disease , other cardiac arrhythmias , atrial premature depolarization',\n  0.41288941202546214],\n ['Pulseless Ventricular Tachycardia or Ventricular Fibrillation (PALS dosing) (Off-label)',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the circulatory and respiratory systems , abnormalities of heart beat , tachycardia, unspecified',\n  0.4994547437561272],\n ['Paroxysmal Supraventricular Tachycardia',\n  'diseases of the circulatory system , other forms of heart disease , paroxysmal tachycardia , supraventricular tachycardia',\n  0.7395556852941264],\n ['Stress Testing (Diagnostic)',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving cognition, perception, emotional state and behavior , symptoms and signs involving appearance and behavior , undue concern and preoccupation with stressful events',\n  0.597401712012193],\n ['Paroxysmal Superventricular Tachycardia (per ACLS)',\n  'diseases of the circulatory system , other forms of heart disease , paroxysmal tachycardia , supraventricular tachycardia',\n  0.623455094156824],\n ['PSVT (Adenocard)',\n  'certain infectious and parasitic diseases , other viral diseases , viral infection of unspecified site , adenovirus infection, unspecified',\n  0.37291101659339104],\n ['Adenoscan (Diagnostic)',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , abnormal tumor markers , abnormal tumor markers , other abnormal tumor markers',\n  0.5117591546204439],\n ['Atrial Fibrillation',\n  'diseases of the circulatory system , other forms of heart disease , atrial fibrillation and flutter , persistent atrial fibrillation , longstanding persistent atrial fibrillation',\n  0.6890514020301138],\n ['Heart Failure/Atrial Fibrillation',\n  'diseases of the circulatory system , other forms of heart disease , atrial fibrillation and flutter , paroxysmal atrial fibrillation',\n  0.633119014219651],\n ['Hypomagnesemia',\n  'endocrine, nutritional and metabolic diseases , metabolic disorders , disorders of mineral metabolism , disorders of magnesium metabolism , hypomagnesemia',\n  0.6776336795632325],\n ['Toxemia of Pregnancy',\n  'certain conditions originating in the perinatal period , hemorrhagic and hematological disorders of newborn , other perinatal hematological disorders , congenital anemia from fetal blood loss',\n  0.5410209209421144],\n ['Torsades de Pointes',\n  'diseases of the circulatory system , other forms of heart disease , paroxysmal tachycardia , ventricular tachycardia , torsades de pointes',\n  0.5252028482563782],\n ['Preterm Labor (Off-label)',\n  'pregnancy, childbirth and the puerperium , complications of labor and delivery , preterm labor , preterm labor with preterm delivery , preterm labor with preterm delivery, unspecified trimester , not applicable or unspecified',\n  0.5254708920482827],\n ['Acute Nephritis',\n  'diseases of the genitourinary system , glomerular diseases , acute nephritic syndrome , acute nephritic syndrome with other morphologic changes',\n  0.7037789812901009],\n ['Bronchospasm (Off-label)',\n  'diseases of the respiratory system , other diseases of the respiratory system , other respiratory disorders , diseases of bronchus, not elsewhere classified , acute bronchospasm',\n  0.5264845394819927],\n ['Acute Coronary Syndrome or History of MI',\n  'diseases of the circulatory system , ischemic heart diseases , acute myocardial infarction , acute myocardial infarction, unspecified',\n  0.5000488310628872],\n ['Coronary Artery Disease',\n  'diseases of the circulatory system , ischemic heart diseases , chronic ischemic heart disease , atherosclerotic heart disease of native coronary artery , without angina pectoris',\n  0.6826627633339539],\n ['Acute Ischemic Stroke or TIA',\n  'diseases of the nervous system , episodic and paroxysmal disorders , transient cerebral ischemic attacks and related syndromes , multiple and bilateral precerebral artery syndromes',\n  0.5446964514485146],\n ['Acute Coronary Syndrome',\n  'diseases of the circulatory system , ischemic heart diseases , other acute ischemic heart diseases , acute coronary thrombosis not resulting in myocardial infarction',\n  0.6293843833433482],\n ['Recent MI, Stroke, or Established Peripheral Arterial Disease',\n  'diseases of the circulatory system , diseases of arteries, arterioles and capillaries , other peripheral vascular diseases , peripheral vascular disease, unspecified',\n  0.5528326378824887],\n ['Cardioembolic Stroke',\n  'diseases of the circulatory system , cerebrovascular diseases , cerebral infarction , cerebral infarction due to embolism of precerebral arteries , cerebral infarction due to embolism of basilar artery',\n  0.49422348723776593],\n ['Carotid Artery Stenting (Off-label)',\n  'diseases of the circulatory system , cerebrovascular diseases , occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction , occlusion and stenosis of carotid artery , occlusion and stenosis of bilateral carotid arteries',\n  0.4888256610390868],\n ['Left Ventricular Dysfunction Following Myocardial Infarction',\n  'diseases of the circulatory system , ischemic heart diseases , acute myocardial infarction , st elevation stemi myocardial infarction of anterior wall , st elevation stemi myocardial infarction involving left main coronary artery',\n  0.5815636242707429],\n ['Angina pectoris',\n  'diseases of the circulatory system , ischemic heart diseases , angina pectoris , other forms of angina pectoris',\n  0.7081592560537818],\n ['Conversion to Extended Release Form',\n  'mental, behavioral and neurodevelopmental disorders , anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders , dissociative and conversion disorders , conversion disorder with mixed symptom presentation',\n  0.263467137797208],\n ['Post Myocardial Infarction',\n  'diseases of the circulatory system , ischemic heart diseases , certain current complications following st elevation stemi and non-st elevation nstemi myocardial infarction within the 28 day period , postinfarction angina',\n  0.5597367185759117],\n ['Alcohol Withdrawal Syndrome (Off-label)',\n  'mental, behavioral and neurodevelopmental disorders , mental and behavioral disorders due to psychoactive substance use , alcohol related disorders , alcohol dependence , alcohol dependence with withdrawal , uncomplicated',\n  0.653505490410427],\n ['Supraventricular Arrhythmias (Off-label)',\n  'diseases of the circulatory system , other forms of heart disease , other cardiac arrhythmias , atrial premature depolarization',\n  0.440434875409504],\n ['Migraine Prophylaxis (Off-label)',\n  'diseases of the nervous system , episodic and paroxysmal disorders , migraine , migraine, unspecified , migraine, unspecified, intractable , with status migrainosus',\n  0.47655409926933723],\n ['Pulmonary Hypertension',\n  'diseases of the circulatory system , pulmonary heart disease and diseases of pulmonary circulation , other pulmonary heart diseases , other secondary pulmonary hypertension , chronic thromboembolic pulmonary hypertension',\n  0.6902283466930402],\n ['Raynaud Phenomenon (Off-label)',\n  'diseases of the circulatory system , diseases of arteries, arterioles and capillaries , other peripheral vascular diseases , raynauds syndrome , without gangrene',\n  0.5797095393896705],\n ['Anal Fissures (Off-label)',\n  'diseases of the digestive system , other diseases of intestines , fissure and fistula of anal and rectal regions , chronic anal fissure',\n  0.5082317575520796],\n ['Subarachnoid Hemorrhage',\n  'diseases of the circulatory system , cerebrovascular diseases , nontraumatic subarachnoid hemorrhage , other nontraumatic subarachnoid hemorrhage',\n  0.6518603960870679],\n ['Edema',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , general symptoms and signs , edema, not elsewhere classified , edema, unspecified',\n  0.7015356563708657],\n ['Hypertension, Resistant',\n  'diseases of the circulatory system , hypertensive diseases , secondary hypertension , renovascular hypertension',\n  0.5049004482658835],\n ['Acute Pulmonary Edema/Hypertensive Crisis/Increased Intracranial Pressure',\n  'diseases of the nervous system , other disorders of the nervous system , intraoperative and postprocedural complications and disorders of nervous system, not elsewhere classified , intracranial hypotension following ventricular shunting',\n  0.46614345496262044],\n ['Hyperkalemia in Advanced Cardiac Life Support (ACLS)',\n  'endocrine, nutritional and metabolic diseases , metabolic disorders , other disorders of fluid, electrolyte and acid-base balance , hyperkalemia',\n  0.49338223388521557],\n ['Hypermagnesemia in ACLS',\n  'endocrine, nutritional and metabolic diseases , metabolic disorders , disorders of mineral metabolism , disorders of magnesium metabolism , hypermagnesemia',\n  0.4082310830567485],\n ['Resistant Hypertension',\n  'diseases of the circulatory system , hypertensive diseases , secondary hypertension , secondary hypertension, unspecified',\n  0.5095184309441523],\n ['Hypertension in Heart Failure (Off-label)',\n  'diseases of the circulatory system , hypertensive diseases , hypertensive heart disease , hypertensive heart disease with heart failure',\n  0.5629816494618223],\n ['Mild Fluid Retention in Heart Failure (Off-label)',\n  'external causes of morbidity , misadventures to patients during surgical and medical care , failure in dosage during surgical and medical care , incorrect dilution of fluid used during infusion',\n  0.49475918513964756],\n ['Diuresis',\n  'diseases of the genitourinary system , other diseases of the urinary system , other disorders of urinary system , other specified urinary incontinence , post-void dribbling',\n  0.47255315778532087],\n ['Hypertriglyceridemia, Hypercholesterolemia',\n  'endocrine, nutritional and metabolic diseases , metabolic disorders , disorders of lipoprotein metabolism and other lipidemias , pure hypercholesterolemia , familial hypercholesterolemia',\n  0.7246626995449985],\n ['Hypercholesterolemia',\n  'endocrine, nutritional and metabolic diseases , metabolic disorders , disorders of lipoprotein metabolism and other lipidemias , pure hypercholesterolemia , familial hypercholesterolemia',\n  0.7326845202385055],\n ['Homozygous Familial Hypercholesterolemia',\n  'endocrine, nutritional and metabolic diseases , metabolic disorders , disorders of lipoprotein metabolism and other lipidemias , pure hypercholesterolemia , familial hypercholesterolemia',\n  0.7346106659088322],\n ['Slowing Progression of Atherosclerosis',\n  'diseases of the circulatory system , diseases of arteries, arterioles and capillaries , atherosclerosis , other and unspecified atherosclerosis , generalized atherosclerosis',\n  0.5553460150426853],\n ['Primary Prevention ',\n  'injury, poisoning and certain other consequences of external causes , other and unspecified effects of external causes , effects of other deprivation , other effects of deprivation , sequela',\n  0.3758679410556635],\n ['Familial Hypercholesterolemia',\n  'endocrine, nutritional and metabolic diseases , metabolic disorders , disorders of lipoprotein metabolism and other lipidemias , pure hypercholesterolemia , familial hypercholesterolemia',\n  0.7188027834399232],\n ['Prevention of Coronary Events',\n  'factors influencing health status and contact with health services , persons with potential health hazards related to family and personal history and certain conditions influencing health status , presence of cardiac and vascular implants and grafts , presence of coronary angioplasty implant and graft',\n  0.4748950631882989],\n ['Primary and secondary prevention of atheroschlerotic cardiovascular disease (ASCVD)',\n  'diseases of the circulatory system , ischemic heart diseases , chronic ischemic heart disease , atherosclerotic heart disease of native coronary artery , without angina pectoris',\n  0.5076637816412503],\n ['Hypercholesterolemia & Mixed Dyslipidemia',\n  'endocrine, nutritional and metabolic diseases , metabolic disorders , disorders of lipoprotein metabolism and other lipidemias , mixed hyperlipidemia',\n  0.7396645117646401],\n ['Patients Requiring <25% Decrease in LDL-C',\n  'factors influencing health status and contact with health services , persons with potential health hazards related to family and personal history and certain conditions influencing health status , long term current drug therapy , long term current use of anticoagulants and antithrombotics/antiplatelets , long term current use of antithrombotics/antiplatelets',\n  0.392189364828964],\n ['Heterozygous Familial Hypercholesterolemia',\n  'endocrine, nutritional and metabolic diseases , metabolic disorders , disorders of lipoprotein metabolism and other lipidemias , pure hypercholesterolemia , familial hypercholesterolemia',\n  0.714174764235477],\n ['Primary Hyperlipidemia and Mixed Dyslipidemia Adjunct to Diet',\n  'endocrine, nutritional and metabolic diseases , metabolic disorders , disorders of lipoprotein metabolism and other lipidemias , mixed hyperlipidemia',\n  0.7325206037299671],\n ['Homozygous Sitosterolemia',\n  'congenital malformations, deformations and chromosomal abnormalities , congenital malformations of genital organs , hypospadias , hypospadias, unspecified',\n  0.47664177261137486],\n ['Primary Hyperlipidemia',\n  'endocrine, nutritional and metabolic diseases , metabolic disorders , disorders of lipoprotein metabolism and other lipidemias , other hyperlipidemia , other hyperlipidemia',\n  0.5925724012447725],\n ['Prevention of Cardiovascular Events',\n  'external causes of morbidity , medical devices associated with adverse incidents in diagnostic and therapeutic use , cardiovascular devices associated with adverse incidents , diagnostic and monitoring cardiovascular devices associated with adverse incidents',\n  0.4957002990684618],\n ['Pain/Fever/Dysmenorrhea',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the genitourinary system , pain associated with micturition , painful micturition, unspecified',\n  0.5603000399274292],\n ['Inflammatory Disease',\n  'diseases of the nervous system , inflammatory diseases of the central nervous system , sequelae of inflammatory diseases of central nervous system',\n  0.630635654797412],\n ['Osteoarthritis',\n  'diseases of the musculoskeletal system and connective tissue , osteoarthritis , osteoarthritis of knee , bilateral post-traumatic osteoarthritis of knee',\n  0.6739888163992217],\n ['Rheumatoid Arthritis',\n  'diseases of the musculoskeletal system and connective tissue , inflammatory polyarthropathies , other rheumatoid arthritis , rheumatoid nodule , unspecified site',\n  0.6904569660835188],\n ['Fever',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , general symptoms and signs , fever of other and unknown origin , fever, unspecified',\n  0.6883101820274699],\n ['Pain',\n  'diseases of the nervous system , other disorders of the nervous system , pain, not elsewhere classified , chronic pain, not elsewhere classified , chronic post-thoracotomy pain',\n  0.4608896419873703],\n ['Juvenile Idiopathic Arthritis',\n  'diseases of the musculoskeletal system and connective tissue , inflammatory polyarthropathies , juvenile arthritis , other juvenile arthritis , unspecified site',\n  0.7845218664744094],\n ['Patent Ductus Arteriosus',\n  'congenital malformations, deformations and chromosomal abnormalities , congenital malformations of the circulatory system , congenital malformations of great arteries , patent ductus arteriosus',\n  0.5440732350097807],\n ['Low Cardiac Output, Septic Shock',\n  'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , complications of procedures, not elsewhere classified , postprocedural shock , postprocedural septic shock , sequela',\n  0.5961293972337199],\n ['Actinic Keratosis',\n  'diseases of the skin and subcutaneous tissue , other disorders of the skin and subcutaneous tissue , seborrheic keratosis , inflamed seborrheic keratosis',\n  0.6683262250919745],\n ['Superficial Basal Cell Carcinoma',\n  'neoplasms , melanoma and other malignant neoplasms of skin , other and unspecified malignant neoplasm of skin , other and unspecified malignant neoplasm of overlapping sites of skin , basal cell carcinoma of overlapping sites of skin',\n  0.6631373838521224],\n ['External Genital Warts',\n  'certain infectious and parasitic diseases , infections with a predominantly sexual mode of transmission , other predominantly sexually transmitted diseases, not elsewhere classified , anogenital venereal warts',\n  0.7235407507660703],\n ['Acne Vulgaris',\n  'diseases of the skin and subcutaneous tissue , disorders of skin appendages , acne , acne vulgaris',\n  0.7677694489351926],\n ['Rosacea',\n  'diseases of the skin and subcutaneous tissue , disorders of skin appendages , rosacea , other rosacea',\n  0.7502143617378646],\n ['Tinea Cruris',\n  'certain infectious and parasitic diseases , mycoses , dermatophytosis , tinea cruris',\n  0.5094805518386019],\n ['Tinea Pedis',\n  'certain infectious and parasitic diseases , mycoses , dermatophytosis , tinea pedis',\n  0.5213094987437671],\n ['Tinea Corporis',\n  'certain infectious and parasitic diseases , mycoses , dermatophytosis , tinea corporis',\n  0.5001697169646268],\n ['Dermatophytoses',\n  'certain infectious and parasitic diseases , mycoses , dermatophytosis , other dermatophytoses',\n  0.6999944575288486],\n ['Tinea Corporis ',\n  'certain infectious and parasitic diseases , mycoses , dermatophytosis , tinea corporis',\n  0.5001697169646268],\n ['Psoriatic Arthritis',\n  'diseases of the skin and subcutaneous tissue , papulosquamous disorders , psoriasis , arthropathic psoriasis , psoriatic arthritis mutilans',\n  0.7042304971309314],\n ['Ankylosing Spondylitis',\n  'diseases of the musculoskeletal system and connective tissue , spondylopathies , ankylosing spondylitis , ankylosing spondylitis of thoracic region',\n  0.8321084719833766],\n ['Plaque Psoriasis',\n  'diseases of the skin and subcutaneous tissue , papulosquamous disorders , psoriasis , other psoriasis',\n  0.6832336531652201],\n ['Crohn Disease',\n  'diseases of the digestive system , noninfective enteritis and colitis , crohns disease regional enteritis , crohns disease, unspecified , without complications',\n  0.6986621517089013],\n ['Ulcerative Colitis',\n  'diseases of the digestive system , noninfective enteritis and colitis , ulcerative colitis , ulcerative colitis, unspecified , without complications',\n  0.7039657967563091],\n ['Hidradenitis Suppurativa',\n  'diseases of the skin and subcutaneous tissue , disorders of skin appendages , other follicular disorders , hidradenitis suppurativa',\n  0.7789688813386942],\n ['Uveitis',\n  'diseases of the skin and subcutaneous tissue , radiation-related disorders of the skin and subcutaneous tissue , other acute skin changes due to ultraviolet radiation , acute skin change due to ultraviolet radiation, unspecified',\n  0.5830686039245518],\n ['Pediatric Crohn Disease',\n  'diseases of the digestive system , noninfective enteritis and colitis , crohns disease regional enteritis , crohns disease of both small and large intestine , crohns disease of both small and large intestine with complications , crohns disease of both small and large intestine with rectal bleeding',\n  0.6588104640304077],\n ['Uveitis ',\n  'diseases of the skin and subcutaneous tissue , radiation-related disorders of the skin and subcutaneous tissue , other acute skin changes due to ultraviolet radiation , acute skin change due to ultraviolet radiation, unspecified',\n  0.5830686039245518],\n ['Juvenile Rheumatoid Arthritis',\n  'diseases of the musculoskeletal system and connective tissue , inflammatory polyarthropathies , juvenile arthritis , juvenile rheumatoid arthritis with systemic onset , unspecified site',\n  0.7955099742324583],\n ['Psoriasis',\n  'diseases of the skin and subcutaneous tissue , papulosquamous disorders , psoriasis , psoriasis, unspecified',\n  0.7611438242561889],\n ['Melanin Hyperpigmentation',\n  'diseases of the skin and subcutaneous tissue , other disorders of the skin and subcutaneous tissue , other disorders of pigmentation , other melanin hyperpigmentation',\n  0.7019212533268172],\n ['Severe Asthma',\n  'diseases of the respiratory system , chronic lower respiratory diseases , asthma , severe persistent asthma , with acute exacerbation',\n  0.7323384613589187],\n ['Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome)',\n  'diseases of the skin and subcutaneous tissue , other disorders of the skin and subcutaneous tissue , granulomatous disorders of skin and subcutaneous tissue , granuloma faciale eosinophilic granuloma of skin',\n  0.679636998712376],\n ['Hypereosinophilic Syndrome',\n  'diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism , other disorders of blood and blood-forming organs , other disorders of white blood cells , eosinophilia , hypereosinophilic syndrome hes , idiopathic hypereosinophilic syndrome ihes',\n  0.7063047793681672],\n ['Chronic Rhinosinusitis with Nasal Polyps',\n  'diseases of the respiratory system , other diseases of upper respiratory tract , nasal polyp , polyp of nasal cavity',\n  0.7902390889242004],\n ['Antiseptic Wound Cauterization',\n  'pregnancy, childbirth and the puerperium , complications predominantly related to the puerperium , other puerperal infections , infection of obstetric surgical wound , superficial incisional site',\n  0.4035474590566758],\n ['Primary Immunoglobulin A Nephropathy',\n  'diseases of the genitourinary system , glomerular diseases , hereditary nephropathy, not elsewhere classified , hereditary nephropathy, not elsewhere classified with diffuse mesangial proliferative glomerulonephritis',\n  0.595121704317486],\n ['Ulcerative Colitis (Orphan)',\n  'diseases of the digestive system , noninfective enteritis and colitis , ulcerative colitis , ulcerative colitis, unspecified , without complications',\n  0.6006389820321819],\n ['Constipation',\n  'diseases of the digestive system , other diseases of intestines , other functional intestinal disorders , constipation , slow transit constipation',\n  0.6737684916753414],\n ['Portal Systemic Encephalopathy',\n  'diseases of the digestive system , diseases of liver , other diseases of liver , portal hypertension',\n  0.5655063038370934],\n ['Antacid',\n  'mental, behavioral and neurodevelopmental disorders , behavioral syndromes associated with physiological disturbances and physical factors , abuse of non-psychoactive substances , abuse of antacids',\n  0.43362209871372653],\n ['Calcium Supplementation',\n  'endocrine, nutritional and metabolic diseases , other nutritional deficiencies , dietary calcium deficiency',\n  0.6032239626453161],\n ['Calcium dietary supplementation',\n  'endocrine, nutritional and metabolic diseases , other nutritional deficiencies , dietary calcium deficiency',\n  0.6331508835833052],\n ['Acute Diarrhea',\n  'diseases of the digestive system , other diseases of intestines , irritable bowel syndrome , irritable bowel syndrome with diarrhea',\n  0.5659767000768764],\n ['Chronic Diarrhea',\n  'diseases of the digestive system , other diseases of intestines , other functional intestinal disorders , functional diarrhea',\n  0.6587214850427127],\n [\"Traveler's Diarrhea\",\n  'diseases of the digestive system , other diseases of intestines , irritable bowel syndrome , irritable bowel syndrome with diarrhea',\n  0.4615295990231133],\n ['Hepatic Encephalopathy ',\n  'diseases of the digestive system , diseases of liver , other diseases of liver , other specified diseases of liver , hepatic encephalopathy',\n  0.7387374952226271],\n ['Irritable Bowel Syndrome',\n  'diseases of the digestive system , other diseases of intestines , irritable bowel syndrome , mixed irritable bowel syndrome',\n  0.8345931791196517],\n ['Chemotherapy-Induced Nausea & Vomiting',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the digestive system and abdomen , nausea and vomiting , nausea with vomiting, unspecified',\n  0.5652594841506906],\n ['Postoperative Nausea & Vomiting',\n  'diseases of the digestive system , other diseases of the digestive system , intraoperative and postprocedural complications and disorders of digestive system, not elsewhere classified , vomiting following gastrointestinal surgery',\n  0.6326924723094027],\n ['Radiation-Induced Nausea & Vomiting',\n  'injury, poisoning and certain other consequences of external causes , other and unspecified effects of external causes , radiation sickness, unspecified , radiation sickness, unspecified, subsequent encounter',\n  0.6969916490535774],\n ['Cholestatic Pruritus (Off-label)',\n  'diseases of the skin and subcutaneous tissue , dermatitis and eczema , pruritus , pruritus, unspecified',\n  0.5718948569304008],\n ['Uremic Pruritus (Off-label)',\n  'diseases of the skin and subcutaneous tissue , dermatitis and eczema , pruritus , anogenital pruritus, unspecified',\n  0.5537197086093848],\n ['Spinal Opioid-Induced Pruritus (Off-label)',\n  'diseases of the nervous system , other disorders of the nervous system , intraoperative and postprocedural complications and disorders of nervous system, not elsewhere classified , other reaction to spinal and lumbar puncture',\n  0.4857506538811689],\n ['Rosacea (Off-label)',\n  'diseases of the skin and subcutaneous tissue , disorders of skin appendages , rosacea , rosacea, unspecified',\n  0.6507617664937128],\n ['Hyperemesis Gravidarum',\n  'pregnancy, childbirth and the puerperium , other maternal disorders predominantly related to pregnancy , excessive vomiting in pregnancy , mild hyperemesis gravidarum',\n  0.5311710469605498],\n ['Acute Gastroenteritis (Off-Label)',\n  'certain infectious and parasitic diseases , intestinal infectious diseases , infectious gastroenteritis and colitis, unspecified',\n  0.5115664231132933],\n ['Chemotherapy-Induced Nausea & Vomiting (Orphan)',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the digestive system and abdomen , nausea and vomiting , nausea with vomiting, unspecified',\n  0.5311399826234509],\n ['Vasodilatory Shock',\n  'injury, poisoning and certain other consequences of external causes , other and unspecified effects of external causes , other and unspecified effects of other external causes , effects of vibration , traumatic vasospastic syndrome , sequela',\n  0.5582670001884732],\n ['Abdominal Distention (Off-label)',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the digestive system and abdomen , other symptoms and signs involving the digestive system and abdomen , abdominal rigidity , epigastric abdominal rigidity',\n  0.4955342956193332],\n ['Diabetes Insipidus (Off-label)',\n  'endocrine, nutritional and metabolic diseases , disorders of other endocrine glands , hypofunction and other disorders of the pituitary gland , diabetes insipidus',\n  0.4918042071558453],\n ['Abdominal Roentgenography (Off-label)',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , abnormal findings on diagnostic imaging and in function studies, without diagnosis , abnormal findings on diagnostic imaging of other body structures , abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum',\n  0.5748533219179429],\n ['Gastrointestinal Hemorrhage (Off-label)',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , general symptoms and signs , hemorrhage, not elsewhere classified',\n  0.5622302860319462],\n ['Obesity Management',\n  'endocrine, nutritional and metabolic diseases , overweight, obesity and other hyperalimentation , overweight and obesity , obesity due to excess calories , morbid severe obesity due to excess calories',\n  0.5371029398238757],\n ['Duodenal Ulcer',\n  'diseases of the digestive system , diseases of esophagus, stomach and duodenum , duodenal ulcer , acute duodenal ulcer with both hemorrhage and perforation',\n  0.7528728290012029],\n ['Stress Ulcer (Off-label)',\n  'diseases of the skin and subcutaneous tissue , other disorders of the skin and subcutaneous tissue , pressure ulcer , pressure ulcer of unspecified site , unstageable',\n  0.5358100232075949],\n ['Active Duodenal Ulcer (Off-label)',\n  'diseases of the digestive system , diseases of esophagus, stomach and duodenum , duodenal ulcer , acute duodenal ulcer with perforation',\n  0.64341166187167],\n ['Stomatitis (Off-label)',\n  'diseases of the digestive system , diseases of oral cavity and salivary glands , stomatitis and related lesions , other forms of stomatitis',\n  0.5655412894330719],\n ['Gastric Ulcer (Off-label)',\n  'diseases of the digestive system , diseases of esophagus, stomach and duodenum , gastric ulcer , acute gastric ulcer with perforation',\n  0.6188301271219239],\n ['Gas Retention in Gastrointestinal Tract',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the digestive system and abdomen , flatulence and related conditions , abdominal distension gaseous',\n  0.6000201365582246],\n ['Doage Forms & Strengths',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , general symptoms and signs , lack of expected normal physiological development in childhood and adults , adult failure to thrive',\n  0.23124620985157604],\n ['Active Duodenal Ulcer',\n  'diseases of the digestive system , diseases of esophagus, stomach and duodenum , duodenal ulcer , acute duodenal ulcer with both hemorrhage and perforation',\n  0.7377517090800007],\n ['Duodenal Ulcer Maintenance',\n  'diseases of the digestive system , diseases of esophagus, stomach and duodenum , duodenal ulcer , acute duodenal ulcer with perforation',\n  0.6850666369161791],\n ['Benign Gastric Ulcer',\n  'diseases of the digestive system , diseases of esophagus, stomach and duodenum , gastric ulcer , chronic gastric ulcer without hemorrhage or perforation',\n  0.6732857039197936],\n ['GERD',\n  'diseases of the digestive system , diseases of esophagus, stomach and duodenum , gastro-esophageal reflux disease , gastro-esophageal reflux disease without esophagitis',\n  0.38780233209622683],\n ['Active duodenal ulcer',\n  'diseases of the digestive system , diseases of esophagus, stomach and duodenum , duodenal ulcer , acute duodenal ulcer with both hemorrhage and perforation',\n  0.7377517090800007],\n ['Duodenal ulcer maintenance',\n  'diseases of the digestive system , diseases of esophagus, stomach and duodenum , duodenal ulcer , acute duodenal ulcer with perforation',\n  0.6850666369161791],\n ['Benign gastric ulcer',\n  'diseases of the digestive system , diseases of esophagus, stomach and duodenum , gastric ulcer , chronic gastric ulcer without hemorrhage or perforation',\n  0.6732857039197936],\n ['Constipation ',\n  'diseases of the digestive system , other diseases of intestines , other functional intestinal disorders , constipation , slow transit constipation',\n  0.6737684916753414],\n ['Acid Indigestion',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the digestive system and abdomen , heartburn',\n  0.5451584072023907],\n ['Nutritional Supplementation',\n  'endocrine, nutritional and metabolic diseases , other nutritional deficiencies , sequelae of malnutrition and other nutritional deficiencies , sequelae of vitamin a deficiency',\n  0.5646661132113987],\n ['Constipation/Laxative',\n  'diseases of the digestive system , other diseases of intestines , other functional intestinal disorders , constipation , drug induced constipation',\n  0.6209470640274537],\n ['Erosive Esophagitis',\n  'diseases of the digestive system , diseases of esophagus, stomach and duodenum , esophagitis , eosinophilic esophagitis',\n  0.6664786236650371],\n ['Gastroesophageal Reflux Disease',\n  'diseases of the digestive system , diseases of esophagus, stomach and duodenum , gastro-esophageal reflux disease , gastro-esophageal reflux disease without esophagitis',\n  0.7844964489096242],\n ['GERD Without Erosive Esophagitis',\n  'diseases of the digestive system , diseases of esophagus, stomach and duodenum , gastro-esophageal reflux disease , gastro-esophageal reflux disease without esophagitis',\n  0.6122774688650896],\n ['GERD With Erosive Esophagitis',\n  'diseases of the digestive system , diseases of esophagus, stomach and duodenum , esophagitis , eosinophilic esophagitis',\n  0.6477740509873299],\n ['Helicobacter Pylori Eradication',\n  'certain infectious and parasitic diseases , bacterial and viral infectious agents , other bacterial agents as the cause of diseases classified elsewhere , other specified bacterial agents as the cause of diseases classified elsewhere , helicobacter pylori h pylori as the cause of diseases classified elsewhere',\n  0.5131228659721226],\n ['Risk Reduction of NSAID-Associated Gastric Ulcer',\n  'diseases of the digestive system , diseases of esophagus, stomach and duodenum , gastric ulcer , acute gastric ulcer with perforation',\n  0.5546654758849533],\n ['NSAID-Induced Gastric Ulcer',\n  'diseases of the digestive system , diseases of esophagus, stomach and duodenum , gastric ulcer , chronic or unspecified gastric ulcer with perforation',\n  0.5646669287714519],\n ['Gastric or Duodenal Ulcers Following Therapeutic Endoscopy ',\n  'diseases of the digestive system , diseases of esophagus, stomach and duodenum , gastric ulcer , acute gastric ulcer with both hemorrhage and perforation',\n  0.6658919151328064],\n ['Frequent Heartburn',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the digestive system and abdomen , heartburn',\n  0.6650809823488704],\n ['Hepatic Impairment',\n  'diseases of the digestive system , diseases of liver , hepatic failure, not elsewhere classified , hepatic failure, unspecified , without coma',\n  0.709158727745867],\n ['Short-term Treatment of GERD',\n  'diseases of the digestive system , diseases of esophagus, stomach and duodenum , gastro-esophageal reflux disease , gastro-esophageal reflux disease without esophagitis',\n  0.3449603357433594],\n ['GERD With Erosive Esophagitis (Healing)',\n  'diseases of the digestive system , diseases of esophagus, stomach and duodenum , esophagitis , eosinophilic esophagitis',\n  0.5328415075153695],\n ['Gastric Ulcer',\n  'diseases of the digestive system , diseases of esophagus, stomach and duodenum , gastric ulcer , acute gastric ulcer with perforation',\n  0.7276211587312575],\n ['NSAID-associated GU',\n  'mental, behavioral and neurodevelopmental disorders , mental and behavioral disorders due to psychoactive substance use , sedative, hypnotic, or anxiolytic related disorders , sedative, hypnotic or anxiolytic-related use, unspecified , sedative, hypnotic or anxiolytic use, unspecified with withdrawal , delirium',\n  0.284946256740859],\n ['Hypersecretory Condition (eg, Zollinger-Ellison Syndrome)',\n  'diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism , certain disorders involving the immune mechanism , immunodeficiency associated with other major defects , di georges syndrome',\n  0.5232377160913331],\n ['Helicobacter Pylori Infection',\n  'certain infectious and parasitic diseases , bacterial and viral infectious agents , other bacterial agents as the cause of diseases classified elsewhere , other specified bacterial agents as the cause of diseases classified elsewhere , helicobacter pylori h pylori as the cause of diseases classified elsewhere',\n  0.6397889912835479],\n ['Heartburn',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the digestive system and abdomen , heartburn',\n  0.6128808410597572],\n ['GERD, Erosive Esophagitis',\n  'diseases of the digestive system , diseases of esophagus, stomach and duodenum , esophagitis , eosinophilic esophagitis',\n  0.6694593480611655],\n ['Nonerosive GERD',\n  'diseases of the digestive system , diseases of esophagus, stomach and duodenum , gastro-esophageal reflux disease , gastro-esophageal reflux disease without esophagitis',\n  0.377879862172471],\n ['Hypersecretory Conditions (eg, Zollinger-Ellison Syndrome)',\n  'diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism , certain disorders involving the immune mechanism , immunodeficiency associated with other major defects , di georges syndrome',\n  0.5365651746078799],\n ['Neonates (Off-label)',\n  'certain conditions originating in the perinatal period , transitory endocrine and metabolic disorders specific to newborn , other transitory neonatal electrolyte and metabolic disturbances , disturbances of sodium balance of newborn , hypernatremia of newborn',\n  0.3195542426418722],\n ['Erosive Esophagitis Associated With GERD',\n  'diseases of the digestive system , diseases of esophagus, stomach and duodenum , esophagitis , eosinophilic esophagitis',\n  0.6643882793138268],\n ['Zollinger-Ellison Syndrome',\n  'congenital malformations, deformations and chromosomal abnormalities , other congenital malformations , phakomatoses, not elsewhere classified , other phakomatoses, not elsewhere classified , von hippel-lindau syndrome',\n  0.48138463113346386],\n ['Peptic Ulcer Disease (Off-label)',\n  'diseases of the digestive system , diseases of esophagus, stomach and duodenum , peptic ulcer, site unspecified , acute peptic ulcer, site unspecified, with perforation',\n  0.6763253025165873],\n ['Kidney Transplantation',\n  'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , complications of transplanted organs and tissue , complications of kidney transplant , unspecified complication of kidney transplant',\n  0.5601403810490941],\n ['Lupus Nephritis (Off-label)',\n  'diseases of the musculoskeletal system and connective tissue , systemic connective tissue disorders , systemic lupus erythematosus sle , systemic lupus erythematosus with organ or system involvement , tubulo-interstitial nephropathy in systemic lupus erythematosus',\n  0.602578764122947],\n ['Crohn Disease (Off-label)',\n  'diseases of the digestive system , noninfective enteritis and colitis , crohns disease regional enteritis , crohns disease, unspecified , without complications',\n  0.608498661566003],\n ['Ulcerative Colitis (Off-label)',\n  'diseases of the digestive system , noninfective enteritis and colitis , ulcerative colitis , ulcerative colitis, unspecified , without complications',\n  0.5712476320521636],\n ['Chronic Refractory Thrombocytopenic Purpura (Off-label)',\n  'diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism , coagulation defects, purpura and other hemorrhagic conditions , purpura and other hemorrhagic conditions , other primary thrombocytopenia , other primary thrombocytopenia',\n  0.5679215301017487],\n ['Transplantation (Off-label)',\n  'neoplasms , malignant neoplasms of ill-defined, other secondary and unspecified sites , malignant neoplasm without specification of site , malignant neoplasm associated with transplanted organ',\n  0.3548700582388277],\n ['Acute Lymphoblastic Leukemia',\n  'neoplasms , malignant neoplasms of lymphoid, hematopoietic and related tissue , lymphoid leukemia , acute lymphoblastic leukemia all , acute lymphoblastic leukemia, in remission',\n  0.7158015508072656],\n ['Non-Hodgkin Lymphoma',\n  'neoplasms , malignant neoplasms of lymphoid, hematopoietic and related tissue , other specified and unspecified types of non-hodgkin lymphoma , other specified types of non-hodgkin lymphoma , intrapelvic lymph nodes',\n  0.6211998404105483],\n ['Osteosarcoma',\n  'diseases of the musculoskeletal system and connective tissue , other osteopathies , osteopathies in diseases classified elsewhere , osteitis deformans in neoplastic diseases , unspecified site',\n  0.561490249214686],\n ['Breast Cancer',\n  'neoplasms , malignant neoplasms of breast , malignant neoplasm of breast , malignant neoplasm of breast of unspecified site , malignant neoplasm of breast of unspecified site, female , malignant neoplasm of unspecified site of unspecified female breast',\n  0.5995671412612964],\n ['Squamous Cell Carcinoma of the Head and Neck',\n  'neoplasms , malignant neoplasms of ill-defined, other secondary and unspecified sites , malignant neoplasm of other and ill-defined sites , malignant neoplasm of head, face and neck',\n  0.6538319655087644],\n ['Gestational Trophoblastic Neoplasia',\n  'pregnancy, childbirth and the puerperium , pregnancy with abortive outcome , hydatidiform mole , hydatidiform mole, unspecified',\n  0.5034564622310429],\n ['Ectopic Pregnancy (Off-label)',\n  'pregnancy, childbirth and the puerperium , pregnancy with abortive outcome , ectopic pregnancy , ectopic pregnancy, unspecified , unspecified ectopic pregnancy without intrauterine pregnancy',\n  0.6682587999745756],\n ['Meningeal Leukemia',\n  'neoplasms , neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes , neoplasm of uncertain behavior of meninges , neoplasm of uncertain behavior of meninges, unspecified',\n  0.534048171327083],\n ['Giant Cell Arteritis',\n  'diseases of the musculoskeletal system and connective tissue , systemic connective tissue disorders , other necrotizing vasculopathies , other giant cell arteritis',\n  0.6970072319649073],\n ['Systemic Sclerosis-Associated Interstitial Lung Disease',\n  'diseases of the musculoskeletal system and connective tissue , systemic connective tissue disorders , systemic sclerosis scleroderma , other forms of systemic sclerosis , systemic sclerosis with lung involvement',\n  0.7148781448428063],\n ['Cytokine Release Syndrome',\n  'diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism , certain disorders involving the immune mechanism , other disorders involving the immune mechanism, not elsewhere classified , other specified disorders involving the immune mechanism, not elsewhere classified , cytokine release syndrome , grade 1',\n  0.5767737848238084],\n ['COVID-19',\n  'codes for special purposes , provisional assignment of new diseases of uncertain etiology or emergency use , emergency use of , covid-19',\n  0.5016322819456102],\n ['Systemic Juvenile Idiopathic Arthritis',\n  'diseases of the musculoskeletal system and connective tissue , inflammatory polyarthropathies , juvenile arthritis , juvenile rheumatoid arthritis with systemic onset , unspecified site',\n  0.7760212058227521],\n ['Polyarticular Juvenile Idiopathic Arthritis',\n  'diseases of the musculoskeletal system and connective tissue , inflammatory polyarthropathies , juvenile arthritis , other juvenile arthritis , multiple sites',\n  0.8023430424380388],\n ['Cytokine Release Syndrome (CRS)',\n  'diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism , certain disorders involving the immune mechanism , other disorders involving the immune mechanism, not elsewhere classified , other specified disorders involving the immune mechanism, not elsewhere classified , cytokine release syndrome , grade 1',\n  0.47384056138272007],\n ['COVID-19 (EUA)',\n  'codes for special purposes , provisional assignment of new diseases of uncertain etiology or emergency use , emergency use of , covid-19',\n  0.46851022784216656],\n ['Multiple Sclerosis',\n  'diseases of the nervous system , demyelinating diseases of the central nervous system , multiple sclerosis',\n  0.7493384093627987],\n ['Type 2 Diabetes Mellitus',\n  'endocrine, nutritional and metabolic diseases , diabetes mellitus , type 2 diabetes mellitus , type 2 diabetes mellitus with unspecified complications',\n  0.702638506854811],\n ['Maximum Dose',\n  'injury, poisoning and certain other consequences of external causes , poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of diuretics and other and unspecified drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of antidotes and chelating agents , poisoning by, adverse effect of and underdosing of antidotes and chelating agents , poisoning by antidotes and chelating agents, assault , sequela',\n  0.4049013727784221],\n ['Diabetes Mellitus Type 2',\n  'endocrine, nutritional and metabolic diseases , diabetes mellitus , type 2 diabetes mellitus , type 2 diabetes mellitus with unspecified complications',\n  0.6911361987795583],\n ['Obesity',\n  'endocrine, nutritional and metabolic diseases , overweight, obesity and other hyperalimentation , overweight and obesity , other obesity',\n  0.6271759833126686],\n ['Weight Management',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , general symptoms and signs , symptoms and signs concerning food and fluid intake , underweight',\n  0.4302465070927247],\n ['Type 1 or 2 Diabetes Mellitus',\n  'endocrine, nutritional and metabolic diseases , diabetes mellitus , type 1 diabetes mellitus , type 1 diabetes mellitus with unspecified complications',\n  0.6610745332861868],\n ['Type 1 Diabetes Mellitus',\n  'endocrine, nutritional and metabolic diseases , diabetes mellitus , type 1 diabetes mellitus , type 1 diabetes mellitus with unspecified complications',\n  0.6913454117177733],\n ['Diabetes Mellitus Type I or II ',\n  'endocrine, nutritional and metabolic diseases , diabetes mellitus , type 2 diabetes mellitus , type 2 diabetes mellitus with other specified complications , type 2 diabetes mellitus with other specified complication',\n  0.6282494083444626],\n ['Type 1 Diabetes Mellitus ',\n  'endocrine, nutritional and metabolic diseases , diabetes mellitus , type 1 diabetes mellitus , type 1 diabetes mellitus with unspecified complications',\n  0.6913454117177733],\n ['Type I or II Diabetes Mellitus',\n  'endocrine, nutritional and metabolic diseases , diabetes mellitus , type 2 diabetes mellitus , type 2 diabetes mellitus with unspecified complications',\n  0.6349834718957182],\n ['Chronic Kidney Disease',\n  'diseases of the genitourinary system , acute kidney failure and chronic kidney disease , chronic kidney disease ckd , chronic kidney disease, stage 1',\n  0.7467431670218847],\n ['Primary Hyperparathyroidism (HPT)',\n  'endocrine, nutritional and metabolic diseases , disorders of other endocrine glands , hyperparathyroidism and other disorders of parathyroid gland , primary hyperparathyroidism',\n  0.584808110782902],\n ['Secondary Hyperparathyroidism',\n  'endocrine, nutritional and metabolic diseases , disorders of other endocrine glands , hyperparathyroidism and other disorders of parathyroid gland , secondary hyperparathyroidism, not elsewhere classified',\n  0.7328534084918272],\n ['Parathyroid Carcinoma',\n  'neoplasms , malignant neoplasms of thyroid and other endocrine glands , malignant neoplasm of other endocrine glands and related structures , malignant neoplasm of parathyroid gland',\n  0.6957821380139593],\n ['Allergic Conditions',\n  'diseases of the skin and subcutaneous tissue , dermatitis and eczema , allergic contact dermatitis , allergic contact dermatitis due to other chemical products',\n  0.6182882524166842],\n ['Acute Exacerbations of Multiple Sclerosis',\n  'diseases of the nervous system , demyelinating diseases of the central nervous system , multiple sclerosis',\n  0.6385424910902325],\n ['COVID-19 (Off-label)',\n  'codes for special purposes , provisional assignment of new diseases of uncertain etiology or emergency use , emergency use of , covid-19',\n  0.4553796558044756],\n ['Pneumocystis (carinii) jiroveci Pneumonia in AIDS Patients (Off-label)',\n  'certain infectious and parasitic diseases , protozoal diseases , pneumocystosis',\n  0.6013195116150962],\n ['Acute Spinal Cord Injury (Off-label)',\n  'injury, poisoning and certain other consequences of external causes , injuries to the neck , injury of nerves and spinal cord at neck level , concussion and edema of cervical spinal cord , sequela',\n  0.5495907741625531],\n ['Severe Lupus Nephritis (Off-label)',\n  'diseases of the musculoskeletal system and connective tissue , systemic connective tissue disorders , systemic lupus erythematosus sle , systemic lupus erythematosus with organ or system involvement , tubulo-interstitial nephropathy in systemic lupus erythematosus',\n  0.5705851324315222],\n ['Inflammation',\n  'diseases of the genitourinary system , inflammatory diseases of female pelvic organs , other inflammation of vagina and vulva , other specified inflammation of vagina and vulva , other specified inflammation of vagina and vulva',\n  0.5553314345770901],\n ['Status Asthmaticus',\n  'diseases of the respiratory system , chronic lower respiratory diseases , asthma , other and unspecified asthma , unspecified asthma , with status asthmaticus',\n  0.7431995933198292],\n ['Hyperprolactinemia',\n  'endocrine, nutritional and metabolic diseases , disorders of other endocrine glands , hyperfunction of pituitary gland , hyperprolactinemia',\n  0.5590789926910431],\n ['Postpartum Hemorrhage',\n  'pregnancy, childbirth and the puerperium , complications of labor and delivery , postpartum hemorrhage , other immediate postpartum hemorrhage',\n  0.7724548331522798],\n ['Labor Induction',\n  'pregnancy, childbirth and the puerperium , complications of labor and delivery , failed induction of labor , failed instrumental induction of labor',\n  0.6254644744714879],\n ['Incomplete or Inevitable Abortion',\n  'pregnancy, childbirth and the puerperium , pregnancy with abortive outcome , spontaneous abortion , complete or unspecified spontaneous abortion without complication',\n  0.6749642262907308],\n ['Serum Phosphorus Regulation',\n  'endocrine, nutritional and metabolic diseases , metabolic disorders , disorders of mineral metabolism , disorders of phosphorus metabolism and phosphatases , other disorders of phosphorus metabolism',\n  0.6920035960295465],\n ['Osteoporosis',\n  'diseases of the musculoskeletal system and connective tissue , disorders of bone density and structure , osteoporosis without current pathological fracture , age-related osteoporosis without current pathological fracture',\n  0.684113401113404],\n ['Cervical Ripening',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , abnormal findings on examination of other body fluids, substances and tissues, without diagnosis , abnormal findings in specimens from female genital organs , abnormal cytological findings in specimens from female genital organs , abnormal cytological findings in specimens from cervix uteri , satisfactory cervical smear but lacking transformation zone',\n  0.47402194467726627],\n ['Pregnancy Termination',\n  'pregnancy, childbirth and the puerperium , pregnancy with abortive outcome , failed attempted termination of pregnancy , failed attempted termination of pregnancy with other and unspecified complications , cardiac arrest following failed attempted termination of pregnancy',\n  0.7222194895764574],\n ['Myasthenia Gravis',\n  'diseases of the nervous system , diseases of myoneural junction and muscle , myasthenia gravis and other myoneural disorders , myasthenia gravis , with acute exacerbation',\n  0.6240334292372801],\n ['Reversal of Nondepolarizing Muscle Relaxants',\n  'injury, poisoning and certain other consequences of external causes , poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of agents primarily acting on smooth and skeletal muscles and the respiratory system , poisoning by, adverse effect of and underdosing of skeletal muscle relaxants neuromuscular blocking agents , poisoning by, adverse effect of and underdosing of skeletal muscle relaxants neuromuscular blocking agents , poisoning by skeletal muscle relaxants neuromuscular blocking agents, undetermined , sequela',\n  0.45463736242914154],\n ['Pretreatment for Soman Nerve Gas Exposure',\n  'injury, poisoning and certain other consequences of external causes , poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of anesthetics and therapeutic gases , poisoning by, adverse effect of and underdosing of therapeutic gases , poisoning by, adverse effect of and underdosing of therapeutic gases , poisoning by therapeutic gases, intentional self-harm , initial encounter',\n  0.48410182325765966],\n ['Alzheimer Dementia',\n  'diseases of the nervous system , other degenerative diseases of the nervous system , alzheimers disease , alzheimers disease with late onset',\n  0.6178095815100902],\n ['Parkinson Dementia',\n  'diseases of the nervous system , extrapyramidal and movement disorders , parkinsons disease',\n  0.6050305312256584],\n ['Muscle Spasticity ',\n  'diseases of the musculoskeletal system and connective tissue , disorders of muscles , other disorders of muscle , other specified disorders of muscle , muscle spasm , other muscle spasm',\n  0.7013343653935012],\n ['Panic Disorder',\n  'mental, behavioral and neurodevelopmental disorders , anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders , phobic anxiety disorders , agoraphobia , with panic disorder',\n  0.618473880127383],\n ['Seizure Disorders',\n  'diseases of the nervous system , episodic and paroxysmal disorders , epilepsy and recurrent seizures , other epilepsy and recurrent seizures , lennox-gastaut syndrome , intractable, without status epilepticus',\n  0.6880930875681822],\n ['Essential Tremor (Off-label)',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the nervous and musculoskeletal systems , abnormal involuntary movements , tremor, unspecified',\n  0.6174554300469673],\n ['REM Sleep Behavior Disorder (Off-label)',\n  'diseases of the nervous system , episodic and paroxysmal disorders , sleep disorders , parasomnia , rem sleep behavior disorder',\n  0.6322040783628179],\n ['Burning Mouth Syndrome (Off-label)',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , general symptoms and signs , other general symptoms and signs , dry mouth, unspecified',\n  0.47844484381766883],\n ['Recurrent, Acute, Repetitive Seizures (Orphan)',\n  'diseases of the nervous system , episodic and paroxysmal disorders , epilepsy and recurrent seizures , juvenile myoclonic epilepsy impulsive petit mal , juvenile myoclonic epilepsy, intractable , without status epilepticus',\n  0.6354240736522031],\n ['Anxiety',\n  'mental, behavioral and neurodevelopmental disorders , anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders , phobic anxiety disorders , social phobias , social phobia, unspecified',\n  0.5987565786005519],\n ['Alcohol Withdrawal',\n  'mental, behavioral and neurodevelopmental disorders , mental and behavioral disorders due to psychoactive substance use , alcohol related disorders , alcohol dependence , alcohol dependence with withdrawal , uncomplicated',\n  0.7005114541074744],\n ['Endoscopic Precedures',\n  'external causes of morbidity , misadventures to patients during surgical and medical care , failure of sterile precautions during surgical and medical care , failure of sterile precautions during endoscopic examination',\n  0.4874679435881577],\n ['Preoperative Sedation',\n  'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , failed moderate sedation during procedure , subsequent encounter',\n  0.6701472733303535],\n ['Sedation in the ICU',\n  'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , failed moderate sedation during procedure , sequela',\n  0.6105923325901542],\n ['Muscle Spasm',\n  'diseases of the musculoskeletal system and connective tissue , disorders of muscles , other disorders of muscle , other specified disorders of muscle , muscle spasm , other muscle spasm',\n  0.6977825662900164],\n ['Seizure Disorder',\n  'diseases of the nervous system , episodic and paroxysmal disorders , epilepsy and recurrent seizures , other epilepsy and recurrent seizures , lennox-gastaut syndrome , intractable, without status epilepticus',\n  0.6536481584486475],\n ['Status Epilepticus',\n  'diseases of the nervous system , episodic and paroxysmal disorders , epilepsy and recurrent seizures , absence epileptic syndrome , absence epileptic syndrome, intractable , with status epilepticus',\n  0.6974264608227598],\n ['Cardioversion',\n  'external causes of morbidity , supplementary factors related to causes of morbidity classified elsewhere , activity codes , activities involving other cardiorespiratory exercise , activity, circuit training',\n  0.38601445066343837],\n ['Sedative/Muscle Relaxant',\n  'mental, behavioral and neurodevelopmental disorders , mental and behavioral disorders due to psychoactive substance use , sedative, hypnotic, or anxiolytic related disorders , sedative, hypnotic or anxiolytic-related use, unspecified , sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced mood disorder',\n  0.4459195500450254],\n ['Preoperative Sedation/Anxiolysis With Anterograde Amnesia',\n  'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , failed moderate sedation during procedure , sequela',\n  0.578772753310776],\n ['Sedation of Intubated/Ventilated Patients',\n  'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , failed moderate sedation during procedure , sequela',\n  0.6422758704297096],\n ['Sedation',\n  'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , failed moderate sedation during procedure , sequela',\n  0.6264159547915191],\n ['Anesthesia (Non-neonatal)',\n  'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , unintended awareness under general anesthesia during procedure , sequela',\n  0.603069140985851],\n ['Anesthesia (Neonatal)',\n  'pregnancy, childbirth and the puerperium , other maternal disorders predominantly related to pregnancy , complications of anesthesia during pregnancy , unspecified complication of anesthesia during pregnancy , first trimester',\n  0.6294129167835063],\n ['Preoperative Sedation/Anxiolysis with Anterograde Amnesia',\n  'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , failed moderate sedation during procedure , sequela',\n  0.578772753310776],\n ['Glaucoma',\n  'diseases of the eye and adnexa , glaucoma , glaucoma , other glaucoma , other specified glaucoma',\n  0.6528334574871053],\n ['Acute Altitude Sickness',\n  'injury, poisoning and certain other consequences of external causes , other and unspecified effects of external causes , effects of air pressure and water pressure , other and unspecified effects of high altitude , other effects of high altitude , subsequent encounter',\n  0.6508288037730534],\n ['Seizure',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , general symptoms and signs , convulsions, not elsewhere classified , post traumatic seizures',\n  0.5836796080405172],\n ['Drug-induced Edema',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , general symptoms and signs , edema, not elsewhere classified , edema, unspecified',\n  0.6589251896839309],\n ['Epilepsy',\n  'diseases of the nervous system , episodic and paroxysmal disorders , epilepsy and recurrent seizures , epilepsy, unspecified , epilepsy, unspecified, not intractable , with status epilepticus',\n  0.713341430656229],\n ['Trigeminal Neuralgia',\n  'diseases of the nervous system , nerve, nerve root and plexus disorders , disorders of trigeminal nerve , trigeminal neuralgia',\n  0.7641485699186855],\n ['Bipolar Mania',\n  'mental, behavioral and neurodevelopmental disorders , mood affective disorders , bipolar disorder , bipolar disorder, current episode manic without psychotic features , severe',\n  0.7000081420984756],\n ['Restless Legs Syndrome (Off-label)',\n  'diseases of the nervous system , extrapyramidal and movement disorders , other extrapyramidal and movement disorders , other specified extrapyramidal and movement disorders , restless legs syndrome',\n  0.6041023312425793],\n ['Schizophrenia (Off-label)',\n  'mental, behavioral and neurodevelopmental disorders , schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders , unspecified psychosis not due to a substance or known physiological condition',\n  0.5242506012837038],\n ['Postherpatic Neuralgia',\n  'diseases of the nervous system , other disorders of the nervous system , pain, not elsewhere classified , acute pain, not elsewhere classified , acute post-thoracotomy pain',\n  0.559744391792498],\n ['Partial-Onset or Primary Generalized Tonic-Clonic Seizures',\n  'diseases of the nervous system , episodic and paroxysmal disorders , epilepsy and recurrent seizures , localization-related focal partial symptomatic epilepsy and epileptic syndromes with simple partial seizures , localization-related focal partial symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable , without status epilepticus',\n  0.673429658189103],\n ['Lennox-Gastaut Syndrome',\n  'diseases of the nervous system , episodic and paroxysmal disorders , epilepsy and recurrent seizures , other epilepsy and recurrent seizures , lennox-gastaut syndrome , intractable, with status epilepticus',\n  0.5431959787501262],\n ['Migraine Headache',\n  'diseases of the nervous system , episodic and paroxysmal disorders , migraine , migraine, unspecified , migraine, unspecified, intractable , with status migrainosus',\n  0.6514398534163539],\n ['Cluster Headache (Off-label)',\n  'diseases of the nervous system , episodic and paroxysmal disorders , other headache syndromes , cluster headaches and other trigeminal autonomic cephalgias tac , chronic cluster headache , intractable',\n  0.49226310698868325],\n ['Alcoholism (Off-label)',\n  'mental, behavioral and neurodevelopmental disorders , mental and behavioral disorders due to psychoactive substance use , alcohol related disorders , alcohol use, unspecified , alcohol use, unspecified with withdrawal , uncomplicated',\n  0.5295073770855275],\n ['Partial Onset Seizures',\n  'diseases of the nervous system , episodic and paroxysmal disorders , epilepsy and recurrent seizures , localization-related focal partial symptomatic epilepsy and epileptic syndromes with simple partial seizures , localization-related focal partial symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable , without status epilepticus',\n  0.6644114427526169],\n ['Primary Generalized Tonic-Clonic Seizures ',\n  'diseases of the nervous system , episodic and paroxysmal disorders , epilepsy and recurrent seizures , other generalized epilepsy and epileptic syndromes , other generalized epilepsy and epileptic syndromes, intractable , with status epilepticus',\n  0.6168897127592169],\n ['Partial-Onset Seizures (Conversion to Monotherapy)',\n  'diseases of the nervous system , episodic and paroxysmal disorders , epilepsy and recurrent seizures , localization-related focal partial symptomatic epilepsy and epileptic syndromes with simple partial seizures , localization-related focal partial symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable , with status epilepticus',\n  0.5195852221237651],\n ['Bipolar Disorder',\n  'mental, behavioral and neurodevelopmental disorders , mood affective disorders , bipolar disorder , bipolar disorder, unspecified',\n  0.6922456181293313],\n ['Diabetic Peripheral Neuropathic Pain',\n  'endocrine, nutritional and metabolic diseases , diabetes mellitus , diabetes mellitus due to underlying condition , diabetes mellitus due to underlying condition with neurological complications , diabetes mellitus due to underlying condition with diabetic autonomic polyneuropathy',\n  0.6284465558646599],\n ['Postherpetic Neuralgia',\n  'diseases of the nervous system , other disorders of the nervous system , pain, not elsewhere classified , acute pain, not elsewhere classified , acute post-thoracotomy pain',\n  0.5993357141710594],\n ['Fibromyalgia',\n  'diseases of the musculoskeletal system and connective tissue , other soft tissue disorders , other and unspecified soft tissue disorders, not elsewhere classified , fibromyalgia',\n  0.7254734369843544],\n ['Neuropathic Pain With Spinal Cord Injury',\n  'diseases of the nervous system , other disorders of the nervous system , pain, not elsewhere classified , acute pain, not elsewhere classified , acute pain due to trauma',\n  0.6178243908117534],\n ['Partial Seizures',\n  'diseases of the nervous system , episodic and paroxysmal disorders , epilepsy and recurrent seizures , localization-related focal partial symptomatic epilepsy and epileptic syndromes with simple partial seizures , localization-related focal partial symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable , without status epilepticus',\n  0.6643703968213162],\n ['Bipolar Disorder (Off-label)',\n  'mental, behavioral and neurodevelopmental disorders , mood affective disorders , bipolar disorder , bipolar disorder, currently in remission , most recent episode unspecified',\n  0.6014804268066126],\n ['Diabetic Neuropathy (Off-label)',\n  'endocrine, nutritional and metabolic diseases , diabetes mellitus , drug or chemical induced diabetes mellitus , drug or chemical induced diabetes mellitus with neurological complications , with diabetic neuropathy, unspecified',\n  0.671928766437383],\n ['Neuralgia/Neuropathy (Off-label)',\n  'diseases of the nervous system , other disorders of the nervous system , pain, not elsewhere classified , acute pain, not elsewhere classified , other acute postprocedural pain',\n  0.5565088379865302],\n ['Partial Seizures (Adjunctive Treatment)',\n  'diseases of the nervous system , episodic and paroxysmal disorders , epilepsy and recurrent seizures , localization-related focal partial symptomatic epilepsy and epileptic syndromes with simple partial seizures , localization-related focal partial symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable , with status epilepticus',\n  0.5452385619192573],\n ['Partial Seizures (Monotherapy)',\n  'diseases of the nervous system , episodic and paroxysmal disorders , epilepsy and recurrent seizures , localization-related focal partial symptomatic epilepsy and epileptic syndromes with simple partial seizures , localization-related focal partial symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable , without status epilepticus',\n  0.514301719807022],\n ['Cluster Headache',\n  'diseases of the nervous system , episodic and paroxysmal disorders , other headache syndromes , cluster headaches and other trigeminal autonomic cephalgias tac , chronic cluster headache , intractable',\n  0.6052018501080019],\n ['Parkinson Disease',\n  'diseases of the nervous system , extrapyramidal and movement disorders , parkinsons disease',\n  0.696968131051117],\n ['Restless Legs Syndrome',\n  'diseases of the nervous system , extrapyramidal and movement disorders , other extrapyramidal and movement disorders , other specified extrapyramidal and movement disorders , restless legs syndrome',\n  0.6966921757866193],\n ['Restless legs syndrome (Off-label)',\n  'diseases of the nervous system , extrapyramidal and movement disorders , other extrapyramidal and movement disorders , other specified extrapyramidal and movement disorders , restless legs syndrome',\n  0.6041023312425793],\n ['Cocaine withdrawal (Off-label)',\n  'mental, behavioral and neurodevelopmental disorders , mental and behavioral disorders due to psychoactive substance use , cocaine related disorders , cocaine dependence , with withdrawal',\n  0.623712800774415],\n ['Insomnia (Off-label)',\n  'diseases of the nervous system , episodic and paroxysmal disorders , sleep disorders , insomnia , other insomnia',\n  0.4717616706829935],\n ['Tremors in multiple sclerosis (Off-label)',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the nervous and musculoskeletal systems , abnormal involuntary movements , tremor, unspecified',\n  0.6588413122327005],\n ['Hot flashes-cancer related (Off-label)',\n  'external causes of morbidity , contact with heat and hot substances , contact with hot drinks, food, fats and cooking oils , contact with hot drinks , sequela',\n  0.34556675626992245],\n ['Amyotrophic Lateral Sclerosis (Orphan)',\n  'diseases of the nervous system , systemic atrophies primarily affecting the central nervous system , spinal muscular atrophy and related syndromes , motor neuron disease , amyotrophic lateral sclerosis',\n  0.5734764990596052],\n ['Insomnia (Sleep Onset & Maintenance)',\n  'diseases of the nervous system , episodic and paroxysmal disorders , sleep disorders , insomnia , other insomnia',\n  0.5830948596811565],\n ['Insomnia (Middle of Night Awakening)',\n  'diseases of the nervous system , episodic and paroxysmal disorders , sleep disorders , insomnia , other insomnia',\n  0.5422848036429396],\n ['Insomnia (Sleep Onset & Sleep Maintenance)',\n  'diseases of the nervous system , episodic and paroxysmal disorders , sleep disorders , insomnia , other insomnia',\n  0.5912440039095178],\n ['Myoclonic Seizures',\n  'diseases of the nervous system , episodic and paroxysmal disorders , epilepsy and recurrent seizures , juvenile myoclonic epilepsy impulsive petit mal , juvenile myoclonic epilepsy, intractable , with status epilepticus',\n  0.6720556832468367],\n ['Partial Onset Seizure',\n  'diseases of the nervous system , episodic and paroxysmal disorders , epilepsy and recurrent seizures , localization-related focal partial symptomatic epilepsy and epileptic syndromes with simple partial seizures , localization-related focal partial symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable , without status epilepticus',\n  0.6265816463487563],\n ['Primary Generalized Tonic-Clonic Seizures',\n  'diseases of the nervous system , episodic and paroxysmal disorders , epilepsy and recurrent seizures , other generalized epilepsy and epileptic syndromes , other generalized epilepsy and epileptic syndromes, intractable , with status epilepticus',\n  0.6168897127592169],\n ['Rheumatoid Arthritis, Osteoarthritis, Ankylosing Spondylitis',\n  'diseases of the musculoskeletal system and connective tissue , spondylopathies , ankylosing spondylitis , ankylosing spondylitis of thoracic region',\n  0.767644974197646],\n ['Dysmenorrhea',\n  'diseases of the genitourinary system , noninflammatory disorders of female genital tract , pain and other conditions associated with female genital organs and menstrual cycle , primary dysmenorrhea',\n  0.622006140160788],\n ['Gout, Acute',\n  'diseases of the musculoskeletal system and connective tissue , inflammatory polyarthropathies , gout , gout, unspecified',\n  0.6436459588412432],\n ['Migraine (Off-label)',\n  'diseases of the nervous system , episodic and paroxysmal disorders , migraine , migraine with aura , migraine with aura, intractable , without status migrainosus',\n  0.5225847025623236],\n ['Moderate-to-Severe Pain',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the genitourinary system , pain associated with micturition , painful micturition, unspecified',\n  0.5013567659690313],\n ['Acute Pain or Primary Dysmenorrhea',\n  'diseases of the genitourinary system , noninflammatory disorders of female genital tract , pain and other conditions associated with female genital organs and menstrual cycle , primary dysmenorrhea',\n  0.6319843506275867],\n ['Familial Adenomatous Polyposis (Off-label)',\n  'neoplasms , neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes , neoplasm of uncertain behavior of endocrine glands , neoplasm of uncertain behavior of aortic body and other paraganglia',\n  0.4509006932028433],\n ['Pain Management',\n  'diseases of the nervous system , other disorders of the nervous system , pain, not elsewhere classified , chronic pain, not elsewhere classified , chronic post-thoracotomy pain',\n  0.5495463747320158],\n ['Rheumatoid Arthritis or Osteoarthritis',\n  'diseases of the musculoskeletal system and connective tissue , inflammatory polyarthropathies , other rheumatoid arthritis , rheumatoid arthritis, unspecified',\n  0.7164409797623332],\n ['Acute Pain',\n  'diseases of the nervous system , other disorders of the nervous system , pain, not elsewhere classified , acute pain, not elsewhere classified , acute pain due to trauma',\n  0.6251560837933741],\n ['Primary Dysmenorrhea',\n  'diseases of the genitourinary system , noninflammatory disorders of female genital tract , pain and other conditions associated with female genital organs and menstrual cycle , primary dysmenorrhea',\n  0.6683638525861695],\n ['Acute pain',\n  'diseases of the nervous system , other disorders of the nervous system , pain, not elsewhere classified , acute pain, not elsewhere classified , acute pain due to trauma',\n  0.6251560837933741],\n ['Spasticity',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the nervous and musculoskeletal systems , abnormal involuntary movements , cramp and spasm',\n  0.4942620845690029],\n ['Orphan Indications',\n  'diseases of the genitourinary system , intraoperative and postprocedural complications and disorders of genitourinary system, not elsewhere classified , intraoperative and postprocedural complications and disorders of genitourinary system, not elsewhere classified , accidental puncture and laceration of a genitourinary system organ or structure during a procedure , accidental puncture and laceration of a genitourinary system organ or structure during a genitourinary system procedure',\n  0.45977296846666993],\n ['Attention Deficit Hyperactivity Disorder',\n  'mental, behavioral and neurodevelopmental disorders , behavioral and emotional disorders with onset usually occurring in childhood and adolescence , attention-deficit hyperactivity disorders , attention-deficit hyperactivity disorder, predominantly hyperactive type',\n  0.7333720630453493],\n ['Narcolepsy',\n  'diseases of the nervous system , episodic and paroxysmal disorders , sleep disorders , narcolepsy and cataplexy , narcolepsy , with cataplexy',\n  0.6218050267947173],\n ['Anxiety Associated With Depression',\n  'mental, behavioral and neurodevelopmental disorders , mental disorders due to known physiological conditions , dementia in other diseases classified elsewhere , dementia in other diseases classified elsewhere, severe , with anxiety',\n  0.5563014931606136],\n ['Premenstrual Syndrome (Off-label)',\n  'diseases of the genitourinary system , noninflammatory disorders of female genital tract , pain and other conditions associated with female genital organs and menstrual cycle , premenstrual tension syndrome',\n  0.4847436838188749],\n ['Depression',\n  'mental, behavioral and neurodevelopmental disorders , mood affective disorders , depressive episode , depression, unspecified',\n  0.5479845351356714],\n ['Post-traumatic Stress Disorder (Off-label)',\n  'mental, behavioral and neurodevelopmental disorders , anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders , reaction to severe stress, and adjustment disorders , post-traumatic stress disorder ptsd , post-traumatic stress disorder, unspecified',\n  0.6286279332840853],\n ['Hot Flashes (Off-label)',\n  'external causes of morbidity , contact with heat and hot substances , contact with hot drinks, food, fats and cooking oils , contact with hot drinks , subsequent encounter',\n  0.34866320498348563],\n ['Major Depressive Disorder',\n  'mental, behavioral and neurodevelopmental disorders , mood affective disorders , major depressive disorder, recurrent , major depressive disorder, recurrent, unspecified',\n  0.6694929879975056],\n ['Generalized Anxiety Disorder',\n  'mental, behavioral and neurodevelopmental disorders , anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders , other anxiety disorders , generalized anxiety disorder',\n  0.6681982472035856],\n ['Chronic Musculoskeletal Pain',\n  'diseases of the musculoskeletal system and connective tissue , other joint disorders , other joint disorder, not elsewhere classified , pain in joint , pain in unspecified joint',\n  0.6609322924952639],\n ['Obsessive-Compulsive Disorder',\n  'mental, behavioral and neurodevelopmental disorders , anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders , obsessive-compulsive disorder , mixed obsessional thoughts and acts',\n  0.6761303827681255],\n ['Social Phobia',\n  'mental, behavioral and neurodevelopmental disorders , anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders , phobic anxiety disorders , social phobias , social phobia, generalized',\n  0.7083949912037699],\n ['Posttraumatic Stress Disorder',\n  'mental, behavioral and neurodevelopmental disorders , anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders , reaction to severe stress, and adjustment disorders , post-traumatic stress disorder ptsd , post-traumatic stress disorder, unspecified',\n  0.6832184915619786],\n ['Premenstrual Dysphoric Disorder',\n  'mental, behavioral and neurodevelopmental disorders , mood affective disorders , depressive episode , other depressive episodes , premenstrual dysphoric disorder',\n  0.6687770711498284],\n ['Menopausal Vasomotor Symptoms',\n  'diseases of the genitourinary system , noninflammatory disorders of female genital tract , menopausal and other perimenopausal disorders , postmenopausal atrophic vaginitis',\n  0.5203941208142565],\n ['Stuttering (Off-label)',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving speech and voice , speech disturbances, not elsewhere classified , other speech disturbances , fluency disorder in conditions classified elsewhere',\n  0.28282095984433653],\n ['Vasovagal Syncope (Off-label)',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , general symptoms and signs , syncope and collapse',\n  0.3811496354845654],\n ['Binge-eating Disorder (Off-label)',\n  'mental, behavioral and neurodevelopmental disorders , behavioral syndromes associated with physiological disturbances and physical factors , eating disorders , other eating disorders , binge eating disorder',\n  0.4708910396912677],\n ['Generalized Anxiety Disorder (Off-label)',\n  'mental, behavioral and neurodevelopmental disorders , anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders , other anxiety disorders , panic disorder episodic paroxysmal anxiety',\n  0.5994594358525038],\n ['Obsessive-Compulsive Disorder (Off-label)',\n  'mental, behavioral and neurodevelopmental disorders , anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders , obsessive-compulsive disorder , mixed obsessional thoughts and acts',\n  0.6143763193373591],\n ['Premenstrual Dysphoric Disorder (Off-label)',\n  'mental, behavioral and neurodevelopmental disorders , mood affective disorders , depressive episode , other depressive episodes , premenstrual dysphoric disorder',\n  0.6530460998423622],\n ['Depression (Off-label)',\n  'mental, behavioral and neurodevelopmental disorders , mood affective disorders , depressive episode , depression, unspecified',\n  0.4818919703971566],\n ['Impulsive Aggresive Behavior (Off-label)',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving cognition, perception, emotional state and behavior , symptoms and signs involving emotional state , other symptoms and signs involving emotional state , impulsiveness',\n  0.36496240246877276],\n ['Depression Associated with Bipolar I Disorder ',\n  'mental, behavioral and neurodevelopmental disorders , mood affective disorders , bipolar disorder , bipolar disorder, currently in remission , bipolar disorder, in full remission, most recent episode depressed',\n  0.638400949241672],\n ['Bulimia Nervosa',\n  'mental, behavioral and neurodevelopmental disorders , behavioral syndromes associated with physiological disturbances and physical factors , eating disorders , bulimia nervosa',\n  0.6666128576376543],\n ['Depression Associated with Bipolar I Disorder',\n  'mental, behavioral and neurodevelopmental disorders , mood affective disorders , bipolar disorder , bipolar disorder, currently in remission , bipolar disorder, in full remission, most recent episode depressed',\n  0.638400949241672],\n ['Dosage Forms Strengths',\n  'external causes of morbidity , misadventures to patients during surgical and medical care , failure in dosage during surgical and medical care , failure in dosage during unspecified surgical and medical care',\n  0.42029068900310146],\n ['Major depressive disorder',\n  'mental, behavioral and neurodevelopmental disorders , mood affective disorders , major depressive disorder, recurrent , major depressive disorder, recurrent, unspecified',\n  0.6694929879975056],\n ['Social Anxiety Disorder',\n  'mental, behavioral and neurodevelopmental disorders , anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders , phobic anxiety disorders , social phobias , social phobia, unspecified',\n  0.6867464546757036],\n ['Schizophrenia',\n  'mental, behavioral and neurodevelopmental disorders , schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders , unspecified psychosis not due to a substance or known physiological condition',\n  0.6525001124370385],\n ['Dosage Modifications (Oral)',\n  'injury, poisoning and certain other consequences of external causes , poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinorlaryngological and dental drugs , poisoning by, adverse effect of and underdosing of dental drugs, topically applied , poisoning by, adverse effect of and underdosing of dental drugs, topically applied , adverse effect of dental drugs, topically applied , sequela',\n  0.4440568755137045],\n ['Dosage Modifications (Abilify Maintena)',\n  'injury, poisoning and certain other consequences of external causes , poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of hormones and their synthetic substitutes and antagonists, not elsewhere classified , poisoning by, adverse effect of and underdosing of other and unspecified hormones and synthetic substitutes , poisoning by, adverse effect of and underdosing of unspecified hormones and synthetic substitutes , adverse effect of unspecified hormones and synthetic substitutes , sequela',\n  0.366381463408274],\n ['Dosage Modifications (Aristada)',\n  'injury, poisoning and certain other consequences of external causes , poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of agents primarily affecting the gastrointestinal system , poisoning by, adverse effect of and underdosing of other antacids and anti-gastric-secretion drugs , poisoning by, adverse effect of and underdosing of other antacids and anti-gastric-secretion drugs , poisoning by other antacids and anti-gastric-secretion drugs, undetermined , sequela',\n  0.43875676660845514],\n ['Dosage Modifications (Abilify Asimtufii)',\n  'injury, poisoning and certain other consequences of external causes , poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of nonopioid analgesics, antipyretics and antirheumatics , poisoning by, adverse effect of and underdosing of salicylates , poisoning by, adverse effect of and underdosing of aspirin , adverse effect of aspirin , sequela',\n  0.4519695580323973],\n ['Autism',\n  'mental, behavioral and neurodevelopmental disorders , pervasive and specific developmental disorders , pervasive developmental disorders , autistic disorder',\n  0.6153416509249702],\n ['Tourette Disorder',\n  'mental, behavioral and neurodevelopmental disorders , behavioral and emotional disorders with onset usually occurring in childhood and adolescence , tic disorder , tourettes disorder',\n  0.7071535787131572],\n ['Bipolar Depression',\n  'mental, behavioral and neurodevelopmental disorders , mood affective disorders , bipolar disorder , bipolar disorder, currently in remission , bipolar disorder, in full remission, most recent episode depressed',\n  0.6840402334553976],\n ['Chemotherapy Associated Nausea or Vomiting (Off-label)',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the digestive system and abdomen , nausea and vomiting , vomiting , without nausea',\n  0.5600552933626436],\n ['Bipolar I Disorder (Manic or Mixed Episodes) ',\n  'mental, behavioral and neurodevelopmental disorders , mood affective disorders , bipolar disorder , bipolar disorder, current episode mixed , severe, without psychotic features',\n  0.7445765986951068],\n ['Schizophrenia or Bipolar-Related Agitation',\n  'mental, behavioral and neurodevelopmental disorders , mood affective disorders , manic episode , manic episode, severe with psychotic symptoms',\n  0.6166552796655268],\n ['Tourette Syndrome (Off-label)',\n  'mental, behavioral and neurodevelopmental disorders , behavioral and emotional disorders with onset usually occurring in childhood and adolescence , tic disorder , tourettes disorder',\n  0.6216553834021923],\n ['Posttraumatic Stress Disorder (Off-label)',\n  'mental, behavioral and neurodevelopmental disorders , anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders , reaction to severe stress, and adjustment disorders , post-traumatic stress disorder ptsd , post-traumatic stress disorder, unspecified',\n  0.6286279332840853],\n ['Schizophrenia, Bipolar Mania',\n  'mental, behavioral and neurodevelopmental disorders , mood affective disorders , bipolar disorder , bipolar disorder, current episode manic severe with psychotic features',\n  0.7093026834403987],\n ['Psychosis, Agitation Related to Alzheimer Dementia (Off-label) ',\n  'mental, behavioral and neurodevelopmental disorders , mental disorders due to known physiological conditions , unspecified dementia , unspecified dementia, moderate , unspecified dementia, moderate, with behavioral disturbance , unspecified dementia, moderate, with agitation',\n  0.6459341620623416],\n ['Bipolar I Disorder, Mania',\n  'mental, behavioral and neurodevelopmental disorders , mood affective disorders , bipolar disorder , bipolar disorder, current episode manic severe with psychotic features',\n  0.6931230411455208],\n ['Bipolar Disorder, Depressive Episodes',\n  'mental, behavioral and neurodevelopmental disorders , mood affective disorders , bipolar disorder , bipolar disorder, current episode depressed, severe, without psychotic features',\n  0.7621696007053727],\n ['Bipolar I Disorder, Maintenance',\n  'mental, behavioral and neurodevelopmental disorders , mood affective disorders , bipolar disorder , bipolar disorder, currently in remission , most recent episode unspecified',\n  0.6439788800923446],\n ['Alcohol Dependence (Off-label)',\n  'mental, behavioral and neurodevelopmental disorders , mental and behavioral disorders due to psychoactive substance use , alcohol related disorders , alcohol dependence , alcohol dependence with withdrawal , with perceptual disturbance',\n  0.575123109627885],\n ['Schizophrenia, Bipolar Disorder',\n  'mental, behavioral and neurodevelopmental disorders , schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders , schizoaffective disorders , schizoaffective disorder, bipolar type',\n  0.695236807155102],\n ['Psychosis, Agitation Related to Alzheimer Dementia (Off-label)',\n  'mental, behavioral and neurodevelopmental disorders , mental disorders due to known physiological conditions , unspecified dementia , unspecified dementia, moderate , unspecified dementia, moderate, with behavioral disturbance , unspecified dementia, moderate, with agitation',\n  0.6459341620623416],\n ['Schizophrenia, Psychosis',\n  'mental, behavioral and neurodevelopmental disorders , schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders , unspecified psychosis not due to a substance or known physiological condition',\n  0.6951292543298905],\n ['Schizophrenia, Psychosis/Sedation',\n  'mental, behavioral and neurodevelopmental disorders , schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders , unspecified psychosis not due to a substance or known physiological condition',\n  0.6557397423116603],\n ['Behavioral Disorders',\n  'mental, behavioral and neurodevelopmental disorders , behavioral syndromes associated with physiological disturbances and physical factors , psychological and behavioral factors associated with disorders or diseases classified elsewhere',\n  0.7243571084973248],\n ['Acute Agitation',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving cognition, perception, emotional state and behavior , symptoms and signs involving emotional state , restlessness and agitation',\n  0.5322732952860377],\n ['Non Psychotic Anxiety',\n  'mental, behavioral and neurodevelopmental disorders , schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders , unspecified psychosis not due to a substance or known physiological condition',\n  0.5968549248730982],\n ['Schizophrenia/Psychosis ',\n  'mental, behavioral and neurodevelopmental disorders , schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders , unspecified psychosis not due to a substance or known physiological condition',\n  0.7033191169005963],\n ['Schizoaffective Disorder',\n  'mental, behavioral and neurodevelopmental disorders , schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders , schizoaffective disorders , schizoaffective disorder, unspecified',\n  0.7133494627634815],\n ['Respiratory Distress Syndrome',\n  'diseases of the respiratory system , other respiratory diseases principally affecting the interstitium , acute respiratory distress syndrome',\n  0.694740403330364],\n ['Erectile Dysfunction',\n  'diseases of the genitourinary system , diseases of male genital organs , male erectile dysfunction , drug-induced erectile dysfunction',\n  0.6907445939065252],\n ['Benign Prostatic Hyperplasia',\n  'diseases of the genitourinary system , diseases of male genital organs , benign prostatic hyperplasia , benign prostatic hyperplasia with lower urinary tract symptoms',\n  0.7480303729061745],\n ['Pulmonary Arterial Hypertension',\n  'diseases of the circulatory system , pulmonary heart disease and diseases of pulmonary circulation , other pulmonary heart diseases , other secondary pulmonary hypertension , chronic thromboembolic pulmonary hypertension',\n  0.6697142473821439],\n ['Acute Bronchospasm',\n  'diseases of the respiratory system , other diseases of the respiratory system , other respiratory disorders , diseases of bronchus, not elsewhere classified , acute bronchospasm',\n  0.7063471445057428],\n ['Bronchospasm',\n  'diseases of the respiratory system , other diseases of the respiratory system , other respiratory disorders , diseases of bronchus, not elsewhere classified , acute bronchospasm',\n  0.6506355685616334],\n ['Neonatal Apnea',\n  'certain conditions originating in the perinatal period , respiratory and cardiovascular disorders specific to the perinatal period , other respiratory conditions originating in the perinatal period , other apnea of newborn , mixed neonatal apnea of newborn',\n  0.7268648429704037],\n ['Pulmonary Disease',\n  'diseases of the circulatory system , pulmonary heart disease and diseases of pulmonary circulation , other pulmonary heart diseases , pulmonary heart disease, unspecified',\n  0.7034021046870558],\n ['Diagnostic Bronchography',\n  'diseases of the respiratory system , chronic lower respiratory diseases , unspecified chronic bronchitis',\n  0.6386093169394901],\n ['Contrast Agent-Associated Nephrotoxicity (Off-label)',\n  'diseases of the genitourinary system , renal tubulo-interstitial diseases , drug- and heavy-metal-induced tubulo-interstitial and tubular conditions , nephropathy induced by other drugs, medicaments and biological substances , contrast-induced nephropathy',\n  0.4648329208559992],\n ['Keratoconjunctivitis Sicca (Off-label)',\n  'diseases of the eye and adnexa , disorders of sclera, cornea, iris and ciliary body , keratitis , keratoconjunctivitis , keratoconjunctivitis sicca, not specified as sjögrens , bilateral',\n  0.6150694633061693],\n ['Idiopathic Pulmonary Fibrosis',\n  'diseases of the respiratory system , other respiratory diseases principally affecting the interstitium , other interstitial pulmonary diseases , other interstitial pulmonary diseases with fibrosis , other interstitial pulmonary diseases with fibrosis in diseases classified elsewhere , interstitial lung disease with progressive fibrotic phenotype in diseases classified elsewhere',\n  0.6423326729280686],\n ['Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype',\n  'diseases of the respiratory system , other respiratory diseases principally affecting the interstitium , other interstitial pulmonary diseases , other interstitial pulmonary diseases with fibrosis , other interstitial pulmonary diseases with fibrosis in diseases classified elsewhere , interstitial lung disease with progressive fibrotic phenotype in diseases classified elsewhere',\n  0.7569085406475992],\n ['Systemic Sclerosis-associated Interstitial Lung Disease',\n  'diseases of the musculoskeletal system and connective tissue , systemic connective tissue disorders , systemic sclerosis scleroderma , other forms of systemic sclerosis , systemic sclerosis with lung involvement',\n  0.7148781448428063],\n ['Gout',\n  'diseases of the musculoskeletal system and connective tissue , inflammatory polyarthropathies , gout , other secondary gout , unspecified site',\n  0.6042833298713683],\n ['Antineoplastic-Induced Hyperuricemia',\n  'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , malignant hyperthermia due to anesthesia , sequela',\n  0.4900519911006394],\n ['Hyperuricemia',\n  'endocrine, nutritional and metabolic diseases , metabolic disorders , other disorders of fluid, electrolyte and acid-base balance , hyperosmolality and hypernatremia',\n  0.5254624332053015],\n ['Oral Ulcers associated with Behςet Disease',\n  'diseases of the digestive system , diseases of oral cavity and salivary glands , stomatitis and related lesions , oral mucositis ulcerative , unspecified',\n  0.6091201150423505],\n ['Cardiac Arrest',\n  'diseases of the circulatory system , other forms of heart disease , cardiac arrest , cardiac arrest due to underlying cardiac condition',\n  0.7065530117732068],\n ['Hyperkalemia',\n  'endocrine, nutritional and metabolic diseases , metabolic disorders , other disorders of fluid, electrolyte and acid-base balance , hyperkalemia',\n  0.6572610833098618],\n ['Metabolic Acidosis (Non-Life-Threatening)',\n  'endocrine, nutritional and metabolic diseases , metabolic disorders , other disorders of fluid, electrolyte and acid-base balance , acidosis , acute metabolic acidosis',\n  0.7433569247661758],\n ['Hypokalemia Prophylaxis',\n  'endocrine, nutritional and metabolic diseases , metabolic disorders , other disorders of fluid, electrolyte and acid-base balance , hypokalemia',\n  0.584759793823786],\n ['IV intermittent infusions',\n  'external causes of morbidity , misadventures to patients during surgical and medical care , failure in dosage during surgical and medical care , excessive amount of blood or other fluid given during transfusion or infusion',\n  0.48527610185308906],\n ['Hypokalemia prophylaxis ',\n  'endocrine, nutritional and metabolic diseases , metabolic disorders , other disorders of fluid, electrolyte and acid-base balance , hypokalemia',\n  0.584759793823786],\n ['Cardiac Decompensation',\n  'diseases of the circulatory system , other forms of heart disease , other cardiac arrhythmias , other and unspecified premature depolarization , other premature depolarization',\n  0.5324273340675196],\n ['Low Cardiac Output (Off-label)',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the circulatory and respiratory systems , abnormalities of heart beat , tachycardia, unspecified',\n  0.35096466086594147],\n ['Severe Essential Hypertension',\n  'diseases of the circulatory system , hypertensive diseases , essential primary hypertension',\n  0.6303752701091893],\n ['Hypertension (Chronic)',\n  'diseases of the circulatory system , hypertensive diseases , secondary hypertension , renovascular hypertension',\n  0.6145634467462824],\n ['Hypertensive Crisis',\n  'diseases of the circulatory system , hypertensive diseases , hypertensive crisis , hypertensive crisis, unspecified',\n  0.6772948698339131],\n ['Heart Failure, Afterload Reduction',\n  'diseases of the circulatory system , other and unspecified disorders of the circulatory system , intraoperative and postprocedural complications and disorders of circulatory system, not elsewhere classified , other postprocedural cardiac functional disturbances , postprocedural heart failure , following other surgery',\n  0.5232866229992478],\n ['Chronic Kidney Disease-Associated Anemia',\n  'diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism , aplastic and other anemias and other bone marrow failure syndromes , anemia in chronic diseases classified elsewhere , anemia in chronic kidney disease',\n  0.7987100486077929],\n ['Chemotherapy-Related Anemia with Nonmyeloid Malignancies',\n  'diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism , aplastic and other anemias and other bone marrow failure syndromes , other anemias , other specified anemias , anemia due to antineoplastic chemotherapy',\n  0.7109793683991166],\n ['Myelosuppressive Chemotherapy Treatment',\n  'factors influencing health status and contact with health services , persons with potential health hazards related to family and personal history and certain conditions influencing health status , long term current drug therapy , long term current use of immunomodulators and immunosuppressants , long term current use of myelosuppressive agent',\n  0.5000574270550261],\n ['Induction or Consolidation Chemotherapy',\n  'factors influencing health status and contact with health services , encounters for other specific health care , encounter for other aftercare and medical care , encounter for antineoplastic chemotherapy and immunotherapy , encounter for antineoplastic chemotherapy',\n  0.38625064495974554],\n ['Bone Marrow Transplantation',\n  'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , complications of transplanted organs and tissue , complications of bone marrow transplant , unspecified complication of bone marrow transplant',\n  0.5778567543346528],\n ['Peripheral Blood Progenitor Cell Collection',\n  'diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism , aplastic and other anemias and other bone marrow failure syndromes , anemia in chronic diseases classified elsewhere , anemia in neoplastic disease',\n  0.3675954631756319],\n ['Acute Radiation Syndrome',\n  'injury, poisoning and certain other consequences of external causes , other and unspecified effects of external causes , radiation sickness, unspecified , radiation sickness, unspecified, initial encounter',\n  0.6517141864970821],\n ['Autologous Peripheral Blood Progenitor Cell Collection and Therapy',\n  'neoplasms , malignant neoplasms of lymphoid, hematopoietic and related tissue , multiple myeloma and malignant plasma cell neoplasms , solitary plasmacytoma , not having achieved remission',\n  0.37875003403729957],\n ['Patients with Cancer Undergoing Bone Marrow Transplantation',\n  'factors influencing health status and contact with health services , encounters for other specific health care , donors of organs and tissues , bone marrow donor',\n  0.5352154989085004],\n ['Neutropenia',\n  'diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism , other disorders of blood and blood-forming organs , neutropenia , neutropenia, unspecified',\n  0.7178616189410192],\n ['Intermittent Claudication',\n  'diseases of the circulatory system , diseases of arteries, arterioles and capillaries , atherosclerosis , atherosclerosis of native arteries of the extremities , atherosclerosis of native arteries of extremities with intermittent claudication , bilateral legs',\n  0.5122364202511738],\n ['Recommended Daily Allowance (Elemental Iron)',\n  'endocrine, nutritional and metabolic diseases , other nutritional deficiencies , deficiency of other nutrient elements , iron deficiency',\n  0.3737262413585384],\n ['Iron Deficiency Anemia',\n  'diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism , nutritional anemias , iron deficiency anemia , other iron deficiency anemias',\n  0.7706013978597829],\n ['Visipaque 320 ',\n  'diseases of the eye and adnexa , visual disturbances and blindness , visual disturbances , subjective visual disturbances , visual discomfort , unspecified',\n  0.23997414464094793],\n ['Visipaque 270',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the nervous and musculoskeletal systems , other symptoms and signs involving the nervous and musculoskeletal systems , national institutes of health stroke scale nihss score , nihss score 30-39 , nihss score 30',\n  0.22740431916507528],\n ['Intra-arterial administration',\n  'external causes of morbidity , legal intervention, operations of war, military operations, and terrorism , legal intervention , legal intervention, means unspecified , legal intervention, means unspecified, unspecified person injured , sequela',\n  0.36249240644827424],\n ['Intra-arterial administration (IA-DSA)',\n  'factors influencing health status and contact with health services , persons encountering health services for examinations , encounter for administrative examination , encounter for other administrative examinations , encounter for adoption services',\n  0.3647582704106994],\n ['IV administration',\n  'external causes of morbidity , legal intervention, operations of war, military operations, and terrorism , legal intervention , legal intervention, means unspecified , legal intervention, means unspecified, law enforcement official injured , sequela',\n  0.32460575588761414],\n ['Intrathecal',\n  'diseases of the musculoskeletal system and connective tissue , other joint disorders , internal derangement of knee , unspecified internal derangement of knee , unspecified internal derangement of unspecified knee',\n  0.35066492004378713],\n ['Intravascular',\n  'diseases of the circulatory system , cerebrovascular diseases , other and unspecified nontraumatic intracranial hemorrhage , nontraumatic intracranial hemorrhage, unspecified',\n  0.5025149570274756],\n ['CT Scanning of the Body',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , abnormal findings on diagnostic imaging and in function studies, without diagnosis , abnormal findings on diagnostic imaging of other body structures , abnormal findings on diagnostic imaging of other specified body structures , abnormal findings on diagnostic imaging of other specified body structures',\n  0.47568057096213945],\n ['Digital Subtraction',\n  'neoplasms , malignant neoplasms of breast , malignant neoplasm of breast , malignant neoplasm of lower-outer quadrant of breast , malignant neoplasm of lower-outer quadrant of breast, female , malignant neoplasm of lower-outer quadrant of unspecified female breast',\n  0.17142734499772924],\n ['Excretory Urography',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , symptoms and signs involving the genitourinary system , retention of urine , retention of urine, unspecified',\n  0.543917128875089],\n ['Oral',\n  'diseases of the digestive system , diseases of oral cavity and salivary glands , other disorders of teeth and supporting structures , unsatisfactory restoration of tooth , unrepairable overhanging of dental restorative materials',\n  0.44817243436750803],\n ['Intracavity',\n  'injury, poisoning and certain other consequences of external causes , other and unspecified effects of external causes , other and unspecified effects of other external causes , other specified effects of external causes , effects of abnormal gravitation g forces , sequela',\n  0.3162721627933037],\n ['Body Imaging',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , abnormal findings on diagnostic imaging and in function studies, without diagnosis , abnormal findings on diagnostic imaging of other body structures , diagnostic imaging inconclusive due to excess body fat of patient',\n  0.5165599416195341],\n ['Hypocalcemia, Emergency Treatment',\n  'injury, poisoning and certain other consequences of external causes , complications of surgical and medical care, not elsewhere classified , other complications of surgical and medical care, not elsewhere classified , other complications of anesthesia , hypothermia following anesthesia , sequela',\n  0.5103988351687937],\n ['Arrhythmias, Emergent',\n  'diseases of the circulatory system , other forms of heart disease , paroxysmal tachycardia , re-entry ventricular arrhythmia',\n  0.5665191040786018],\n ['Hypermagnesemia',\n  'endocrine, nutritional and metabolic diseases , metabolic disorders , disorders of mineral metabolism , disorders of magnesium metabolism , hypermagnesemia',\n  0.5930110727235487],\n ['Calcium Channel Blocker Overdose',\n  'injury, poisoning and certain other consequences of external causes , poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system , poisoning by, adverse effect of and underdosing of calcium-channel blockers , poisoning by, adverse effect of and underdosing of calcium-channel blockers , poisoning by calcium-channel blockers, undetermined , initial encounter',\n  0.7166754623292605],\n ['Beta-blocker Overdose, Refractory to Glucagon & High Dose Vasopressor',\n  'injury, poisoning and certain other consequences of external causes , poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of drugs primarily affecting the autonomic nervous system , poisoning by, adverse effect of and underdosing of beta-adrenoreceptor antagonists , poisoning by, adverse effect of and underdosing of beta-adrenoreceptor antagonists , adverse effect of beta-adrenoreceptor antagonists , sequela',\n  0.4735871198901394],\n ['Hypocalcemic Tetany',\n  'endocrine, nutritional and metabolic diseases , metabolic disorders , other disorders of fluid, electrolyte and acid-base balance , hypo-osmolality and hyponatremia',\n  0.4415889795104692],\n ['Hypocalcemia',\n  'endocrine, nutritional and metabolic diseases , metabolic disorders , other disorders of fluid, electrolyte and acid-base balance , hypo-osmolality and hyponatremia',\n  0.5853640455464768],\n ['Cardiac Arrest (Off-label)',\n  'diseases of the circulatory system , other forms of heart disease , cardiac arrest , cardiac arrest, cause unspecified',\n  0.5612026622467434],\n ['Hydrofluoric Acid Burn (Off-label)',\n  'injury, poisoning and certain other consequences of external causes , toxic effects of substances chiefly nonmedicinal as to source , toxic effect of other gases, fumes and vapors , toxic effect of fluorine gas and hydrogen fluoride , toxic effect of fluorine gas and hydrogen fluoride , toxic effect of fluorine gas and hydrogen fluoride, accidental unintentional , subsequent encounter',\n  0.2897122229658777],\n ['Calcium Channel Blocker Overdose (Off-label)',\n  'injury, poisoning and certain other consequences of external causes , poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system , poisoning by, adverse effect of and underdosing of calcium-channel blockers , poisoning by, adverse effect of and underdosing of calcium-channel blockers , poisoning by calcium-channel blockers, undetermined , initial encounter',\n  0.640458619315117],\n ['Hyperkalemia (Off-label)',\n  'endocrine, nutritional and metabolic diseases , metabolic disorders , other disorders of fluid, electrolyte and acid-base balance , hyperkalemia',\n  0.5619917158718347],\n ['Hypermagnesemia (Off-label)',\n  'endocrine, nutritional and metabolic diseases , metabolic disorders , disorders of mineral metabolism , disorders of magnesium metabolism , hypermagnesemia',\n  0.5483104027434755],\n ['RDA',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , abnormal tumor markers , abnormal tumor markers , elevated prostate specific antigen psa , rising psa following treatment for malignant neoplasm of prostate',\n  0.23478997809217134],\n ['Urinary Acidification',\n  'endocrine, nutritional and metabolic diseases , metabolic disorders , other disorders of amino-acid metabolism , disorders of urea cycle metabolism , arginosuccinic aciduria',\n  0.48213589353262565],\n ['Ascorbic Acid Deficiency (Scurvy)',\n  'endocrine, nutritional and metabolic diseases , other nutritional deficiencies , ascorbic acid deficiency',\n  0.6485286816768794],\n ['Macular Degeneration (Off-label)',\n  'diseases of the eye and adnexa , disorders of choroid and retina , other retinal disorders , degeneration of macula and posterior pole , nonexudative age-related macular degeneration , nonexudative age-related macular degeneration, bilateral , advanced atrophic without subfoveal involvement',\n  0.5886182325650162],\n ['Neural Tube Defects Prophylaxis',\n  'external causes of morbidity , misadventures to patients during surgical and medical care , other misadventures during surgical and medical care , endotracheal tube wrongly placed during anesthetic procedure',\n  0.5057553573437964],\n ['Folic Acid Deficiency',\n  'diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism , nutritional anemias , folate deficiency anemia , dietary folate deficiency anemia',\n  0.6910450564556077],\n ['Methanol Toxicity',\n  'injury, poisoning and certain other consequences of external causes , toxic effects of substances chiefly nonmedicinal as to source , toxic effect of alcohol , toxic effect of methanol , toxic effect of methanol , toxic effect of methanol, undetermined , sequela',\n  0.7943522362805838],\n ['Methotrexate Toxicity Prophylaxis (Off-label)',\n  'injury, poisoning and certain other consequences of external causes , poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances , poisoning by, adverse effect of and underdosing of narcotics and psychodysleptics hallucinogens , poisoning by, adverse effect of and underdosing of methadone , poisoning by, adverse effect of and underdosing of methadone , adverse effect of methadone , sequela',\n  0.42627430814462197],\n ['Advanced Ovarian Carcinoma',\n  'neoplasms , malignant neoplasms of female genital organs , malignant neoplasm of ovary , malignant neoplasm of bilateral ovaries',\n  0.6458383231137834],\n ['Metastatic Testicular Tumors',\n  'neoplasms , malignant neoplasms of male genital organs , malignant neoplasm of testis , malignant neoplasm of undescended testis , malignant neoplasm of undescended left testis',\n  0.6562473300426735],\n ['Advanced Bladder Cancer',\n  'neoplasms , malignant neoplasms of urinary tract , malignant neoplasm of bladder , malignant neoplasm of anterior wall of bladder',\n  0.6698103463482161],\n ['Metastatic Ovarian Carcinoma',\n  'neoplasms , malignant neoplasms of female genital organs , malignant neoplasm of ovary , malignant neoplasm of bilateral ovaries',\n  0.6536093886214558],\n ['Cancers (Off-label)',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , abnormal tumor markers , abnormal tumor markers , other abnormal tumor markers',\n  0.498835710270362],\n ['Osteogenic Sarcoma/Neuroblastoma (Off-label)',\n  'neoplasms , secondary neuroendocrine tumors , secondary neuroendocrine tumors , secondary carcinoid tumors , of bone',\n  0.43383999691416486],\n ['Brain Tumors, Recurrent (Off-label)',\n  'neoplasms , malignant neoplasms of ill-defined, other secondary and unspecified sites , secondary malignant neoplasm of other and unspecified sites , secondary malignant neoplasm of brain and cerebral meninges , secondary malignant neoplasm of brain',\n  0.5611564067515105],\n ['Malignant Diseases',\n  'neoplasms , malignant neoplasms of ill-defined, other secondary and unspecified sites , malignant neoplasm without specification of site , disseminated malignant neoplasm, unspecified',\n  0.5556523355738056],\n ['Nephrotic Syndrome',\n  'diseases of the genitourinary system , glomerular diseases , nephrotic syndrome , nephrotic syndrome with other morphologic changes',\n  0.7813387381257315],\n ['Non-Hodgkin Lymphoma ',\n  'neoplasms , malignant neoplasms of lymphoid, hematopoietic and related tissue , other specified and unspecified types of non-hodgkin lymphoma , other specified types of non-hodgkin lymphoma , intrapelvic lymph nodes',\n  0.6211998404105483],\n ['Juvenile Idiopathic Arthritis/Vasculitis (Off-label)',\n  'diseases of the musculoskeletal system and connective tissue , inflammatory polyarthropathies , juvenile arthritis , juvenile rheumatoid arthritis with systemic onset , unspecified site',\n  0.6972722280809247],\n ['Lupus Nephritis (Off-Label)',\n  'diseases of the musculoskeletal system and connective tissue , systemic connective tissue disorders , systemic lupus erythematosus sle , systemic lupus erythematosus with organ or system involvement , tubulo-interstitial nephropathy in systemic lupus erythematosus',\n  0.602578764122947],\n ['Juvenile Idiopathic Arthritis/Vasculitis',\n  'diseases of the musculoskeletal system and connective tissue , inflammatory polyarthropathies , juvenile arthritis , juvenile rheumatoid arthritis with systemic onset , unspecified site',\n  0.7239502538685436],\n ['Systemic Lupus Erythematosus',\n  'diseases of the musculoskeletal system and connective tissue , systemic connective tissue disorders , systemic lupus erythematosus sle , other forms of systemic lupus erythematosus',\n  0.7541405024135127],\n ['Breast Cancer Prevention (Off-label)',\n  'factors influencing health status and contact with health services , genetic carrier and genetic susceptibility to disease , genetic susceptibility to disease , genetic susceptibility to malignant neoplasm , of breast',\n  0.5137977582601945],\n ['Ovarian Epithelial Cancer (Off-label)',\n  'neoplasms , malignant neoplasms of ill-defined, other secondary and unspecified sites , secondary malignant neoplasm of other and unspecified sites , secondary malignant neoplasm of ovary , secondary malignant neoplasm of bilateral ovaries',\n  0.6498449536028468],\n ['Ductal Carcinoma in Situ',\n  'neoplasms , in situ neoplasms , carcinoma in situ of breast , unspecified type of carcinoma in situ of breast , unspecified type of carcinoma in situ of unspecified breast',\n  0.6596427592548613],\n ['Breast Cancer Prevention',\n  'factors influencing health status and contact with health services , genetic carrier and genetic susceptibility to disease , genetic susceptibility to disease , genetic susceptibility to malignant neoplasm , of breast',\n  0.5362699149237633],\n ['Ovulation Induction (Off-label)',\n  'pregnancy, childbirth and the puerperium , pregnancy with abortive outcome , other abnormal products of conception , other specified abnormal products of conception , inappropriate change in quantitative human chorionic gonadotropin hcg in early pregnancy',\n  0.42458812120268546],\n ['Mastalgia (Off-label)',\n  'diseases of the musculoskeletal system and connective tissue , other soft tissue disorders , other and unspecified soft tissue disorders, not elsewhere classified , myalgia , of mastication muscle',\n  0.5193840758316258],\n ['Advanced Prostate Cancer',\n  'symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified , abnormal tumor markers , abnormal tumor markers , elevated prostate specific antigen psa , elevated prostate specific antigen psa',\n  0.6196499879571782],\n ['Central Precocious Puberty',\n  'endocrine, nutritional and metabolic diseases , disorders of other endocrine glands , disorders of puberty, not elsewhere classified , precocious puberty',\n  0.5909570752573874],\n ['Metastatic Colorectal Cancer',\n  'neoplasms , malignant neoplasms of digestive organs , malignant neoplasm of colon , malignant neoplasm of descending colon',\n  0.565896391733592],\n ['Non-Small Cell Lung Cancer',\n  'neoplasms , malignant neoplasms of ill-defined, other secondary and unspecified sites , secondary malignant neoplasm of respiratory and digestive organs , secondary malignant neoplasm of lung , secondary malignant neoplasm of unspecified lung',\n  0.5151814349772889],\n ['Renal Cell Carcinoma',\n  'neoplasms , malignant neuroendocrine tumors , malignant neuroendocrine tumors , malignant carcinoid tumors , malignant carcinoid tumors of other sites , malignant carcinoid tumor of the kidney',\n  0.6968122920662378],\n ['Ovarian, Fallopian Tube, or Peritoneal Cancer',\n  'diseases of the genitourinary system , noninflammatory disorders of female genital tract , noninflammatory disorders of ovary, fallopian tube and broad ligament , prolapse and hernia of ovary and fallopian tube , prolapse and hernia of right ovary and fallopian tube',\n  0.5942835029798959],\n ['Glioblastoma',\n  'neoplasms , malignant neoplasms of eye, brain and other parts of central nervous system , malignant neoplasm of brain , malignant neoplasm of occipital lobe',\n  0.430641619211111],\n ['Exudative ARMD (Off-label)',\n  'factors influencing health status and contact with health services , encounters for other specific health care , encounter for fitting and adjustment of external prosthetic device , encounter for fitting and adjustment of artificial arm , encounter for fitting and adjustment of partial artificial arm , unspecified arm',\n  0.30584931849762215],\n ['Hepatocellular Carcinoma',\n  'neoplasms , malignant neoplasms of digestive organs , malignant neoplasm of liver and intrahepatic bile ducts , hepatoblastoma',\n  0.6174727710738023],\n ['Orphan Designations',\n  'congenital malformations, deformations and chromosomal abnormalities , other congenital malformations , other congenital malformations, not elsewhere classified , congenital malformation, unspecified',\n  0.41143290585126185],\n ['Myelodysplastic/Myeloproliferative Diseases',\n  'neoplasms , neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes , other neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue , chronic myeloproliferative disease',\n  0.6573744193829861],\n ['Hypereosinophilic Syndrome and/or Chronic Eosinophilic Leukemia',\n  'diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism , other disorders of blood and blood-forming organs , other disorders of white blood cells , eosinophilia , hypereosinophilic syndrome hes , idiopathic hypereosinophilic syndrome ihes',\n  0.689196814784804],\n ['Chronic Myeloid Leukemia Philadelphia-Chromosome-positive',\n  'neoplasms , malignant neoplasms of lymphoid, hematopoietic and related tissue , myeloid leukemia , chronic myeloid leukemia, bcr/abl-positive , in relapse',\n  0.5266864214751059],\n ['Dermatofibrosarcoma Protuberans',\n  'diseases of the skin and subcutaneous tissue , dermatitis and eczema , seborrheic dermatitis , seborrheic infantile dermatitis',\n  0.552073256141716],\n ['Mastocytosis',\n  'congenital malformations, deformations and chromosomal abnormalities , other congenital malformations , other congenital malformations of skin , congenital cutaneous mastocytosis',\n  0.6490237274752277],\n ['Gastrointestinal Stromal Tumors',\n  'neoplasms , malignant neoplasms of mesothelial and soft tissue , malignant neoplasm of other connective and soft tissue , gastrointestinal stromal tumor , of other sites',\n  0.7283954797718981],\n ['Chronic Myeloid Leukemia',\n  'neoplasms , malignant neoplasms of lymphoid, hematopoietic and related tissue , myeloid leukemia , atypical chronic myeloid leukemia, bcr/abl-negative , in relapse',\n  0.6843957581114509],\n ['Mydriasis/Cycloplegia Diaganosis',\n  'certain infectious and parasitic diseases , mycoses , coccidioidomycosis , cutaneous coccidioidomycosis',\n  0.5993079354754315],\n ['Mydriasis/Cycloplegia',\n  'certain infectious and parasitic diseases , other viral diseases , other viral diseases, not elsewhere classified , epidemic myalgia',\n  0.537550459747091],\n ['Ocular Hypertension or Open-Angle Glaucoma',\n  'diseases of the eye and adnexa , glaucoma , glaucoma , open-angle glaucoma , low-tension glaucoma , low-tension glaucoma, unspecified eye , moderate stage',\n  0.7605035980172175],\n ['Elevated Intraocular Pressure',\n  'diseases of the eye and adnexa , glaucoma , glaucoma , glaucoma suspect , ocular hypertension , bilateral',\n  0.5099929150618064],\n ['Hypotrichosis of the Eyelashes',\n  'diseases of the eye and adnexa , disorders of vitreous body and globe , disorders of globe , hypotony of eye , unspecified hypotony of eye',\n  0.45421602707421355],\n ['Ocular Inflammation',\n  'diseases of the eye and adnexa , disorders of choroid and retina , chorioretinal inflammation , focal chorioretinal inflammation , focal chorioretinal inflammation of posterior pole , unspecified eye',\n  0.6763454492752929],\n ['Ocular Inflammation ',\n  'diseases of the eye and adnexa , disorders of choroid and retina , chorioretinal inflammation , focal chorioretinal inflammation , focal chorioretinal inflammation of posterior pole , unspecified eye',\n  0.6763454492752929],\n ['Refraction (Mydriasis)',\n  'diseases of the eye and adnexa , disorders of ocular muscles, binocular movement, accommodation and refraction , disorders of refraction and accommodation , myopia , bilateral',\n  0.5859127309506084],\n ['Funduscopic Exam (Cycloplegia)',\n  'diseases of the eye and adnexa , disorders of ocular muscles, binocular movement, accommodation and refraction , other strabismus , other and unspecified heterotropia , cyclotropia , left eye',\n  0.4561503615646212],\n ['Benign Prostatic Hyperplasia ',\n  'diseases of the genitourinary system , diseases of male genital organs , benign prostatic hyperplasia , benign prostatic hyperplasia with lower urinary tract symptoms',\n  0.7480303729061745],\n ['Androgenic Alopecia (Men Only)',\n  'diseases of the skin and subcutaneous tissue , disorders of skin appendages , androgenic alopecia , other androgenic alopecia',\n  0.6905264308000986],\n ['Female Hirsutism (Off-label)',\n  'diseases of the genitourinary system , inflammatory diseases of female pelvic organs , salpingitis and oophoritis , salpingitis and oophoritis, unspecified , salpingitis, unspecified',\n  0.41619573102292734],\n ['Benign Prostatic Hyperplasia (BPH)',\n  'diseases of the genitourinary system , diseases of male genital organs , benign prostatic hyperplasia , benign prostatic hyperplasia with lower urinary tract symptoms',\n  0.6419908135600085],\n ['Hypertension ',\n  'diseases of the circulatory system , hypertensive diseases , essential primary hypertension',\n  0.5760609641624918]]"
     },
     "execution_count": 77,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "similarities"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T09:48:50.412322Z",
     "start_time": "2024-01-30T09:48:50.311914900Z"
    }
   },
   "id": "376b1817ab7ab299"
  },
  {
   "cell_type": "code",
   "execution_count": 78,
   "outputs": [],
   "source": [
    "drug_data['most_similar_description']=drug_data['medical_condition_h3'].apply(lambda x:sim_dict[x])\n",
    "drug_data['similarity_score']=drug_data['medical_condition_h3'].apply(lambda x:sim_score_dict[x])"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T09:50:04.044111400Z",
     "start_time": "2024-01-30T09:50:03.955300Z"
    }
   },
   "id": "85a3dcbd1c3d94f"
  },
  {
   "cell_type": "code",
   "execution_count": 79,
   "outputs": [
    {
     "data": {
      "text/plain": "                 drug_name  Age Range           medical_condition_h3  \\\nUnnamed: 0                                                             \n367         dimenhydrinate      Adult  Prevention of Motion Sickness   \n367         dimenhydrinate      Adult  Prevention of Motion Sickness   \n367         dimenhydrinate      Adult  Prevention of Motion Sickness   \n368         dimenhydrinate      Adult  Meniere's Disease (Off-label)   \n369         dimenhydrinate      Adult  Meniere's Disease (Off-label)   \n...                    ...        ...                            ...   \n20220           vardenafil      Adult           Erectile Dysfunction   \n20221           vardenafil  Geriatric           Erectile Dysfunction   \n20222           vardenafil  Geriatric           Erectile Dysfunction   \n20223           vardenafil  Geriatric           Erectile Dysfunction   \n20224           vardenafil  Geriatric           Erectile Dysfunction   \n\n           medical_condition_h4 medical_condition_h5  \\\nUnnamed: 0                                             \n367                         NaN                  NaN   \n367                         NaN                  NaN   \n367                         NaN                  NaN   \n368                         NaN                  NaN   \n369                         NaN                  NaN   \n...                         ...                  ...   \n20220                       NaN                  NaN   \n20221                       NaN                  NaN   \n20222                       NaN                  NaN   \n20223                       NaN                  NaN   \n20224                       NaN                  NaN   \n\n                                    dose_title dose  dose_range_start  \\\nUnnamed: 0                                                              \n367                                        NaN  NaN              50.0   \n367                                        NaN  NaN              50.0   \n367                                        NaN  NaN              50.0   \n368                                        NaN  NaN              25.0   \n369                                        NaN   50               NaN   \n...                                        ...  ...               ...   \n20220                                      NaN   10               5.0   \n20221                       Film-coated tablet   10               5.0   \n20222       Orally disintegrating tablet (ODT)   10               NaN   \n20223                       Film-coated tablet  NaN               NaN   \n20224                                      NaN    5               NaN   \n\n            dose_range_end dose_unit_new  ... age_range_end  age_range_unit  \\\nUnnamed: 0                                ...                                 \n367                  100.0            mg  ...           NaN             NaN   \n367                  100.0            mg  ...           NaN             NaN   \n367                  100.0            mg  ...           NaN             NaN   \n368                   50.0            mg  ...           NaN             NaN   \n369                    NaN            mg  ...           NaN             NaN   \n...                    ...           ...  ...           ...             ...   \n20220                 20.0            mg  ...           NaN             NaN   \n20221                 20.0            mg  ...            65           years   \n20222                  NaN            mg  ...            65           years   \n20223                  NaN           NaN  ...           NaN             NaN   \n20224                  NaN            mg  ...           NaN             NaN   \n\n           body_weight_range_start  body_weight_range_end  \\\nUnnamed: 0                                                  \n367                            NaN                    NaN   \n367                            NaN                    NaN   \n367                            NaN                    NaN   \n368                            NaN                    NaN   \n369                            NaN                    NaN   \n...                            ...                    ...   \n20220                          NaN                    NaN   \n20221                          NaN                    NaN   \n20222                          NaN                    NaN   \n20223                          NaN                    NaN   \n20224                          NaN                    NaN   \n\n           body_weight_range_unit  \\\nUnnamed: 0                          \n367                           NaN   \n367                           NaN   \n367                           NaN   \n368                           NaN   \n369                           NaN   \n...                           ...   \n20220                         NaN   \n20221                         NaN   \n20222                         NaN   \n20223                         NaN   \n20224                         NaN   \n\n                                                    reference  \\\nUnnamed: 0                                                      \n367         50-100 mg PO/IV/IM q4-6hr PRN, 30 minutes befo...   \n367         50-100 mg PO/IV/IM q4-6hr PRN, 30 minutes befo...   \n367         50-100 mg PO/IV/IM q4-6hr PRN, 30 minutes befo...   \n368         25-50 mg PO q8hr for maintenance\\n\\n50 mg IM f...   \n369         25-50 mg PO q8hr for maintenance\\n\\n50 mg IM f...   \n...                                                       ...   \n20220       10 mg PO ~1 hour before sexual activity; may b...   \n20221       <65 years\\n\\nFilm-coated tablet: 10 mg PO ~1 h...   \n20222       <65 years\\n\\nFilm-coated tablet: 10 mg PO ~1 h...   \n20223       <65 years\\n\\nFilm-coated tablet: 10 mg PO ~1 h...   \n20224       <65 years\\n\\nFilm-coated tablet: 10 mg PO ~1 h...   \n\n           administration_notes is_medical_diagnosis  \\\nUnnamed: 0                                             \n367                         NaN                 True   \n367                         NaN                 True   \n367                         NaN                 True   \n368                         NaN                 True   \n369                         NaN                 True   \n...                         ...                  ...   \n20220                       NaN                 True   \n20221                       NaN                 True   \n20222                       NaN                 True   \n20223                       NaN                 True   \n20224                       NaN                 True   \n\n                                     most_similar_description similarity_score  \nUnnamed: 0                                                                      \n367         injury, poisoning and certain other consequenc...         0.714263  \n367         injury, poisoning and certain other consequenc...         0.714263  \n367         injury, poisoning and certain other consequenc...         0.714263  \n368         diseases of the ear and mastoid process , dise...         0.745549  \n369         diseases of the ear and mastoid process , dise...         0.745549  \n...                                                       ...              ...  \n20220       diseases of the genitourinary system , disease...         0.690745  \n20221       diseases of the genitourinary system , disease...         0.690745  \n20222       diseases of the genitourinary system , disease...         0.690745  \n20223       diseases of the genitourinary system , disease...         0.690745  \n20224       diseases of the genitourinary system , disease...         0.690745  \n\n[4032 rows x 34 columns]",
      "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>drug_name</th>\n      <th>Age Range</th>\n      <th>medical_condition_h3</th>\n      <th>medical_condition_h4</th>\n      <th>medical_condition_h5</th>\n      <th>dose_title</th>\n      <th>dose</th>\n      <th>dose_range_start</th>\n      <th>dose_range_end</th>\n      <th>dose_unit_new</th>\n      <th>...</th>\n      <th>age_range_end</th>\n      <th>age_range_unit</th>\n      <th>body_weight_range_start</th>\n      <th>body_weight_range_end</th>\n      <th>body_weight_range_unit</th>\n      <th>reference</th>\n      <th>administration_notes</th>\n      <th>is_medical_diagnosis</th>\n      <th>most_similar_description</th>\n      <th>similarity_score</th>\n    </tr>\n    <tr>\n      <th>Unnamed: 0</th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n      <th></th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>367</th>\n      <td>dimenhydrinate</td>\n      <td>Adult</td>\n      <td>Prevention of Motion Sickness</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>50.0</td>\n      <td>100.0</td>\n      <td>mg</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>50-100 mg PO/IV/IM q4-6hr PRN, 30 minutes befo...</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>injury, poisoning and certain other consequenc...</td>\n      <td>0.714263</td>\n    </tr>\n    <tr>\n      <th>367</th>\n      <td>dimenhydrinate</td>\n      <td>Adult</td>\n      <td>Prevention of Motion Sickness</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>50.0</td>\n      <td>100.0</td>\n      <td>mg</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>50-100 mg PO/IV/IM q4-6hr PRN, 30 minutes befo...</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>injury, poisoning and certain other consequenc...</td>\n      <td>0.714263</td>\n    </tr>\n    <tr>\n      <th>367</th>\n      <td>dimenhydrinate</td>\n      <td>Adult</td>\n      <td>Prevention of Motion Sickness</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>50.0</td>\n      <td>100.0</td>\n      <td>mg</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>50-100 mg PO/IV/IM q4-6hr PRN, 30 minutes befo...</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>injury, poisoning and certain other consequenc...</td>\n      <td>0.714263</td>\n    </tr>\n    <tr>\n      <th>368</th>\n      <td>dimenhydrinate</td>\n      <td>Adult</td>\n      <td>Meniere's Disease (Off-label)</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>25.0</td>\n      <td>50.0</td>\n      <td>mg</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>25-50 mg PO q8hr for maintenance\\n\\n50 mg IM f...</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>diseases of the ear and mastoid process , dise...</td>\n      <td>0.745549</td>\n    </tr>\n    <tr>\n      <th>369</th>\n      <td>dimenhydrinate</td>\n      <td>Adult</td>\n      <td>Meniere's Disease (Off-label)</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>50</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>mg</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>25-50 mg PO q8hr for maintenance\\n\\n50 mg IM f...</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>diseases of the ear and mastoid process , dise...</td>\n      <td>0.745549</td>\n    </tr>\n    <tr>\n      <th>...</th>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n    </tr>\n    <tr>\n      <th>20220</th>\n      <td>vardenafil</td>\n      <td>Adult</td>\n      <td>Erectile Dysfunction</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>10</td>\n      <td>5.0</td>\n      <td>20.0</td>\n      <td>mg</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>10 mg PO ~1 hour before sexual activity; may b...</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>diseases of the genitourinary system , disease...</td>\n      <td>0.690745</td>\n    </tr>\n    <tr>\n      <th>20221</th>\n      <td>vardenafil</td>\n      <td>Geriatric</td>\n      <td>Erectile Dysfunction</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Film-coated tablet</td>\n      <td>10</td>\n      <td>5.0</td>\n      <td>20.0</td>\n      <td>mg</td>\n      <td>...</td>\n      <td>65</td>\n      <td>years</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>&lt;65 years\\n\\nFilm-coated tablet: 10 mg PO ~1 h...</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>diseases of the genitourinary system , disease...</td>\n      <td>0.690745</td>\n    </tr>\n    <tr>\n      <th>20222</th>\n      <td>vardenafil</td>\n      <td>Geriatric</td>\n      <td>Erectile Dysfunction</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Orally disintegrating tablet (ODT)</td>\n      <td>10</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>mg</td>\n      <td>...</td>\n      <td>65</td>\n      <td>years</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>&lt;65 years\\n\\nFilm-coated tablet: 10 mg PO ~1 h...</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>diseases of the genitourinary system , disease...</td>\n      <td>0.690745</td>\n    </tr>\n    <tr>\n      <th>20223</th>\n      <td>vardenafil</td>\n      <td>Geriatric</td>\n      <td>Erectile Dysfunction</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Film-coated tablet</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>&lt;65 years\\n\\nFilm-coated tablet: 10 mg PO ~1 h...</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>diseases of the genitourinary system , disease...</td>\n      <td>0.690745</td>\n    </tr>\n    <tr>\n      <th>20224</th>\n      <td>vardenafil</td>\n      <td>Geriatric</td>\n      <td>Erectile Dysfunction</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>5</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>mg</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>&lt;65 years\\n\\nFilm-coated tablet: 10 mg PO ~1 h...</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>diseases of the genitourinary system , disease...</td>\n      <td>0.690745</td>\n    </tr>\n  </tbody>\n</table>\n<p>4032 rows × 34 columns</p>\n</div>"
     },
     "execution_count": 79,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drug_data"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T09:50:05.058553600Z",
     "start_time": "2024-01-30T09:50:04.984268500Z"
    }
   },
   "id": "2f29e5f9cf041098"
  },
  {
   "cell_type": "markdown",
   "source": [],
   "metadata": {
    "collapsed": false
   },
   "id": "1b9da141405e89d"
  },
  {
   "cell_type": "code",
   "execution_count": 82,
   "outputs": [
    {
     "data": {
      "text/plain": "                     medical_condition_h3  \\\nUnnamed: 0                                  \n367         Prevention of Motion Sickness   \n367         Prevention of Motion Sickness   \n367         Prevention of Motion Sickness   \n368         Meniere's Disease (Off-label)   \n369         Meniere's Disease (Off-label)   \n...                                   ...   \n20220                Erectile Dysfunction   \n20221                Erectile Dysfunction   \n20222                Erectile Dysfunction   \n20223                Erectile Dysfunction   \n20224                Erectile Dysfunction   \n\n                                     most_similar_description  \nUnnamed: 0                                                     \n367         injury, poisoning and certain other consequenc...  \n367         injury, poisoning and certain other consequenc...  \n367         injury, poisoning and certain other consequenc...  \n368         diseases of the ear and mastoid process , dise...  \n369         diseases of the ear and mastoid process , dise...  \n...                                                       ...  \n20220       diseases of the genitourinary system , disease...  \n20221       diseases of the genitourinary system , disease...  \n20222       diseases of the genitourinary system , disease...  \n20223       diseases of the genitourinary system , disease...  \n20224       diseases of the genitourinary system , disease...  \n\n[4032 rows x 2 columns]",
      "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>medical_condition_h3</th>\n      <th>most_similar_description</th>\n    </tr>\n    <tr>\n      <th>Unnamed: 0</th>\n      <th></th>\n      <th></th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>367</th>\n      <td>Prevention of Motion Sickness</td>\n      <td>injury, poisoning and certain other consequenc...</td>\n    </tr>\n    <tr>\n      <th>367</th>\n      <td>Prevention of Motion Sickness</td>\n      <td>injury, poisoning and certain other consequenc...</td>\n    </tr>\n    <tr>\n      <th>367</th>\n      <td>Prevention of Motion Sickness</td>\n      <td>injury, poisoning and certain other consequenc...</td>\n    </tr>\n    <tr>\n      <th>368</th>\n      <td>Meniere's Disease (Off-label)</td>\n      <td>diseases of the ear and mastoid process , dise...</td>\n    </tr>\n    <tr>\n      <th>369</th>\n      <td>Meniere's Disease (Off-label)</td>\n      <td>diseases of the ear and mastoid process , dise...</td>\n    </tr>\n    <tr>\n      <th>...</th>\n      <td>...</td>\n      <td>...</td>\n    </tr>\n    <tr>\n      <th>20220</th>\n      <td>Erectile Dysfunction</td>\n      <td>diseases of the genitourinary system , disease...</td>\n    </tr>\n    <tr>\n      <th>20221</th>\n      <td>Erectile Dysfunction</td>\n      <td>diseases of the genitourinary system , disease...</td>\n    </tr>\n    <tr>\n      <th>20222</th>\n      <td>Erectile Dysfunction</td>\n      <td>diseases of the genitourinary system , disease...</td>\n    </tr>\n    <tr>\n      <th>20223</th>\n      <td>Erectile Dysfunction</td>\n      <td>diseases of the genitourinary system , disease...</td>\n    </tr>\n    <tr>\n      <th>20224</th>\n      <td>Erectile Dysfunction</td>\n      <td>diseases of the genitourinary system , disease...</td>\n    </tr>\n  </tbody>\n</table>\n<p>4032 rows × 2 columns</p>\n</div>"
     },
     "execution_count": 82,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drug_data[['medical_condition_h3','most_similar_description']]"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T09:50:49.370698800Z",
     "start_time": "2024-01-30T09:50:49.292815200Z"
    }
   },
   "id": "7f09d401a6913063"
  },
  {
   "cell_type": "code",
   "execution_count": 83,
   "outputs": [
    {
     "data": {
      "text/plain": "Index(['drug_name', 'Age Range', 'medical_condition_h3',\n       'medical_condition_h4', 'medical_condition_h5', 'dose_title', 'dose',\n       'dose_range_start', 'dose_range_end', 'dose_unit_new', 'per_with_unit',\n       'is_divided', 'route_of_administration', 'PRN', 'infusion_rate_unit',\n       'frequency', 'frequency_range_start', 'frequency_range_end',\n       'frequency_unit', 'duration', 'duration_unit', 'maximum_dose',\n       'maximum_dose_unit', 'age_range_start', 'age_range_end',\n       'age_range_unit', 'body_weight_range_start', 'body_weight_range_end',\n       'body_weight_range_unit', 'reference', 'administration_notes',\n       'is_medical_diagnosis', 'most_similar_description', 'similarity_score'],\n      dtype='object')"
     },
     "execution_count": 83,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drug_data.columns"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T09:53:13.350936800Z",
     "start_time": "2024-01-30T09:53:13.328590900Z"
    }
   },
   "id": "70a6b90204ad9d4e"
  },
  {
   "cell_type": "code",
   "execution_count": 91,
   "outputs": [
    {
     "data": {
      "text/plain": "      diseaseCode                                        description\n0           A00.0  certain infectious and parasitic diseases , in...\n1           A00.1  certain infectious and parasitic diseases , in...\n2           A00.9  certain infectious and parasitic diseases , in...\n3          A01.00  certain infectious and parasitic diseases , in...\n4          A01.01  certain infectious and parasitic diseases , in...\n...           ...                                                ...\n50123      Z99.12  factors influencing health status and contact ...\n50124       Z99.2  factors influencing health status and contact ...\n50125       Z99.3  factors influencing health status and contact ...\n50126      Z99.81  factors influencing health status and contact ...\n50127      Z99.89  factors influencing health status and contact ...\n\n[50128 rows x 2 columns]",
      "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>diseaseCode</th>\n      <th>description</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>A00.0</td>\n      <td>certain infectious and parasitic diseases , in...</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>A00.1</td>\n      <td>certain infectious and parasitic diseases , in...</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>A00.9</td>\n      <td>certain infectious and parasitic diseases , in...</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>A01.00</td>\n      <td>certain infectious and parasitic diseases , in...</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>A01.01</td>\n      <td>certain infectious and parasitic diseases , in...</td>\n    </tr>\n    <tr>\n      <th>...</th>\n      <td>...</td>\n      <td>...</td>\n    </tr>\n    <tr>\n      <th>50123</th>\n      <td>Z99.12</td>\n      <td>factors influencing health status and contact ...</td>\n    </tr>\n    <tr>\n      <th>50124</th>\n      <td>Z99.2</td>\n      <td>factors influencing health status and contact ...</td>\n    </tr>\n    <tr>\n      <th>50125</th>\n      <td>Z99.3</td>\n      <td>factors influencing health status and contact ...</td>\n    </tr>\n    <tr>\n      <th>50126</th>\n      <td>Z99.81</td>\n      <td>factors influencing health status and contact ...</td>\n    </tr>\n    <tr>\n      <th>50127</th>\n      <td>Z99.89</td>\n      <td>factors influencing health status and contact ...</td>\n    </tr>\n  </tbody>\n</table>\n<p>50128 rows × 2 columns</p>\n</div>"
     },
     "execution_count": 91,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_codes"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T10:00:10.397663100Z",
     "start_time": "2024-01-30T10:00:10.316359700Z"
    }
   },
   "id": "7de778d53d95b159"
  },
  {
   "cell_type": "code",
   "execution_count": 95,
   "outputs": [],
   "source": [
    "drug_data_merged=drug_data.merge(df_codes,left_on='most_similar_description',right_on='description')\n"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T10:01:12.853643700Z",
     "start_time": "2024-01-30T10:01:12.713569300Z"
    }
   },
   "id": "7d19dde06ccb614d"
  },
  {
   "cell_type": "code",
   "execution_count": 99,
   "outputs": [
    {
     "data": {
      "text/plain": "           drug_name  Age Range            medical_condition_h3  \\\n0     dimenhydrinate      Adult   Prevention of Motion Sickness   \n1     dimenhydrinate      Adult   Prevention of Motion Sickness   \n2     dimenhydrinate      Adult   Prevention of Motion Sickness   \n3     dimenhydrinate  Pediatric   Prevention of Motion Sickness   \n4     dimenhydrinate  Pediatric   Prevention of Motion Sickness   \n...              ...        ...                             ...   \n4027     tropicamide  Pediatric          Refraction (Mydriasis)   \n4028     tropicamide      Adult  Funduscopic Exam (Cycloplegia)   \n4029     tropicamide  Pediatric  Funduscopic Exam (Cycloplegia)   \n4030     finasteride      Adult  Androgenic Alopecia (Men Only)   \n4031     finasteride      Adult    Female Hirsutism (Off-label)   \n\n     medical_condition_h4 medical_condition_h5    dose_title  dose  \\\n0                     NaN                  NaN           NaN   NaN   \n1                     NaN                  NaN           NaN   NaN   \n2                     NaN                  NaN           NaN   NaN   \n3                     NaN                  NaN  General dose  37.5   \n4                     NaN                  NaN  General dose  37.5   \n...                   ...                  ...           ...   ...   \n4027                  NaN                  NaN         Adult   NaN   \n4028                  NaN                  NaN           NaN   NaN   \n4029                  NaN                  NaN    Adult dose   NaN   \n4030                  NaN                  NaN      Propecia     1   \n4031                  NaN                  NaN           NaN     5   \n\n      dose_range_start  dose_range_end dose_unit_new  ...  \\\n0                 50.0           100.0            mg  ...   \n1                 50.0           100.0            mg  ...   \n2                 50.0           100.0            mg  ...   \n3                  NaN             NaN            mg  ...   \n4                  NaN             NaN            mg  ...   \n...                ...             ...           ...  ...   \n4027               NaN             NaN          drop  ...   \n4028               1.0             2.0          drop  ...   \n4029               1.0             2.0          drop  ...   \n4030               NaN             NaN            mg  ...   \n4031               NaN             NaN            mg  ...   \n\n     body_weight_range_start  body_weight_range_end body_weight_range_unit  \\\n0                        NaN                    NaN                    NaN   \n1                        NaN                    NaN                    NaN   \n2                        NaN                    NaN                    NaN   \n3                        NaN                    NaN                    NaN   \n4                        NaN                    NaN                    NaN   \n...                      ...                    ...                    ...   \n4027                     NaN                    NaN                    NaN   \n4028                     NaN                    NaN                    NaN   \n4029                     NaN                    NaN                    NaN   \n4030                     NaN                    NaN                    NaN   \n4031                     NaN                    NaN                    NaN   \n\n                                              reference administration_notes  \\\n0     50-100 mg PO/IV/IM q4-6hr PRN, 30 minutes befo...                  NaN   \n1     50-100 mg PO/IV/IM q4-6hr PRN, 30 minutes befo...                  NaN   \n2     50-100 mg PO/IV/IM q4-6hr PRN, 30 minutes befo...                  NaN   \n3     General dose: 1.25 mg/kg or 37.5 mg/sq.meter I...                  NaN   \n4     General dose: 1.25 mg/kg or 37.5 mg/sq.meter I...                  NaN   \n...                                                 ...                  ...   \n4027  As adult; 1-2 gtt of 1% solution in eye(s), re...                  NaN   \n4028  1-2 gtt of 0.5% solution in eyes 15-20 min bef...                  NaN   \n4029  As adult; 1-2 gtt of 0.5% solution in eyes 15-...                  NaN   \n4030       Propecia: 1 mg PO qDay for at least 3 months                  NaN   \n4031                                       5 mg PO qDay                  NaN   \n\n     is_medical_diagnosis                           most_similar_description  \\\n0                    True  injury, poisoning and certain other consequenc...   \n1                    True  injury, poisoning and certain other consequenc...   \n2                    True  injury, poisoning and certain other consequenc...   \n3                    True  injury, poisoning and certain other consequenc...   \n4                    True  injury, poisoning and certain other consequenc...   \n...                   ...                                                ...   \n4027                False  diseases of the eye and adnexa , disorders of ...   \n4028                 True  diseases of the eye and adnexa , disorders of ...   \n4029                 True  diseases of the eye and adnexa , disorders of ...   \n4030                 True  diseases of the skin and subcutaneous tissue ,...   \n4031                 True  diseases of the genitourinary system , inflamm...   \n\n     similarity_score diseaseCode  \\\n0            0.714263    T75.3XXS   \n1            0.714263    T75.3XXS   \n2            0.714263    T75.3XXS   \n3            0.714263    T75.3XXS   \n4            0.714263    T75.3XXS   \n...               ...         ...   \n4027         0.585913      H52.13   \n4028         0.456150     H50.412   \n4029         0.456150     H50.412   \n4030         0.690526       L64.8   \n4031         0.416196      N70.91   \n\n                                            description  \n0     injury, poisoning and certain other consequenc...  \n1     injury, poisoning and certain other consequenc...  \n2     injury, poisoning and certain other consequenc...  \n3     injury, poisoning and certain other consequenc...  \n4     injury, poisoning and certain other consequenc...  \n...                                                 ...  \n4027  diseases of the eye and adnexa , disorders of ...  \n4028  diseases of the eye and adnexa , disorders of ...  \n4029  diseases of the eye and adnexa , disorders of ...  \n4030  diseases of the skin and subcutaneous tissue ,...  \n4031  diseases of the genitourinary system , inflamm...  \n\n[4032 rows x 36 columns]",
      "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>drug_name</th>\n      <th>Age Range</th>\n      <th>medical_condition_h3</th>\n      <th>medical_condition_h4</th>\n      <th>medical_condition_h5</th>\n      <th>dose_title</th>\n      <th>dose</th>\n      <th>dose_range_start</th>\n      <th>dose_range_end</th>\n      <th>dose_unit_new</th>\n      <th>...</th>\n      <th>body_weight_range_start</th>\n      <th>body_weight_range_end</th>\n      <th>body_weight_range_unit</th>\n      <th>reference</th>\n      <th>administration_notes</th>\n      <th>is_medical_diagnosis</th>\n      <th>most_similar_description</th>\n      <th>similarity_score</th>\n      <th>diseaseCode</th>\n      <th>description</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>dimenhydrinate</td>\n      <td>Adult</td>\n      <td>Prevention of Motion Sickness</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>50.0</td>\n      <td>100.0</td>\n      <td>mg</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>50-100 mg PO/IV/IM q4-6hr PRN, 30 minutes befo...</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>injury, poisoning and certain other consequenc...</td>\n      <td>0.714263</td>\n      <td>T75.3XXS</td>\n      <td>injury, poisoning and certain other consequenc...</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>dimenhydrinate</td>\n      <td>Adult</td>\n      <td>Prevention of Motion Sickness</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>50.0</td>\n      <td>100.0</td>\n      <td>mg</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>50-100 mg PO/IV/IM q4-6hr PRN, 30 minutes befo...</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>injury, poisoning and certain other consequenc...</td>\n      <td>0.714263</td>\n      <td>T75.3XXS</td>\n      <td>injury, poisoning and certain other consequenc...</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>dimenhydrinate</td>\n      <td>Adult</td>\n      <td>Prevention of Motion Sickness</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>50.0</td>\n      <td>100.0</td>\n      <td>mg</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>50-100 mg PO/IV/IM q4-6hr PRN, 30 minutes befo...</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>injury, poisoning and certain other consequenc...</td>\n      <td>0.714263</td>\n      <td>T75.3XXS</td>\n      <td>injury, poisoning and certain other consequenc...</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>dimenhydrinate</td>\n      <td>Pediatric</td>\n      <td>Prevention of Motion Sickness</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>General dose</td>\n      <td>37.5</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>mg</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>General dose: 1.25 mg/kg or 37.5 mg/sq.meter I...</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>injury, poisoning and certain other consequenc...</td>\n      <td>0.714263</td>\n      <td>T75.3XXS</td>\n      <td>injury, poisoning and certain other consequenc...</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>dimenhydrinate</td>\n      <td>Pediatric</td>\n      <td>Prevention of Motion Sickness</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>General dose</td>\n      <td>37.5</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>mg</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>General dose: 1.25 mg/kg or 37.5 mg/sq.meter I...</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>injury, poisoning and certain other consequenc...</td>\n      <td>0.714263</td>\n      <td>T75.3XXS</td>\n      <td>injury, poisoning and certain other consequenc...</td>\n    </tr>\n    <tr>\n      <th>...</th>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n    </tr>\n    <tr>\n      <th>4027</th>\n      <td>tropicamide</td>\n      <td>Pediatric</td>\n      <td>Refraction (Mydriasis)</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Adult</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>drop</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>As adult; 1-2 gtt of 1% solution in eye(s), re...</td>\n      <td>NaN</td>\n      <td>False</td>\n      <td>diseases of the eye and adnexa , disorders of ...</td>\n      <td>0.585913</td>\n      <td>H52.13</td>\n      <td>diseases of the eye and adnexa , disorders of ...</td>\n    </tr>\n    <tr>\n      <th>4028</th>\n      <td>tropicamide</td>\n      <td>Adult</td>\n      <td>Funduscopic Exam (Cycloplegia)</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>1.0</td>\n      <td>2.0</td>\n      <td>drop</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>1-2 gtt of 0.5% solution in eyes 15-20 min bef...</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>diseases of the eye and adnexa , disorders of ...</td>\n      <td>0.456150</td>\n      <td>H50.412</td>\n      <td>diseases of the eye and adnexa , disorders of ...</td>\n    </tr>\n    <tr>\n      <th>4029</th>\n      <td>tropicamide</td>\n      <td>Pediatric</td>\n      <td>Funduscopic Exam (Cycloplegia)</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Adult dose</td>\n      <td>NaN</td>\n      <td>1.0</td>\n      <td>2.0</td>\n      <td>drop</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>As adult; 1-2 gtt of 0.5% solution in eyes 15-...</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>diseases of the eye and adnexa , disorders of ...</td>\n      <td>0.456150</td>\n      <td>H50.412</td>\n      <td>diseases of the eye and adnexa , disorders of ...</td>\n    </tr>\n    <tr>\n      <th>4030</th>\n      <td>finasteride</td>\n      <td>Adult</td>\n      <td>Androgenic Alopecia (Men Only)</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Propecia</td>\n      <td>1</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>mg</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Propecia: 1 mg PO qDay for at least 3 months</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>diseases of the skin and subcutaneous tissue ,...</td>\n      <td>0.690526</td>\n      <td>L64.8</td>\n      <td>diseases of the skin and subcutaneous tissue ,...</td>\n    </tr>\n    <tr>\n      <th>4031</th>\n      <td>finasteride</td>\n      <td>Adult</td>\n      <td>Female Hirsutism (Off-label)</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>5</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>mg</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>5 mg PO qDay</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>diseases of the genitourinary system , inflamm...</td>\n      <td>0.416196</td>\n      <td>N70.91</td>\n      <td>diseases of the genitourinary system , inflamm...</td>\n    </tr>\n  </tbody>\n</table>\n<p>4032 rows × 36 columns</p>\n</div>"
     },
     "execution_count": 99,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drug_data_merged"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T10:02:43.594812200Z",
     "start_time": "2024-01-30T10:02:43.523537200Z"
    }
   },
   "id": "42fa3304647e6804"
  },
  {
   "cell_type": "code",
   "execution_count": 100,
   "outputs": [],
   "source": [
    "drug_data_merged=drug_data_merged[['drug_name', 'Age Range', 'medical_condition_h3',\n",
    "       'medical_condition_h4', 'medical_condition_h5','is_medical_diagnosis', 'most_similar_description', 'similarity_score','diseaseCode','dose_title', 'dose',\n",
    "       'dose_range_start', 'dose_range_end', 'dose_unit_new', 'per_with_unit',\n",
    "       'is_divided', 'route_of_administration', 'PRN', 'infusion_rate_unit',\n",
    "       'frequency', 'frequency_range_start', 'frequency_range_end',\n",
    "       'frequency_unit', 'duration', 'duration_unit', 'maximum_dose',\n",
    "       'maximum_dose_unit', 'age_range_start', 'age_range_end',\n",
    "       'age_range_unit', 'body_weight_range_start', 'body_weight_range_end',\n",
    "       'body_weight_range_unit', 'reference', 'administration_notes',\n",
    "       ]]"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T10:03:06.000256100Z",
     "start_time": "2024-01-30T10:03:05.934017Z"
    }
   },
   "id": "6a1eab13dbddbf4a"
  },
  {
   "cell_type": "code",
   "execution_count": 101,
   "outputs": [
    {
     "data": {
      "text/plain": "           drug_name  Age Range            medical_condition_h3  \\\n0     dimenhydrinate      Adult   Prevention of Motion Sickness   \n1     dimenhydrinate      Adult   Prevention of Motion Sickness   \n2     dimenhydrinate      Adult   Prevention of Motion Sickness   \n3     dimenhydrinate  Pediatric   Prevention of Motion Sickness   \n4     dimenhydrinate  Pediatric   Prevention of Motion Sickness   \n...              ...        ...                             ...   \n4027     tropicamide  Pediatric          Refraction (Mydriasis)   \n4028     tropicamide      Adult  Funduscopic Exam (Cycloplegia)   \n4029     tropicamide  Pediatric  Funduscopic Exam (Cycloplegia)   \n4030     finasteride      Adult  Androgenic Alopecia (Men Only)   \n4031     finasteride      Adult    Female Hirsutism (Off-label)   \n\n     medical_condition_h4 medical_condition_h5  is_medical_diagnosis  \\\n0                     NaN                  NaN                  True   \n1                     NaN                  NaN                  True   \n2                     NaN                  NaN                  True   \n3                     NaN                  NaN                  True   \n4                     NaN                  NaN                  True   \n...                   ...                  ...                   ...   \n4027                  NaN                  NaN                 False   \n4028                  NaN                  NaN                  True   \n4029                  NaN                  NaN                  True   \n4030                  NaN                  NaN                  True   \n4031                  NaN                  NaN                  True   \n\n                               most_similar_description  similarity_score  \\\n0     injury, poisoning and certain other consequenc...          0.714263   \n1     injury, poisoning and certain other consequenc...          0.714263   \n2     injury, poisoning and certain other consequenc...          0.714263   \n3     injury, poisoning and certain other consequenc...          0.714263   \n4     injury, poisoning and certain other consequenc...          0.714263   \n...                                                 ...               ...   \n4027  diseases of the eye and adnexa , disorders of ...          0.585913   \n4028  diseases of the eye and adnexa , disorders of ...          0.456150   \n4029  diseases of the eye and adnexa , disorders of ...          0.456150   \n4030  diseases of the skin and subcutaneous tissue ,...          0.690526   \n4031  diseases of the genitourinary system , inflamm...          0.416196   \n\n     diseaseCode    dose_title  ... maximum_dose  maximum_dose_unit  \\\n0       T75.3XXS           NaN  ...          400                NaN   \n1       T75.3XXS           NaN  ...          400                NaN   \n2       T75.3XXS           NaN  ...          400                NaN   \n3       T75.3XXS  General dose  ...          300                 mg   \n4       T75.3XXS  General dose  ...          300                 mg   \n...          ...           ...  ...          ...                ...   \n4027      H52.13         Adult  ...          NaN                NaN   \n4028     H50.412           NaN  ...          NaN                NaN   \n4029     H50.412    Adult dose  ...          NaN                NaN   \n4030       L64.8      Propecia  ...          NaN                NaN   \n4031      N70.91           NaN  ...          NaN                NaN   \n\n      age_range_start age_range_end age_range_unit  body_weight_range_start  \\\n0                 NaN           NaN            NaN                      NaN   \n1                 NaN           NaN            NaN                      NaN   \n2                 NaN           NaN            NaN                      NaN   \n3                 NaN           NaN            NaN                      NaN   \n4                 NaN           NaN            NaN                      NaN   \n...               ...           ...            ...                      ...   \n4027              NaN           NaN            NaN                      NaN   \n4028              NaN           NaN            NaN                      NaN   \n4029              NaN           NaN            NaN                      NaN   \n4030              NaN           NaN            NaN                      NaN   \n4031              NaN           NaN            NaN                      NaN   \n\n     body_weight_range_end  body_weight_range_unit  \\\n0                      NaN                     NaN   \n1                      NaN                     NaN   \n2                      NaN                     NaN   \n3                      NaN                     NaN   \n4                      NaN                     NaN   \n...                    ...                     ...   \n4027                   NaN                     NaN   \n4028                   NaN                     NaN   \n4029                   NaN                     NaN   \n4030                   NaN                     NaN   \n4031                   NaN                     NaN   \n\n                                              reference administration_notes  \n0     50-100 mg PO/IV/IM q4-6hr PRN, 30 minutes befo...                  NaN  \n1     50-100 mg PO/IV/IM q4-6hr PRN, 30 minutes befo...                  NaN  \n2     50-100 mg PO/IV/IM q4-6hr PRN, 30 minutes befo...                  NaN  \n3     General dose: 1.25 mg/kg or 37.5 mg/sq.meter I...                  NaN  \n4     General dose: 1.25 mg/kg or 37.5 mg/sq.meter I...                  NaN  \n...                                                 ...                  ...  \n4027  As adult; 1-2 gtt of 1% solution in eye(s), re...                  NaN  \n4028  1-2 gtt of 0.5% solution in eyes 15-20 min bef...                  NaN  \n4029  As adult; 1-2 gtt of 0.5% solution in eyes 15-...                  NaN  \n4030       Propecia: 1 mg PO qDay for at least 3 months                  NaN  \n4031                                       5 mg PO qDay                  NaN  \n\n[4032 rows x 35 columns]",
      "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>drug_name</th>\n      <th>Age Range</th>\n      <th>medical_condition_h3</th>\n      <th>medical_condition_h4</th>\n      <th>medical_condition_h5</th>\n      <th>is_medical_diagnosis</th>\n      <th>most_similar_description</th>\n      <th>similarity_score</th>\n      <th>diseaseCode</th>\n      <th>dose_title</th>\n      <th>...</th>\n      <th>maximum_dose</th>\n      <th>maximum_dose_unit</th>\n      <th>age_range_start</th>\n      <th>age_range_end</th>\n      <th>age_range_unit</th>\n      <th>body_weight_range_start</th>\n      <th>body_weight_range_end</th>\n      <th>body_weight_range_unit</th>\n      <th>reference</th>\n      <th>administration_notes</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>dimenhydrinate</td>\n      <td>Adult</td>\n      <td>Prevention of Motion Sickness</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>injury, poisoning and certain other consequenc...</td>\n      <td>0.714263</td>\n      <td>T75.3XXS</td>\n      <td>NaN</td>\n      <td>...</td>\n      <td>400</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>50-100 mg PO/IV/IM q4-6hr PRN, 30 minutes befo...</td>\n      <td>NaN</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>dimenhydrinate</td>\n      <td>Adult</td>\n      <td>Prevention of Motion Sickness</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>injury, poisoning and certain other consequenc...</td>\n      <td>0.714263</td>\n      <td>T75.3XXS</td>\n      <td>NaN</td>\n      <td>...</td>\n      <td>400</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>50-100 mg PO/IV/IM q4-6hr PRN, 30 minutes befo...</td>\n      <td>NaN</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>dimenhydrinate</td>\n      <td>Adult</td>\n      <td>Prevention of Motion Sickness</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>injury, poisoning and certain other consequenc...</td>\n      <td>0.714263</td>\n      <td>T75.3XXS</td>\n      <td>NaN</td>\n      <td>...</td>\n      <td>400</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>50-100 mg PO/IV/IM q4-6hr PRN, 30 minutes befo...</td>\n      <td>NaN</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>dimenhydrinate</td>\n      <td>Pediatric</td>\n      <td>Prevention of Motion Sickness</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>injury, poisoning and certain other consequenc...</td>\n      <td>0.714263</td>\n      <td>T75.3XXS</td>\n      <td>General dose</td>\n      <td>...</td>\n      <td>300</td>\n      <td>mg</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>General dose: 1.25 mg/kg or 37.5 mg/sq.meter I...</td>\n      <td>NaN</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>dimenhydrinate</td>\n      <td>Pediatric</td>\n      <td>Prevention of Motion Sickness</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>injury, poisoning and certain other consequenc...</td>\n      <td>0.714263</td>\n      <td>T75.3XXS</td>\n      <td>General dose</td>\n      <td>...</td>\n      <td>300</td>\n      <td>mg</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>General dose: 1.25 mg/kg or 37.5 mg/sq.meter I...</td>\n      <td>NaN</td>\n    </tr>\n    <tr>\n      <th>...</th>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n    </tr>\n    <tr>\n      <th>4027</th>\n      <td>tropicamide</td>\n      <td>Pediatric</td>\n      <td>Refraction (Mydriasis)</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>False</td>\n      <td>diseases of the eye and adnexa , disorders of ...</td>\n      <td>0.585913</td>\n      <td>H52.13</td>\n      <td>Adult</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>As adult; 1-2 gtt of 1% solution in eye(s), re...</td>\n      <td>NaN</td>\n    </tr>\n    <tr>\n      <th>4028</th>\n      <td>tropicamide</td>\n      <td>Adult</td>\n      <td>Funduscopic Exam (Cycloplegia)</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>diseases of the eye and adnexa , disorders of ...</td>\n      <td>0.456150</td>\n      <td>H50.412</td>\n      <td>NaN</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>1-2 gtt of 0.5% solution in eyes 15-20 min bef...</td>\n      <td>NaN</td>\n    </tr>\n    <tr>\n      <th>4029</th>\n      <td>tropicamide</td>\n      <td>Pediatric</td>\n      <td>Funduscopic Exam (Cycloplegia)</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>diseases of the eye and adnexa , disorders of ...</td>\n      <td>0.456150</td>\n      <td>H50.412</td>\n      <td>Adult dose</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>As adult; 1-2 gtt of 0.5% solution in eyes 15-...</td>\n      <td>NaN</td>\n    </tr>\n    <tr>\n      <th>4030</th>\n      <td>finasteride</td>\n      <td>Adult</td>\n      <td>Androgenic Alopecia (Men Only)</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>diseases of the skin and subcutaneous tissue ,...</td>\n      <td>0.690526</td>\n      <td>L64.8</td>\n      <td>Propecia</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Propecia: 1 mg PO qDay for at least 3 months</td>\n      <td>NaN</td>\n    </tr>\n    <tr>\n      <th>4031</th>\n      <td>finasteride</td>\n      <td>Adult</td>\n      <td>Female Hirsutism (Off-label)</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>diseases of the genitourinary system , inflamm...</td>\n      <td>0.416196</td>\n      <td>N70.91</td>\n      <td>NaN</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>5 mg PO qDay</td>\n      <td>NaN</td>\n    </tr>\n  </tbody>\n</table>\n<p>4032 rows × 35 columns</p>\n</div>"
     },
     "execution_count": 101,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drug_data_merged"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T10:03:08.519478300Z",
     "start_time": "2024-01-30T10:03:08.466505800Z"
    }
   },
   "id": "7277357498f1b77c"
  },
  {
   "cell_type": "code",
   "execution_count": 102,
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\omar.wafy\\AppData\\Local\\Temp\\ipykernel_9432\\1159961089.py:18: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "  drug_data_merged[columns_to_replace] = drug_data_merged.apply(\n"
     ]
    }
   ],
   "source": [
    "# def replace_columns_with_none(row, columns_to_replace):\n",
    "#     if not row['is_medical_diagnosis']:\n",
    "#         return [None] * len(columns_to_replace)\n",
    "#     else:\n",
    "#         return [row[column] for column in columns_to_replace]\n",
    "# \n",
    "# # Specify the list of columns to replace with None\n",
    "# columns_to_replace = ['diseaseCode', 'similarity_score', 'most_similar_diagnosis']\n",
    "def replace_columns_with_none(row, columns_to_replace):\n",
    "    if not row['is_medical_diagnosis']:\n",
    "        return [np.NaN] * len(columns_to_replace)\n",
    "    else:\n",
    "        return [row[column] for column in columns_to_replace]\n",
    "\n",
    "# Specify the list of columns to replace with None\n",
    "columns_to_replace = ['diseaseCode', 'similarity_score', 'most_similar_description']\n",
    "# Apply the function to the specified columns\n",
    "drug_data_merged[columns_to_replace] = drug_data_merged.apply(\n",
    "    lambda row: replace_columns_with_none(row, columns_to_replace),\n",
    "    axis=1,\n",
    "    result_type='expand'\n",
    ")"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T10:04:22.743749700Z",
     "start_time": "2024-01-30T10:04:22.602410100Z"
    }
   },
   "id": "4b2bc28eff53648"
  },
  {
   "cell_type": "code",
   "execution_count": 103,
   "outputs": [
    {
     "data": {
      "text/plain": "           drug_name  Age Range            medical_condition_h3  \\\n0     dimenhydrinate      Adult   Prevention of Motion Sickness   \n1     dimenhydrinate      Adult   Prevention of Motion Sickness   \n2     dimenhydrinate      Adult   Prevention of Motion Sickness   \n3     dimenhydrinate  Pediatric   Prevention of Motion Sickness   \n4     dimenhydrinate  Pediatric   Prevention of Motion Sickness   \n...              ...        ...                             ...   \n4027     tropicamide  Pediatric          Refraction (Mydriasis)   \n4028     tropicamide      Adult  Funduscopic Exam (Cycloplegia)   \n4029     tropicamide  Pediatric  Funduscopic Exam (Cycloplegia)   \n4030     finasteride      Adult  Androgenic Alopecia (Men Only)   \n4031     finasteride      Adult    Female Hirsutism (Off-label)   \n\n     medical_condition_h4 medical_condition_h5  is_medical_diagnosis  \\\n0                     NaN                  NaN                  True   \n1                     NaN                  NaN                  True   \n2                     NaN                  NaN                  True   \n3                     NaN                  NaN                  True   \n4                     NaN                  NaN                  True   \n...                   ...                  ...                   ...   \n4027                  NaN                  NaN                 False   \n4028                  NaN                  NaN                  True   \n4029                  NaN                  NaN                  True   \n4030                  NaN                  NaN                  True   \n4031                  NaN                  NaN                  True   \n\n                               most_similar_description  similarity_score  \\\n0     injury, poisoning and certain other consequenc...          0.714263   \n1     injury, poisoning and certain other consequenc...          0.714263   \n2     injury, poisoning and certain other consequenc...          0.714263   \n3     injury, poisoning and certain other consequenc...          0.714263   \n4     injury, poisoning and certain other consequenc...          0.714263   \n...                                                 ...               ...   \n4027                                                NaN               NaN   \n4028  diseases of the eye and adnexa , disorders of ...          0.456150   \n4029  diseases of the eye and adnexa , disorders of ...          0.456150   \n4030  diseases of the skin and subcutaneous tissue ,...          0.690526   \n4031  diseases of the genitourinary system , inflamm...          0.416196   \n\n     diseaseCode    dose_title  ... maximum_dose  maximum_dose_unit  \\\n0       T75.3XXS           NaN  ...          400                NaN   \n1       T75.3XXS           NaN  ...          400                NaN   \n2       T75.3XXS           NaN  ...          400                NaN   \n3       T75.3XXS  General dose  ...          300                 mg   \n4       T75.3XXS  General dose  ...          300                 mg   \n...          ...           ...  ...          ...                ...   \n4027         NaN         Adult  ...          NaN                NaN   \n4028     H50.412           NaN  ...          NaN                NaN   \n4029     H50.412    Adult dose  ...          NaN                NaN   \n4030       L64.8      Propecia  ...          NaN                NaN   \n4031      N70.91           NaN  ...          NaN                NaN   \n\n      age_range_start age_range_end age_range_unit  body_weight_range_start  \\\n0                 NaN           NaN            NaN                      NaN   \n1                 NaN           NaN            NaN                      NaN   \n2                 NaN           NaN            NaN                      NaN   \n3                 NaN           NaN            NaN                      NaN   \n4                 NaN           NaN            NaN                      NaN   \n...               ...           ...            ...                      ...   \n4027              NaN           NaN            NaN                      NaN   \n4028              NaN           NaN            NaN                      NaN   \n4029              NaN           NaN            NaN                      NaN   \n4030              NaN           NaN            NaN                      NaN   \n4031              NaN           NaN            NaN                      NaN   \n\n     body_weight_range_end  body_weight_range_unit  \\\n0                      NaN                     NaN   \n1                      NaN                     NaN   \n2                      NaN                     NaN   \n3                      NaN                     NaN   \n4                      NaN                     NaN   \n...                    ...                     ...   \n4027                   NaN                     NaN   \n4028                   NaN                     NaN   \n4029                   NaN                     NaN   \n4030                   NaN                     NaN   \n4031                   NaN                     NaN   \n\n                                              reference administration_notes  \n0     50-100 mg PO/IV/IM q4-6hr PRN, 30 minutes befo...                  NaN  \n1     50-100 mg PO/IV/IM q4-6hr PRN, 30 minutes befo...                  NaN  \n2     50-100 mg PO/IV/IM q4-6hr PRN, 30 minutes befo...                  NaN  \n3     General dose: 1.25 mg/kg or 37.5 mg/sq.meter I...                  NaN  \n4     General dose: 1.25 mg/kg or 37.5 mg/sq.meter I...                  NaN  \n...                                                 ...                  ...  \n4027  As adult; 1-2 gtt of 1% solution in eye(s), re...                  NaN  \n4028  1-2 gtt of 0.5% solution in eyes 15-20 min bef...                  NaN  \n4029  As adult; 1-2 gtt of 0.5% solution in eyes 15-...                  NaN  \n4030       Propecia: 1 mg PO qDay for at least 3 months                  NaN  \n4031                                       5 mg PO qDay                  NaN  \n\n[4032 rows x 35 columns]",
      "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>drug_name</th>\n      <th>Age Range</th>\n      <th>medical_condition_h3</th>\n      <th>medical_condition_h4</th>\n      <th>medical_condition_h5</th>\n      <th>is_medical_diagnosis</th>\n      <th>most_similar_description</th>\n      <th>similarity_score</th>\n      <th>diseaseCode</th>\n      <th>dose_title</th>\n      <th>...</th>\n      <th>maximum_dose</th>\n      <th>maximum_dose_unit</th>\n      <th>age_range_start</th>\n      <th>age_range_end</th>\n      <th>age_range_unit</th>\n      <th>body_weight_range_start</th>\n      <th>body_weight_range_end</th>\n      <th>body_weight_range_unit</th>\n      <th>reference</th>\n      <th>administration_notes</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>dimenhydrinate</td>\n      <td>Adult</td>\n      <td>Prevention of Motion Sickness</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>injury, poisoning and certain other consequenc...</td>\n      <td>0.714263</td>\n      <td>T75.3XXS</td>\n      <td>NaN</td>\n      <td>...</td>\n      <td>400</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>50-100 mg PO/IV/IM q4-6hr PRN, 30 minutes befo...</td>\n      <td>NaN</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>dimenhydrinate</td>\n      <td>Adult</td>\n      <td>Prevention of Motion Sickness</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>injury, poisoning and certain other consequenc...</td>\n      <td>0.714263</td>\n      <td>T75.3XXS</td>\n      <td>NaN</td>\n      <td>...</td>\n      <td>400</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>50-100 mg PO/IV/IM q4-6hr PRN, 30 minutes befo...</td>\n      <td>NaN</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>dimenhydrinate</td>\n      <td>Adult</td>\n      <td>Prevention of Motion Sickness</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>injury, poisoning and certain other consequenc...</td>\n      <td>0.714263</td>\n      <td>T75.3XXS</td>\n      <td>NaN</td>\n      <td>...</td>\n      <td>400</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>50-100 mg PO/IV/IM q4-6hr PRN, 30 minutes befo...</td>\n      <td>NaN</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>dimenhydrinate</td>\n      <td>Pediatric</td>\n      <td>Prevention of Motion Sickness</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>injury, poisoning and certain other consequenc...</td>\n      <td>0.714263</td>\n      <td>T75.3XXS</td>\n      <td>General dose</td>\n      <td>...</td>\n      <td>300</td>\n      <td>mg</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>General dose: 1.25 mg/kg or 37.5 mg/sq.meter I...</td>\n      <td>NaN</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>dimenhydrinate</td>\n      <td>Pediatric</td>\n      <td>Prevention of Motion Sickness</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>injury, poisoning and certain other consequenc...</td>\n      <td>0.714263</td>\n      <td>T75.3XXS</td>\n      <td>General dose</td>\n      <td>...</td>\n      <td>300</td>\n      <td>mg</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>General dose: 1.25 mg/kg or 37.5 mg/sq.meter I...</td>\n      <td>NaN</td>\n    </tr>\n    <tr>\n      <th>...</th>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n      <td>...</td>\n    </tr>\n    <tr>\n      <th>4027</th>\n      <td>tropicamide</td>\n      <td>Pediatric</td>\n      <td>Refraction (Mydriasis)</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>False</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Adult</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>As adult; 1-2 gtt of 1% solution in eye(s), re...</td>\n      <td>NaN</td>\n    </tr>\n    <tr>\n      <th>4028</th>\n      <td>tropicamide</td>\n      <td>Adult</td>\n      <td>Funduscopic Exam (Cycloplegia)</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>diseases of the eye and adnexa , disorders of ...</td>\n      <td>0.456150</td>\n      <td>H50.412</td>\n      <td>NaN</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>1-2 gtt of 0.5% solution in eyes 15-20 min bef...</td>\n      <td>NaN</td>\n    </tr>\n    <tr>\n      <th>4029</th>\n      <td>tropicamide</td>\n      <td>Pediatric</td>\n      <td>Funduscopic Exam (Cycloplegia)</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>diseases of the eye and adnexa , disorders of ...</td>\n      <td>0.456150</td>\n      <td>H50.412</td>\n      <td>Adult dose</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>As adult; 1-2 gtt of 0.5% solution in eyes 15-...</td>\n      <td>NaN</td>\n    </tr>\n    <tr>\n      <th>4030</th>\n      <td>finasteride</td>\n      <td>Adult</td>\n      <td>Androgenic Alopecia (Men Only)</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>diseases of the skin and subcutaneous tissue ,...</td>\n      <td>0.690526</td>\n      <td>L64.8</td>\n      <td>Propecia</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>Propecia: 1 mg PO qDay for at least 3 months</td>\n      <td>NaN</td>\n    </tr>\n    <tr>\n      <th>4031</th>\n      <td>finasteride</td>\n      <td>Adult</td>\n      <td>Female Hirsutism (Off-label)</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>True</td>\n      <td>diseases of the genitourinary system , inflamm...</td>\n      <td>0.416196</td>\n      <td>N70.91</td>\n      <td>NaN</td>\n      <td>...</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>NaN</td>\n      <td>5 mg PO qDay</td>\n      <td>NaN</td>\n    </tr>\n  </tbody>\n</table>\n<p>4032 rows × 35 columns</p>\n</div>"
     },
     "execution_count": 103,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drug_data_merged"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T10:04:24.802716600Z",
     "start_time": "2024-01-30T10:04:24.723114800Z"
    }
   },
   "id": "91a98b7cc37eff20"
  },
  {
   "cell_type": "code",
   "execution_count": 104,
   "outputs": [
    {
     "data": {
      "text/plain": "4032"
     },
     "execution_count": 104,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(drug_data_merged)"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T10:04:27.264332400Z",
     "start_time": "2024-01-30T10:04:27.236108500Z"
    }
   },
   "id": "518c7ad84cab1edb"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "outputs": [],
   "source": [],
   "metadata": {
    "collapsed": false
   },
   "id": "fde34609184781d2"
  },
  {
   "cell_type": "code",
   "execution_count": 127,
   "outputs": [],
   "source": [
    "drug_data_merged.to_excel('data/Drug_Dose_icd10.xlsx',index=False)"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T10:46:46.054975700Z",
     "start_time": "2024-01-30T10:46:43.597583500Z"
    }
   },
   "id": "b786962c8c452be0"
  },
  {
   "cell_type": "markdown",
   "source": [
    "# Testing"
   ],
   "metadata": {
    "collapsed": false
   },
   "id": "7e07fbfdd283a8e7"
  },
  {
   "cell_type": "code",
   "execution_count": 105,
   "outputs": [],
   "source": [
    "threshold=0.6\n",
    "high_conf_data=drug_data_merged[drug_data_merged['similarity_score'] >=threshold].copy()\n",
    "low_conf_data=drug_data_merged[drug_data_merged['similarity_score'] <threshold].copy()"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T10:04:39.079500800Z",
     "start_time": "2024-01-30T10:04:39.043872400Z"
    }
   },
   "id": "440e9c6a9939f882"
  },
  {
   "cell_type": "code",
   "execution_count": 106,
   "outputs": [
    {
     "data": {
      "text/plain": "995"
     },
     "execution_count": 106,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(low_conf_data)"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T10:04:40.357336100Z",
     "start_time": "2024-01-30T10:04:40.315928600Z"
    }
   },
   "id": "9205a324cbe5ed01"
  },
  {
   "cell_type": "code",
   "execution_count": 107,
   "outputs": [
    {
     "data": {
      "text/plain": "2402"
     },
     "execution_count": 107,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(high_conf_data)"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T10:04:55.342648500Z",
     "start_time": "2024-01-30T10:04:55.307342600Z"
    }
   },
   "id": "4e021f245f64b38a"
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "outputs": [],
   "source": [
    "sample_high_conf=high_conf_data.sample(10,random_state=0)[['medical_condition_h3','is_medical_diagnosis','diseaseCode']].copy()\n",
    "sample_low_conf=low_conf_data.sample(10,random_state=0)[['medical_condition_h3','is_medical_diagnosis','diseaseCode']].copy()"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-29T15:51:04.332819Z",
     "start_time": "2024-01-29T15:51:04.210488900Z"
    }
   },
   "id": "b4a846fe2c036075"
  },
  {
   "cell_type": "code",
   "execution_count": 112,
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\omar.wafy\\AppData\\Local\\Temp\\ipykernel_9432\\3046753818.py:1: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "  drug_data_merged['medical_condition_h3']=drug_data_merged['medical_condition_h3'].str.strip()\n"
     ]
    }
   ],
   "source": [
    "drug_data_merged['medical_condition_h3']=drug_data_merged['medical_condition_h3'].str.strip()"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T10:17:16.744313300Z",
     "start_time": "2024-01-30T10:17:16.671509500Z"
    }
   },
   "id": "411d5c1b5ae7e83d"
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "outputs": [],
   "source": [
    "sample_high_conf['medical_condition_h3']=sample_high_conf['medical_condition_h3'].str.strip()\n",
    "sample_low_conf['medical_condition_h3']=sample_low_conf['medical_condition_h3'].str.strip()"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-29T15:51:04.816107800Z",
     "start_time": "2024-01-29T15:51:04.781053600Z"
    }
   },
   "id": "2108253490df1e8"
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "outputs": [],
   "source": [
    "gpt_high_conf_suggest=pd.DataFrame( {\n",
    "    'Condition': [\n",
    "        'Benign Prostatic Hyperplasia (BPH)',\n",
    "        'HIV Infection',\n",
    "        'Skin and Skin Structure Infections',\n",
    "        'Anthrax Infection',\n",
    "        'Schistosomiasis',\n",
    "        'Primary Generalized Tonic-Clonic Seizures',\n",
    "        'Primary Generalized Tonic-Clonic Seizures',\n",
    "        'Major Depressive Disorder',\n",
    "        'Hypokalemia',\n",
    "        'Cryptococcal Meningitis'\n",
    "    ],\n",
    "    'Medical Condition': [\n",
    "        'Yes',\n",
    "        'Yes',\n",
    "        'Yes',\n",
    "        'Yes',\n",
    "        'Yes',\n",
    "        'Yes',\n",
    "        'Yes',\n",
    "        'Yes',\n",
    "        'Yes',\n",
    "        'Yes'\n",
    "    ],\n",
    "    'Suggested ICD-10 Code': [\n",
    "        'N40',\n",
    "        'B20',\n",
    "        'L00-L99',\n",
    "        'A22',\n",
    "        'B65-B83',\n",
    "        'G40.2',\n",
    "        'G40.2',\n",
    "        'F32',\n",
    "        'E87.6',\n",
    "        'B45.1'\n",
    "    ]\n",
    "})"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-29T15:51:05.485731200Z",
     "start_time": "2024-01-29T15:51:05.449521200Z"
    }
   },
   "id": "80387503ad78cfd2"
  },
  {
   "cell_type": "code",
   "execution_count": 117,
   "outputs": [
    {
     "data": {
      "text/plain": "                                     Condition Medical Condition  \\\n0           Benign Prostatic Hyperplasia (BPH)               Yes   \n1                                HIV Infection               Yes   \n15          Skin and Skin Structure Infections               Yes   \n20                           Anthrax Infection               Yes   \n22                             Schistosomiasis               Yes   \n24   Primary Generalized Tonic-Clonic Seizures               Yes   \n100                  Major Depressive Disorder               Yes   \n118                                Hypokalemia               Yes   \n138                    Cryptococcal Meningitis               Yes   \n\n    Suggested ICD-10 Code                       medical_condition_h3  \\\n0                     N40         Benign Prostatic Hyperplasia (BPH)   \n1                     B20                              HIV Infection   \n15                L00-L99         Skin and Skin Structure Infections   \n20                    A22                          Anthrax Infection   \n22                B65-B83                            Schistosomiasis   \n24                  G40.2  Primary Generalized Tonic-Clonic Seizures   \n100                   F32                  Major Depressive Disorder   \n118                 E87.6                                Hypokalemia   \n138                 B45.1                    Cryptococcal Meningitis   \n\n    diseaseCode  \n0         N40.1  \n1           B20  \n15        B00.1  \n20        A22.0  \n22        B65.1  \n24      G40.411  \n100       F33.9  \n118       E87.6  \n138       B45.2  ",
      "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>Condition</th>\n      <th>Medical Condition</th>\n      <th>Suggested ICD-10 Code</th>\n      <th>medical_condition_h3</th>\n      <th>diseaseCode</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>Benign Prostatic Hyperplasia (BPH)</td>\n      <td>Yes</td>\n      <td>N40</td>\n      <td>Benign Prostatic Hyperplasia (BPH)</td>\n      <td>N40.1</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>HIV Infection</td>\n      <td>Yes</td>\n      <td>B20</td>\n      <td>HIV Infection</td>\n      <td>B20</td>\n    </tr>\n    <tr>\n      <th>15</th>\n      <td>Skin and Skin Structure Infections</td>\n      <td>Yes</td>\n      <td>L00-L99</td>\n      <td>Skin and Skin Structure Infections</td>\n      <td>B00.1</td>\n    </tr>\n    <tr>\n      <th>20</th>\n      <td>Anthrax Infection</td>\n      <td>Yes</td>\n      <td>A22</td>\n      <td>Anthrax Infection</td>\n      <td>A22.0</td>\n    </tr>\n    <tr>\n      <th>22</th>\n      <td>Schistosomiasis</td>\n      <td>Yes</td>\n      <td>B65-B83</td>\n      <td>Schistosomiasis</td>\n      <td>B65.1</td>\n    </tr>\n    <tr>\n      <th>24</th>\n      <td>Primary Generalized Tonic-Clonic Seizures</td>\n      <td>Yes</td>\n      <td>G40.2</td>\n      <td>Primary Generalized Tonic-Clonic Seizures</td>\n      <td>G40.411</td>\n    </tr>\n    <tr>\n      <th>100</th>\n      <td>Major Depressive Disorder</td>\n      <td>Yes</td>\n      <td>F32</td>\n      <td>Major Depressive Disorder</td>\n      <td>F33.9</td>\n    </tr>\n    <tr>\n      <th>118</th>\n      <td>Hypokalemia</td>\n      <td>Yes</td>\n      <td>E87.6</td>\n      <td>Hypokalemia</td>\n      <td>E87.6</td>\n    </tr>\n    <tr>\n      <th>138</th>\n      <td>Cryptococcal Meningitis</td>\n      <td>Yes</td>\n      <td>B45.1</td>\n      <td>Cryptococcal Meningitis</td>\n      <td>B45.2</td>\n    </tr>\n  </tbody>\n</table>\n</div>"
     },
     "execution_count": 117,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "gpt_high_conf_suggest.merge(drug_data_merged[['medical_condition_h3','diseaseCode']], how='inner', left_on='Condition',right_on='medical_condition_h3').drop_duplicates()"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T10:20:02.942003600Z",
     "start_time": "2024-01-30T10:20:02.826042800Z"
    }
   },
   "id": "83978f83e2c1bacc"
  },
  {
   "cell_type": "code",
   "execution_count": 117,
   "outputs": [],
   "source": [],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T10:21:33.596856600Z",
     "start_time": "2024-01-30T10:21:33.567898400Z"
    }
   },
   "id": "ff323b4b8388713f"
  },
  {
   "cell_type": "code",
   "execution_count": 118,
   "outputs": [
    {
     "data": {
      "text/plain": "10"
     },
     "execution_count": 118,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(sample_high_conf)"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T10:21:35.267022600Z",
     "start_time": "2024-01-30T10:21:35.223336200Z"
    }
   },
   "id": "df0fb2c62454da81"
  },
  {
   "cell_type": "code",
   "execution_count": 119,
   "outputs": [
    {
     "data": {
      "text/plain": "                  medical_condition_h3  is_medical_diagnosis diseaseCode\n44                        Otitis Media                  True      H66.90\n56                   Migraine Headache                  True     G43.911\n99             Cryptococcal Meningitis                  True       B45.2\n47                       Heart Failure                  True       I50.9\n25                       HIV Infection                  True         B20\n6   Benign Prostatic Hyperplasia (BPH)                  True       N40.1\n54           Major Depressive Disorder                  True       F33.9\n98       Type 1 or 2 Diabetes Mellitus                  True       E10.8\n66           GERD, Erosive Esophagitis                  True       K20.0\n40                             Malaria                  True         B54",
      "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>medical_condition_h3</th>\n      <th>is_medical_diagnosis</th>\n      <th>diseaseCode</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>44</th>\n      <td>Otitis Media</td>\n      <td>True</td>\n      <td>H66.90</td>\n    </tr>\n    <tr>\n      <th>56</th>\n      <td>Migraine Headache</td>\n      <td>True</td>\n      <td>G43.911</td>\n    </tr>\n    <tr>\n      <th>99</th>\n      <td>Cryptococcal Meningitis</td>\n      <td>True</td>\n      <td>B45.2</td>\n    </tr>\n    <tr>\n      <th>47</th>\n      <td>Heart Failure</td>\n      <td>True</td>\n      <td>I50.9</td>\n    </tr>\n    <tr>\n      <th>25</th>\n      <td>HIV Infection</td>\n      <td>True</td>\n      <td>B20</td>\n    </tr>\n    <tr>\n      <th>6</th>\n      <td>Benign Prostatic Hyperplasia (BPH)</td>\n      <td>True</td>\n      <td>N40.1</td>\n    </tr>\n    <tr>\n      <th>54</th>\n      <td>Major Depressive Disorder</td>\n      <td>True</td>\n      <td>F33.9</td>\n    </tr>\n    <tr>\n      <th>98</th>\n      <td>Type 1 or 2 Diabetes Mellitus</td>\n      <td>True</td>\n      <td>E10.8</td>\n    </tr>\n    <tr>\n      <th>66</th>\n      <td>GERD, Erosive Esophagitis</td>\n      <td>True</td>\n      <td>K20.0</td>\n    </tr>\n    <tr>\n      <th>40</th>\n      <td>Malaria</td>\n      <td>True</td>\n      <td>B54</td>\n    </tr>\n  </tbody>\n</table>\n</div>"
     },
     "execution_count": 119,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sample_high_conf"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T10:21:39.464675800Z",
     "start_time": "2024-01-30T10:21:39.426782300Z"
    }
   },
   "id": "816cee6930efc947"
  },
  {
   "cell_type": "code",
   "execution_count": 120,
   "outputs": [],
   "source": [
    "sample_low_conf=low_conf_data[low_conf_data['is_medical_diagnosis']==True].sample(10,random_state=0)[['medical_condition_h3','is_medical_diagnosis','diseaseCode']].copy()"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T10:23:21.168541200Z",
     "start_time": "2024-01-30T10:23:21.145387700Z"
    }
   },
   "id": "fc6ac4641da61afb"
  },
  {
   "cell_type": "code",
   "execution_count": 121,
   "outputs": [
    {
     "data": {
      "text/plain": "['Left Ventricular Dysfunction After Myocardial Infarction',\n 'Dermatofibrosarcoma Protuberans',\n 'Depression',\n 'Anxiety',\n \"Traveler's Diarrhea\",\n 'Acute Pulmonary Edema/Hypertensive Crisis/Increased Intracranial Pressure',\n 'Cancers (Off-label)',\n 'Partial Seizures (Monotherapy)',\n 'Visipaque 320 ',\n 'GERD']"
     },
     "execution_count": 121,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# test on low conf\n",
    "sample_low_conf['medical_condition_h3'].tolist()"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T10:23:21.781745800Z",
     "start_time": "2024-01-30T10:23:21.747213400Z"
    }
   },
   "id": "10d23944c0fb9019"
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "outputs": [],
   "source": [
    "spec_low_conf_data=low_conf_data[low_conf_data['is_medical_diagnosis']==True]"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-29T15:52:08.726361600Z",
     "start_time": "2024-01-29T15:52:08.693854100Z"
    }
   },
   "id": "69d0e1fd8f2bf315"
  },
  {
   "cell_type": "code",
   "execution_count": 124,
   "outputs": [],
   "source": [
    "gpt_low_conf_suggest=pd.DataFrame( {\n",
    "    'Condition': [\n",
    "        'Partial-Onset Seizures (Conversion to Monotherapy)',\n",
    "        'Influenza A and B Treatment',\n",
    "        'Soft Tissue Infections',\n",
    "        'Hot flashes-cancer related (Off-label)',\n",
    "        'Lennox-Gastaut Syndrome',\n",
    "        'Cough',\n",
    "        'Patent Ductus Arteriosus',\n",
    "        'Uveitis',\n",
    "        'Influenza A and B Prophylaxis',\n",
    "        'Intra-abdominal Infections'\n",
    "    ],\n",
    "    'Medical Condition': [\n",
    "        'Yes',\n",
    "        'Yes',\n",
    "        'Yes',\n",
    "        'No',\n",
    "        'Yes',\n",
    "        'Yes',\n",
    "        'Yes',\n",
    "        'Yes',\n",
    "        'Yes',\n",
    "        'Yes'\n",
    "    ],\n",
    "    'Suggested ICD-10 Code': [\n",
    "        'G40.5',\n",
    "        'J10-J11',\n",
    "        'L00-L99',\n",
    "        'Not Applicable',\n",
    "        'G40.4',\n",
    "        'R05',\n",
    "        'PDA-related condition',\n",
    "        'H20-H22',\n",
    "        'Z23',\n",
    "        'K65-K67'\n",
    "    ]\n",
    "}\n",
    ")"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T10:25:50.399587700Z",
     "start_time": "2024-01-30T10:25:50.362530800Z"
    }
   },
   "id": "c2e0e9c383e949db"
  },
  {
   "cell_type": "code",
   "execution_count": 126,
   "outputs": [
    {
     "data": {
      "text/plain": "                                            Condition Medical Condition  \\\n0   Partial-Onset Seizures (Conversion to Monother...               Yes   \n40                        Influenza A and B Treatment               Yes   \n47                             Soft Tissue Infections               Yes   \n51             Hot flashes-cancer related (Off-label)                No   \n52                            Lennox-Gastaut Syndrome               Yes   \n64                                              Cough               Yes   \n85                           Patent Ductus Arteriosus               Yes   \n86                                            Uveitis               Yes   \n92                      Influenza A and B Prophylaxis               Yes   \n98                         Intra-abdominal Infections               Yes   \n\n    Suggested ICD-10 Code                               medical_condition_h3  \\\n0                   G40.5  Partial-Onset Seizures (Conversion to Monother...   \n40                J10-J11                        Influenza A and B Treatment   \n47                L00-L99                             Soft Tissue Infections   \n51         Not Applicable             Hot flashes-cancer related (Off-label)   \n52                  G40.4                            Lennox-Gastaut Syndrome   \n64                    R05                                              Cough   \n85  PDA-related condition                           Patent Ductus Arteriosus   \n86                H20-H22                                            Uveitis   \n92                    Z23                      Influenza A and B Prophylaxis   \n98                K65-K67                         Intra-abdominal Infections   \n\n    is_medical_diagnosis diseaseCode  \n0                   True     G40.101  \n40                  True       J15.3  \n47                  True         B09  \n51                  True    X10.0XXS  \n52                  True     G40.813  \n64                  True       R05.9  \n85                  True       Q25.0  \n86                  True       L56.9  \n92                  True       J18.2  \n98                  True       A04.9  ",
      "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>Condition</th>\n      <th>Medical Condition</th>\n      <th>Suggested ICD-10 Code</th>\n      <th>medical_condition_h3</th>\n      <th>is_medical_diagnosis</th>\n      <th>diseaseCode</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>Partial-Onset Seizures (Conversion to Monother...</td>\n      <td>Yes</td>\n      <td>G40.5</td>\n      <td>Partial-Onset Seizures (Conversion to Monother...</td>\n      <td>True</td>\n      <td>G40.101</td>\n    </tr>\n    <tr>\n      <th>40</th>\n      <td>Influenza A and B Treatment</td>\n      <td>Yes</td>\n      <td>J10-J11</td>\n      <td>Influenza A and B Treatment</td>\n      <td>True</td>\n      <td>J15.3</td>\n    </tr>\n    <tr>\n      <th>47</th>\n      <td>Soft Tissue Infections</td>\n      <td>Yes</td>\n      <td>L00-L99</td>\n      <td>Soft Tissue Infections</td>\n      <td>True</td>\n      <td>B09</td>\n    </tr>\n    <tr>\n      <th>51</th>\n      <td>Hot flashes-cancer related (Off-label)</td>\n      <td>No</td>\n      <td>Not Applicable</td>\n      <td>Hot flashes-cancer related (Off-label)</td>\n      <td>True</td>\n      <td>X10.0XXS</td>\n    </tr>\n    <tr>\n      <th>52</th>\n      <td>Lennox-Gastaut Syndrome</td>\n      <td>Yes</td>\n      <td>G40.4</td>\n      <td>Lennox-Gastaut Syndrome</td>\n      <td>True</td>\n      <td>G40.813</td>\n    </tr>\n    <tr>\n      <th>64</th>\n      <td>Cough</td>\n      <td>Yes</td>\n      <td>R05</td>\n      <td>Cough</td>\n      <td>True</td>\n      <td>R05.9</td>\n    </tr>\n    <tr>\n      <th>85</th>\n      <td>Patent Ductus Arteriosus</td>\n      <td>Yes</td>\n      <td>PDA-related condition</td>\n      <td>Patent Ductus Arteriosus</td>\n      <td>True</td>\n      <td>Q25.0</td>\n    </tr>\n    <tr>\n      <th>86</th>\n      <td>Uveitis</td>\n      <td>Yes</td>\n      <td>H20-H22</td>\n      <td>Uveitis</td>\n      <td>True</td>\n      <td>L56.9</td>\n    </tr>\n    <tr>\n      <th>92</th>\n      <td>Influenza A and B Prophylaxis</td>\n      <td>Yes</td>\n      <td>Z23</td>\n      <td>Influenza A and B Prophylaxis</td>\n      <td>True</td>\n      <td>J18.2</td>\n    </tr>\n    <tr>\n      <th>98</th>\n      <td>Intra-abdominal Infections</td>\n      <td>Yes</td>\n      <td>K65-K67</td>\n      <td>Intra-abdominal Infections</td>\n      <td>True</td>\n      <td>A04.9</td>\n    </tr>\n  </tbody>\n</table>\n</div>"
     },
     "execution_count": 126,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "gpt_low_conf_suggest.merge(drug_data_merged[['medical_condition_h3','is_medical_diagnosis','diseaseCode']], how='inner', left_on='Condition',right_on='medical_condition_h3').drop_duplicates()"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-01-30T10:26:06.944371100Z",
     "start_time": "2024-01-30T10:26:06.857227300Z"
    }
   },
   "id": "2c33dca8f3f5df9f"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "outputs": [],
   "source": [],
   "metadata": {
    "collapsed": false
   },
   "id": "f8e9cc30a1bda694"
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 2
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython2",
   "version": "2.7.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
